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Leprosy is an ancient human disease that was thought to have been eradicated from the 
British Isles. The last case of autochthonous human infection was documented in the 1950’s. 
Natural infection with leprosy bacilli in species other than humans was first described in nine-
banded armadillos in the 1970s in the United States of America. Recently, both bacterial 
species causing leprosy, Mycobacterium leprae and Mycobacterium lepromatosis, were 
isolated from Eurasian red squirrels (Sciurus vulgaris, ERS) across the British Isles. ERS are 
endangered in this part of their range, and efforts are made for their protection. 
This thesis offers insight into important aspects (clinical presentation, pathology, 
epidemiology) of the basic description of leprosy in live ERS, based on data from two wild 
British island ERS populations naturally infected with leprosy bacilli. The populations, one in 
Scotland and one in England, were studied for 18 and 24 months respectively, with live 
sampling taking place every six months. Additionally, samples from ERS, Eastern grey 
squirrels (Sciurus carolinensis, GS) and Pallas’s squirrels (Callosciurus erythraeus, PS) were 
obtained from Britain (ERS, GS), Germany (ERS, PS) and Italy (ERS, GS, PS) and screened 
for the presence of leprosy bacilli to provide new epidemiological surveillance information on 
squirrel leprosy.  
Established, adapted, and novel tests were used to diagnose leprosy in squirrels. Accurate 
clinical diagnosis is important to identify populations affected by the disease. Serological 
methods were useful to confirm the clinical diagnosis. Molecular methods were the only way 
to identify leprosy bacilli in squirrels without clinical signs of disease. A diagnostic decision 
tree is proposed to allow optimised, consistent use of the methods now available depending 
on the situation in which a diagnosis is sought. 
ERS that are infected with M. leprae and develop clinical leprosy usually showed a 
multibacillary, lepromatous or borderline lepromatous form of the disease. Lepromatous 
leprosy is characterised by an inability of the host immune response to control bacterial 
replication and dissemination. Leprosy in ERS progressed slowly, and the intensity of lesions 
could easily be separated into four categories from mild to severe based on lesion size, 
structural characteristics and the presence or absence of ulceration. Several months passed 
between the time when the bacteria first became detectable in an ERS tissues and the onset 
of clinical disease. Clinical disease then progressed on varying timescales in different 
individuals, but usually allowed the individuals to thrive for long time frames (months – 
years). The maximum time period a clinically diseased ERS was followed in this study was 
18 months. Prevalence and morbidity differed in individual ERS populations. In one 
population the total apparent two-year prevalence of leprosy was 36% with a morbidity rate 
of 22% for the same population and timeframe. In the other the apparent two-year 
prevalence was only 4% and no clinical cases of leprosy were observed. The presence of 
leprosy did not have a negative effect on individual ERS or whole populations that could be 
measured using health indicators such as body condition, weight, general health and 
ectoparasite burdens. As part of this study, M. leprae was identified in ERS in two new 
locations within the UK, but not in British GS or any squirrel species in Germany or Italy.   
The results indicate that leprosy alone is unlikely to be a major factor contributing to ERS 
mortalities and thus may not be of great conservation concern in this species. Continued 
research into ERS leprosy in natural systems could provide valuable insight into disease 
dynamics that may benefit humans and other hosts in a One Health and conservation 
medicine framework.  
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Lay summary  
Leprosy is an ancient human disease that no longer occurs in people in the British Isles, 
other than for a few occasional cases in which the patients became infected abroad. Two 
bacteria, Mycobacterium leprae and Mycobacterium lepromatosis, cause the disease. It has 
only been known since the 1970’s that leprosy bacilli can also cause disease in other 
species. Then the bacilli were found in nine-banded armadillos in the United States of 
America. Within the last 5 years it was discovered that skin lesions in Eurasian red squirrels 
(ERS) in the British Isles can be caused by leprosy bacilli. ERS are endangered in this part 
of their range and efforts are made to protect them.  
This thesis provides insights into the effect leprosy is having on ERS on an individual and 
population level, and also explores whether the disease is limited to ERS in the British Isles. 
Two island ERS populations, one in England, one in Scotland, in which the presence of 
leprosy bacilli has been confirmed previously, were studied over a two-year period. 
Additionally, samples from ERS and other squirrel species were obtained from Britain, 
Germany and Italy and it was determined whether they contained leprosy bacilli. Methods 
that can be used in live and dead ERS to diagnose leprosy were assessed and adapted 
where necessary. The clinical diagnosis of leprosy is extremely important in ERS to identify 
where the disease occurs. Laboratory methods were useful to confirm the clinical diagnosis 
and to identify leprosy bacilli in ERS that do not (yet) show clinical signs of disease. 
ERS infected with M. leprae usually showed a form of the disease in which large numbers of 
bacilli are present and the main clinical signs are hairless nodular swellings on ears and 
hocks. Leprosy progressed slowly in ERS, and several months passed between the first 
detection of bacilli and the onset of clinical lesions. Leprosy then progressed over varying 
timescales in individual ERS, but usually allowed affected ERS to thrive for months and 
sometimes years. The maximum time period a diseased ERS could be followed in this study 
was 18 months. The proportion of ERS affected by leprosy differed between the two 
populations. In one, leprosy bacilli were found in over a third of ERS seen within the two 
years of the study, with about 1/5 showing clinical signs of disease. In the other population 
no clinically diseased ERS were seen and leprosy bacilli were present in only 4% of the ERS 
assessed. As part of this study, M. leprae was identified in ERS in two new locations within 
the UK, but not in British grey squirrels or any squirrel species in Germany or Italy.   
The results indicate that leprosy alone is not a threat to British ERS. Continued efforts are 
necessary to identify the full host range of leprosy bacilli around the world. Studying leprosy 
in this endangered wildlife host in the wild may offer a unique opportunity for future research: 
to understand the transmission of leprosy in a natural disease system. This study provides 
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Chapter 1: Leprosy - an ancient disease and its hosts 
1.1. Introduction  
Upon hearing the word leprosy, almost every person immediately has some dramatic, often 
prejudice driven and inaccurate, images in their mind. These include severely disfigured 
people, whose limbs or facial annexes will fall off when touched, and that need to be avoided 
at all costs. As a result, the disease is still associated with severe stigma and negative 
reactions from the wider society (WHO, 2017). This has been summarised in the phrase 
“Leprosy impairs and society disables” (Kumar, Lambert and Lockwood, 2019). Those 
images that people have in their heads have been helpful in attracting attention, raising 
awareness and driving donations, but they are not representative of the disease, and 
ultimately, these misconceptions hinder the understanding and control of the disease (Monte 
et al., 2017; Kumar, Lambert and Lockwood, 2019). Few individuals are aware that humans 
are no longer the only host for the disease and how limited our knowledge still is about even 
basic disease processes, such as transmission.  
This study aims to provide a basic description of leprosy in its most recently discovered 
endangered wildlife host, the Eurasian red squirrel (Sciurus vulgaris, ERS). This information 
would ideally enable a rational debate about how the presence of a disease that was thought 
to be eradicated in most of Western Europe should be addressed in a conservation sensitive 
host species.  
1.1.1. Leprosy, an ancient disease 
Leprosy – as a disease of man – has been described convincingly in ancient texts since 
1500 B.C. (Rojas-Espinosa and Lovik, 2001). Palaeopathological findings suggest the 
occurrence of leprosy as far back as 3780-3650 calculated BC in Hungary, 2500-1700 BC in 
the Indus Valley and in the 4th-3rd century BC in Italy (Donoghue, 2019). Even greater 
certainty about the fact that leprosy has indeed been present in the human population for a 
huge part of its history is provided by the isolation of ancient Mycobacterium leprae DNA 
from archaeological specimens. M. leprae aDNA has been isolated from human remains 
dating back to the 1st to 7th century AD in Palestine, Uzbekistan, Egypt, and Israel 
(Donoghue, 2019). The genetically most ancestral M. leprae strains have been isolated from 
Japan, China, Korea, the Marshall Islands and New Caledonia (Benjak et al., 2018).  
In Europe, leprosy occasionally occurred in the Roman period, but it was during medieval 
times that its prevalence drastically increased (Donoghue et al., 2015). Genetic evidence 
supports the hypothesis that ancient Greek and Roman travelling routes connecting Europe, 
the Middle East, East Africa and South Asia contributed to the spread of leprosy (Benjak et 
al., 2018).  
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The oldest M. leprae genome isolated from human remains in the United Kingdom dates 
back to 415+/- 545 calibrated AD (Schuenemann et al., 2018). In medieval times, leprosy 
was highly endemic all across Europe as attested by the existence of ~19,000 leprosaria 
between the 12th and 15th century (Little, Farmer and Rosenwein, 2000). The decline of 
human leprosy in Europe began in the 15-16th century (Schuenemann et al., 2018). It 
persisted in the Iberian Peninsula, the Mediterranean, the Balkans, Scandinavia and Baltic 
countries into the 20th century. About 10,000 human cases were recorded in Norway, 
Sweden, Finland and Iceland between 1856 and 1956 (Robertson, 2008). Leprosy was 
introduced into the Americas with European colonialists and the slave trade (Donoghue, 
2019). Leprosy strains now found in the south eastern United States of America (USA) 
originated from Scandinavia, France and England (Donoghue, 2019) and some strains in 
South America are related to strains in West Africa (Schuenemann et al., 2018) and ancient 
Europe (Benjak et al., 2018). This illustrates that at least one ancient pathogen causing 
leprosy has been able to persist through the ages. 
Today, Great Britain is used as an example of a country where leprosy was successfully 
eradicated in humans, with decades without autochthonous infections and low numbers of 
imported cases (Saunderson, 2008; Fulton et al., 2016). The last autochthonous human 
leprosy case was reported in 1954 in Northwest England (Gill, Gill and Beeching, 2008). 
According to Fulton et al. imported cases do still occur in the country today with a large 
proportion of patients having been born in South Asia (Fulton et al., 2016).  Unfortunately, no 
details on the leprosy strains identified in these patients are available.  
From the information readily available the human leprosy situation in several European 
countries such as Germany and France is very similar to that in Great Britain (Koch et al., 
2006; Hundeiker and Broemmelhaus, 2007; Ezzedine et al., 2009; Reibel et al., 2015; 
Gilsdorf and Robert Koch Institute, 2017). However, in addition to imported cases occasional 
autochthonous transmission of leprosy has been reported more recently in southern 
European countries such as Italy, Portugal, and Spain (Greco and Galanti, 1983; Massone et 
al., 2012; Maritati and Contini, 2016; Ramos, Romero and Belinchón, 2016; Cusini et al., 
2017; Esgueva et al., 2019). In Europe, no hosts for leprosy other than humans were 
described until 2014 (Meredith et al., 2014; Schuenemann et al., 2018). 
1.1.2. M. leprae and Mycobacterium lepromatosis 
Two mycobacterial species are causing leprosy, and can occur separately or as coinfections 
(Polycarpou, Walker and Lockwood, 2013). While M. leprae was identified in 1873 by Dr. 
Hansen (Rojas-Espinosa and Lovik, 2001), M. lepromatosis was only described in 2008 
(Han et al., 2008). The latter has not yet been isolated from ancient human samples and it is 
thus unknown for how long it has been causing disease in humans (Donoghue, 2019). Both 




M. leprae is a very slow growing bacterium, with a generation time of approximately 12- 14 
days in animal models and tick cell lines (Blake et al., 1987; Ferreira et al., 2018). Freezing 
or heating above 37°C impairs M. leprae viability (<1% retained). This was determined by 
harvesting bacteria from mouse foot pads and storing them at varying temperatures before 
using the suspension to inoculate new mice and assess infection. The optimal growing 
temperature for M. leprae in vivo is thought to be 27-33°C, however no studies have been 
published that assessed the exact temperature at the site of growth within the host and 
related growth rates, as such data is extremely difficult to obtain (Truman and Krahenbuhl, 
2001; Lastória and de Abreu, 2014b). Newly developed in vitro systems use this temperature 
recommendation and now hold the potential to set up experiments to determine the true 
optimal growth temperature (Ferreira et al., 2018). 
M. leprae has the smallest genome of all mycobacteria currently sequenced (3.3 Mb), and it 
contains almost as many pseudogenes as protein-coding genes (1300 and 1624, 
respectively). This reduced, highly conserved genome (less than 300 single-nucleotide 
polymorphisms (SNPs) even between distantly related strains) makes the bacterium 
dependant on a suitable host. M. leprae diverged from a common ancestor with 
Mycobacterium tuberculosis approximately 66 million years ago. Its adaption to an 
intracellular lifestyle is estimated to have occurred around 9 million years ago (Franco-
Paredes and Rodriguez-Morales, 2016). Four SNP types (1-4) and 16 subtypes (A-P) have 
been identified today (Schuenemann et al., 2018). Based on whole genome comparison M. 
leprae strains are also grouped into branches (0-5), which reflect greater complexity than the 
SNP types. These grouping systems have provided valuable insights into the worldwide 
geographical distribution and dissemination of the bacteria (Benjak et al., 2018; 
Schuenemann et al., 2018). Four branches are known to have been present in humans in 
Europe at some point in history (0, 2F, 3, 4). Branch 1 is only known to occur in South-East 
Asia, Eastern Africa, and South America, and branch 5 in some Pacific Islands 
(Schuenemann et al., 2018).  
It is thought that the rod shaped, acid-fast, microaerophilic, non-spore forming, non-motile, 
obligate intracellular bacilli have a low virulence and low transmissibility, and can thus persist 
in a host population almost unnoticed for long periods of time (Scollard et al., 2006; 
Chinchilla, 2011). M. leprae is described as “well adapted, minimally toxic pathogen, capable 
of inhabiting various cells without marked injury or dysfunction” (Scollard, Truman and 
Ebenezer, 2015). M. leprae has an affinity for keratinocytes, macrophages and histiocytes is 
the skin and for Schwann cells of peripheral nerves. The bacilli interact with the host cell lipid 
metabolism to be able to survive (White and Franco-Paredes, 2015). In highly infected 
tissues the bacilli form clumps (globi) that can contain hundreds of bacilli (Reibel, Cambau 
and Aubry, 2015). M. leprae has a very thick cell wall containing components 
(lipoarabinomannan and phenolic glycolipid-I (PGL-I)) that can cause depression of 
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suppressor T-cells and inhibit macrophage bactericidal function. PGL-I induces the 
production of IgM antibodies in the host (Jurado et al., 2015).  
M. lepromatosis has been identified from human patients in Mexico, Brazil, the Caribbean, 
Myanmar, Singapore, Canada and India, and has been linked to diffuse lepromatous leprosy 
in particular (Han et al., 2014; Ahuja et al., 2018). No leprosy cases in sub-Saharan Africa 
have yet been linked to M. lepromatosis (Quao and Amankrah-Otabir, 2016). M. 
lepromatosis is very similar to M. leprae in all its main characteristics and can often only be 
differentiated by sequencing. It has been accepted as a separate species as there is an 
overall difference of about 9% between the whole genome sequences of both bacilli 
(Scollard, 2016). More differences exist between pseudogenes than between protein-coding 
genes. The two species diverged from a common ancestor about ten to fourteen million 
years ago (Han and Silva, 2014; Singh et al., 2015). M. lepromatosis can heavily infect 
internal organs and is thus predicted to be able to grow at higher temperatures than M. 
leprae, to potentially be more virulent and to multiply more rapidly (Han et al., 2008).  
Until recently, growing either M. leprae or M. lepromatosis in vitro was simply impossible. 
This made both pathogens extremely difficult to study and is at least part of the reason why 
wide knowledge gaps still exist with respect to leprosy (Anand et al., 2014; Reibel, Cambau 
and Aubry, 2015). Two animal models are established in which M. leprae can be 
propagated: the footpad of thymectomised mice and the nine-banded armadillo (Dasypus 
novemcinctus, NBA). However, both methods are cumbersome and time-intensive (Benjak 
et al., 2018). In December 2018 M. leprae was successfully propagated the in Ixodes 
scapularis embryo-derived tick cell line IDE8. An increase in bacterial numbers occurred in 
these cells for at least 20 days (Ferreira et al., 2018). This system holds the promise to make 
large scale in vitro propagation of leprosy bacilli and experimental manipulation finally 
possible.  
1.1.3. Today’s relevance of human leprosy 
Leprosy is generally regarded as the “least infectious of all infectious diseases” (Rojas-
Espinosa and Lovik, 2001). Humans are still seen as the main host and reservoir for leprosy 
bacilli (Reibel, Cambau and Aubry, 2015). Generally speaking, leprosy is a non-fatal disease 
(Bhat and Prakash, 2012). The majority of humans is thought to be genetically resistant to 
leprosy today and 90-95% of people will not develop clinical disease even when exposed to 
the pathogen (Scollard, Truman and Ebenezer, 2015; Quao and Amankrah-Otabir, 2016). 
The global World Health Organisation (WHO) human leprosy elimination target was met in 
2000, with reported leprosy cases dropping to 1 per 10,000 (Fulton et al., 2016). At the 
national level, most countries were able to reach this target by 2005 (WHO, 2017). Brazil still 
has not been able to meet this target (Salgado, Barreto, et al., 2018). Lately, the WHO global 
strategy for leprosy control has moved on from the elimination of leprosy as a public health 
problem to aiming to reduce transmission and to achieve a reduction of individual disease 
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burden, particularly in terms of disability and discrimination (WHO, 2018a). Worldwide more 
than 200.000 new cases are still occurring each year. Annual statistics on leprosy 
occurrence are currently provided by 150 WHO member countries. The number of newly 
detected cases per annum and the number of leprosy patients under treatment at the end of 
the calendar year are reported (Table 1).  
TABLE 1:  HUMAN LEPROSY CASES REPORTED IN 2017 (WHO, 2018a) 
WHO region 
Number of cases under 
treatment at the end of 
2017 
Number of new cases 
detected during 2017 
Africa 30,654 20,416 
Americas 31,527 29,101 
Eastern Mediterranean 4,405 3,550 
South-East Asia 119,055 153,487 
Western Pacific 7,040 4,084 
Europe 32 33 
Global total 192,713 210,671 
Most cases (199,713; 94.8%) are reported from just 22 global priority countries, with India 
(126,164), Brazil (26,875), Indonesia (15,910), Bangladesh (3,754), the Democratic Republic 
of the Congo (3,649), and Nepal (3,215) reporting the highest case numbers (WHO, 2018a). 
One reason that has been proposed for regionally persisting human infections with leprosy 
are bad socioeconomic conditions (Schmitt et al., 2010). 
In Britain, similar to other European countries, up to approximately ten cases are notified 
each year, mainly in migrants or related to long term stay in high prevalence regions (Gill et 
al., 2005). There is however some evidence that supports the possibility that leprosy can still 
occasionally be acquired locally in Western Europe (Greco and Galanti, 1983; Gill et al., 
2005; Ezzedine et al., 2009; Maritati and Contini, 2016; Esgueva et al., 2019).  
The reporting system has come under criticism of potentially underrepresenting the true 
number of human leprosy cases worldwide (Smith et al., 2015). Apart from the fact that only 
patients under treatment at the end of the calendar year are included, it has been pointed out 
that countries with well-structured health care systems, such as most European countries, 
the USA, Australia and Japan all report cases, while low-income countries did not report any, 
potentially not representing a true absence of disease but a lack of detection (Salgado, 
Barreto, et al., 2018). Salgado et al. (2018) point out a need for active surveillance to identify 
all leprosy cases and provide them with adequate treatment, to reduce the risk of stagnating 
rates of new cases detected every year while exposure continues. Continued exposure to 
not identified cases also entails the risk that case numbers could rise again in the future 
(Smith et al., 2015; Salgado, Barreto, et al., 2018). 
One big issue in controlling human leprosy is that even today the exact mechanisms of 
leprosy transmission, as well as the role of reservoirs, vectors and the environment are 
poorly understood (Smith et al., 2015). Factors making the disease so very difficult to 
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understand include the long and variable incubation period, low incidence rates in exposed 
people, cases in people without known contact to active cases, and highly variable clinical 
presentations (Schmitt et al., 2010; Smith et al., 2015). The upper airway is believed to be 
the main site of entry into a new host, while both discharge from infected skin and airways 
are believed to be sources of viable bacteria for disease transmission (Silva et al., 2013). 
Inhalation of aerosolized discharge is therefore currently seen as most likely route of 
transmission. Prolonged close contact to infected individuals may also be important, but 
currently proposed modes of transmission cannot explain the patchy distribution of leprosy, 
even when considering individual resistance (Franco-Paredes and Rodriguez-Morales, 
2016).  
Regarding leprosy resistance, the hypothesis has been put forward that a greater mortality in 
individuals co-infected with M. leprae and M. tuberculosis has driven the development of 
genetic resistance to leprosy in Europe (Donoghue, 2019). Effective Multi-drug (rifampicin, 
dapsone and clofazimine) treatment has been available worldwide since the 1980s, and is 
likely to have made a significant contribution to the reduction of case numbers. Human 
patients undergoing treatment are believed to no longer be a source of infection from day 
one of treatment (Lastória and de Abreu, 2014a). While no fully satisfactory vaccine has 
been produced yet, Bacille Calmette-Guerin (BCG) vaccination at birth can reduce the risk of 
leprosy by approximately 50%. It is already part of the vaccination policy in most leprosy-
endemic countries and usually not recommended as control tool for leprosy specifically 
(Scollard et al., 2006; WHO, 2017).  
Continued efforts to control leprosy in humans are being made and are necessary, given the 
emergence of antibiotic resistant M. leprae strains (Benjak et al., 2018), as well as the 
accepted status of leprosy as an emerging infectious disease in some countries such as the 
USA (Levis, Rendini and Martiniuk, 2018). Furthermore, ending social and legal 
discrimination and preventing lifelong disabilities in those affected by the disease are 
important current goals of human leprosy programs (WHO, 2018a). Leprosy continues to be 
an important human disease and great challenge to researchers and health managers.  
Clinical symptoms in humans 
Humans are a long-lived host species offering a range of different conditions to pathogens 
across their different organ systems. Individuals living for 115 to 122 years have been 
reported (Rafi and Alavi, 2017). The average global life expectancy at birth was 72 years in 
2016 (WHO, 2018b). The average core body temperature of healthy individuals is given as 
35 to 37.5°C (Geneva et al., 2019). However, peripheral organs, such as the skin, are likely 
to have a lower temperature, influenced by the ambient temperature.  
Most information on clinical leprosy in humans comes from patients infected with M. leprae 
(Han et al., 2012). The incubation period for leprosy in humans is generally measured in 
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years (Blake et al., 1987). The shortest incubation time for humans was described in a two-
month-old child, but in most cases between six months and 20 years (mean incubation 
period two to four years) pass between initial infection and onset of clinical disease (Rojas-
Espinosa and Lovik, 2001; Lastória and de Abreu, 2014b). Disease progression is slow 
(Ferreira et al., 2018), but variable depending on the form of leprosy a patient exhibits and 
the occurrence of leprosy reactions. Information on exact timescales is rarely available, but 
the delay between onset of symptoms and diagnosis can be very long, i.e. 41.7 +/- 49.8 
months (Li et al., 2016), indicating that patients do not seek diagnosis when symptoms first 
occur or that initial misdiagnosis is possible. Pre-clinical identification of leprosy in humans is 
mainly achieved using serological methods (Anouk van Hooij et al., 2016), but identification 
of infected individuals using molecular methods is also possible prior to the onset of clinical 
disease (Martinez et al., 2014).  
For a long time it has been argued that certain conditions (i.e. worm infestation, syphilis, 
influenza) which reduce the general resistance of an individual can correlate with the onset 
or intensification of leprosy lesions in human patients (Gordon-Napier, 1933; Sandre, 
Poenaru and Boggild, 2018). (Re-)activation of M. leprae infection in the postpartum period 
and during lactation, i.e. when the immunosuppressive status necessary to maintain 
pregnancy is reversed, has been described (Singh and Perfect, 2007). However, an infection 
with human immunodeficiency virus (HIV) was not linked to a higher rate of leprosy infection 
or clinical disease (Scollard et al., 2006; Virmond, Grzybowski and Virmond, 2015). 
Antimicrobial and supportive treatment is usually initiated in patients as soon as the 
diagnosis is made and continued over six to 24 months (Reibel, Cambau and Aubry, 2015), 
thus the full natural course of infection is not usually observed and documented in humans in 
modern times.  
When clinical leprosy develops its presentation is highly variable, shaped by the individual’s 
genetically determined immune reaction towards the pathogen (Govindan et al., 2018). The 
definitions for the main clinical forms of leprosy still used today were proposed by Ridley and 
Jopling in 1966 (Ridley and Jopling, 1966; Virmond, Grzybowski and Virmond, 2015). As the 
clinical presentation is so strongly linked to the host immune response, the five main 
categories to which human leprosy cases are assigned reflect a range from strong 
(tuberculoid, TT) to weak host immune response (lepromatous, LL), with three categories in 
between: borderline tuberculoid (BT), borderline borderline (BB), and borderline lepromatous 
(BL) (White and Franco-Paredes, 2015). Table 2 summarises the defining features of these 




TABLE 2:  CLINICAL FEATURES OF THE FIVE MAIN FORMS OF HUMAN LE PROSY (Ridley and 
Jopling, 1966; Bhat and Prakash, 2012; Virmond, Grzybowski and Virmond, 2015; 
Gaschignard et al., 2016) 
Characteristic TT BT BB BL LL 
No. of 
lesions 
One up to 
three 
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Anaesthesia Very marked Marked Moderate Slight Minimal 




















T-helper cell (Th) 1  
mediated, strong 
Th 2 mediated, weak 
At the TT end of the leprosy spectrum, lesions are usually restricted to the skin and 
peripheral nerves. Systemic leprosy in humans is mainly described on the LL end of the 
spectrum, i.e. in individuals with a weak cellular immune response. Then involvement of and 
bacterial presence in most internal organs is possible. In diffuse LL (DLL) AFB have been 
observed in skin, liver, spleen, lymph nodes, bone marrow, kidneys, adrenal glands and 
tracheal mucosa (Han et al., 2008). Even in ancient remains of human lepromatous patients, 
high burdens of M. leprae are often found in the vomer (Mendum et al., 2014). When LL 
leprosy affects the eyes, AFB are present in conjunctiva, cornea, ciliary body, ora serrata 
and sclera (Rathinam, Khazaei and Job, 2008).  
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Advanced, obvious clinical leprosy symptoms in humans are mainly the result of untreated 
LL (Ridley and Jopling, 1966; Han et al., 2008). They include clawed hands due to lesions of 
the ulnar nerve, drop foot as a result of damage to the lateral peroneal nerve, madarosis 
(loss of eyebrows and eyelashes), and changes to the eye (corneal nerve beading, iris 
atrophy, iris pearls, iridocyclitis, keratitis) (Virmond, Grzybowski and Virmond, 2015). Bone 
changes can occur in hands and feet, in LL also in the rhinomaxillary area (Mariotti et al., 
2005). Ocular involvement is estimated to be present in 70-75% of human leprosy patients. 
Symptoms are severe in 10-50% of the patients and blindness occurs in about 5% 
(Grzybowski, Nita and Virmond, 2015). Leprosy is the leading cause of permanent disability 
due to an infectious disease (Fulton et al., 2016). 
Involvement of the peripheral nervous system is present in all forms of human leprosy 
(Soares et al., 2017). Nerve damage can present as autonomic, sensory or motor 
disfunction, particularly sensory disfunction means that the host can suffer tissue damage 
without even realising it. Damage is caused either by an unrestricted replication of M. leprae 
or by the granulomatous host immune response to the presence of the pathogen (Duthie et 
al., 2014). Very occasionally a purely neural form of leprosy without involvement of the skin 
is described (Primary neural leprosy, PNL) (Quao and Amankrah-Otabir, 2016). 
Additional forms of leprosy that are described regularly are indeterminate leprosy (InL), 
histoid leprosy, and Lucio-Latapi leprosy. InL is a purely macular condition with 
hypopigmentation and slight anaesthesia. Macules can be ill-defined and bizarre with a 
smooth or scaly surface (Bhat and Prakash, 2012). Spontaneous resolution without 
treatment is described in this form. It can also develop into one of the five main forms (Rojas-
Espinosa and Lovik, 2001; Quao and Amankrah-Otabir, 2016). Histoid leprosy is a sub-form 
of LL characterised by firm, reddish or skin coloured, dome shaped or oval papules or 
nodules, with regular contour, translucent shiny and stretched overlying skin (Massone, 
Belachew and Schettini, 2015; Talhari, Talhari and Penna, 2015). Lucio-Latapi leprosy is a 
polar type of LL. The skin shows a generalized infiltration without nodules, which give a 
brilliant and moist, healthy appearance. It was supposed to be unique to Mexico, but a few 
cases have been diagnosed in Brazil and India. (Virmond, Grzybowski and Virmond, 2015). 
Patients may develop fever, arthralgias, myalgias, and very painful red or purpuric macules 
of irregular shapes on lower legs, thighs, hip, trunk and upper limbs (Massone, Belachew 
and Schettini, 2015). The more recently described infection with M. lepromatosis mainly 
results in LL or DLL (Han et al., 2012).  
An additional complication of leprosy in humans are so called leprosy reactions. Two types 
are generally distinguished: reversal reactions (RR) and erythema nodosum leprosum (ENL). 
RR are caused by an immunocellular response of the host. They usually occur in TT or 
borderline patients. Clinical signs include swelling and reddening of pre-existing lesions. 
Necrosis and ulceration can occur in intense cases (Soares et al., 2017). The reaction is 
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characterised by a delayed hypersensitivity to M. leprae antigen (Gell and Coombs type-IV 
reaction) and a sudden increase in the cell-mediated immune response (Fava et al., 2012). 
ENL can occur when the cellular immune response to the presence of leprosy bacilli is weak, 
i.e. in LL cases. ENL are characterised by erythematous papules, nodules or plaques on 
lesions that can become necrotic and ulcerate, combined with systemic manifestations such 
as fever and inflammation of all bacteria containing organs (Soares et al., 2017). Risk factors 
for developing such a reaction include high bacterial indices (3+), certain major hormonal 
changes in women (puberty, pregnancy, lactation), vaccinations, and emotional and 
psychological stress (White and Franco-Paredes, 2015; Sandre, Poenaru and Boggild, 
2018). High levels of proinflammatory cytokines such as interferon-γ (INF-γ), TNF-α, IL-6, IL-
12 and IL-1β are present in the serum of humans showing an ENL reaction (Bhat and 
Prakash, 2012; Fava et al., 2012). During ENL reactions inflammation implying the presence 
of mycobacterial antigen can occur in a range of tissues, including peripheral nerves, joints, 
lymph nodes, oral cavity, larynx, liver, spleen, eyes, testes, kidney and bones (Soares et al., 
2017). In ocular ENL an influx of neutrophils on the background of macrophages packed with 
AFB has been described (Rathinam, Khazaei and Job, 2008).  
Clinical differential diagnosis in humans 
Clinical differential diagnosis for leprosy in humans are naturally manifold, given the diverse 
nature of the disease. Initially human leprosy can be mistaken for an allergic reaction, 
autoimmune disease, fungal infection, vitiligo, other mycobacterial infections, 
mucocutaneous leishmaniasis, syphilis or rheumatoid arthritis (White and Franco-Paredes, 
2015). In the long run a range of non-infectious granulomatous dermatotic conditions, 
superficial non-granulomatous skin infections, non-infectious plaque and nodular diseases, 
cutaneous infectious granulomas and systemic disorders with diffuse cutaneous infiltration 
can look similar to different forms and stages of leprosy (Moschella and Garcia-Albea, 2016). 
Among the infectious diseases that could cause similar lesions are tuberculosis, atypical 
mycobacterial infection, leishmaniasis, syphilis, different forms of blastomycosis and African 
histoplasmosis (Moschella and Garcia-Albea, 2016). 
Histological presentation of leprosy in humans 
Histological descriptions in humans are often focussed on the skin, but according to Ridley 
and Jopling (1966) lesions in other tissues are essentially similar. Leprous granulomas are 
rarely found in the superficial dermis only, usually dermis and sometimes subcutis are 
involved. The presence of AFB inside a nerve is diagnostic of leprosy (Massone, Belachew 
and Schettini, 2015).  
The clinical classification of leprosy lesions does not always correlate with the histological 
features. Ridley-Jopling categories assigned to a patient clinically and histologically differ in 
30% to 62% of cases. Discrepancies mainly occur in borderline cases (Massone, Belachew 
and Schettini, 2015). Nevertheless, the five main histological categories of leprosy lesions 
11 
 
have the same names as the clinical categories. Criteria correlated with the histological 
progress and classification of leprosy lesions are: “foam cells, large globi, epithelioid cells, 
Langhans giant cells, lymphocytes, plasma cells, fibroblasts, a clear subepidermal zone, the 
cellular cuffing of nerves, and infiltration of nerves” (Ridley and Jopling, 1966). Table 3 
details the characteristics of the different histological leprosy presentations. Histological 
features may be in between Ridley Jopling categories. This can be described by combining 
the categories, i.e. TT-BT (Massone, Belachew and Schettini, 2015). 
TABLE 3:  HISTOLOGICAL FEATURES OF THE FIVE MAIN FORMS OF HUMA N LEPROSY (Ridley 
and Jopling, 1966; Bhat and Prakash, 2012; Massone, Belachew and Schettini, 2015) 






















































































































The bacterial index (BIn) was introduced to comparably quantify AFB seen in skin smear 
samples from human leprosy patients (Virmond, Grzybowski and Virmond, 2015) or in 
histopathologic sections of granulomas (Massone, Belachew and Schettini, 2015). It is 
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expressed on a logarithmic scale (Ridley and Jopling, 1966; Talhari, Talhari and Penna, 
2015):  
o 1= at least 1 bacillus in every 100 fields  
o 2= at least 1 bacillus in every 10 fields 
o 3= at least 1 bacillus in every field 
o 4= at least 10 bacilli in every field  
o 5= at least 100 bacilli in every field 
o 6= at least 1000 bacilli in every field. 
InL is histologically often indistinguishable from other forms of chronic dermatitis. 
Lymphocytes and histiocytes are localised around skin annexe. Fibrocytes are often 
increased and perineural cuffing or increased cellularity in a nerve bundle can be present. 
AFB are scarce or absent, a polymerase chain reaction (PCR) test for DNA from lesion 
tissue is only positive in a small number of cases (Massone, Belachew and Schettini, 2015). 
Histoid leprosy presents with spindle-shaped cells, which gave this sub form its name. Small 
numbers of foamy macrophages and unusually large numbers of AFB can be present 
(Massone, Belachew and Schettini, 2015; Talhari, Talhari and Penna, 2015). Lucio-Latapi 
leprosy presents with epidermal necrosis, ulceration, features of DLL, including numerous 
AFB, and a panvasculitis of superficial and deep vessel (Massone, Belachew and Schettini, 
2015).  
RR are histologically characterised by poorly delimited granulomas associated with 
intracellular and interstitial oedema, fibrin deposition, necrosis and varying degrees of 
epithelial hyperplasia (Soares et al., 2017).The number of lymphocytes in the dermis is 
increased, and Langhans giant cells may be observed (Fava et al., 2012). ENL presents 
histologically as an acute or subacute non-granulomatous inflammatory reaction with 
vascular proliferation, endothelial swelling, disorganisation of pre-existing granulomas and 
formation of micro-abscesses (Soares et al., 2017).  
Histological differential diagnosis for leprosy include, on the TT-BT end of the spectrum 
sarcoidosis, tuberculosis, leishmaniasis, and secondary syphilis (Massone, Belachew and 
Schettini, 2015). On the BL-LL end of the spectrum xanthomas and xanthogranulomas, 
post–kala-azar dermal leishmaniasis, paraffinoma, and rarely infections caused by other 
nontuberculous (atypical) mycobacteria can look similar (Massone, Belachew and Schettini, 
2015) 
Diagnosing leprosy in humans 
Leprosy in human patients is usually diagnosed clinically, once symptoms of the disease 
become obvious. (Lumpkin III et al., 1983; Rojas-Espinosa and Lovik, 2001; WHO, 2016a). 
In non-endemic areas the lack of awareness of clinicians regarding the symptoms of leprosy 
is an important cause for delayed or non-diagnosis (Moschella and Garcia-Albea, 2016). 
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In most cases (90%) dermatological signs are the main indicators for leprosy, while about 
10% of patients present with neurological signs only (Reibel, Cambau and Aubry, 2015). 
Hypopigmented or reddened anaesthetic skin lesions, thickening of peripheral nerves and 
the presence of AFB are the cardinal symptoms of leprosy in humans (ILA Technical Forum, 
2002; Quao and Amankrah-Otabir, 2016). For field diagnosis and treatment purposes human 
leprosy patients are usually separated into multibacillary (MB) and paucibacillary (PB) cases, 
based on the number of observed skin lesions (<5 = PB, >5= MB) (Quao and Amankrah-
Otabir, 2016; WHO, 2016a). However, some local adaptions in determining whether a 
patient has a MB or PB form of leprosy exist, where, for example, the number of affected 
body areas is assessed rather than the number of lesions alone (Rao et al., 2005). Additional 
grading systems exist  to class the disabilities a leprosy patient has developed (van Brakel, 
Reed and Reed, 1999). The more detailed histological Ridley-Jopling classification system is 
mainly used for research purposes (Ridley and Jopling, 1966; Reibel, Cambau and Aubry, 
2015).  
Available complementary techniques for the diagnosis of leprosy include skin smear and fine 
needle aspirate microscopy, histopathology, PCR, serology, Mitsuda intradermal reaction, 
immunohistochemistry, imaging, and electromyography (Scollard et al., 2006; White and 
Franco-Paredes, 2015; Baddam et al., 2018). Availability of all tests depends strongly on 
local infrastructure and expertise.  
The RLEP qPCR is the best currently available molecular method to confirm a leprosy 
diagnosis, when M. leprae is the causative agent (Braet et al., 2018). Highly specific PCR 
protocols to identify M. lepromatosis DNA are also established (Han et al., 2008; Vera-
Cabrera et al., 2015). Molecular methods are however usually limited to well-equipped 
laboratories. They can be performed using skin biopsies, slit skin smear and fine-needle 
aspirates from active lesions. Specificity is 100%, and in MB cases sensitivity is equally high. 
In PB cases however, sensitivity is lower (84.6%), and false negative results will occur 
(Baddam et al., 2018; Braet et al., 2018). A recent review, not taking different forms of 
leprosy into consideration summarised the diagnostic sensitivity of conventional PCR 
techniques in humans to be 75.3% (95% CI 67.9 to 81.5%, included studies reporting 50% to 
93% sensitivity) and the specificity as 94.5% (95% CI 91.4 to 96.5, included studies reporting 
90% to 100%) (Gurung et al., 2019). Whole blood is another sample type to which PCR 
methods have been successfully applied to confirm a leprosy diagnosis. In one study M. 
leprae DNA was successfully isolated from blood samples of 47 out of 49 (95.92%) MB 
patients and from 70% (21/30) of the included PB patients (Wen et al., 2013). Molecular 
methods have also been successfully applied to other sample types such as nasal swabs 
and sputum. These sample types are of slightly lower diagnostic value, as it is difficult to 
discern a transient presence of leprosy bacilli following contact from a true infection in which 
the bacteria have broken through the host defence (Wen et al., 2013). Molecular methods, 
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first established in 1989, are mainly used in surveillance efforts driven by well-funded 
research groups and not widely part of the diagnostic toolkit available to health workers in 
the field (Scollard et al., 2006; Fontes et al., 2018) 
Huge efforts have been made to develop serological tools suitable not only to confirm the 
clinical diagnosis of leprosy but also to identify infected and exposed individuals before the 
onset of clinical disease as part of surveillance efforts. These efforts aim to enable an early 
delivery of treatment and to break transmission chains (Lastória and de Abreu, 2014b; 
Corstjens et al., 2019). The longest and most widely used parameter is leprosy specific anti-
PGL-I antibody (αPGL-I) titres (Spencer and Brennan, 2011). Positive αPGL-1 titres alone do 
not imply that a patient will develop clinical leprosy (Wen et al., 2013; van Hooij et al., 2018). 
Alone PGL-I is mainly useful to identify or confirm MB cases (Bobosha et al., 2014). Even in 
these cases the sensitivity differs between study populations and ranges from 75 to 100% 
(Lastória and de Abreu, 2014a; van Hooij et al., 2018). Other proteins and antigens used in 
leprosy diagnostics include for example leprosy Infectious Disease Research Institute (IDRI) 
diagnostic-1 (LID-1), protein advances for the diagnosis of leprosy (PADL) and antigen 85B 
(de Souza et al., 2014; Duthie et al., 2014; de Santana et al., 2018). Most recently developed 
tests combine the detection of αPGL-I IgM (humoral immune response) and IFN-c induced 
protein (IP-10), and C reactive protein (CRP) (cellular immune response) to improve the 
ability of serological tests to identify PB cases (van Hooij et al., 2018; Corstjens et al., 2019). 
These additional parameters can increase the sensitivity for the detection/confirmation of PB 
cases to 63-80%, depending on assessed population (van Hooij et al., 2018). Lateral flow 
assays using up-converting phosphor reporter technology (UCP-LFA) have enabled field 
friendly, relatively cheap, quantitative serological testing (Bobosha et al., 2014). They offer a 
diagnostic aid that does not require specialist knowledge and can be made available even in 
regions where other tools, like histopathology or molecular assays cannot be accessed 
(Corstjens et al., 2019). As the sensitivity and specificity of serological tests continues to be 
improved, their value and relevance, particularly for large scale population screening on 
minimally invasive samples (fingerstick blood), is likely to continue to increase (Corstjens et 
al., 2019).  
Histopathological assessment of Ziehl-Neelsen (ZN) or Fite-Faro (FF) stained slit skin 
smear, fine needle aspirates, or biopsies taken from lesions, allows experienced 
investigators to establish the presence and number of AFB and some frequently present cell 
types and thus assign a category along the histological Ridley and Jopling spectrum (Ridley 
and Jopling, 1966; Scollard et al., 2006). However, PB cases are easily overlooked 
(Massone, Belachew and Schettini, 2015) and in the absence of lesions deciding on a site 
for a biopsy or getting consent to take such is likely to be difficult. Histopathology, while 
important in clinical cases, therefore plays no or a very limited role in active surveillance 
efforts. Immunohistopathological techniques can increase the sensitivity and specificity of the 
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histopathological diagnostics, but they require specialist knowledge and adequate laboratory 
facilities (ILA Technical Forum, 2002). 
The Mitsuda intradermal reaction is not diagnostic of leprosy or exposure to leprosy bacilli, 
but assists in placing a patient within the leprosy spectrum (Scollard et al., 2006). Another 
simple test occasionally described is the reduced reaction of leprous hypochromic lesions to 
the application of histamine due to the destruction of local sympathetic nerve fibres (Talhari, 
Talhari and Penna, 2015). Imaging technologies are mainly employed to assess the effects 
the disease has already had on a patient following the confirmed diagnosis of leprosy (White 
and Franco-Paredes, 2015).  
1.1.4. Leprosy as a multi host disease 
Many animal pathogens can infect and cause disease in multiple hosts. Factors influencing 
which potentially susceptible hosts a pathogen, or specific strains of a pathogen, will affect 
and how it will affect them, depend on host and pathogen range, inherited traits, life history, 
and external requirements for transmission being met (Bowden and Drake, 2013).  
In the 1970s it was realised that humans were not the only natural host for M. leprae, during 
attempts made to establish an animal model for human leprosy (Scollard et al. 2006). 
Natural infection in a non-human animal with M. leprae was first described in nine-banded 
armadillos (Dasypus novemcinctus, NBA) in Louisiana, USA (Walsh, Meyers and Binford, 
1986) and has since been confirmed for a range of species (see below).  
M. leprae strains isolated from species other than humans belong to branches 3I, 4 and 0. 
The same strains have been or are present in the human populations in each given 
geographic area (Schuenemann et al., 2018). Branch 3I has been isolated in NBA and ERS, 
while branch 4 has been isolated from a chimpanzee (Sierra Leone) and a soothy mangabey 
monkey (Cercocebus atys, West Africa), and branch 0 from a cynomolgus macaque 
(Macaca fascicularis) from The Philippines (Schuenemann et al., 2018).  
Leprosy in armadillos 
NBA are THE armadillo of leprosy research, both due to their use in experimental settings 
and because natural infection has been described most frequently in this species 
(Balamayooran et al., 2015). They have a shorter lifespan than humans and their core body 
temperature is lower than that of man with 30 to 35°C (McDonald and Larson, 2011). 
Mortality rates in juvenile NBA are relatively high, compared to those observed in adults, as 
is the case for many wildlife species. NBAs that reach maturity have been reported to live for 
seven to 20 years in the wild. The oldest reported NBA in captivity lived to an age of 23 
years (McDonald and Larson, 2011).  
Other armadillo species have been found to be susceptible to experimental M. leprae 
infection or harbour M. leprae DNA as well. These include Northern long-nosed armadillos 
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(Dasypus sabanicola), Southern long-nosed armadillos (Dasypus hybridus) and six-banded 
armadillos (Euphratus sexcinctus) (Storrs, 1978; Frota et al., 2012). Efforts to identify M. 
leprae in small numbers of wild Southern naked-tailed armadillos (Cabassous unicinctus) 
and Greater naked-tailed armadillos (Cabassous tatouay) were unsuccessful (Pedrini et al., 
2010), but this does not exclude that individuals from even more of the 21 extant armadillo 
species (Gardner, 2006) could be susceptible to an infection with M. leprae under certain 
circumstances. 
It is believed that armadillos, who are only found in the Americas, first acquired M. leprae 
from a human source (European explorers, slave trade) and that the infection is now 
sustained in the armadillo populations (Cardona-Castro et al., 2009; Han and Silva, 2014). 
This is for example supported by the fact that in Louisiana human leprosy was reported as 
early as 1766 and the first leprosarium was opened in 1785. Positive serum samples from 
wild armadillos have tested positive as far back as 1961, though sample availability is likely 
to be a limitation here (Blake et al., 1987). The low diversity in M. leprae strains identified in 
wild NBA in the Southern USA (3I-2-v1, 3I-2-v14, 3I-2-v13, 3I-2-v15) is thought to imply that 
interspecies transfers from humans to armadillos have been limited to rare, uncommon 
events, and that highly efficient intra-species transmission has led to leprosy distribution 
pattern seen in NBA today (Truman et al., 2011; Sharma et al., 2015). SNP type 3 M. leprae 
strains have also been identified in a small number of NBA in Brazil (Frota et al., 2012). M. 
leprae strain diversity in humans in the Americas is much higher than in NBA (Sharma et al., 
2015; Schuenemann et al., 2018).  
In wild NBAs in Louisiana and Texas the prevalence for αPGL-I was determined to be 16% 
in the overall population and 28.5-32% if only adult armadillos were considered (Truman et 
al., 1991). Histopathological prevalence in the Louisiana population had been determined to 
be 4% some years earlier (Walsh, Meyers and Binford, 1986). Other authors reported a 
seroprevalence of αPGL-I of 19% and a histopathological prevalence of 3% in the Louisiana 
armadillo population (no age correction) (Paige, Scholl and Truman, 2002). In a longitudinal 
study from Mississippi annual seroprevalence in the NBA population ranged from 4.5-15% 
but unfortunately the serological status varied in many animals and none were seropositive 
for more than three consecutive years (Williams and Loughry, 2012). In Brazil, M. leprae 
DNA was isolated from 21% of the animals in a mixed sample of six- and nine-banded 
armadillos, with the ear tissues having the highest rates of detection compared to liver, nose 
and spleen biopsies (Frota et al., 2012). The disease seems to have minimal impact on the 
individual in wild NBA (Morgan and Loughry, 2009). Paige et al. (2002) estimated a serologic 
and histopathological incidence density to range from 0.47 to 3.5 per 1,000 animal-days, and 
therefore relatively high inter-armadillo transmission rates, with direct contact and habitat 
sharing being the most likely routes of infection (Paige, Scholl and Truman, 2002). 
Alternatively, vector born, environmental or food (insects) based transmission route have 
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been proposed (Walsh, Meyers and Binford, 1986). Under laboratory conditions NBA can be 
infected with M. leprae via intravenous, intradermal, percutaneous and respiratory 
administration of the bacteria (Pena, Sharma and Truman, 2018). M. leprae can be isolated 
from all organs in infected NBA, but cooler body regions, like ears, nose, tongue, footpads, 
lungs and bronchi show higher numbers of bacteria (Pena, Sharma and Truman, 2018).  
NBAs always give birth to identical quadruplets. While individuals from the same litter, when 
infected with M. leprae will all show similar numbers of bacteria over time, there are 
differences between litters (Pena, Sharma and Truman, 2018). These can be grouped in 
three categories: High responders (high bacterial count), low responders (low bacterial 
count), and resistant individuals (about 15-20% of all individuals) (Truman et al., 2014; Pena, 
Sharma and Truman, 2018). Some of these resistant armadillos have SNPs in toll-like 
receptors in similar locations as resistant humans (Pena, Sharma and Truman, 2018).  
Clinical signs and histological presentation in NBA 
The initial discovery of leprosy in NBA followed observations of enlarged inguinal lymph 
nodes in wild caught animals. The lymph nodes contained large numbers of AFB (Walsh, 
Meyers and Binford, 1986).  
Naturally acquired leprosy infection is rarely described in juveniles or subadult NBAs, and 
most are thought to be older than two years at the time of initial disease detection, with the 
incubation period estimated to be 12-24 months (Walsh, Meyers and Binford, 1986; Oli et al., 
2017). Leprosy appears to be a disease of older NBA (Morgan and Loughry, 2009). There is 
little evidence of clinical disease, deformities or impairment due to leprosy in wild NBA and 
endemic infection does not appear to put a population at a disadvantage (Truman, 2005; 
Morgan and Loughry, 2009). Often NBA infected with M. leprae cannot clinically be 
distinguished from uninfected animals (Truman, 2005). In a population with a seroprevalence 
of 20% only 5% showed clinical signs of disease, and other studies also showed 10% or less 
of infected NBAs to be clinically diseased (Truman et al., 1986; Walsh, Meyers and Binford, 
1986). If wild NBA do develop clinical signs of leprosy they are usually few (Cardona-Castro 
et al., 2009), and may be nodule-like lesions or non-specific abrasions around eyes, nose 
and feet (Frota et al., 2012; Sharma et al., 2013). Some studies have found more females to 
be infected than males, in others the sex ratio was balanced (Morgan and Loughry, 2009). 
In experimentally infected (intravenous administration of a bacillary suspension containing 
2x109 viable bacilli), wild caught, adult NBA  abnormalities in nerve conduction velocity can 
be observed within 12 months post infection, and disseminated disease is present 18-24 
months post infection (Sharma et al., 2018). The earliest neurological effects have been 
documented in an individual 90 days post infection and were correlated with a detectable 
immune response (Scollard, Truman and Ebenezer, 2015). αPGL-I can be detected earlier 
than clinical signs of disease or bacterial DNA in NBA, usually within a third of the time 
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required for the development of clinical signs (Truman et al., 1991; Loughry et al., 2009). 
Deaths from leprosy or its complications have been reported in experimentally infected NBA 
15 to 41 months post infection (average survival time 31 months, n= 8). However, deaths 
can occur in NBA under laboratory conditions in a similar timeframe, even if infection with 
leprosy bacilli is unsuccessful (n= 5; Storrs et al., 1974). NBA can show the full spectrum of 
immunological responses described in humans when infected with M. leprae (TT to LL), 
though the majority (~70%) of armadillo cases appear to be MB, and at the BL-LL end of the 
spectrum (Truman, 2005; Sharma et al., 2013). Increased metabolic rates, asymmetrically 
distributed, focal, ulcerative dermatitis, extensive neurological involvement, anaemia and 
compromised liver and renal function are reported for NBAs under experimental conditions 
(Morgan and Loughry, 2009; Sharma et al., 2013; Truman et al., 2014).  
Differential diagnosis for leprosy in NBA is not currently discussed in the literature and will 
depend on the individual disease presentation observed in a specific NBA.  
As with clinical lesions, all five main types of histological lesions known in humans have 
been described in armadillos, with MB presentation being more frequent (Truman, 2005; 
Sharma et al., 2013). Histological changes described in naturally infected armadillos include 
lesions containing macrophages filled with AFB in the skin, here often arranged in globi, as 
well as AFB in small and large peripheral nerves, lymph nodes, histiocytes in spleen and 
liver, and pulmonary macrophages (Walsh, Meyers and Binford, 1986; Rojas-Espinosa and 
Lovik, 2001). AFB in dermal nerves were only found in the latest stages of natural infection, 
long after the NBA had seroconverted (Paige, Scholl and Truman, 2002).  
Leprosy bacilli can be found in all organs in armadillos, if the infection can progresses for 
long enough, but cooler body regions tend to exhibit greater involvement (Truman, 2005). 
Internal tissues of the nose are frequently affected by leprosy, but apparently are not the 
primary focus of infection. The tongue is also regularly involved, but lesions appear to be 
transient (Walsh, Meyers and Binford, 1986). Lepromatous placentitis and intrauterine foetal 
infections are possible in armadillos, and AFB may be found in milk and mammary glands 
(Walsh, Meyers and Binford, 1986; Rastogi, Legrand and Sola, 2001). Ocular involvement 
has also been described, with AFB in macrophages in all ocular tissues but for lens, retina, 
aqueous and vitreous humours (Hobbs et al., 1978). When looking at six leprosy infected 
armadillos, Frota et al. found M. leprae DNA in the ear tissue of all six, in the nose and liver 
of five and in the spleen of three, implying that distribution through the body is uneven, even 
in systemic disease (Frota et al., 2012). 
Diagnosing leprosy in NBA 
Serological tests, aiming to identify αPGL-I were trialled and used in NBAs early on (Truman, 
1985; Truman et al., 1986), along with histopathological confirmation of the presence of AFB 
in a variety of tissues (Walsh, Meyers and Binford, 1986; Stallknecht et al., 1987). It has 
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been shown that αPGL-I begin to rise before bacteria can be detected in skin scrapings or 
ear biopsies in this species. PGL-I IgM increase with increasing bacterial loads and persists 
throughout the infection (Truman, 2005). While serology is the most sensitive diagnostic tool 
in NBA, surveillance efforts attempting to identify wild armadillos infected with leprosy have 
also used PCR methods to identify individuals carrying the bacteria (Sharma et al., 2015). 
Especially where opportunistic sampling is used, it might be more feasible to acquire tissue 
samples for PCR and (immuno-)histopathological assessment than to collect serum (Pedrini 
et al., 2010; daSilva et al., 2018). In one study an 85B qPCR (single copy M. leprae gene), 
an RLEP qPCR (multi-copy M. leprae gene) and a combination of both was used to identify 
M. leprae DNA in buccal swabs of experimentally infected NBA. This sample type was 
however not suitable to identify all infected NBA (85B: sensitivity 0.36, specificity 1.00; RLEP 
sensitivity 0.72, specificity 0.60; 85B+RLEP sensitivity 0.60, specificity 0.85) with 28-64% of 
NBA testing false negative (Housman et al., 2015). Other armadillo species harbouring 
leprosy bacilli have been identified using molecular methods. M. leprae DNA was isolated 
from a range of tissues (ear, nose, liver, spleen) in these (Frota et al., 2012).  
Leprosy in squirrels  
Naturally acquired infection with M. lepromatosis (Meredith et al., 2014; Simpson et al., 
2015) and M. leprae (Avanzi et al., 2016) has recently been described in wild ERS in the 
British Isles as part of ongoing disease surveillance efforts. Naturally occurring leprosy has 
not been described in any other squirrel species. Targeted screening efforts were limited at 
the start of this study. Four grey squirrels were screened for leprosy with the same methods 
that revealed disease presence in ERS, and neither mycobacterial species was detected 
(Avanzi et al., 2016). However, hibernating Thirteen-lined ground squirrels (Ictidomys 
tridecemlineatus) and Siberian chipmunks (Tamias sibiricus) were successfully 
experimentally infected with AFB isolated from human leprosy patients in the 1970s/80s 
(Lew, Yang and Pyun, 1974; Galetti, Cavicchi and Ussia, 1982). In Thirteen-lined ground 
squirrels bacteria multiplied in all organs but counts were higher in the skin than in visceral 
organs (Galetti, Cavicchi and Ussia, 1982). However, these species have not been further 
used as leprosy models, and no coordinated screenings of wild populations have been 
published. 
The M. leprae strain isolated from ERS is closely related to ancient human strains from 
England (Great Chesterford, Winchester) and Denmark (Odense), and current strains 
isolated from human patients in Brazil (Avanzi et al., 2016; Benjak et al., 2018; 
Schuenemann et al., 2018). Only a single strain of M. leprae belonging to branch 3I could be 
sequenced from ERS so far (Avanzi et al., 2016). Beyond its relatedness to human strains it 
is also of the same sequence type as strains isolated from NBA (Avanzi et al., 2016). It is 
hypothesised that ERS first became infected with leprosy from a human source (Avanzi et 
al., 2016; Schuenemann et al., 2018). Current evidence is too scarce to determine when 
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ERS first became infected with M. leprae and no evidence is available for the presence of 
leprosy in ERS in Scandinavia or the Baltic region, two areas that have been implicated as 
potential points of origin for M. leprae strains present in Britain (Inskip et al., 2017).  
Unfortunately, no similar ancient DNA data exists yet to clarify the origin of M. lepromatosis 
strains found in ERS. It is however likely, based on comparisons made between strains in 
British and Irish ERS, that M. lepromatosis was present in ERS before they were 
reintroduced into Ireland 200 years ago. Infected ERS could have brought the bacteria with 
them during the reintroduction (Avanzi et al., 2016). Locally acquired human infection with M. 
lepromatosis has not been described in the UK to date. The strains present in ERS in the UK 
and in human patients in Mexico are thought to have diverged from their most recent 
common ancestor about 27,000 years ago (Avanzi et al., 2016).  
SNPs identified in the toll-like receptor I (TLR-I) of ERS that seem to correlate with disease 
resistance are different from those identified in humans and armadillos (Avanzi et al., 2016). 
ERS can develop clinical disease when infected with leprosy bacilli, but bacteria have also 
been isolated from apparently healthy ERS (Avanzi et al., 2016).  
Clinical signs in ERS 
The most prominent clinical signs of leprosy described  in ERS are bilateral areas of alopecia 
and cutaneous swelling on snout, lips, eyelids, ears and distal aspects of the limbs (Meredith 
et al., 2014). Clinical signs are highly similar between ERS infected by M. leprae and those 
infected by M. lepromatosis (Avanzi et al., 2016). Simpson et al. (2015) described a crusty 
thickening of the ears with some keratinisation and wart-like protuberances in two ERS from 
the Isle of Wight infected with M. lepromatosis. This implies, that more variations in clinical 
presentation of ERS may exist. Skin conditions in ERS that are relevant differential diagnosis 
for leprosy, are summarised in Table 4 (p. 21).   
Histological presentation in ERS 
The first leprosy lesions in Scottish ERS, caused by M. lepromatosis were described as 
presenting with large numbers of AFB and consistent with DLL (n=3) (Meredith et al., 2014). 
Leprosy lesions caused by M. lepromatosis in ERS on the Isle of Wight were also described 
as consistent with DLL, despite the unusual clinical presentation and only moderate numbers 
of AFB (n=3) (Simpson et al., 2015). Additional M. lepromatosis cases (tissue= pinna) from 
Scotland with typical clinical lesions (n=4), were described as LL (75%) or BL (25%) and on 
the Isle of Wight (n=1, again with atypical clinical presentation) as LL but with only sparse 
numbers of AFB in bands of macrophages close to the cartilage of the pinna and in the 
spleen. In an Irish sample of two M. lepromatosis positive ERS without clinical signs, only 
skin from the front foot (dorsum and footpad) were available. In only one of these ERS were 
AFB observed and, based on the description provided, the lesion appeared to be 
indeterminate (Avanzi et al., 2016).  
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al., 2013) 
Twenty-five squirrels from which M. leprae DNA had been isolated were assessed 
histologically prior to this study, eight of which had clinical lesions (Avanzi et al., 2016). Out 
of the 17 clinically negative, PCR positive ERS only six showed histological features 
indicating leprosy in the form of a mild chronic perineuritis in the pinna or muzzle. In the 
other 11 no histological features indicating leprosy were found. The clinically diseased 
animals were again classed as either LL (n=6, BIn 2+/3+) or BL (n=2, BIn 1+/2+), and 
neuritis was noted in all these cases at least in the most affected sections. The study also 
indicated that the anatomical location of the skin sample was influencing the intensity of AFB 
and pathological changes observed (Avanzi et al., 2016). Ulcerations, but not vasculitis, 
have been described in squirrels with clinical leprosy lesions infected with either M. 
lepromatosis or M. leprae (Avanzi et al., 2016). 
Diagnosing leprosy in ERS 
Leprosy in ERS was initially diagnosed histologically in animals presenting with unusual 
clinical skin lesions at post mortem examination. Subsequent PCR analysis and sequencing 
of the product confirmed the presence of M. lepromatosis (Meredith et al., 2014). The same 




The largest currently published study on leprosy detection in opportunistic samples from 
dead squirrels combined histological and PCR analysis with sequencing of the isolated 
bacterial DNA and serological screening of body cavity fluid collected post mortem for M. 
leprae- and M. lepromatosis-specific αPGL (Avanzi et al., 2016). The latter was less effective 
in identifying cases than histology and PCR. An ML Flow test developed by KIT (Royal 
Tropical Institute) Biomedical Research in Amsterdam developed for diagnosing leprosy in 
humans had been used. Later post mortem screening efforts for leprosy in squirrels have 
relied primarily on PCR testing (Butler et al., 2017; Schilling, Avanzi, et al., 2019).  
Leprosy in other species 
Clinical leprosy has not been reported among free-ranging primates. However, individuals of 
some species can be infected experimentally and in a few instances wild caught non-human 
primates have developed clinical leprosy in captivity, without being experimentally infected 
(Truman and Fine, 2010).  
Naturally acquired leprosy infection was first diagnosed in a captive sooty mangabey 
monkey in 1979. A contact animal developed disease seven years later. Leprosy has also 
been described in a white-handed gibbon (Hylobates lar) in Malaysia, that was kept at a 
leprosarium. The animal was experimentally inoculated with leprosy bacilli, but did not 
develop leprosy until 15 years after the experiments. In the meantime, it had been tended by 
human leprosy patients. It can therefore not be said whether the infection was experimental 
or natural (Meyers et al., 1991).  
Clinical leprosy was also observed in a wild caught chimpanzee (Pan troglodytes 
scheinfurthii) kept in a research facility. A West African M. leprae strain (Branch 4) was 
isolated, implying an infection acquired around the time of capture and an incubation period 
of about 30 years. The animal responded well to multi drug treatment as used for humans. It 
cannot be discerned whether the chimpanzee was infected by a strain circulating in the 
primate population or from a human source during initial captivity (Suzuki et al., 2010).  
Natural infection in a cynomolgus macaque in the Philippines was described in 1998 
(Valverde et al., 1998). The M. leprae strain isolated from the cynomolgus macaque from 
The Philippines is most closely related to a human M. leprae strain belonging to branch 0 
from New Caledonia, while strains isolated from a different chimpanzee than those 
mentioned above and a sooty mangabey monkey belong to branch 4 and are again related 
to human strains present in West Africa (Honap et al., 2018).  
However generally, the prevalence of natural leprosy infection in non-human primates is 
thought to be low,  based on negative results for example from a proactive screening of 
buccal swabs of 41 wild ring-tailed lemurs (Lemur catta) from Madagascar and 22 wild 
chimpanzees from Uganda (Honap et al., 2018).  
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In experiments 80% of sooty mangabey monkeys (24/36) inoculated with leprosy bacilli 
developed leprosy. Experimental intravenous and intradermal infection was also successful 
in rhesus macaque (Macaca mulatta, 7/34) and African green monkeys (Cercopithecus 
aethiops, 15/19), while squirrel monkeys (Saimiri sciureus) were resistant to the infection 
(Gormus et al., 1988; Meyers et al., 1991).  
Twenty-four cynomolgus monkeys experimentally infected with M. leprae showed negligible 
susceptibility to the disease. Four animals developed papules at the inoculation site, but then 
lived for 2-8 years without showing skin lesions or neurological deficits. On necropsy AFB 
were observed in the earlobes, scrotum, ulnar nerve and nasal mucosa. Among the M. 
leprae sources were three mangabey monkeys, two of which were also simian 
immunodeficiency virus (SIV) positive, human multibacillary leprosy patients and an 
experimentally infected armadillo. Of the four cynomolgus monkeys that became sub-
clinically infected by M. leprae one was infected with M. leprae from all three sources, two 
with human isolates and one with a mangabey monkey isolate (Walsh et al., 2012).  
An experimental infection of mice and rats is only successful in thymectomised and 
immunosuppressed individuals, and infection usually remains limited to the footpad (Hobbs 
et al., 1978). While these species are thus unlikely to play a major role as natural hosts, 
particularly the mouse footpad model is of high scientific importance for the propagation of 
leprosy bacilli (Lahiri et al., 2011).  
Recently, M. leprae DNA was isolated from nasal swabs from one captive margay 
(Leopardus wiedii), one wild and one captive lowland tapir (Tapirus terrestris), two wild 
capuchin monkeys (Sapius apella), and one wild owl monkey (Aotus trivirgatus) from the 
Mato Grosso and Pantanal region of Brazil, after collecting samples from 69 wild and captive 
animals belonging to 25 different species (Autorizac et al., 2018). However, the strains 
detected were not sequenced in full and the presence of leprosy bacilli on the nasal mucosa 
alone cannot provide information on whether these animals were transiently colonised or 
actually infected by the bacterium.  
Low numbers of tissue samples collected from a range of species in Brazil and screened by 
PCR did not contain M. leprae DNA. This included Ring-tailed coati (Nasua nasua, n= 2), 
skunk (Didelphis albiventris, n= 1), hedgehog (Sphigurrus spinosus, n= 1),  crab eating 
racoon (Procyon cancrivoros, n= 1), restless cavy (Cavia aperea, n= 1), ferrets (Gallictis 
vittata, n= 2), and crab eating fox (Cerdocyon thous, n= 2) (Pedrini et al., 2010). Another 
species that has recently been screened for the presence of M. leprae DNA in Brazil using 
buccal swabs are marmosets (Callithrix jacchus, Callithrix penicillate, and hybrids of both; n= 
98). No M. leprae DNA was detected in any of the samples (Housman et al., 2015).  
Given this evidence it appears possible that the full host spectrum of M. leprae and M. 
lepromatosis is still unknown, and that in some species very specific, individual factors will 
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sometimes make an individual susceptible to an infection with these pathogens, even if most 
immunocompetent members of the species are resistant in most circumstances.  
Infections with AFB that were associated with skin disease resembling leprosy have been 
described in other species as well, but where genetic analysis was available the bacteria 
were identified as mycobacterial species other than M. leprae or M. lepromatosis (Hutyra, 
Marek and Manninger, 1938; Rojas-Espinosa and Lovik, 2001; Malik, Brien and Fyfe, 2009; 
Pin et al., 2014).  
Clinical signs and histological presentation in other species 
In chimpanzees disseminated LL with swellings and nodules on face, around eyes, lips, 
abdomen forearms and lower legs has been described (Walsh, Meyers and Binford, 1986; 
Suzuki et al., 2010). In mangabey monkeys clinical symptoms in line with human LL have 
been described. Clinical signs in this species included infiltration and thickening of facial 
skin, erythematous thickening of the margins of both ears, lesions on the lateral surface of 
the feet that can ulcerate and anaemia (Gormus et al., 1988). As the number of clinical 
cases described is low, differential diagnosis are not widely discussed and will depend on 
the individual presentation observed in an animal. Histological presentations have been 
described as being in line with human BL-LL and LL leprosy (Meyers et al., 1991; Suzuki et 
al., 2010).   
Clinical disease caused by M. leprae or M. lepromatosis in other species is not currently 
described.  
Diagnosing leprosy in other species 
The few reported cases of leprosy in primates were diagnosed using histopathological 
methods following the observation of suspicious skin lesions (Walsh, Meyers and Binford, 
1986; Gormus et al., 1988). Serological assessment of αPGL-I levels has been used 
successfully in a chimpanzee after clinical signs of leprosy had been identified (Suzuki et al., 
2010). Recently, molecular methods have been used to sequence the M. leprae strains 
present in historic primate cases and to screen, unsuccessfully, for leprosy in two wild 
primate populations (ring-tailed lemurs from Madagascar and chimpanzees from Uganda) 
(Honap et al., 2018).  
As mentioned before nasal swabs have enabled the detection of M. leprae DNA in an owl 
monkey, two capuchin monkeys, tow lowland tapirs and a margay (Autorizac et al., 2018). 
However, where only this sample type is available it cannot be said whether the animal was 
infected with the bacillus or its upper respiratory tract only transiently colonised. Buccal 
swabs from marmosets did not allow the identification of any leprosy carriers (Housman et 
al., 2015). It is not possible to say whether this is due to an absence of disease or this 
sample type being unsuitable for leprosy diagnostics in this species.  
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Leprosy as potential zoonosis 
Diseases affecting wildlife species are of human concern in several respects. From a 
biocentric position, wildlife diseases are relevant as they may pose a threat to ecologically 
important or conservation sensitive species and they could be the cause of avoidable 
individual suffering, where they are amplified due to imbalances in ecosystems under stress. 
From an anthropocentric position they are relevant as they may pose a threat to domestic 
animal and human health, when they are caused by pathogens that can affect more than 
one host (Decker et al., 2016). If such multi-host diseases affect humans and other animals, 
they are called zoonotic. Zoonoses are defined as “diseases naturally transmissible between 
vertebrate animals and man including those transmitted by direct contact with infected 
animals or carcasses, by food or water contamination, and by inhalation of infected dust” 
(Palmer, 2011). In laymen dictionaries the specification “vertebrate animals” is often reduced 
to “animals” (e.g. Cambridge Dictionary, Merriam-Webster), thus potentially creating 
confusion as this could imply including for example invertebrate borne diseases in the term.  
Zoonotic disease research often focuses on which diseases could be transmitted TO a 
human, paying less attention to diseases that can be transmitted BY humans to other 
species. However, looking at examples for the latter, highly relevant pathogens such as 
methicillin-resistant Staphylococcus aureus, influenza A virus and Mycobacterium 
tuberculosis are included (Messenger, Barnes and Gray, 2014). M. leprae is another 
example.  
Historic disease distribution information (Blake et al., 1987; Truman, 2005), experimental 
data (Storrs et al., 1974; Hamilton et al., 2008) and genetic evidence (Truman et al., 2011; 
Avanzi et al., 2016; Benjak et al., 2018; Honap et al., 2018) suggest that NBA, ERS and 
several primates did become infected with leprosy from a human source. Some species or 
even just individual populations of these species then appear to be able to naturally sustain 
the infection, as seen in NBA and ERS (Williams and Loughry, 2012; Avanzi et al., 2016). 
This can and is thought to have resulted in an expansion of the pathogen range along with 
the NBA host species range in the Southern USA (Loughry et al., 2009). However, NBA are 
currently present in Texas, Oklahoma, Kansa, Missouri, Arkansas, Louisiana, Mississippi, 
Tennessee, Illinois, Kentucky, Alabama, Georgia, Florida and South Carolina (Taulman and 
Robbins, 2014), while human leprosy cases are reported from other states such as 
California, Hawaii or New York as well (Aslam et al., 2019). The example of ERS shows that 
leprosy may remain endemic in the animal host population beyond its eradication in the local 
human population (Avanzi et al., 2016).  
Paragraph eliminated  
While leprosy is likely to have been transmitted from humans to other animal hosts in the 
past (Schuenemann et al., 2018), it is harder to tell whether, how and how frequently a 
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transmission from an animal host back to humans occurs. Case studies have to rely on 
humans reporting NBA contact, and as contacts often date back by years or decades, it is 
not usually possible to obtain samples from these animals anymore. Even in cases, where 
NBA were trapped for leprosy research and it should be assumed that these animals were 
tested for leprosy when first taken into captivity, information about the leprosy status of the 
NBA a person had contact to is usually not available (Logas and Holloway, 2019). The 
dynamics of leprosy transmission may also be changing over time. This could for example 
be caused by changes in host range overlap or when susceptibility in one host population 
shifts towards resistance, changing in which host intraspecies transmission can occur most 
effectively, or at all.  
Human to human transmission continues to be the most effective route for a person to 
become infected with leprosy bacilli (Pedrini et al., 2010; Araújo Stefani et al., 2019). Reports 
linking human leprosy cases to NBA contact in a geographic area to which human leprosy is 
not endemic exist (Lumpkin III et al., 1983; Domozych et al., 2016), but at the same time 
autochthonous cases are reported from non-endemic areas where no armadillos exist or 
where patients cannot recall any contact to armadillos (Villada et al., 2016; Rendini and 
Levis, 2017; Aslam et al., 2019). Even attempts to link NBA meat consumption and leprosy 
risk have returned inconsistent results so far (Deps et al., 2008; Schmitt et al., 2010). 
The low prevalence of leprosy in some NBA populations also means that humans can have 
contact with many armadillos without being exposed to leprosy bacilli. Together with the fact 
that no autochthonous human leprosy cases occur in the UK where an animal reservoir is 
present as well, and the generally low transmissibility of leprosy bacilli, this implies that while 
the risk of leprosy transmission from an animal source to humans exists, it is most likely very 
low (Truman, 2008; Sharma et al., 2015; Avanzi et al., 2016; HAIRS, 2016). Prolonged close 
contact to or sharing the environment with heavily infected and clinically diseased animals in 
bad socioeconomic conditions may increase the risk (daSilva et al., 2018), at least for the 
minority of humans (5-10%) who are still susceptible to an infection with leprosy bacilli 
(Scollard et al., 2006). 
Additional sources of infection are likely to exist. This could be subclinically infected or 
colonised human and non-human animal hosts, which are difficult to detect, not yet identified 
host species or non-vertebrate environmental sources (Blake et al., 1987; Araujo et al., 
2016). Especially in India, where no animal reservoir for leprosy is known and new cases 
keep emerging in certain areas without a history of prolonged contact to leprosy patients, it 
has been suggested that the environment also plays a role in the transmission of leprosy 
(Mohanty et al., 2016). Both M. leprae DNA and RNA, as well as M. lepromatosis DNA have 
been successfully detected in the environment in areas where leprosy hosts live (Miskin, 
Farrimond and Head, 1999; Chilima et al., 2006; Lavania et al., 2008; Mohanty et al., 2016; 
Tio-Coma et al., 2019), more specifically from soil, washing and bathing places (Turankar et 
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al., 2012; Mohanty et al., 2016; Tio-Coma et al., 2019). Detection rates are variable and 
lower in areas where no active human cases reside. Interestingly, M. leprae DNA was still 
present in soil in areas where no known cases of leprosy had resided in the past 5 years 
(Turankar et al., 2019). A majority (76.7%) of natural water sources can contain viable M. 
leprae (determined by the presence of mRNA) in areas where human leprosy is endemic 
(Virk et al., 2017). It has been shown that M. leprae can survive up to 46 days in wet soil 
(Desikan and Sreevatsa, 1995). It has been suggested that free-living amoeba could 
become infected by M. leprae, thus allowing the pathogen to survive and remain infective in 
the environment for extended periods of time (Wheat et al., 2014; Franco-Paredes and 
Rodriguez-Morales, 2016; Turankar et al., 2019). AFB expressing M. leprae-specific PGL-1 
have also been isolated from Sphagnum mosses in Norway (Rojas-Espinosa & Lovik 2001). 
In ticks, more precisely in the species Amblyomma sculptum, the transovarial transmission of 
viable M. leprae has been experimentally demonstrated. After offspring of orally infected 
adults fed on a rabbit, viable bacteria were present in the skin (Ferreira et al., 2018). Leprosy 
transmission does not obviously show seasonal patterns, but may be influenced by other 
climatic factors such as temperature and humidity (Valois, Campos and Ignotti, 2015).  
Many other diseases caused by members of the family Mycobacteriaceae are zoonotic, 
sapronotic (organic matter, soil and plants can be a reservoir) or both, and most share the 
characteristic of a wide geographic distribution with leprosy bacilli (Hubálek and Rudolf, 
2011). Research into all these pathogens struggles with the complexity that comes with a 
wide range of hosts and additional reservoirs, where some potential sources may not be 
identified until an unusual emergence of disease cases stems from one of them, or there is a 
commitment to widespread, active surveillance. Despite being one of the longest known 
diseases, leprosy remains an elusive and puzzling disease, where any new discovery is 
hoped to finally hold the key to understanding and controlling it. Whether leprosy truly 
deserves to be labelled a zoonosis will depend on evidence of continued transmission 
events across species barriers being presented.  
1.1.5. ERS in the British Isles – an endangered wildlife species 
ERS are small, tree-living, terrestrial mammals belonging to the Sciuridae family within the 
order Rodentia. ERS have a body temperature ranging from 38 to 40°C (Bosch and Lurz, 
2012), which does not drop significantly even in times of reduced activity (Dausmann et al., 
2013). Mortality rates within the first year of life can be as high as 75-85%. Those who 
survive the first six months have an average life expectancy of three to five years in the wild 
and occasionally up to ten years in captivity (Bosch and Lurz, 2012). The average year to 
year adult survival in ERS populations is ~50%. About 16% of a population are taken by 
predators each year (Lurz, Gurnell and Magris, 2005).  
Aside from the well-documented population declines in the British Isles and Italy, ERS are 
common throughout their large Palaearctic range on the Eurasian continent and considered 
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as least concern by the International Union for Conservation of Nature (IUCN; Shar et al., 
2016). Beyond its native range the species has been introduced into Armenia, Azerbaijan, 
Georgia, Kazakhstan, Kyrgyzstan, and Saint Kitts and Nevis. Populations can flourish in 
coniferous forests, but also in deciduous woods, mixed forests, parks, gardens, and even 
just small stand of conifers. Population densities are usually about 0.1 to 1.5 individuals per 
hectare. At high densities behaviours like bark stripping can lead to forest damage (Shar et 
al., 2016). ERS mainly feed on seeds, acorn, fungus, bark and sapwood, but occasionally 
eggs, young birds and bone are consumed (Bosch and Lurz, 2012; Shar et al., 2016). Coat 
colours vary in different shades of red through to almost black. Albinos are rare (Madsen, 
2011). ERS are in some countries (e.g. Japan) kept as pets and in others still hunted for their 
fur (e.g. Mongolia). Historically ERS were hunted for their meat and pelts across their range 
(Shar et al., 2016; Inskip et al., 2017). ERS are listed on Appendix III (Protected fauna 
species) of the Bern Convention on the Conservation of European Wildlife and Natural 
Habitats (Shar et al., 2016).  
ERS have been present in the British Isles since circa 5000-8000 BC. Populations here have 
always fluctuated but the recent population decline has been so steep that populations are at 
risk of local extinction in the short term but without management, eventual complete 
extinction (Madsen, 2011; Bosch and Lurz, 2012). Though road traffic and predation by pets 
are the most frequent causes of death for red squirrels (as reported from surveillance 
efforts), the lack of suitable habitat, resulting in malnutrition and starvation, fragmentation of 
habitat, and particularly the competition from introduced Eastern grey squirrels (Sciurus 
carolinensis, GS), in conjunction with the introduction of squirrel poxvirus significantly 
contribute to the decline (Meredith and Romeo, 2015). Up to 61% of healthy GS can carry 
the poxvirus and under these circumstances can replace ERS 20 times faster than if only 
direct competition occurred (Rushton et al., 2006; Bruemmer et al., 2010).  
The main stronghold for ERS in the British Isles is Scotland, with about 120,000 individuals 
remaining. Populations in England (~15,000), Wales (~3,000) and Ireland (40,000) are much 
smaller and in many instances fragmented or limited to islands or protected areas (Gurnell, 
2013). Most of the British ERS are of continental ancestry, with a recent (1960’s) surge in 
ERS with Scandinavian origins (Hale, Lurz and Wolff, 2004). 
In the United Kingdom ERS are protected under the Wildlife and Countryside Act 1981 
Section 11, as amended by the Countryside and Rights of Way Act 2000 for England and 
Wales, and the Wildlife (Northern Ireland) Order 1985 Article 12, as well as the Wild Mammal 
(Protection) Act 1996, the Welfare of Animals (Northern Ireland) Act 1972, and the Animal 
Welfare Act 2006. This means ERS cannot be intentionally killed, injured or captured, their 
shelters may not be intentionally or recklessly damaged or destroyed, and they may not be 
possessed or sold. Exceptions for research and conservation purposes require the 
appropriate licences. The regulations laid out in the Wildlife and Countryside act to manage 
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the threat from invasive grey squirrels were reinforced in the Invasive Alien Species 
(Enforcement and Permitting) Order in 2019 implementing the EU Regulation (1143/2014) 
on invasive alien (non-native) species. A UK Species Action plan has been laid out to 
facilitate conservation efforts. Dedicated conservation organisations are working towards the 
protection of remaining ERS populations and aim for their restoration to suitable habitats 
within the UK, where it is possible to remove GS. Many of these projects are very successful, 
however, the continuing threats have not yet allowed the overall population numbers to 
increase significantly again (Shuttleworth, Lurz and Halliwell, 2015).  
Impact of infectious disease on ERS populations 
Understanding infectious diseases present in a conservation sensitive species is of particular 
interest, as disease risk analysis has become an integral part of reintroduction and 
conservation translocation efforts and threats to these species can only be managed when 
they are known (IUCN/SSC, 2013; McInnes, 2018). It is also important to remember that, 
while infectious disease may currently only be a threat to few species, their impact on 
already-endangered species, with few viable populations remaining, can be immense (Smith, 
Acevedo-Whitehouse and Pedersen, 2009). Surveillance in existing populations has and 
continues to provide the necessary baseline data on existing diseases and the impact they 
are having. It allows to identify potential threats to ERS (Duff et al., 2010; LaRose et al., 
2010; Simpson et al., 2013; Meredith and Romeo, 2015; Shuttleworth et al., 2015; Blackett 
et al., 2018). As these efforts usually rely on convenience or opportunistic sampling, they 
may not be representative of the wider population and may not allow the identification of all 
pathogens present (Meredith and Romeo, 2015). ERS are susceptible to a range of 
infectious agents, some of which appear to have little impact on ERS survival, while others 
have been linked to numerous mortality events. It has been implied since the 1930s that 
infectious diseases may play a role in ERS population declines (McInnes, 2018).  
Table 5 summarises infective agents, the effect they are having in British ERS and control 
measures in place for their management. Potentially zoonotic pathogens are indicated in 
bold.  
Looking at the data provided by surveillance efforts on the Isle of Wight, on Jersey and in 
Scotland changes associated with infectious disease occur in circa 35% of ERS found dead 
(LaRose et al., 2010; Simpson et al., 2013; Blackett et al., 2018). This implies that they can 
be factor with high impact on ERS populations and makes it urgent to understand the extent 
to which each of them could pose a threat and how this threat could be managed. This is 
particularly true in populations where lowered genetic diversity and the presence of genetic 
traits possibly conferring lower disease resistance do occur. This is was hypothesised to be 
the case in ERS populations in the British Isles (Barratt et al., 1999; Hale, Lurz and Wolff, 





TABLE 5:  INFECTIOUS AGENTS DESCRIBED IN ERS, THEIR EFFECTS AND CONTROL MEASURES 
IN PLACE (POTENTIAL ZOONOSES IN BOLD ) 
Pathogen Effect on ERS Control measures  Source 
Squirrelpox Virus (SQPV) 
Severe, erythematous, 
exudative dermatitis 
around face, feet and 
ventrum, ulceration of 
lesions and lethargy, 
mortality possible. 
Outbreaks in populations 

















Fiegna et al., 
2016; Everest 




diarrhoea, sudden death, 
outbreaks with high 
mortality described in the 
UK and Germany; can 

















et al., 2015; 
Blackett et al., 
2018; Wernike 
et al., 2018) 
Rotavirus 
Diarrhoea in juveniles; no 








MLSTCC49 luk M 
Fatal exudative dermatitis 
(FED), necrotising lingual 
and laryngopharyngeal 
ulceration, inhalation 
pneumonia; can affect 
significant proportion 
(15%) of ERS sampled 











et al., 2015; 
Blackett et al., 
2018) 
Staphylococcus sciuri 
Secondary infection of 
wounds or pox lesions; no 
negative effect at 








Bulbous skin lesions in 
individual ERS, can be 
non-clinical; effect at 




(Avanzi et al., 
2016) 
Pasteurella multocida 
Pneumonia, Enteritis; no 










sometimes fatal; no effect 











Salmonella spp.  Enteritis; no effect at 






Pathogen Effect on ERS Control measures Source 
Borrelia burgdorferi 
Non-clinical (?); no effect 







Campylobacter spp.  Enteritis; no effect at 









infection, pneumonia; no 









Non-clinical (?); no effect 







Francisella tularensis Non-clinical; no effect at 






Leptospira spp.  
Non-clinical, occasional 
nephritis; no effect at 







Liver lesions, mortality; no 














possible; no effect at 







et al., 2015) 
Toxoplasma gondii 
Necrosis in liver, spleen 
and lungs, focal 
cardiomyopathia; acute 
fatalities can occur; can 
have a negative impact on 
populations 
Limit access 









Hepatozoon app.  Non-clinical; no effect at 









Oral candidiasis; no effect 









granulomatous reaction in 
the lungs; no effect at 




















Assessing population health 
Whether a population of wild animals is ‘healthy’ is difficult to determine. On the individual 
level the modern definition of health is not the absence of disease, but the ability to adapt 
and self-manage (Huber et al., 2011), while population health has been defined as the 
“health outcome of a group of individuals, including the distribution of such outcomes within 
the group” (Kindig and Stoddart, 2003). For wildlife, it has been proposed to define health as 
the capacity to cope with biological, social and environmental changes over time, based on 
individual and ecosystem capacities. It has been pointed out that “wildlife health is not a 
biologic state but rather a dynamic human social construct based on social expectations and 
scientific knowledge” (Stephen, 2014). Some infectious diseases or parasites may be 
sustained in a population without negatively affecting it as a whole, as long as no other 
stressors or changes to the ecosystem disrupt the balance (Real, 1996; Cunningham, 
Daszak and Wood, 2017).  
A range of animal related parameters can be used as indicators of the health of a population. 
Indicators need to be measurable in some form, they should ideally be independent from one 
another, reliable, readily available, unambiguous and representative of an animal’s health. 
They can include the presence of certain pathogens, morbidity and mortality events, endo- 
and ectoparasite burdens observed in individuals, reproductive success, general health and 
well-being of individuals, or for example parameters such as weight, body condition score 
(BCS) or results of laboratory tests assessing organ function. In some situations where lots 
of information is available and certain parameters show higher suitability than others to 
indicate health, different parameters used may be weighed and an integrated health score 
calculated (Depoorter et al., 2015). In wildlife, observable health outcomes such as 
nutritional status, reproductive success, longevity and the presence of diseases and 
parasites are the most frequently used indicators. Much information can be collected in this 
manner by observing live animals from a distance and using carcasses opportunistically 
found for more detailed assessment and disease and parasite screenings (Jamot, 2013). 
Such fairly easily collectable general parameters suitable to assess individual and population 
health in ERS specifically are introduced in chapter 2 (p. 43).  
1.2. Research objectives 
Leprosy has only been described recently (2014) in ERS. Initial research using opportunistic 
samples has produced a bulk of highly relevant information regarding the geographic spread 
of the pathogens throughout the British Isles, the specific strains present as well as on some 
clinical presentations and established the existence of non-clinical cases (Meredith et al., 
2014; Simpson et al., 2015; Avanzi et al., 2016; Butler et al., 2017). However, in live ERS the 
basic characteristics of leprosy have not yet been assessed and carcasses can still provide 
additional information to what has currently been published.  
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Three aspects are usually included in the basic description of a disease: clinical 
presentation, pathology, and epidemiological characteristics. This piece of work aims to 
provide new information on all three aspects, to increase the understanding of this ancient 
disease in its newly discovered wildlife host. The collected information should be relevant to 
the formulation of an appropriate response to ERS leprosy in a species conservation context.  
Currently, no information exists on the diagnosis, progression and prevalence of leprosy in 
live ERS, or about the effect leprosy is having on ERS populations. Efforts to identify leprosy 
in GS in the British Isles have been minimal and it is unknown whether leprosy occurs in 
ERS outside the British Isles. To address these knowledge gaps the following hypotheses 
are explored:  
1. The same diagnostic methods used in other hosts and in ERS carcasses can be 
applied to live ERS under field conditions.  
2. The clinical presentation of leprosy in ERS is pathognomonic and very similar 
between individuals.  
3. Leprosy has an impact on health indicators in individual ERS. 
4. Leprosy is as frequently observed in male as in female ERS.  
5. A histopathological lesion spectrum similar to other host species is present in ERS.  
6. Molecular and histological methods are both suited to identify leprosy in ERS. 
7. Leprosy bacilli can be detected in a range of organs in ERS.  
8. Lesion development and changes in clinical signs of leprous ERS can be observed 
within a two-year period.   
9. Leprosy prevalence and morbidity is similar in two British Island populations. 
10. The presence of leprosy has a negative effect on ERS population health. 
11. Both leprosy bacilli are present in ERS in different locations throughout the British 
Isles. 
12. Leprosy is exclusive to British ERS.  
Chapter 2 will introduce the study sites and populations used and provide information on 
trapping and anaesthetic methods, as well as general information on the ERS seen in the 
two focus populations. Chapter 3 focusses on adapting diagnostic methods for the use in live 
ERS (hypothesis 1). Chapter 4 collates information on the clinical and histological 
presentation of leprosy in ERS collected throughout this study, including the distribution of 
leprosy bacilli throughout the host body (hypothesis 2-7). Chapter 5 compiles longitudinal 
data to illustrate the progression of leprosy in ERS under natural conditions (hypothesis 8). 
Chapter 6 addresses epidemiological aspects of ERS leprosy in two ways. First, the 
prevalence and impact of leprosy on the two focus populations is explored using health 
indicators (hypothesis 9-10). Secondly, active surveillance efforts are made in ERS and 
other squirrel populations not previously assessed for the presence of leprosy, both in the 
UK and in Continental Europe (hypothesis 11-12). In Chapter 7 the new information gathered 
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on ERS leprosy is put into context in terms of its implications for ERS conservation efforts, 

























Chapter 2: Study sites and overview of study population 
health      
2.1. Introduction 
The apparently sporadic occurrence of leprosy in ERS seen in opportunistic sampling efforts 
makes it difficult to understand the effects this ancient disease is having on individuals and 
populations. To investigate the impact leprosy is having on its conservation sensitive wildlife 
host, in situ assessment over time is necessary.  
Population dynamics are usually influenced by a range of factors: habitat area, habitat 
quality, community composition and community interactions, mutualism, parasitism and 
transmissible diseases, predation, competition (Begon, Townsend and Harper, 2006). 
Islands offer a downscaling of these factors and therefore advantages as disease study 
systems. Generally, species diversity decreases with island area (Begon, Townsend and 
Harper, 2006), resulting in fewer species that could be involved when looking at disease 
dynamics in such settings. Active habitat and species conservation management on islands 
can create a situation in which ERS populations are relatively stable over time, except for 
limited and predictable fluctuations depending on annual tree seed crop quality. Unexpected 
reductions of populations can thus be more easily identified and their causes investigated, 
compared to open population systems where migration would be a major additional factor to 
be considered. GS are still absent from some smaller British islands, and will thus not 
influence ERS populations here as competitors and potential source of SQPV (Chantrey et 
al., 2014). Therefore, island populations were chosen to study leprosy in ERS. 
Two different leprosy bacilli, M. leprae and M. lepromatosis have been identified in British 
ERS. It was therefore decided to include two island populations in this study, for which the 
presence of either one or the other leprosy bacillus had previously been confirmed. There is 
no information currently available as to when and how exactly leprosy was introduced to 
British ERS populations, however, data available on the bacterial strains present suggests 
that the initial introduction may have occurred centuries ago (Avanzi et al., 2016). 
Timing of the biannual trapping sessions was chosen such as to avoid the main reproductive 
peaks in late  spring and summer (Bosch and Lurz, 2012) and very cold and wet weather, 
i.e. winter.  
2.1.1. Selected study sites  
The field study locations for this project were Brownsea Island (BI) in England (50° 41’ 30” N, 
1° 58’ 20” W), and the Isle of Arran (AR) in Scotland (55° 34’ N, 5° 15’W). Access and local 
support were readily provided in both locations. On both islands ERS are the only wild 
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squirrel species present. Edinburgh was the central location for the coordination of this 
project as well as site of most of the post mortem and laboratory work.  
Brownsea  
BI is one and a half miles long and located in Poole Harbour, Dorset, in South West England. 
The earliest evidence of settlement on the island dates back to the 5th-century BC 
(NationalTrust, 2017c). Over time the island has been used in different ways. In 1927 the 
private owner of the island abandoned farming and other entrepreneurial aspirations, 
allowed the farm animals to roam freely, and natural heath and woodland to take over the 
island (NationalTrust, 2017c). In 1961 the National Trust, a national heritage conservation 
charity, took over responsibility for the island. Today the island is famous for red squirrels, 
other wildlife, including seabirds, water voles, and sika deer, as well as scouting 
(DorsetWildlifeTrust, 2017; NationalTrust, 2017a). The northern half of the island is leased 
and managed by the Dorset Wildlife Trust (DorsetWildlifeTrust, 2017). Of the island’s 203 
hectares, 127 are covered with diverse forest habitat, featuring over 100 tree species, mostly 
planted from the 1700s onwards (NationalTrust, 2017d) (Figure 1). The climate on BI is mild, 
with average temperatures of 11-17 °C in spring and 12-20 °C in autumn (Figure 2).  
 





FIGURE 2:  METEOBLUE CLIMATE DIAGRAM FOR BI  BASED ON 30 YEARS OF HOURLY WEATHER 
MODEL SIMULATIONS (Meteoblue, no date a) 
Arran 
AR is Scotland’s seventh largest island (432 km2/43200 hectares), located on the west coast 
in the Firth of Clyde. It is part of the North Ayrshire council area. The woodland on the island 
is fragmented, with a mixture of high and low connectivity, dominated by coniferous trees 
and covering about 6803 hectares of the island, of which roughly 87% were seed producing 
in 2014 (Macpherson, 2014). The main tree species are Sitka spruce, pine, and larch 
(Meredith, Gurnell and Lurz, 2014). The woodlands on the eastern side of AR form a 
contiguous system with those in the south-central area of the island, while the connectivity is 
low on the western side of the island (Lurz, 2012). Roads running around and through the 
island can be a danger to squirrels moving around the island. Forest free areas in the hills 
limit squirrel movement across the island (Figure 3). Average temperatures on AR are 6-11 





FIGURE 3:  TOPOGRAPHIC MAP OF AR  (COPYRIGHT:  ORDNANCE SURVEY, OS OPENDATA) 
 
 
FIGURE 4:  METEOBLUE CLIMATE DIAGRAM FOR AR  BASED ON 30 YEARS OF HOURLY 
WEATHER MODEL SIMULATIONS (Meteoblue, no date b) 
2.1.2. Local ERS populations  
Local support efforts for ERS are similar for both islands, mainly through environmental 
management, but also with some provision of feeding stations or nesting opportunities. 
Feeding stations are used on both islands within our trapping areas to make squirrels more 
visible to visitors and engage the public in the protection of the species. Such wildlife hot 
spots are increasing the risk of infection for a range of species and pathogens (Rushton et 
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al., 2000; Adelman et al., 2015). It cannot be said at this point if this is true for leprosy as 
well, as transmission within the ERS population is too poorly understood.  
Brownsea 
ERS are believed to have been introduced to BI no earlier than the 18th century (Crispin, 
1979). The population is estimated to consist of about 200 individuals, with numbers varying 
between years depending on food availability (NationalTrust, 2017b). First written reports of 
clinical signs suggestive of  leprosy in the population date back to the 1970s (Banks, 1971; 
Crispin, 1979). The population is not exposed to any specific current threats, but is limited in 
growth by the carrying capacity of the suitable habitat and the size of the island.  
ERS on BI have been found to be infected with M. leprae. The disease appears to have 
been endemic to the island for a prolonged time and it presents with a range of clinical signs, 
from clinically unsuspicious to severe, pathognomonic lesions. Avanzi et al. (2016) found 
eight out of 25 (32%) M. leprae positive ERS (determined by detecting mycobacterial DNA in 
tissues) from BI to have obvious clinical signs of leprosy.  
The BI ERS population was chosen as it appears to have the highest known prevalence of 
leprosy in the British Isles, and is one of the few places in which clinical cases of squirrel 
leprosy are regularly observed (Avanzi et al., 2016). BI is therefore an ideal study site to 
investigate the effects of leprosy as an endemic disease in an ERS population. However, this 
potentially atypically high prevalence and the fact that only M. leprae has been isolated from 
squirrels on this island (Avanzi et al., 2016) may limit applicability of information collected 
here to other populations.   
Arran 
ERS have been introduced to AR from other populations, in this case most likely from the 
European continent. Introductions took place in the late 1930s with a second release 
suspected in the 1950s (Lurz, 2012). Today they present a system of linked sub-populations, 
which are largely in good health, and vary in numbers with annual food availability (Meredith, 
Gurnell and Lurz, 2014). About 400 to 1800 red squirrels can be supported by the local 
ecosystem, depending on tree seed crop year (Meredith, Gurnell and Lurz, 2014). For the 
purposes of this thesis an estimated mean population size of 1100 ERS is used. ERS are 
present all around the island (Lurz, 2012). The population is under no imminent conservation 
threat and is being managed to further increase and stabilise its numbers (Meredith, Gurnell 
and Lurz, 2014).  
Earlier modelling studies investigating the potential effects of disease introduction on ERS on 
AR have assumed the town of Brodick - as the islands main harbour - to be the most likely 
point of introduction (Macpherson, 2014). Predictions from this study conclude that a chronic 
disease which is transmitted slowly, characteristics met by leprosy, would become endemic 
on AR following introduction to the ERS population (Macpherson, 2014).  
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In 2016 tissues from one out of ten ERS (10%) tested from AR were positive for the 
presence of M. lepromatosis DNA. The animal did not show clinical signs of leprosy (Avanzi 
et al., 2016). However, members of the public have reported seeing squirrels with clinical 
signs of leprosy on AR.  
It was assumed possible to gather information on the prevalence and effects of M. 
lepromatosis in an ERS population here that could serve as a small-scale model for the 
wider situation on mainland Britain and Ireland. It was also hoped that with intensified 
carcass collection and trapping efforts, collection of clinically diseased carcasses would 
enable comparison of the histological presentation of the disease caused by M. lepromatosis 
with that caused by M. leprae in ERS on BI. 
2.1.3. Licensing 
All procedures carried out in this project were approved by the Animal Welfare and Ethical 
Review Body (AWERB) at the University of Edinburgh (UoE) and undertaken under the 
appropriate Home Office Licences (PPL70/9023; PIL I3A4168A8 (AM); PIL I39FBB99D 
(AKS)), and additional licences by Natural England (2016-24517-SCI-SCI; 2018-36360-SCI-
SCI) and Scottish Natural Heritage (90896).  
Trapping, anaesthesia and general health assessment techniques for live animals and post 
mortem assessments for carcasses were consistent throughout the project and are 
presented in this chapter, along with background information on the ERS assessed in the 
two focus populations of this project.  
2.2. Methods 
2.2.1. Live trapping and general anaesthesia 
Trapping 
Red squirrels were trapped systematically twice a year, with each trapping session 
consisting of one preparation day, three trapping days, and one clean-up day. The first time 
an ERS was seen it was microchipped. Local members of the National Trust for Scotland 
and the Forestry Commission (AR), and the National Trust and Dorset Wildlife Trust (BI), 
placed the traps (Albion Manufacturing© Mink/Squirrel Trap Type – Albi 079 (079S, 034)) in 
pre-agreed locations 1-2 weeks before the planned trapping session and pre-baited with the 
traps fixed in an open-position.  
On BI 21 non-customised traps were used. The fields outlined in yellow in the Google 
satellite image below (Figure 5) indicate trapping areas. Most traps (n=15) were placed in 
the larger area around the “Villa” in the part of the island managed by the Dorset Wildlife 




FIGURE 5:  SATELLITE OVERVIEW OF BI.  AREAS IN WHICH SQUIRREL TRAPS WERE PLACED 
ARE CIRCLED IN YELLOW (IMAGE SCREENSHOT VIEW OF GOOGLE MAP).  
On AR traps were customised by fitting a wooden floor and a peanut reservoir. Fifteen traps 
were used in spring 2017. An additional 10 traps were bought following that session and 
worn-down traps replaced, so that in the following sessions a total of 16 customised traps 
were used. Exact trap locations varied slightly from session to session depending on current 
ERS sightings, forestry operations (thinning and felling) and risk of interference from other 
wildlife, particularly badgers. They were always within the large area indicated in yellow in 
the satellite image below. The smaller yellow square indicates the location of Brodick Castle 
grounds in which squirrel feeding stations exist and where traps were placed at highest 
density following very good trapping success rates (Figure 6). 
 
FIGURE 6:  SATELLITE VIEW OF THE SEGMENT OF AR  IN WHICH TRAPS WERE PLACED . THE 
SMALL YELLOW SQUARE MARKS BRODICK CASTLE GROUNDS , THE LARGER YELLOW AREA 




At the beginning of each trip the traps were checked by the research team. If deemed 
necessary for success and safety purposes, they were slightly relocated, but kept close 
enough to the pre-baiting location to not decrease chances of successful trapping. On each 
trapping day the traps were set at dawn and regularly checked thereafter. On BI check 
intervals were between 30 min to 1 h, while they were closer to 1 h on AR.  
Once an ERS was trapped, the trap was covered with a blanket and transported by hand or 
by vehicle to the designated processing area established for each session. Depending on a 
day’s working speed, cut-off points at which all traps were closed were determined. This 
avoided excessive waiting times for squirrels between capture, processing and release, and 
releasing squirrels outside their normal activity hours, i.e. after sundown. Animals which did 
not calm down within a few minutes of being recovered were taken back to the trapping site 
and immediately released without attempting anaesthesia and sampling, as the higher stress 
levels in these animals were deemed to increase anaesthetic risk and to have a negative 
effect on animal welfare. Peanuts and apple slices were offered to the squirrels while they 
awaited anaesthesia and during recovery.  
Predicted size of the sub-population covered by trapping efforts 
Mark-recapture information can be used to estimate population size where the estimated 
number (N) of individuals in the population is calculated by multiplying the number of 
individuals captured and marked (M) with the total number of animals captured the second 
time (C) and dividing the result by the number of individuals recaptured (R).  
N= (M*C)/R 
In the current study setup, trap placement was confined to certain areas of both islands. 
Mark-recapture data can therefore not provide information on the total size of the population 
of ERS on BI and AR. It is however of interest to know which proportion of this total 
population was within the reach of the assessments by trapping just in the chosen focus 
areas. This allowed to fully appreciate how this approach may limit the ability to extrapolate 
from the current data to the populations as a whole.  
Local population size estimates were therefore calculated for BI and AR, using sessions six 
months apart, allowing for four calculations for BI and three for AR. The average local 
population size was also calculated from these individual values. All animals seen in a 
marking session were treated as newly marked for calculation and only those marked in the 
immediately previous session counted as returns for calculation. 
Anaesthesia 
All animals were visually assessed for fitness for anaesthesia while in the trap by carefully 
lifting the corner of the cover. Conditions that would have excluded an animal from 
anaesthesia were heavy pregnancy or immediately obvious active lactation. In accordance 
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with the Home Office licence, animals with acute injuries were anaesthetised and assessed 
by a veterinary surgeon.  
All animals were transferred from the trap into a bottle shaped clear plastic induction 
chamber using hessian sacks for stress reduced transferral and avoidance of direct 
handling. Once in the induction chamber, the chamber was immediately covered to keep the 
animal calm, and connected via an Ayes’s T-piece circuit to a Stinger backpack anaesthetic 
gas machine (Darvallvet). Before and at the end of each anaesthesia the circuit and system 
were flushed with oxygen. Induction was achieved using 0.6-1.5 l/min oxygen and 5% 
isoflurane, closely monitoring the reaction of each individual.  
Once all proprioceptive reflexes were lost, which usually occurred within the 5-10 minutes 
previously described for inhalant induction of rodents (Heard, 2014), the animals were taken 
from the induction chamber and a mask fitted. Anaesthesia was maintained on 0.6 to 1 l/min 
oxygen and 1.8-3% isoflurane, closely monitoring the respiratory rate and anaesthetic depth 
of each individual, aiming for a light anaesthetic plane sufficient for sample collection. During 
the anaesthetic period the animals were placed on a heat pad to maintain body temperature. 
In accordance with the Home Office licence, depending on individual findings during the 
health assessment, one-off veterinary treatment was provided if judged to be necessary or 
euthanasia was conducted under general anaesthesia. The latter was only considered when 
in the best interest of an individual animal’s welfare, for example if animals were severely 
affected by leprosy and/or other diseases, or had severe injuries that could not be resolved 
in a one-off treatment.  
Once all sampling was completed the isoflurane was turned off and pure oxygen was 
administered for a minute (or until ERS began to move). Each ERS was then transferred 
back into the trap it had been caught in, providing incontinence pads for insulation, covered 
and placed close to a heat source until fully recovered. Each ERS was released close to its 
capture site. 
Equipment management 
To avoid becoming a disease vector when moving between the two populations, single use 
equipment was employed as much as possible. Equipment that needed to be reused was 
cleaned thoroughly with disinfectants approved in local SOPs at the time of each trip. 
Equipment was stored for at least one week in a dry, clean storage following disinfection 
before being moved to the next work site. Fabric items, such as hessian bags and blankets 
were washed with disinfectant and exposed to sunlight. Traps were not moved between the 
islands but disinfected and stored in secure locations between sampling sessions. 
2.2.2. General health assessment in live animals 
A visual health check following a defined protocol (Appendix I, p. 224) was carried out for all 
squirrels trapped throughout this project and any abnormalities were noted. Health was 
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assessed each time an animal was trapped to provide an overview of the health status of 
each squirrel population by sampling group.  
Age, sex and reproductive status 
To determine a squirrel’s age, the crown-rump length was measured with a ruler from the 
cranial base of the ear to the base of the tail, and the shin length of the left shin measured 
with callipers. Body weight was determined using a 600g capacity spring weighing scale 
(Pesola® Light-Line). Additionally, the maturity of the coat was noted. This information was 
combined to group the ERS into one of three age classes (juvenile, subadult, adult) as 
detailed in Table 6.  
TABLE 6:  AGE GROUPING PARAMETERS FOR ERS 
Parameter  Juvenile  Subadult  Adult  
Body weight <160g <280g >280g 
Crown-rump length <110mm <160mm >160mm 
Shin length <58mm 59-66mm >66mm 





Inactive Inactive or 
beginning to be 
active 
Active or signs of 
previous activity 
More sophisticated ageing of adult squirrels is only possible in fresh carcasses, where eye 
lens weight, bones and teeth can offer additional information (Bosch and Lurz, 2012). In live 
squirrels it is only possible to say that adult squirrels are most likely born before the year in 
which they are seen. In females, bald circles around the teats can indicate that they have 
suckled young before. If this is observed in a not currently lactating or pregnant female in 
early spring, it is likely that it raised young the year before, i.e. is at least in the second year 
of adulthood/third year of life.  
The sex of each ERS was noted along with its reproductive status. For males the 
reproductive categories used were 1) abdominal testes indicating reproductive inactivity, 2) 
scrotal testes usually present shortly before/after and during the breeding season, and 3) 
scrotal pigment usually only present in sexually mature, reproductively active ERS (Bosch 
and Lurz, 2012). Females were grouped as either 1) inactive, 2) in oestrus, when a mild 
swelling of the vulva was present and the season appropriate, 3) pregnant, when signs of 
pregnancy like prominent but not yet lactating mammary glands, or palpable amniotic sacs or 
foetuses in the uterus were observed, or 4) lactating when brief stimulation of a mammary 
segment resulted in milk flow (Bosch and Lurz, 2012).  
Body condition score (BCS) and weight 
The BCS was established by palpating the muscle and fat cover in the lumbar area and 
along the caudal thoracic, lumbar and sacral spine. The BCS is an easy, subjective method 
to assess body tissue reserves. It is independent from size and weight (Sakaguchi, 2009). 
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The four category body condition scoring system previously described for squirrels (LaRose 
et al., 2010) was used as detailed in Table 7. The weight determined during the ageing of 
squirrels is presented along with the BCS.  
TABLE 7:  BCS  CATEGORIES FOR ERS 
Body condition Description 
Emaciated No fat and very little muscle cover, with strongly protruding, visible 
bones 
Thin Little fat and muscle cover and the bone structure can be easily felt 
but is not visible (physiological at the end of lactation) 
Normal Bone structure is just palpable when applying light pressure to the 
muscle/fat cover 
Fat Impossible to distinguish hip bones and spinous processes even 
with pressure 
 
General health status (GHS) 
To assess the influence leprosy has on an ERS, it is relevant to assess their health 
independent of their leprosy status. This can provide information on whether leprous ERS 
are likely to suffer co-morbidities or if they can fare equally well as ERS not affected by the 
disease.  
For the purpose of this project a GHS ignoring leprosy lesions was created. Based on 
observations made during the health check each squirrel was sorted into one of six general 
health categories: 
• 1= in good health 
• 2= in good health, minor injury that is likely to heal without complication or has 
already healed 
• 3= acutely unwell, improvement likely 
• 4= acutely unwell, improvement unlikely 
• 5= chronically unwell, able to cope 
• 6= chronically unwell, unable to cope.  
Causes of observed conditions were not followed up diagnostically, due to financial and time 
restrictions within this project. Healed punch biopsy sites were noted but not included as old 
injuries, as they are of known iatrogenic origin and part of this study. 
Outside this project leprous ERS should always be considered as chronically diseased, 
either coping with the disease or not. For the purpose of this study the leprosy status of 
individual ERS and populations will be described and assessed separately in the following 
chapters, only the number of squirrels seen with lesions will be mentioned at the end of the 
GHS sections of this chapter.   
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2.2.3. Carcass collection and post mortem assessment 
Local rangers and volunteers, members of the Forestry Commission and general public 
collected ERS carcasses in the wild between 2015 and 2018 and made these available for 
this study. Some of these were in good condition (road kills), while others were incomplete 
(prey) or severely desiccated (discovered during annual nest box checks). In addition, the 
carcasses of three ERS euthanised during field work on BI (as required by the Home Office 
licence for animals with severely impaired welfare/unfit for release back into the wild) and of 
three ERS that died of sudden cardiac arrest under general anaesthesia on AR were 
included. All carcasses were stored frozen (-20°C) from the time of collection until post 
mortem examination. The post mortem (PM) examination was carried out with relevant risk 
management measures in place, following 24 hours of thawing of carcasses at room 
temperature at the UoE. The PM protocol collected information in a manner that allowed 
direct comparison of carcass data to that collected during live sampling (Appendix II, p. 225).  
Data analysis 
Information was summarised using Microsoft Excel® and R (https://www.r-project.org/). 
Analysis of the collected data is purely descriptive to provide a population health background 
for the remainder of this work. Results for general health and post mortem assessment are 
initially given separately for each island, but discussed together.  
2.3. Results  
2.3.1. Live trapping and general anaesthesia  
Trapping 
A total of 127 ERS were trapped for assessment across the five sessions completed on BI 
(1= autumn 2016, 2= spring 2017, 3= autumn 2017, 4= spring 2018, 5= autumn 2018). Only 
one ERS was released without attempting anaesthesia. All other squirrels appeared to settle 
and did consume the peanuts and apple slices offered. Across all session a total of 73 re-
trapping events of ERS within the same session occurred, in which the ERS were 
immediately released. Traps were usually closed by noon, as squirrels very readily entered 
in the morning. On several occasions ERS were observed searching for peanuts outside a 
trap that already contained an ERS.  
On AR a total of 62 trapping events with full assessment occurred across four sessions 
(numbering of sampling sessions followed the system established on BI, starting with 2). Re-
trapping of the same ERS within a sampling session occurred only six times on this island. 
ERS appeared to settle calmly in the traps and were consuming the food offered.  
Size of the sub-population realistically covered by our trapping efforts 
The average local sub-population size in the trapping area was 54 ERS on BI, i.e. about a 
quarter of the estimated total island population. For AR it was 120 squirrels, i.e. 1/10 of the 
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total estimated average population. The estimate varied between mark-recapture pairs 
(Table 8).  
TABLE 8:  LOCAL SUB -POPULATION ESTIMATES FOR BI  AND AR  BASED ON THE DIFFERENT 





Pop. Estimate BI Pop. Estimate AR 
Autumn 2016 Spring 2017 52 NA 
Spring 2017 Autumn 2017 43 102 
Autumn 2017 Spring 2018 56 84 
Spring 2018 Autumn 2018 66 175 
 
Anaesthesia 
A total of 188 general anaesthetic procedures were completed throughout this study. Three 
animals, all from AR, did not recover from anaesthesia, representing an anaesthetic mortality 
of 1.6%. In all three ERS underlying pathology was detected during necropsy and 
attributable as increased anaesthetic risk factor (Table 9).   
TABLE 9:  AGE, SEX AND REPRODUCTIVE STATUS OF SQUIRRELS THAT DIED  OF SUDDEN 
CARDIAC ARREST UNDER GENERAL ANAESTHESIA AND CHANGE S OBSERVED AT POST MORTEM 
EXAMINATION  
Animal Age Gender  Reproductive 
status 
PM observations 
AR029_18 adult female pregnant Dilated right heart, most of lung 
tissue dark red and non-floating, liver 
dark red, fibrotic inguinal cyst 
AR042_18 adult female inactive Majority of lung tissue dark red 
colour, firm consistency & non-
floating, liver enlarged & dark red 
AR051_18 adult male Abdominal testis Dilated right heart, some lung tissue 
dark red and non-floating 
 
2.3.2. General health assessment in live animals 
Brownsea 
A total of 126 health assessments were completed on ERS from the BI population across the 
five sampling sessions.  
Age, sex and reproductive status 
Most trapped ERS were adults (121/126; 96%) with an overall male to female ratio of 1.14:1. 
No juveniles were trapped. The remaining five ERS were subadults. Trapping of subadults 




FIGURE 7:  SEX AND AGE OF ERS TRAPPED ON BI  PER SESSION AND IN TOTAL  
The average crown-rump length measured was 169.3mm (Min= 115.0mm, Max= 185.0mm, 
SD= 8.4g). Shin-lengths ranged from 61.0 to 73.2mm (M= 68.8mm, SD= 2.1g). 
Most adult females were reproductively inactive at the time of trapping (43/58; 74.1%). In all 
but one session (spring 2017) more than half of the female squirrels seen were not 
reproductively active (Figure 8).  
 
FIGURE 8:  REPRODUCTIVE STATUS OF FEMALE ERS ASSESSED ON BI 
In males the sexual activity status was variable. Male squirrels showing signs of reproductive 
activity like scrotal pigment were seen in almost all trapping sessions. More males presented 
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with scrotal pigment in spring than in autumn (Figure 9). The five subadult individuals were 
excluded from the reproductive status dataset, as they may not yet have reached sexual 
maturity. 
 
FIGURE 9:  REPRODUCTIVE STATUS OF MALE ERS ASSESSED ON BI 
Body condition and weight 
Most animals on BI were in normal body condition at the time of the assessments (n= 
79/126, 62.7%). Another 46 (36.5%) were thin. Only one animal (0.8%) was emaciated. 
While the proportion of normal and thin animals seen changed over time, this did not appear 
to reflect a seasonal variation between spring and autumn assessments (Figure 10).   
 
FIGURE 10:  PROPORTION OF BCS  OF ERS SEEN IN THE FIVE ASSESSMENT SESSIONS ON BI   
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The average weight of all ERS assessed on BI was 314.3g (SD= 32.9g, Min= 200.0g, Max= 
435.0g). The variation of the average weight between the different sessions was minor, 
however some individuals weighed much more or less than the average (Figure 11).  
 
FIGURE 11:  BODY WEIGHT BI  ERS GIVEN IN GRAM ACROSS THE DIFFERENT SAMPLING 
SESSIONS.  
General health status 
Most BI ERS (73.8%, n= 93/126) were classified as in good health (excluding signs of 
leprosy). One of these animals had severe, ulcerated leprosy lesions, leading to the decision 
to euthanise it. Another 23.8% (n= 30/126) of the squirrels were classed as in good health 
with minor or healed injuries. Observed were loss of ear tissue unrelated to our sampling (n= 
15), mild injuries that could have been linked to trying to escape from the trap (n= 10), old 
scars or scabs (n= 9), a crust on the ear (n= 1), and a missing toe (n= 1). Up to two different 
injury types were seen in the same animal. 
One squirrel categorised as acutely unwell but likely to improve (0.8%) presented with a 
drained scrotal abscess, which was further treated while the animal was under general 
anaesthesia for assessment.  
One ERS (0.8%) was classed as acutely unwell and unlikely to improve due to laboured 
breathing and wheezing breathing noises, indicating acute pneumonia, and severe, 
ulcerated leprosy lesions. Another (0.8%) was classed as chronically unwell and unable to 
cope for much longer, as it was suffering from a mammary abscess and intense swelling of 
multiple joints, with reduced range of movement, as well as severe ulcerated leprosy lesions. 
These two animals were euthanised in compliance with the licence conditions. Figure 12 
summarises the GHS assigned to all ERS seen on BI (total), and broken down by 




FIGURE 12:  GHS OF ERS ASSESSED ON BI   
Clinical skin lesions that were assumed to be due to an infection with leprosy bacilli were 
seen in all assessment sessions. They were seen in seven squirrels in autumn 2016, nine in 
spring 2017, four in autumn 2017 and spring 2018 each, and in six ERS in autumn 2018, i.e. 
in a total of 30 assessments across the study duration.  
Ectoparasites 
In one out of the 126 assessments no ectoparasites were observed on the ERS or in the 
induction chamber (0.8%). On 42 animals (33.3%) only ticks (Ixodes ventalloi, Ixodes ricinus, 
Ixodes spp., species information provided by the Tick Surveillance Scheme) were observed, 
on 13 (10.3%) only fleas (Ceratophyllidae, species not determined) were seen, 65 (51.6%) 
had ticks and fleas, four (3.2%) had ticks and harvest mites (Trombicula autumnalis) and on 
one squirrel ticks, fleas and harvest mites were seen (0.8%). Figure 13 shows the proportion 




FIGURE 13:  ECTOPARASITES OBSERVED ON ERS FROM BI  IN THE DIFFERENT ASSESSMENT 
SESSIONS.  
Less than five obvious ectoparasites (= intensity category 1) were noted on 49 ERS (38.9%), 
six to ten parasites (= intensity category 2) on 24 of the assessed ERS (19%), and on the 
remaining 52 ERS (41.3%) more than ten ectoparasites (= intensity category 3) were 
counted. More ERS with intensity category 3 were seen in autumn (Sessions 1, 3, 5) than in 
spring (Sessions 2, 4) assessment sessions (Figure 14).  
 
FIGURE 14:  INTENSITY OF ECTOPARASITE INFESTATION OF ERS ON BI  IN THE FIVE SAMPLING 
SESSIONS. CATEGORIES :  0= NO OBVIOUS PARASITES , 1= 1-5 OBVIOUS PARASITES , 2= 6-10 
OBVIOUS PARASITES , 3= >10 OBVIOUS PARASITES .  
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None of the animals appeared anaemic, or showed any other signs of disease attributable to 
the observed parasite burdens. Ticks were often clustered around the upper body, head and 
ears of ERS, but were rarely present on the lower abdomen and hind legs.  
Arran 
On AR 62 ERS health assessments were completed across the four sampling sessions.  
Age, sex and reproductive status 
All squirrels assessed on this island were adults and the total number of males and females 
seen were almost even (32 and 30 respectively; Figure 15).  
 
FIGURE 15:  SEX AND AGE -GROUP OF THE ERS ASSESSED ON AR  ACROSS ALL SAMPLING 
SESSIONS 
The AR squirrels had an average crown-rump length of 177.2mm (SD= 7.7g, Min= 156.0mm, 
Max= 193.0mm). The average shin length measured was 71.3mm (SD= 2.9g, Min= 63.7mm, 
Max= 77.1mm). 
On AR reproductively active females were only observed in spring. These were either in 
oestrus or pregnant. Pregnant females could only be identified by abdominal palpation, not 
by visual inspection. At least half of the female squirrels were reproductively inactive at the 




FIGURE 16:  REPRODUCTIVE STATUS OF FEMALE ERS ASSESSED ON AR  
Most male ERS assessed on AR in spring were reproductively active, while they were 
inactive in autumn. Overall, almost equal numbers of clearly reproductively active (scrotal 
pigment; 16/32, 50%) and inactive males (abdominal testes; 15/32, 46.9%) were seen 
(Figure 17).  
 
FIGURE 17:  REPRODUCTIVE STATUS OF MALE ERS ASSESSED ON AR 
Body condition and weight 
On AR 20 ERS (32.3%) were in thin body condition at the time of assessment. The other 42 
(67.7%) were in normal body condition. More thin animals were seen in spring 2018 than in 




FIGURE 18:  PROPORTION OF BCS  OF ERS SEEN IN THE FOUR ASSESSMENT SESSIONS ON 
AR.   
The average weight of squirrels on AR was 359g (SD 34.4g, min= 285 g, max= 430g). 
Average weight appeared higher in spring than in autumn (Figure 19).  
 
FIGURE 19:  BODY WEIGHT AR  ERS ACROSS SESSIONS GIVEN IN GRAM .  
Due to the low number of animals trapped in autumn 2016, values from both spring and 
autumn sessions were combined (n= 31 each) to assess whether the weight difference 
between spring and autumn was statistically significant. Both sets of weights are normally 
distributed (Shapiro-Wilk test p= 0.496 and p= 0.377, respectively). The mean weight was 
378.7g in spring and 340g in autumn. The null hypothesis that there is no difference in 
squirrel weight between spring and autumn can be rejected (two-sample t-test, p= 
0.000003091). ERS trapped on AR had a higher average weight in spring than in autumn 




FIGURE 20:  BODY WEIGHT OF AR  ERS BY SEASON  
General health status 
The majority of squirrels trapped and assessed on AR were in good health (n= 42; 67.8%). 
Less than a third of the animals (n= 17, 27.4%) showed minor or healed injuries while 
generally being in good health. Changes observed in this group were mild trauma to the face 
and limbs that could have occurred while trying to find a way out of the trap (n=  8), loss of 
ear tissue unrelated to our sampling (n= 6), old scars indicating parasite bites or injury (n= 
4), small crusts on the ear (n = 3), a healed penis injury (n= 1), a broken off lower incisor (n= 
1), and hair loss and scales on the back, with signs of regrowth (n= 1). A maximum of three 
of these injuries were seen in the same squirrel.  
Two ERS (3.2%) were classed as acutely unwell. One due to the presence of inflamed tick 
bites, which were deemed likely to heal with time, and the other due to an acute degloving 
injury to the last third of its tail that had occurred after fur got entangled inside the trap. The 
wound was treated and the animal released with a good prognosis, able to climb well 
immediately. In one ERS (1.6%) that was classed as chronically unwell and coping, an 
inguinal fibrotic cyst was present. This assessment only included clinical observations that 
could be made in the field. Otherwise, the three individuals that died under general 
anaesthesia and were available for full post mortem would have to be classed as chronically 
unwell, but coping until the additional stressor of general anaesthesia was added. However, 
as post mortem information is only available for this small subset of animals, it was decided 
to use the information that had been noted for them prior to their death, collected in the same 
manner as for all other animals, instead of the full information available post mortem here.  
All unwell animals were seen in 2018. Overall healthy animals dominated the subpopulation 
of squirrels assessed on AR (Figure 21). No leprosy lesions were observed during the 




FIGURE 21:  GHS OF ERS ASSESSED ON AR.   
Ectoparasites 
Nine animals (14.5%) had no visible ectoparasites. While both ticks and fleas were seen on 
the majority of ERS (n= 30, 48.4%), some had only fleas (n= 20, 32.3%) or ticks (n= 3, 
4.8%). In spring no ectoparasites were found on some ERS, and very few presented with 
ticks, while in autumn most ERS were infested with ticks and fleas. No harvest mites were 
seen on AR ERS (Figure 22). The highest parasite burdens were observed on AR in autumn 
2018 (Figure 23). 
 




FIGURE 23:  INTENSITY OF ECTOPARASITE INFESTATION OF ERS ON AR  IN THE DIFFERENT 
SAMPLING SESSIONS . CATEGORIES :  0= NO OBVIOUS PARASITES , 1= 1-5 OBVIOUS PARASITES , 
2= 6-10 OBVIOUS PARASITES , 3= >10 OBVIOUS PARASITES . 
2.3.3. Carcass collection and post mortem assessment 
A total of 21 carcasses were collected from BI and 29 from AR. 
Brownsea 
Of the carcasses collected from BI two were too desiccated for any relevant analysis, while 
from one other only a dried ear sample could still be collected. Therefore, post mortem 
examination was carried out for 18 carcasses (eight male, ten female).  
Age, sex and reproductive status 
Out of these 18 ERS four were juveniles, one subadult, and 13 adults. Crown-rump length 
could no longer be realistically determined in four carcasses due to post mortem changes. 
Values were thus available for nine adults, one subadult and the four juveniles. Three out of 
the four juveniles had a longer crown-rump length than normally expected for this age group, 
but for two their shin length, weight and coat were within the limits, so they were still placed 
here. For the third, the shin length was slightly above the expected value for juveniles as 
well, but the weight wasn’t. As this individual was not emaciated and an investigator error of 
a few mm on the measurements could be possible, this ERS was overall still classed as 
juvenile. As a result, the average crown-rump length for carcasses in this group was 
122.8mm (SD= 12.8mm). The subadult had a crown-rump length of 132mm. The adults had 
an average crown-rump length of 172.8mm (SD= 7mm). Shin length could be determined in 
all 21 carcasses originally collected. Again, values differed when animals were assessed live 
and post mortem by 0.8, 2 and 4.1mm. Using the post mortem values, juveniles had an 
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average shin length of 54mm (SD= 4.3mm), the subadult had a shin length of 56.1 mm, and 
adults had an average shin length of 66.2mm (SD= 3mm).  
Most males (n= 6) had abdominal testicles, in one scrotal testis and in one scrotal pigment 
was seen. The majority of females (n= 6) were reproductively inactive, two appeared to be in 
oestrus, one was pregnant and one late lactating.  
Body condition and weight 
Assessing the BCS emaciation was noted in eight animals, while four were thin or normal 
and one was actually categorised as fat. In one carcass the BCS could no longer be 
assessed due to severe autolysis. The body weight may have been influenced by the state 
of the carcass in some instances. For example, some carcasses were wet after thawing and 
therefore heavier, others were incomplete or in advanced state of decay. Animals weighed 
alive and after a freeze thaw cycle were 5-20g lighter at PM examination. Eliminating values 
from animals whose carcasses were obviously not going to give an accurate weight 
(incomplete or very wet) post mortem weights were available for 15 animals. Juveniles 
weighed between 105 and 135g (M= 110g, SD= 16.2g). The subadult squirrel weighed only 
125g and was classed as emaciated. Adults weighed between 225 and 365g (M= 308g, SD= 
43.8g).  
General health status 
For four carcasses it was no longer possible to determine how healthy they had been ante 
mortem. Of the remaining 17 one (5.9%) was deemed to have been in good health. This 
animal was most likely killed by a bird of prey. The ERS that had been euthanised due to its 
severe leprosy lesions but otherwise been deemed in good health was classed as 
chronically unwell but able to cope following the post mortem assessment, due to presence 
of severe lung pathology. Another euthanised ERS (joint swelling, abscess) was classed as 
chronically unwell and unable to cope. The remaining 14 carcasses (82.3%) were classed as 
acutely unwell and unlikely to improve. For most of them acute disease was assumed to be 
the cause of death. In the case of the third euthanised animal it is assumed that it would 
have succumbed to the acute lung infection had it not been euthanised. Out of the 18 
carcasses that could be assessed for the presence of leprosy lesions, seven (38.9%) 
showed clinical signs of leprosy, all of these were adults. For detailed post mortem findings 
of each carcass see appendix III (p. 226).  
Ectoparasites 
Some unengorged juvenile ticks were present on one carcass (5.6%) and fleas were 
observed on five (27.5%) carcasses. In one carcass large numbers of maggots of different 




All 29 carcasses collected from AR could at least partially be assessed in a post mortem 
examination. The full list of observations made during the post mortem assessment can 
again be found in appendix III (p. 226). One ERS collected carried a microchip from having 
been included in a sampling session. It was run over by a car about three weeks after 
assessment and microchipping. 
Age, sex and reproductive status 
One animal collected from AR was subadult, all others were adults. Sex and breeding status 
could be established for 28 carcasses. Crown-rump length was measurable in 20 carcasses 
and ranged from 162 to 188mm (M= 172.6mm, SD= 6.8mm). Shin length was measurable in 
all carcasses and ranged from 65.1 to 75.2mm (M= 69.6, SD= 2.2mm). Half of them were 
male (n=14), the others female (n=14). Most males (64.3%) had abdominal testis, in the 
other five scrotal pigmentation was present. The majority of females (92.9%) were not 
reproductively active at the time of their death, but one was pregnant.  
Body condition and weight 
Body condition could only be assessed in 20 carcasses. Most (n=13, 65%) were in normal 
body condition while seven were classed as thin. Body weight may have been influenced as 
described above for BI carcasses. It ranged between 220 and 430g (M= 340.9g, SD= 35.9g).  
General health status 
The underlying pathology for the three animals that died of sudden cardiac arrest is detailed 
in Table 9 (p. 47) and appendix III (p. 226) and was likely to have contributed to their death 
as well as the general anaesthesia. These three ERS (10.3%) were classed as chronically 
unwell but coping up to the time they underwent anaesthesia. All others were classed as 
acutely unwell but unlikely to improve, as their acute condition resulted in their death 
(89.7%). One had been euthanised at a local wildlife centre after having been seen in a 
garden with two amputated front legs and trapped for veterinary assessment. One had 
puncture wounds to its chest that could imply predation and the other 24 had been run over 
by cars. None of the carcasses showed pathognomonic leprosy lesions.  
Ectoparasites 
Ectoparasites were only seen on two of the carcasses (ticks, fleas).  
2.4. Discussion 
2.4.1. Live trapping and general anaesthesia  
Trapping 
According to expert opinion (P. W. W. Lurz) the trapping efforts in this project were highly 
successful. High trapping success and particularly the high number of apparently ‘trap 
happy’ ERS on BI underline this. The lower numbers of ERS trapped on AR are likely due to 
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population specific factors, such as lower squirrel densities. With increased experience in 
later sessions trapping success increased on AR as well, likely due to more traps being 
strategically placed in ERS hotspots.  
Areas of (artificially created) high animal densities, such as feeders or particularly crop rich 
habitat, which were chosen for trapping are likely to support frequent inter-animal contacts. 
These can be stressors, and such areas may be linked to a higher risk of disease 
transmission (Rushton et al., 2000). This aspect will be revisited in later chapters.   
While the chosen trapping regime was very successful in recruiting a large number of ERS 
for assessment, which was the main goal at this early stage of better understanding leprosy 
in ERS populations, it is likely to be biased. It only allowed to assess the subpopulation 
present in the trapping area (see below: Size of subpopulation realistically covered by 
trapping efforts). Future studies designed with different trapping strategies may be necessary 
to address some questions around squirrel leprosy, such as the true disease prevalence 
across the whole population or the presence of disease in very young live animals (Albert et 
al., 2010). These would need a wider spread of traps and are likely to create the need to 
sample animals at the trapping site. This would require the transport of equipment and 
investigator over wider distances and would likely reduce the number of animals that could 
be sampled per day. Alternatively, hands off health assessment strategies tailored to leprosy 
involving for example camera traps or detection of pathogens in debris collected from 
customised, strategically placed nest boxes could allow to collect information on the whole 
local ERS population.  
Predicted size of the subpopulation covered by trapping efforts 
On both island the subpopulation likely to be present within our trapping area represented a 
good proportion of the total island population (1/4 for BI, 1/10 for AR). The variation between 
mark-recapture pairs could either be due to true variations in the population density or linked 
to varying trapping success due to other factors like weather, exact placement of traps et 
cetera.  
BI is a continuous population and it is likely that the epidemiological situation is similar 
throughout. This could be confirmed by using different and/or additional trapping areas in 
future studies.  
On AR the ERS population is fragmented and can vary greatly in size with food crop 
availability. The subpopulation sampled here was relatively small and to fully clarify the 
question whether truly no clinical leprosy cases are present on the island or if they are 




Both subpopulations should be large enough to maintain a slow acting pathogen throughout 
the study period, an important factor for successful surveillance (Guberti, Stancampiano and 
Ferrari, 2014; Macpherson, 2014).  
Anaesthesia 
The anaesthetic mortality in this study (1.6%) was lower than the anaesthetic mortality rates 
reported for pet rats (2.01%) and wild GS (2.2%) (Brodbelt et al., 2008; Parker et al., 2008). 
The underlying chronic heart and lung conditions seen in these ERS post mortem may not 
have been discovered, even if a hands-on pre-anaesthetic assessment had been possible, 
due to the high heart and respiratory rate normal to ERS which is likely to be increased 
further if a wild animal was restrained for auscultation.  
The stress added by handling wild ERS pre-anaesthesia is likely to increase the anaesthetic 
risk, and throughout the study best practice recommendations for wildlife anaesthesia were 
followed (Chinnadurai et al., 2016) and reliance placed on expert advice (A. L. Meredith). 
Cardiac arrest occurred suddenly and after variable time spans. It was in all cases 
recognised immediately and cardiopulmonary resuscitation (CPR) initiated without success. 
CPR can be successfully performed in small rodents, as for example demonstrated in 
studies using mice and rats as models in CPR research (Papadimitriou et al., 2008). 
However, animals in such studies are likely to not suffer from underlying conditions.  
Every anaesthesia holds a risk, one that is much higher in small mammals compared to for 
example cats and dogs (Brodbelt et al., 2008). However, without a general anaesthesia the 
detailed health assessment and sampling carried out in this study would not have been 
possible. Adverse incidence frequency was kept lower than reported for comparable species, 
which makes the protocol used in this study very successful and suitable for future use.  
2.4.2. General health assessment in live animals 
Age, sex and reproductive status 
It had to be expected that given the timing and equipment used for trapping in this project 
mainly adults would be caught. Given previous observations, clinical leprosy appears to be a 
disease of adult squirrels (Meredith et al., 2014; Simpson et al., 2015; Avanzi et al., 2016) so 
this bias may be an advantage for this project.  
Squirrels on both islands appeared to be on average slightly smaller than the 180-280mm 
crown-rump length reported for ERS in the literature (Bosch and Lurz, 2012). While ERS on 
AR were on average slightly larger than on BI, this difference was on average less than 1cm. 
According to expert opinion (P. W. W. Lurz) AR ERS are larger than ERS in some mainland 
populations in North-west England. However, the literature does not provide enough detail 
on measurement methodology to know if the observed differences may just be technical. It is 
unlikely that a single factor is responsible for size differences in the two populations, 
particularly when one considers that they are likely to be of different origin (Ballingall et al., 
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2016; Hardouin et al., 2019). Chronic disease can be a cause of growth impairment (Patel, 
2008). The data collected in this study may allow to assess whether there is a difference in 
growth of ERS affected and unaffected by leprosy within our target populations. However, 
many other factors, such as genetics or food availability, can also influence growth, and 
without having the opportunity to compare ERS populations free of leprosy living otherwise 
under the exact same conditions present on AR and BI, it will not be possible to assess 
whether the relatively smaller size of ERS in these populations is due to the presence of 
disease or other factors. 
While not completely balanced, the sex distribution in the assessed sub-populations from 
both islands should permit assessment of a correlation between ERS sex and leprosy status. 
Fewer reproductively active ERS were encountered in the autumn assessments than in 
spring in both populations. Reproductive activity of ERS can occur between late December 
and the following August, but precise timing is influenced by factors like weather including 
temperature and food availability (Bosch and Lurz, 2012). More northern populations like the 
one on AR may be reproductively active for a shorter period than populations in warmer 
locations like BI. To get an initial understanding of the timescales on which leprosy 
progresses in squirrels and to be able to assess whether there are seasonal differences in 
the frequency with which cases are identified, it was necessary to trap twice a year, thus 
invariably ending up with one annual assessment session falling within the time during which 
squirrels could be reproductively active. The assessment in spring was chosen to avoid very 
cold and wet winter weather, which could potentially pose more intense stress on trapped 
animals than reproductive activity, particularly in the northern population on AR where the 
average winter temperature is just 4°C (Figure 4, p. 38). Pregnant females could only be 
identified by abdominal palpation, not by visual inspection. It was therefore not possible to 
avoid anaesthetising and including such animals in the current study. 
Body condition and weight 
On both islands the majority of animals were in normal body condition, with a smaller but 
again similar proportion being classed as thin. Even with one emaciated ERS seen on BI, the 
results do not spark immediate concern.  The average weight observed was in line with the 
normal weight range reported for the species (202-480g) (Bosch and Lurz, 2012). 
While on BI no seasonal difference in body condition and weight was observed, differences 
were present on AR. This could be attributed to the milder climate on BI, resulting in greater 
availability of food sources (Figure 2, p. 37; Figure 4, p. 38) and seems to be supported by 
that fact that more thin animals were seen on AR in spring 2018 than in the other sessions. 
This particular spring had snow in February and March, which might have resulted in 
reduced access to food or increased cold stress leading to a loss of body condition. 
Interestingly though, average body weight on AR was significantly higher in spring than in 
autumn. This may seem to be a contradiction, but could be explained with the inclusion of 
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pregnant female ERS in the spring samplings, which in AR occurred exclusively in spring. 
Pregnant females have a higher average body weight, but when food availability is reduced, 
they may still be in reduced body condition.  
General health status 
Leprosy has so far only been detected in dead ERS (Meredith et al., 2014; Simpson et al., 
2015; Avanzi et al., 2016; Butler et al., 2017). Their death implied that they were no longer 
able to cope with all the factors having an impact on them, including leprosy. However, 
assessing the general health of individuals in two ERS populations affected by leprosy, 95% 
of all live squirrels assessed on both islands were “in good health” and “in good health with 
minor or healed injury”. If population health is seen as the sum of the health outcomes of its 
individuals, then this relates to both the AR and BI ERS population appearing to be by and 
large in good health. While some individuals may be harbouring pathogens, no single cause 
for obvious ill-health in large numbers of ERS in these populations was seen, if leprosy bacilli 
are ignored. The presence of another major disease influencing the populations thus 
appears unlikely. This should make the investigation into the impact leprosy bacilli have on 
ERS in this study viable.   
On AR all unwell animals were seen in 2018, however, with data from just 2 years it is 
impossible to know whether this observation has any relevance. The absence of leprosy 
lesions on AR means that this study will not be able to compare the clinical and histological 
effects of M. leprae and M. lepromatosis infection in ERS as intended, as ERS on AR may 
not be infected with either leprosy bacillus at all. If infected ERS are present on AR, changes 
caused by the bacilli are likely to be minor, and without a reference point informing about the 
time since initial infection cannot be compared to results of clinically diseased ERS on BI.  
Ectoparasites 
Small mammals are regular hosts to a wide range of arthropod species (Maaz et al., 2018). 
While ectoparasites were present on a large proportion of the ERS included in the study, 
they did not appear to have an immediate negative impact on their health. The observed 
patterns in parasite distribution on the host body could be explained by the ease with which 
an animal would be able to remove the parasite or could reflect preferred bite sites.  
Parasite burdens are influenced by factors intrinsic to the host, such as age and immune 
status, and by environmental factors such as temperature or host and parasite density 
(Cardon et al., 2011). Most ERS included in this study were adults, and, unfortunately, more 
detailed ageing in this group is not currently possible in live animals (Bosch and Lurz, 2012). 
As the immune status of a host cannot be determined just by external observation, the 
impact of host associated factors on parasite burdens cannot be assessed in this study.  
However, information on temperatures and host densities are available for both locations 
and could explain the higher parasite burdens and more frequent occurrence of ticks along 
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with fleas seen on BI compared to AR. ERS densities are lower on AR, as is the ambient 
temperature throughout the year. Particularly during our early spring sampling sessions, the 
lower average temperatures may be linked to reduced ectoparasite activity. This is especially 
true for ticks, which are only occasionally active when temperature drop below 10°C (Perret 
et al., 2000), something that is more likely to occur on AR at the times of our sampling than 
on BI. In spring 2018 it had in fact still been snowing on both islands shortly before our 
assessments commenced, which is most likely the reason why the lowest ectoparasite 
intensities were observed in this session. 
Flea activity on small rodents has been shown to peak in April/May in a study carried out 
near Berlin (52° 31′ N, 13° 24′ O, average spring/autumn temperature 14°C, i.e. similar to 
BI), while tick larvae peaked in April and August and nymphs in June and July (Maaz et al., 
2018). It is thus likely, that the ectoparasite burdens observed in this study reflect the lower 
end of the spectrum of ectoparasite intensity the ERS in these populations may be facing 
throughout the year. The higher parasite burdens in the autumn sessions can be readily 
explained with the higher ambient temperatures, as can the more frequent observation of 
ticks.  
The fact that no harvest mites were observed on AR could also be linked to environmental 
factors, however, further research would be necessary to determine whether harvest mites 
never occur on ERS on AR, or were only absent at the time of our sampling.  
2.4.3. Carcass collection and post mortem assessment 
Fewer animals were found dead on BI than on AR and more young animals were found. The 
lower total number could be associated with the smaller overall population or the absence of 
major roads or significant vehicle traffic on BI. On both Islands animals were mainly found by 
chance when people moved across the island. Therefore, where carcasses are concerned, 
the differences in how humans looking for ERS carcasses move around the islands is likely 
to have influenced our sample sets, and this bias needs to be considered when comparing 
data from the two locations.  
Age, sex and reproductive status 
Age distribution within the carcasses collected from both islands is almost certainly 
influenced by the location were carcasses where found, i.e. on the road (AR) vs. in the forest 
(BI). Juvenile animals are unlikely to venture onto roads and it can thus be explained that 
none of these young animals were collected from AR. The average crown-rump length of 
adult carcasses was similar on both islands (172.8mm (BI) vs. 172.6mm (AR)). As this 
sample set is smaller than that of live animals assessed this should not overrule the notion 
that ERS on AR may be slightly larger than on BI. The sex ratio for both islands was very 
balanced, while reproductive status is likely to be linked to the time of the year at which an 
ERS died, information which is not available for all ERS included. While the carcasses are 
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unlikely to be fully representative of the wider population, they allow an interesting and 
relevant snapshot into the population. 
Body condition and weight 
Observations made during post mortem assessments of ERS throughout this project have 
important implications for how a thin body condition should be judged. In several thin ERS 
carcasses good internal fat cover was observed. Therefore, thin body condition might not 
necessarily mean reduced fitness, but can occur in well fed ERS. Particularly on BI 
carcasses were in poorer body condition than animals assessed alive. This is likely due to 
the fact that these animals mostly succumbed to conditions that will have had a negative 
impact on their fitness and body condition prior to their death.  
Generally, accidental and predation deaths as they dominate on AR are more likely to 
provide an insight into whether members of an ERS population are suffering from food 
shortages, than deaths that are the result of individuals succumbing to ill health, as appears 
to be more likely on BI.  
General health status 
The most frequently reported single causes of ERS deaths in Scotland are road traffic 
accidents (42.9%), trauma (11%), and starvation (9.8%), while circa 30% of the deaths were 
likely to be pathogen related (LaRose et al., 2010). Other studies in Great Britain also 
identified road traffic as the main cause of ERS deaths (41.7% of deaths on the Isle of Wight, 
50.7% on Jersey, 48% on Anglesey) in surveillance efforts relying on opportunistic sampling. 
Infectious disease was implied in up to 35% of the deaths recorded in these other locations 
(Simpson et al., 2013; Shuttleworth et al., 2015; Blackett et al., 2018).  
Looking at the carcasses collected on both islands, infectious disease was suspected to be 
at least a confounding factor in several animals on BI, but on AR the vast majority of the 
carcasses were healthy or coping with chronic conditions and killed by cars or predators. 
Therefore, findings on both islands seem to fit with the observations made in the extensive 
post mortem studies mentioned above: Where road traffic is present (AR), it is a major cause 
of squirrel deaths.  
Ectoparasites 
It is likely that more ectoparasites were present when the animals were still alive, but that 
they fell off the carcass post mortem or were brushed off when the carcasses were collected 
and frozen. The ectoparasite burdens observed on carcasses in this study are thus unlikely 





In summary, trapping and anaesthetic protocols used in this study were highly successful 
and provide an insight into a reasonably sized subpopulation of ERS on both islands. Two 
healthy ERS populations were picked for this study. In many respects they can be compared 
directly and factors limiting this comparability, i.e. habitat and climate differences, origin of 
populations, average size of ERS and likely causes of death based on location, were 
identified in this chapter. The two populations are suitable for studying the effects of leprosy 
on ERS as aspired, though where clinical leprosy is concerned, this will be limited to disease 






















Chapter 3: Diagnosing leprosy in live ERS 
3.1. Introduction  
Diagnosing leprosy in any host is not a straightforward task. No diagnostic tool today is able 
to identify all individuals colonised by or infected with M. leprae or M. lepromatosis (Truman 
and Fine, 2010; Geluk, 2018). The effects of an infection with leprosy bacilli are largely 
determined by the individual host’s cellular and humoral immunity (Bobosha et al., 2014). 
Where large numbers of bacteria are present (MB cases, ca. 59% of annually reported 
human cases) the diagnosis is more readily confirmed than in PB cases (ca. 41% of annually 
reported human cases (WHO, 2016b)). The development of new diagnostic tests for leprosy, 
especially ones able to detect PB cases and colonised individuals at risk of becoming 
infected and/or diseased, is an active area of research  (Lastória and de Abreu, 2014a; 
Sousa Lima et al., 2019). For each host different tools have proven more or less useful and 
are usually combined to identify cases. 
Leprosy in ERS was initially identified using histological and molecular methods (Meredith et 
al., 2014; Simpson et al., 2015). αPGL-I detection in body cavity fluids was added as a 
method in later studies (Avanzi et al., 2016). In a small pilot which re-tested the original 
serum samples screened in the study presented by Avanzi et al. (2016), collaborating 
researchers at the Leiden University Medical Centre showed that their more recently 
developed UCP-LFA (van Hooij et al., 2017) was able to detect αPGL-I  in even more of 
those samples, thus indicating at least comparable, but most likely better, performance 
(Geluk and van Hooij, unpublished data).   
Later post mortem screening efforts for leprosy in squirrels have relied primarily on PCR 
testing. This allowed the analysis of more samples in a shorter period of time than 
histological assessments, and is especially useful where no clinical lesions are present to 
guide the choice of location for histological sampling and specific experience in analysing 
tissue sections of leprous squirrels is limited (Butler et al., 2017; Schilling, Avanzi, et al., 
2019). Overall, leprosy diagnosis in ERS has relied on being able to collect whole organs or 
at least large tissue sections (> 200mg) for histological assessment, DNA extraction and 
PCR, and on the presence of consistent clinical signs to guide sampling efforts.  
This approach is possible and effective where squirrel carcasses are concerned. However, 
opportunistic sampling can introduce undesirable bias (Sikes and Gannon, 2011). In the 
case of ERS only animals would be included that died in locations where they can be quickly 
found and accessed by humans, for example on the ground near roads, feeders or popular 
woodland trails. These areas may not be frequented by all individuals in a population to the 
same extent, but may particularly attract sick, bold or habituated individuals. These may be 
at a different risk of infection than other members of the population and therefore data from 
these carcasses may over- or underestimate the presence of disease in the population.  
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Collecting tissue sections as large as those taken for diagnostics in carcasses is not an 
option in live ERS that must be released back to the wild immediately after sampling. 
Diagnostic methods do thus need to be adapted for use in live ERS, if less or differently 
biased sampling is to be attempted to get a fuller picture, for example of the prevalence of 
leprosy in an ERS population. Another scenario in which the ability to screen for leprosy in 
live ERS is particularly important is in the preparation of translocations. Such animal 
movements to reintroduce or reinforce ERS populations are ongoing (Shuttleworth, Lurz and 
Halliwell, 2015). Animals should be screened for diseases that could pose a threat to their 
own species, other species they will be sharing an ecosystem with, or to public health prior 
to being moved in such a program (Woodford, 2000), without impairing the individual’s 
fitness for release and survival.   
Ideally, diagnostic methods in live animals would reliably identify leprosy cases, be 
repeatable over time to allow for the comparison of leprosy status of an ERS and be 
minimally invasive, so that the ERS can be released back into the wild immediately after 
diagnostic samples have been collected.  
In this part of the project clinical assessment, molecular and serological methods were 
adapted for use in live ERS under general anaesthesia. The hypothesis guiding this 
exploration was that diagnostic methods used in other host species and in deceased ERS 
can be successfully adapted to diagnose leprosy in live squirrels under field conditions. 
The least invasive method is a visual clinical assessment. A wide range of people, from 
members of the public to wildlife rehabilitation and conservation professionals and 
veterinarians may observe ERS with clinical signs of leprosy in the UK. A standardised 
system is proposed to categorise such observations. This should allow individuals to follow 
changes over time and hopefully enable immediate recommendations for individual ERS 
management.  
While leprosy lesions initially appear to be fairly pathognomonic (Avanzi et al., 2016), there 
are other diseases that may have a similar appearance. Based on what is known from other 
host species the uniformity of clinical lesions observed in ERS during post mortem 
assessment appears unusual. The most visually similar disease is atypical histiocytosis 
(Smith et al., 2017). Cancerous skin tumours could also resemble leprosy lesions. Other, life 
threatening, skin diseases that could be mistaken for leprosy in unusual cases or by an 
inexperienced observer include fatal exudative dermatitis (FED) caused by Staphylococcus 
aureus ST49 with luk M gene (Blackett et al., 2018) and squirrel poxvirus (SQPV) infection 
(McInnes et al., 2009; Everest et al., 2017). It is therefore necessary to have further 
diagnostic techniques available when suspicious skin lesions are observed in an ERS. 
It was assessed whether a small tissue sample that allows immediate release of the sampled 
ERS would suffice to extract DNA and establish the presence of M. leprae/M. lepromatosis 
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DNA using the PCR protocols already validated for ERS tissue sections. Ideally, molecular 
diagnostics for leprosy would fulfil two purposes in live ERS:  
1. Allow the identification of non-clinically affected ERS that harbour the bacteria in their 
tissues without impairing the animals continued welfare, and  
2. Allow the confirmation of a leprosy case where characteristic skin lesions are seen. 
Lastly, the role that leprosy specific αPGL-I diagnostic tests can play in identifying cases of 
ERS leprosy from serum and blood samples was explored.  
The results and experience with these tools throughout the project were then combined to 
propose a diagnostic decision tree and terms to describe ERS with different diagnostic 
outcomes. These could be used in any future studies into ERS leprosy and facilitate 
comparability between different studies, increase the opportunity for data sharing and re-use, 
as well as provide guidance as to which tool combination could be used in surveillance 
efforts and pre-release screenings.  
3.2. Methods 
3.2.1. Clinical assessment of leprosy lesions 
Defining clinical leprosy lesions 
The descriptions of ERS leprosy by Meredith et al. (2014), Simpson et al. (2015) and Avanzi 
et al. (2016) formed the basis for defining a clinical leprosy lesion in ERS. Thus, “bilateral 
areas of alopecia and cutaneous swelling of the snout area, lips, eyelids, pinnae and the 
distal aspect of the limbs” (Meredith et al., 2014) or “crusty thickening of the pinnae, 
sometimes with keratinised or wart-like protuberances” (Simpson et al., 2015) were 
expected. However, milder cases and different presentations could be present in live ERS. 
Therefore, the initial live assessment session in autumn 2016 was used to establish what 
would be considered a clinical leprosy lesion for this project. All ERS trapped in this session 
were assessed under general anaesthesia together with Professor Anna Meredith, an expert 
on ERS leprosy.  
Categorising clinical leprosy lesions in ERS 
Establishing a categorisation system for leprosy lesions in ERS was a multi-step process, 
each step aiming to improve the system in terms of meaningfulness, comparability of results 
and ease of application.  
Step 1: Autumn 2016 – Establishing a subjective categorisation system 
Initially, only the presence or absence and number of leprosy lesions was assessed visually. 
A range of images was taken from these individuals. Lesions were documented in prepared 
schematic drawings of squirrels, a black pen indicating healed traumatic changes unlikely to 
be related to leprosy, blue colour indicating lesions described in the context of leprosy with 
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intact skin, and red for ulcerating lesions indicative of leprosy or fresh traumatic wounds. 
Where necessary for clarity, a short description was added next to the drawing (Figure 24). 
 
FIGURE 24:  DOCUMENTATION OF LEPROSY LESIONS DURING ASSESSMENT  
At the end of the session, subjective categories from 1 to 6 were assigned to each ERS 
based on the observations made during the assessment.  
Step 2: Spring 2017 – Application and review of the subjective classification system 
This ‘subjective’ classification system was applied to all ERS seen in spring 2017 on BI and 
AR and weaknesses and limitations of the system identified. Particular attention was paid to 
see if classification was consistent if used by the same investigator on separate occasions or 
when two separate individuals classified the same ERS. Another important aspect to assess 
was whether the system was suitable to document changes in lesions over time.  
Step 3: Autumn 2017 – Establishing an objective classification system 
Objective parameters to describe lesions (size, shape, presence and state of ulcerations) 
were trialled and then used throughout the session. A point score system was developed 
assigning values to different states of each parameter. It was decided to score the ERS body 
in body segments, to include the appearance of lesions in several body areas as a score 
increasing factor. This additive score was then used to establish a leprosy category for each 
ERS. At the same time, special attention was paid to the apparent well-being of the ERS 
seen with leprosy lesion, by now in some cases multiple times. The apparent welfare status 
was then linked to the categories the ERS had been placed in. Once the system was 
established, ERS seen in previous sessions were re-assessed and re-classified based on 
the notes and images available from them. This created comparable datasets and evaluated 
whether the objective system was able to illustrate changes in lesions that had occurred over 
time.  
Step 4: Comparison of subjective and objective categorisation system 
Ideally, the subjective and objective categorisation of leprosy lesions should correspond as 
this would allow the continued use of the subjective system (albeit observing the category 
names established in the objective system) in instances where full, detailed assessment of 
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all body areas and lesions is not possible in future studies. Table 10 details how the 
categories were expected to correspond.  
TABLE 10:  OBJECTIVE SEVERITY CATEGORIES AND HOW THEY SHOULD CO RRESPOND TO THE 
SUBJECTIVE SYSTEM  
Objective severity 
category 





4 4 or 5 
 
Using R, the Spearman's rank correlation coefficient was calculated to assess whether the 
categories assigned to an ERS using the old ‘subjective’ categorisation system and the new 
‘objective’ system were significantly correlated.  
3.2.2. Molecular diagnostics in live ERS 
Tissue sampling in live ERS 
In previous studies a range of tissues (pinna, muzzle, spleen, liver, front- and hindlimb, and 
genitalia) from carcasses had been used to isolate and amplify M. leprae and M. 
lepromatosis DNA using PCR. Of these the pinna can be sampled in a live animal with ease.   
Trying to balance minimal impact on the animal and sufficient sample size, it was decided to 
use a 2mm thumb style ear punch (World Precision Instruments Limited®), widely employed 
for marking mice in laboratory settings, for tissue sampling. Injuries of a similar size do occur 
in wild ERS and do not seem to reduce their ability to thrive. Unfortunately, we did not have 
previously diagnosed carcasses available to establish the tissue sample size needed for 
molecular analysis at the beginning of the project, and so the biopsy punch size was 
empirically chosen. 
Sampling was done in spring 2017. It was decided to only sample animals without clinical 
signs of leprosy and no other changes to the ear that might put them at risk of developing 
leprosy lesions shortly (thinning of the coat, scaly appearance) to avoid potentially altering 
the onset or progression of lesions while the study was ongoing.  
Two biopsies were taken from the left ear with the ear punch. The punch sites were chosen 
so as to avoid vessels near the rim of the ear that might increase the risk of continued 
bleeding and to avoid the remaining tissue around the punch site ripping to the rim of the ear 
once the animal was back in the wild. Punches were therefore taken caudal of a vertical axis 
through the pinna, at least 2 mm from the rim of the ear and 2-4 mm apart (Figure 25). 
Punch sites were prepared by clipping the fur and cleaning with chlorhexidine solution 
(Hibiscrub®). If any bleeding occurred after the punch was taken, pressure was applied with 
a clean compress until the bleeding ceased. If bleeding could not be readily stopped by 
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pressure alone, a small drop of tissue glue (GLUture Topical Tissue Adhesive (Zoetis UK)) 
was applied to the rim of the punch site.  
 
FIGURE 25:  PUNCH SITES FOR EAR TISSUE COLLECTION :  BLUE DOTS MARK WHERE PUNCHES 
WERE TAKEN 
The tissue samples were immediately placed in 70% ethanol and kept at +4°C during 
transport and storage until analysis. 70% ethanol inactivates both leprosy bacilli species. The 
metal punch was decontaminated in 70% ethanol/15% isopropanol for a minimum of 20 
minutes before being air dried on a single use paper tissue to be ready for re-use.  
Deoxyribonucleic acid (DNA) extraction 
DNA extraction was performed at Moredun Research Institute in a containment level 2 
facility. DNeasy® Blood and Tissue kits (Co. Qiagen) were used to extract DNA from the 
samples. The same method was applied to all tissue samples in this study. Where relevant 
adaptions were made, they are mentioned.  
The punched-out tissue was removed from the ethanol, placed in a sterile petri dish and the 
alcohol was allowed to evaporate. Each tissue sample was transferred into a lysing matrix 
tube (Lysing Matrix B, MP Biomedicals) prepared with 0.1mm silica beads and 320µl ATL 
tissue lysing buffer (Qiagen DNeasy® Blood and Tissue Kit). For each batch of DNA 
extractions three extraction controls were included in the PCR used to screen for M. leprae 
and M. lepromatosis specific sequences: a tissue previously tested positive for leprosy bacilli 
DNA, a tissue known to be free from leprosy bacilli DNA and sterile distilled water (50µl). 
Unfortunately, there was not enough M. lepromatosis positive squirrel tissue available to run 
this control with every batch of DNA extractions. After one hour at room temperature the 
tissue was lysed in a FastPrepTM FP120 (Co. Thermo Savant) or a FastPrep®-24 Classic 
Instrument (Co. MP Biomedicals) for three cycles of 20s at 6m/s. Between cycles the 
samples were cooled on ice for five minutes. 
Samples were then centrifuged in a microfuge at 15500g for five minutes to pellet the beads 
and debris. The supernatant (180µl) was transferred to a fresh microcentrifuge tube and 
proteinase K was added (20µl, activity 600mAU/ml solution, Qiagen DNeasy® Blood and 
Tissue Kit). After thorough vortexing the samples were incubated overnight at 56°C. 
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For DNA extraction the steps of the spin column protocol were followed as detailed in the 
Qiagen DNeasy® Blood and Tissue Kit handbook. Due to the small sample sizes a single 
step elution in 50µl AE buffer (Qiagen DNeasy® Blood and Tissue Kit) was performed as 
advised in the handbook. The eluted DNA samples were stored at +4°C until the PCRs were 
completed. They were then stored at -20°C. 
PCR analysis 
Specific primer pairs were used to perform PCR amplification as described by Avanzi et al. 
(2016); LPM244 (Singh et al., 2015), amplifying a 244-bp fragment of the hemN gene of M. 
lepromatosis, and RLEP 7 and 8 (Monot et al., 2009), amplifying a 500bp fragment of the 
RLEP repetitive sequence of M. leprae. It was decided to rely on the already established 
qualitative PCR protocol for this study instead of adding the additional work and time 
necessary to establish a new, quantitative protocol. A 50µl reaction volume containing 
nuclease-free water, GoTaq® Flexi buffer (Promega®), PCR Nucleotide Mix (Roche®), 
GoTaq® G2 Flexi DNA Polymerase (5u/μl), final concentration of each primer of 0.2µM and 
3µl of DNA or control was used for PCR amplification. DNA from previous experiments was 
used as positive control (M. lepromatosis from previously confirmed squirrel case R30/13 
and M. leprae from previously confirmed squirrel cases BR10/15, BR25/15, later BIC002/16) 
and distilled water as negative PCR control.  
Amplification was performed using a BiometraTOne (Co. AnalytikJena AG). Samples were 
first denaturated at 95°C for five minutes followed by 40 cycles of 30 second denaturation at 
95°C, 45 second primer annealing at 58°C, and 30 second extension at 72°C. Ten minutes 
were allowed for a final extension at 72°C.  
Amplicon analysis was performed by electrophoresis using a 1.5% agarose gel, stained with 
GelRed (Biotium) in 0.5x TBE buffer, at 100 volts for one hour. 3μl of a 100bp DNA ladder 
(Promega®), which is to determine the size of double stranded DNA from 100-1,000 base 
pairs, was loaded before and after the controls and samples. A volume of 10μl (10-15mg 
tissue samples ‘full size sample’) or 15μl (2 mm tissue punches) of each sample was loaded. 
The amplicons were visualised by using an Alphaimager 2200 (Alpha Innotech) or a G:BOX 
F3 gel doc system and GeneSys software (version 1.6.1.0) (both Syngene). The same PCR 
protocol was applied to all DNA extracts in this study. 
Assessing the impact of punch sampling on ERS 
In the autumn 2017 and spring 2018 sampling sessions, punch samples were again 
collected only from animals without clinical leprosy lesions, to avoid altering their progress. 
To avoid “oversampling” of individual ERS, i.e. removing two 2mm more than twice 
throughout the duration of the study, returning ERS in these sessions were also not 
sampled. In autumn 2018, the final sampling session for this project, tissue punches were 
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taken from all ERS (see also “Ability to confirm leprosy cases using punch biopsies” below, 
p. 75).   
It was noted whether the punch sites showed signs of acute or chronic inflammation, and 
whether in hindsight the punch sites were well positioned (i.e. as shown in Figure 25) or if 
one or both of them were slightly closer to the ear rim than aimed for. It was also noted 
whether the punch sites had not ripped at all, only showed minor ripping, or showed a major 
rip all the way to the rim of the ear, and which of the returning ERS had developed clinical 
leprosy lesions.   
Statistical analysis  
Ripping and position 
The first null-hypothesis tested for the punch sampling sites was “Ripping of the sampling 
site is not associated with position of the punch”. A Pearson’s chi-squared test was carried 
out in R. 
Ripping and time 
The second null-hypothesis under investigation was “Ripping is not associated with the time 
passed since the original punch was placed”. A Pearson’s chi-squared test was carried out in 
R.  
Ripping and non-iatrogenic injury 
The third null-hypothesis tested was “The proportion of animals experiencing major rips after 
being punch sampled is equal to the proportion of animals experiencing non-iatrogenic tissue 
loss to their ears”. For this the presence of loss of ear tissue in animals that either were not 
punch sampled or did not return after being punch sampled (i.e. state of the ears was 
assessed only prior to punch sampling) and the presence of major rips by the time of the 
final assessment of the 30 returning ear punch sampled squirrels were compared. A 
Pearson’s chi-squared test was carried out in R.  
Punch sampling and clinical leprosy lesions 
Lastly, returning squirrels on BI were used to assess whether animals from which punch 
samples were taken were more likely to develop leprosy lesions at a later time point 
compared to those from which no punch samples had been collected. A Fisher’s exact test 
was carried out in R to address the hypothesis that the incidence of leprosy lesions is equal 
in squirrels that have and have not been punch sampled.  
Ability to confirm leprosy cases using punch biopsies  
In the final field session in autumn 2018, when monitoring ended, punch biopsies were 
collected from all ERS seen, regardless of their clinical status and whether samples had 
been collected previously. For ERS whose left ear had been previously sampled, the right 
ear was sampled now. Lesions were usually thicker than the biopsy punch could open, and, 
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there is a risk that punch holes in lesions would heal differently from those in apparently 
healthy tissues. As high bacterial loads could be reasonably expected in clinically diseased 
ERS based on carcass data (Avanzi et al., 2016), it was decided to use an apparently 
healthy part of the ear to take the punch biopsies in these ERS.   
3.2.3. Serological testing of ERS 
Sample types 
Three sample types were assessed: serum and blood drop samples for live animals and 
body cavity fluid for carcasses. They were analysed in conjunction with clinical and 
molecular information available for these ERS.  
Serum samples 
Blood samples were collected from the femoral vein under general anaesthesia in the field 
sessions autumn 2016, spring and autumn 2017 and spring 2018. The fur above the vein 
was clipped and the skin prepared using a chlorhexidine solution (Hibiscrub®). Consecutive 
samples from the same animal were assessed separately for this research segment. Serum 
was prepared at room temperature by centrifugation (10 minutes/2000g) and either diluted in 
buffer (1/50, 3µl in 147µl, see below, p. 77) and applied to the LFA strips immediately (spring 
2018) or stored at -20°C until required (autumn 2016, spring and autumn 2017).  
Blood drop samples and prick trial 
Blood drop samples were obtained either using remaining blood in the syringe after ejection 
of the whole blood sample (autumn 2017) or via a skin prick using disposable 20µL 
Minivette® collection tubes (Heparin coated; Sarstedt) (spring 2018).  
Prick sampling was attempted from the ear, the front footpad, the hind footpad or the tail 
respectively using a Sterilance Lite II (26 G x 3/32”; VITREX Medical A/S) or, more 
successfully, a sterile 25G x 5/8” needle. The prick site was prepared by clipping the hair and 
preparing the skin with chlorhexidine solution (Hibiscrub®) or ethanol. Sites that did not 
bleed at all and did not promise more success in additional attempts were not trialled further. 
Where the blood flow from the prick site was insufficient to fill the minivette or it was decided 
not to prick to reduce the time under general anaesthesia (n= 3), the minivette was filled 
from the whole blood sample.  
Body cavity fluid (BCF) 
Body cavity fluid (BCF) was collected from the thorax with a single use 2ml pipette during 
post mortem examination from 24 squirrels (20 adult, 1 subadult, 2 juveniles, 1 age 
unknown). From four of these serum samples taken ante-mortem were available as well. 
One of the squirrels in this subset died from sudden cardiac arrest during the anaesthesia, 
while three were humanely euthanised in accordance with the home office licence 
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conditions. The other 20 carcasses had been found dead in the wild. All carcasses were 
stored at -20°C until the post mortem examination was carried out. 
αPGL-I up-converting phosphor (UCP) lateral flow assay (LFA) 
A quantitative αPGL-I UCP LFA, well established for leprosy serodiagnosis in humans (A. 
van Hooij et al., 2016), along with the necessary buffers was provided by collaborators 
Annemieke Geluk and Anouk van Hooij at Leiden University Medical Centre. As a Packard 
FluoroCount microtiter plate reader adapted for measurement of the UCP label (980nm IR 
excitation, 550nm emission) is needed to read the assay, the test readings were done by 
Anouk in Leiden.  
All samples were diluted 50-fold in high salt lateral flow buffer (HSLF; 100 mM HEPES pH 
7.5, 270 mM NaCl, 1% (w/v) BSA, 0.5% (v/v) Tween-20, later batches additionally contained 
Triton X-100 to lyse red blood cells) provided in lyophilised form by our Dutch collaborators. 
In the field, the HSLF buffer was dissolved in still, commercially available bottled water at the 
start of each sampling session as instructed by our collaborators and stored at +4°C for the 
three sampling days. Body cavity fluid samples were stored frozen and then thawed prior to 
dilution with HSLF buffer. All samples collected in 2016 and 2017 were shipped to the 
Netherlands and processed by Anouk van Hooij and I at Leiden University Medical Centre 
(LUMC), Netherlands, in January 2018. For samples collected in spring 2018, the UCP-LFA 
sticks were taken to the field and the αPGL-I UCP LFA ran here at the end of each sampling 
day (as described below). The dried test sticks were sent to the Netherlands for reading, 
along with four diluted serum samples, for which LFA sticks had not been available.  
Of each sample/buffer mix 50µl were added to a well of a 96-well microplate (Greiner Bio-
One). UCP-LFA strips were labelled on the back with the sample number and placed in the 
sample well with the UCP-containing sampling pad in the buffer. The strips were left in the 
well until all liquid was absorbed and the strip had dried completely. They were stored 
attached to a piece of paper with tape across the absorbent pad and read in the 
FluroCountTM at LUMC. Results were provided as the ratio value between test and flow-
control signal based on relative fluorescence units measured at the respective lines.  
Statistical analysis 
For each sample three values were noted from the strip reading: the area under the curve of 
the sample signal (T), the area under the curve of the flow control signal (FC) and the Ratio 
(T/FC). A test was considered negative when T= 0 or T/FC is below the threshold for 
positivity. The threshold for positivity was initially calculated in Leiden from the sample sets 
taken from autumn 2016 till autumn 2017 and later refined when the samples from spring 
2018 were added using Youden’s index (Fluss, Faraggi and Reiser, 2005). I was involved in 
preparing all data for analysis, but statistical analysis for these experiments was carried out 
by Anouk van Hooij as part of our collaboration.  
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Graphpad Prism version 7.00 for Windows (GraphPad Software, San Diego CA, USA) was 
used to perform Mann-Whitney U tests, Kruskal-Wallis test with Dunn’s correction for 
multiple testing and a Pearson correlation test.  
3.3. Results  
3.3.1. Clinical assessment of leprosy lesions 
Defining clinical leprosy lesions 
Out of the 26 animals seen in autumn 2016, 18 squirrels were deemed free of clinical leprosy 
lesions and eight were classed as showing clinical signs of leprosy. For one of these ERS 
serology results and observations in following sessions indicated that the chin lesion 
observed on this occasion was not a leprosy lesion. There were no other obvious lesions. 
Therefore, for the purpose of defining a leprosy lesion this animal was excluded. Figure 26 to 
Figure 32 inclusive show the clinical skin lesions seen in the remaining seven ERS in the 
order they were seen in the field. 
 
FIGURE 26:  SINGLE NODULAR LEPROSY LESION ON THE CAUDAL RIGHT EA R RIM OF ERS 
BI003_16 
 
FIGURE 27:  NODULAR , BALD , WELL DEFINED LEPROSY LESIONS ON THE LEFT EAR AND B OTH 




FIGURE 28:  ELONGATED AREAS OF BALDING , THICKENED SKIN ON THE CAUDAL AND CRANIAL 
RIM OF BOTH EARS ALONG WITH NODULAR LESIONS ON BOTH  HOCKS;  ULCERATION ON THE 
LEFT HOCK (BI010_16) 
 
  
FIGURE 29:  ELONGATED , BALD , SHINY SWELLINGS ON THE CRANIAL RIM OF BOTH EARS IN  
ERS BI016_16.  LARGE NUMBER OF TICK LARVAE ATTACHED TO CAUDAL RIM O F LEFT EAR .  
 
FIGURE 30:  VERY SMALL BALDING , SHINY, SLIGHTLY BULBOUS SKIN PATCH ON THE OUTER 




FIGURE 31:  OBVIOUS BALD , SHINY, BULBOUS SWELLING ON THE INSIDE OF THE CRANIAL RIM 
OF THE LEFT EAR ;  THICKENING AND BALDING , ALONG WITH MILDLY CRUSTY APPEARANCE OF 
THE CAUDAL RIM OF THE RIGHT EAR (BI023_16) 
 
FIGURE 32:  SMALL BALD , BULBOUS SWELLING CRANIAL RIM OF THE LEFT EAR (BI025_16) 
No lesions resembling the description by Simpson et al. (2015) were seen on BI. Based on 
these observations, leprosy lesions appear to form first on the ear rims and/or on the hocks. 
The balding and shininess of the skin of lesions was very consistent, as was the firm-rubbery 
consistency of the swellings.  
Categorising clinical leprosy lesions in ERS 
Step 1: Autumn 2016 – Establishing a subjective categorisation system 
Based on the expertise acquired in this first field session and images of earlier cases and 
suspect cases available categories were defined to reflect the range of clinical signs that had 
been observed. This system is detailed in Table 11 and Figure 33. This categorisation 
system was applied retrospectively to animals seen in autumn 2016 and applied to squirrels 










No abnormalities indicating leprosy (with or without ear tufts depending on 
season) 
1 
Suspicious (Fur on ears thin, skin seems slightly shiny, muzzle might or might 
not be swollen) 
2 
Small single leprosy lesion (hairless, shiny swelling on one ear, and/or 
generalized swelling of the muzzle) 
3 
Small multiple leprosy lesions (hairless, shiny swelling on both ears or several 
on one ear, generalized swelling of the muzzle or hairless nodular swelling on 
the hind legs  
4 
Severe non-ulcerating lesions (cauliflower appearance of multiple shiny lesion 
on ears, muzzle and/or feet) 
5 
Severe ulcerating lesions on ears, muzzle, and or hock (same shiny, hairless 
lesions have ulcerated and might be affected by secondary infection)  
6 Unusual lesions that could be leprosy associated (crusts on ears) 
 
 
FIGURE 33:  IMAGES USED TO DESCRIBE THE INITIAL CATEGORIES USED IN AUTUMN 2016 
(RETROSPECTIVE) AND SPRING 2017 
Step 2: Spring 2017 – Application and review of the subjective classification system 
While the subjective classification was sufficient for identifying potential cases, it proved 
unable to reflect the intensity of changes in an individual’s condition over time and thus 
insufficient for research purposes. It was also inherently sensitive to inter- and intra-
investigator variation.  
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The numbers assigned to the different categories also proved slightly counterintuitive, as 
individuals classed as suspicious could not be confirmed through laboratory results. This 
category was therefore highly speculative and its usefulness appeared more and more 
questionable as the project progressed.  
New findings also indicated that a ‘cauliflower’ appearance followed repeated ulceration and 
healing cycles, in which case it was inaccurate to assign a seemingly lower category to 
animals with cauliflower lesions than to those with currently ulcerated lesions. 
Lastly, the categories were purely descriptive and not directly associated with the welfare 
impairment an ERS was likely to experience. It was thus not useful for making management 
action recommendations based on category.  
Step 3: Autumn 2017 – Establishing an objective classification system 
Only lesions of the previous categories 2 to 5 were treated as typical clinical leprosy lesions 
and were subjected to full categorisation. Individuals resembling the previously used 
categories 1 and 6 were noted and images taken, but they were not scored or categorized 
within the objective system for clinically leprosy positive ERS, as infection was not detected 
in these ERS.  
To collect the information for the calculation of the numerical lesion score the ERS’s body 
was divided into six sections (1= left side of head, 2= right side of the head, 3= left upper 
body and forelimb, 4= right upper body and forelimb, 5= left lower body and hindlimb, 6= 
right lower body and hindlimb, Figure 34, p. 84). Where several lesioned areas occur in the 
same body sector, the score parameters were assigned based on the most intense lesion 
within the sector. The size of the lesions (<2mm, <5mm, <10mm, >10mm) was measured. 
To describe lesion shape four options were defined (A= one lesion with clearly defined rim, 
or area of balding skin; B= several lesions, separated with clearly defined rim; C= several 
lesions, merging, rim not always clear; D= cauliflower appearance due to merged lesions). 
The presence of ulcerations was noted as either “no”, “could be traumatic”, or “ulceration”. 
Where an ulceration was present it was further noted whether it was dry, bleeding or 
purulent.  
Points were assigned following a pre-determined key (Table 12) for the findings in each body 
area and added per area and for the full body. This delivered the first outcome of the system, 
the full body score, which can reflect small changes in lesions that occur over time in detail. 






TABLE 12:  POINTS ASSIGNED PER BODY SECTION IN STEP 3 OF THE CATEGORISATION 
PROCESS (A= ONE LESION WITH CLEARLY DEFINED RIM OR JUST BALDING SKIN, B= SEVERAL 
LESIONS, SEPARATED WITH CLEARLY DEFINED RIM, C= SEVERAL LESIONS, MERGING, RIM NOT 
ALWAYS CLEAR, D= CAULIFLOWER APPEARANCE DUE TO MERGED LESIONS) 
Points 0 1 2 3 4 
Lesion size 
[mm] 
None <2 <5 <10 >10 
Lesion 
description 
None A B C D 
Ulceration* None Trauma, not 
true ulcer 
- - Yes 
Ulcus 
description 
None - Dry Bleeding Purulent 
*Ulcerations are expected to have a high impact on welfare, points were thus not assigned 
continuously but in relation to the perceived welfare impact 
Based on the scores reached in the individual body sections and the number of affected 
body sections, the ERS was then assigned to one of four categories (1= no more than two 
body sections affected with no more than four points per section; 2= no more than three 
body sections affected, no more than six points per section; 3= up to four body sections 
affected, no more than eight points per section; 4= three or more body sections affected, 
scores of eight and more reached in at least one section). Note that a maximum score per 
individual section is defined above which an ERS is automatically placed in the next higher 
category, even if lesions are locally restricted or for some reason information is not available 
for all body sections. The scoring process is summarised in Figure 34. These severity 




FIGURE 34:  PROCESS OF CATEGORISING TYPICAL LEPROSY LESIONS  
Based on veterinary expertise and experience gained throughout this project the severity 
categories were linked to a welfare state estimate and action recommendations (Table 13). It 
was possible to retrospectively apply this system to ERS seen in previous assessment 
sessions based on stored images and assessment sheets.  




1 Mild case, no welfare impairment expected, no immediate action 
2 
Mild to moderate case, no significant welfare impairment expected, no 
immediate action 
3 Moderate case, welfare may be impaired, monitoring recommended 
4 




Step 4: Comparison of subjective and objective categorisation system 
In total, both systems were used in 69 assessment events. 26 squirrels trapped in autumn 
2016 were only assessed based on our documentation and photographs. 43 were grouped 
according to the original system when seen in the field in spring 2017 (13 were returnees 
from the first trapping session) and then reassessed after the objective system had been 
conceived. Placement of animals in the different categories is indeed correlated well 
between the subjective and objective system (Table 14), with a Spearman’s rank coefficient 
of ρ= 0.91.  




New lesion category 
0 1 2 3 4 
0 47 - - - - 
1 5 - - - - 
2 - 7 1 1 - 
3 - 1 1 - 2 
5 - - - - 4 
 
3.3.2. Molecular diagnostics in live ERS 
Tissue sampling in live ERS 
In total, 31 tissue punch samples were collected in spring 2017, 17 on AR and 14 on BI. M. 
leprae DNA was successfully isolated from six of them. All positive results came from BI. 
This showed that in principle the chosen sampling method and site were suitable to confirm 
the presence of M. leprae DNA in clinically healthy ERS.  
Assessing the impact of punch sampling on ERS 
Over the total course of this study 115 tissue punch samples were analysed. No leprosy 
bacilli DNA was present in 101 (87.8%). Fourteen (12.2%) samples contained M. leprae 
DNA (nBI= 13, nAR= 1). M. lepromatosis was not isolated from any of the samples.  
Thirty punch sampled ERS returned in later assessment sessions. In none of them were 
signs of acute or chronic inflammation observed around the punch sites. Six animals 
returned twice, the other 24 once. Out of the 30 animals three developed leprosy lesions 
after 12 (n= 2) and 18 (n= 1) months, respectively.  
Figure 35 shows fresh and healed punch sites. The changes to the top punch site in the 
middle image illustrate what was classed as minor ripping and a major rip can be seen in the 




FIGURE 35:  LEFT: ERS EAR IMMEDIATELY FOLLOWING TISSUE COLLECTION, ALSO SHOWING A 
NON-IATROGENIC INJURY. MIDDLE: 6 MONTHS AFTER SAMPLING, OPTIMAL HEALING ON THE 
VENTRAL PUNCH SITE, MINOR RIPPING ON THE CAUDAL RIM OF THE DORSAL PUNCH SITE. 
RIGHT: MAJOR RIP OF A PUNCH SITE TO THE RIM OF THE EAR. 
Ripping and position 
In 17 animals the punch sites were classed as well placed, in one the top punch site was as 
intended, while the bottom punch site was slightly closer to the rim than ideal. In the 
remaining 12 animals the punch sites were a bit closer to the rim than ideally aspired. At the 
time of the first re-assessment no rupture was seen in 20 animals (66.7%), minor rips were 
present in five animals (16.7%), and major rips were seen in five squirrels (16.6%). In three 
out of the six animals re-assessed twice, major rips occurred by the time of their second re-
assessment. Leaving to the best of our knowledge 56.7% of the animals without rips and 
26.6% with major rips. Major rips only occurred in one of the punch sites in all of the affected 
ERS. Only once was this the bottom punch site, in the other seven ERS the top punch site 
ripped. The hypothesis that placement of the punch site is not associated with ripping could 
not be rejected based on the data (Pearson’s chi-squared test, n= 30, p=0.1815).  
Ripping and time 
Regardless of time passed since the punch biopsy was taken, most animals did not show 
ripping of their punch sites. Out of the 24 animals re-assessed once, 17 were seen six 
months after the punch had been taken, four were seen 12 months later and three were 
seen again after 18 months. Four animals re-assessed twice were seen six and 12 months 
post initial sampling, and two were seen after 12 and 18 months. However, some ERS were 
seen with major ripping at each time point, and ideally ways should be found to reduce the 
proportion of these animals (Figure 36). Ripping of punch sites is not significantly associated 
with the time that has passed since a punch sample was taken (Pearson’s chi-squared test, 




FIGURE 36:  STATE OF PUNCH SITES OBSERVED IN 36 REASSESSMENTS OF 30 DIFFERENT 
ERS.  
Ripping and non-iatrogenic injury 
Out of the 152 included assessments (non-returning animals), non-iatrogenic loss of 
substance was seen in 27 squirrels (n= 12 on AR, n= 15 on BI), while, as mentioned before, 
eight animals out of the 30 reassessed punch sampled animals experienced major rips. The 
proportion of animals experiencing non-iatrogenic loss of substance to their ears throughout 
their lives is similar to that of punch sampled animals experiencing major rips (Pearson’s chi-
squared test, n= 182, p= 0.38).  
Punch sampling and clinical leprosy lesions 
A total of 31 animals were seen more than once on BI. Punch samples were collected from 
21 returning individuals, of which three later developed leprosy lesions (14.3%). Out of the 
10 returning animals from which no punch samples were collected, four already had leprosy 
lesions when first assessed and were excluded. Of the remaining six animals that did not 
show signs of leprosy in their first assessment, two developed leprosy lesions during the 
duration of this study (33.3%). Based on our limited sample size punch sampling did not 
result in an increased risk of developing leprosy lesions (Fisher’s exact test, n= 27, 
p=0.3031, 95% CI= 0.028-5.482, OR= 0.35).  
Ability to confirm leprosy cases using punch biopsies  
In autumn 2018 punch samples were collected from 52 ERS in total. Six (all BI) showed 
clinical signs of leprosy, 46 did not (23 from BI, 23 from AR). M. leprae DNA was isolated 
from only three animals. Two clinically positive animals from BI, with severe lesions, and one 
clinically negative animal from AR. Two of the clinically positive ERS from which no M. 
leprae DNA was isolated had early, mild lesions (category 1, score 3 and 4, respectively). In 










6 months 12 months 18 months
State of punch sites at the time they were re-assessed
No Ripping Minor ripping Major ripping
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taken from the left ear, while the lesion was on the right. The other two ERS with clinical 
lesions were more severely affected (category 2, score 12, lesions on right ear and scrotum, 
punch taken from left ear; category 4, score 18, lesions on left ear and both hocks, punch 
taken from right ear).   
3.3.3. Serological testing of ERS 
αPGL-I 
Serum samples 
In total, 132 serum samples were available from 90 individual ERS (87 adult, 3 subadult) to 
validate the αPGL-I UCP LFA. Information on the presence of clinical lesions was available 
for all ERS assessments. Clinical lesions were present in 25 instances. Tissue samples 
screened for the presence of leprosy bacilli DNA were available for 64 individuals, who were 
clinically negative at the time of sampling. From 11 of these M. leprae DNA was isolated. For 
25 clinically negative ERS no PCR result was available (reasons see p. 74). 
ERS with clinical lesions had significantly higher αPGL-I ratios than those without lesions 
and a positive (p<0.0001, Kruskal-Wallis test with multiple Dunn’ correction) or negative 
(p<0.0001) PCR result. ERS of unknown PCR status and without clinical lesions were 
excluded from this analysis. The αPGL-I levels of squirrels without clinical lesions did not 
differ significantly between those with a positive or negative PCR result (p>0.9999, Mann-
Whitney U test). The level of αPGL-I is correlated with lesion severity reflected by the lesion 
score in ERS (Pearson correlation, p<0.0001; R2= 0.64).  
The αPGL-I UCP-LFA has a sensitivity of 88% and a specificity of 96% using a cut-off ratio 
of >0.1 to confirm infection with M. leprae in ERS with suspicious skin lesions. Graphs 
illustrating these results are presented in the joint publication “Detection of humoral immunity 
to mycobacteria causing leprosy in Eurasian red squirrels (Sciurus vulgaris) using a 
quantitative rapid test” (Schilling, Hooij, et al., 2019) open access. The paper also details a 
blood drop and prick trial and the results from body cavity fluids. 
Blood drop and prick trial 
Blood drop samples were collected during 65 assessments, comprising 26 syringe samples 
and 39 minivette samples. For each a corresponding serum sample was available. Eight of 
these sample pairs came from squirrels with clinical leprosy lesions, and 57 from animals 
without clinical lesions. From five of these clinically negative ERS M. leprae DNA was 
isolated via PCR. The αPGL-I levels detected in serum and blood drops showed significant 
correlation (Pearson correlation, p<0.0001; R2= 0.9).  
The blood flow from the prick site was insufficient to fill the minivette in 32 attempts. 
Successful collection of enough blood to fill the minivette was only possible from the last 
third of the tail in 4 out of 25 attempts. Attempts to prick the ear, front and hind footpad were 
89 
 
abandoned after four, one and six attempts, respectively. The front footpad did not bleed at 
all following pricking. The four successful attempts on the tail were made after the hair of the 
prick site was clipped very short, the site was disinfected with ethanol, and the tail was 
warmed on a heat pad after the ethanol had evaporated and before the prick was attempted.  
Body cavity fluid 
BCF was collected from seven carcasses with leprosy lesions and detectable M. leprae 
DNA, for three of which ante-mortem serum samples were available as well. Additional BCF 
samples were available from three M. leprae PCR positive carcasses without leprosy lesions 
and 14 ERS carcasses clinically and PCR negative.  
Correlation of αPGL-I levels and clinical signs was weaker in BCF than in samples obtained 
from live ERS. Only four of the seven clinically diseased ERS carcasses (57%) had αPGL-I 
levels above the cut-off ratio. This included the three animals for which serum was available 
as well. In these αPGL-I levels were lower in samples collected during post mortem 
examination, despite the ERS being frozen immediately after euthanasia and thus much 
better preserved than squirrel carcasses found in the wild usually are (Table 15).  
TABLE 15:  COMPARISON OF ALPHA -PGL-I  IN SERUM AND BODY CAVITY FLUID OF THREE 
EUTHANISED ERS 
Animal BI010_16 BI052_17 BI062_17 
Serum αPGL-I ratio 0.74 1.85 0.16 
BCF αPGL-I ratio 0.29 0.28 0.11 
 
3.4. Discussion 
The leading hypothesis of this part of the study, that diagnostic methods used in other host 
species and in deceased ERS can be successfully adapted to diagnose leprosy in live ERS 
under field conditions, is supported by the results presented here.  
It was shown that molecular methods can add information beyond that accessible in a 
clinical assessment, while serological methods can confirm the clinical diagnosis of leprosy 
in ERS. The latter is important when clinical signs are atypical and clinically not clearly 
distinguishable from other skin conditions that could occur in ERS. The diagnostic methods 
introduced here are a useful and suitable toolkit for leprosy diagnostics in live ERS.  
3.4.1. Clinical assessment of leprosy lesions 
Defining clinical leprosy lesions 
The clinical presentation of leprosy lesions is more variable than previously published data 
from carcasses had suggested (Meredith et al., 2014; Avanzi et al., 2016). Based on the 
data presented in this chapter, clinical leprosy lesions will be defined as “skin areas of 
marked shininess and local hair loss, in which firm-rubbery swellings develop”. Especially, 
early lesions can be very discreet and difficult to identify.  
90 
 
More information on the clinical presentation of leprosy in ERS based on all data collected 
throughout this study can be found in chapter 4 (p. 109). It is still possible that the 
presentations observed on BI only represent part of the leprosy spectrum in ERS as they are 
different from the presentations observed on the Isle of Wight (Simpson et al., 2015). 
However, the warts and crustiness observed there could also be the result of multifactorial 
problems.  
Categorising clinical leprosy lesions in ERS 
The desired outcomes of categorising leprosy cases in ERS are different from what is 
needed in humans. In people the main aim of identifying a leprosy patient is assigning the 
patient to a category to place him/her in an adequate treatment group quickly and prevent 
further transmission (WHO, 2016a). Further categorisation of clinical cases aims to assess 
the severity of existing leprosy related disability and how it changes during treatment (van 
Brakel, Reed and Reed, 1999), or reflect histological changes within the clinical lesions in 
detail for scientific purposes (Reibel, Cambau and Aubry, 2015). In wild ERS long term 
antibiotic treatment cannot be reasonably accomplished. Visual signs of disability that could 
imply a loss of nerve function, such as extensive injuries or loss of digits correlated with the 
occurrence of clinical signs of leprosy, were not observed in this study. In live ERS, tissue 
biopsies large enough for full histological assessment may make an immediate release of 
the ERS impossible, and thus collecting detailed information on lesion histology is limited to 
carcass assessments. In ERS the purpose of categorising clinical cases is to allow guidance 
on how to manage an animal that has been seen with lesions by, for example, members of 
the public or wildlife rangers. With such different goals, a clinical categorisation system for 
ERS necessarily had to be different from the systems established for humans, though it can 
borrow ideas from them.  
The initial attempt to create a subjective system with descriptive categories, was based on 
the idea that the system should be easy to communicate and teach, preferably just using one 
typical picture per category. This would have allowed provision of an image catalogue to all 
those working with ERS in the wild and they would have easily been able to place whichever 
ERS they saw in one of the categories.  
However, the subjective system proved prone to variable category placement of ERS by 
different investigators and even for the same investigator on different days, and it did not 
allow follow-up of lesion progression in sufficient detail for this particular research study.  
Subtle changes in lesions that occurred throughout the time of the study, required a more 
differentiated documentation of lesion state during the clinical assessment.  
The objective system addressed these problems by introducing the full body score in 
addition to an overall lesion category. The detailed full body score will allow any investigator 
to follow leprosy lesion progression in ERS over time. The fact that the subjective and 
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objective system correlate well, means that the objective categories can still be illustrated 
with similar, easily communicated images. This, together with the option of using a high 
score in a single body area to immediately place an ERS in a high severity category could be 
very important. It may allow one to assign at least a tentative category to an ERS when only 
part of the body is available for assessment. This is for example the case when concerned 
members of the public take images of affected animals and ask for advice.  
Based on observations made throughout this study, ERS in category 1 and 2 should be able 
to survive and thrive in the wild, but may be or become a source of infection to others. As 
transmission is not fully understood in any host at this point, it is very difficult to judge the 
role of individuals in spreading the disease. ERS in category 3 should be monitored where 
possible (for example if they return to a specific feeder) to pick up any worsening in their 
condition. They may be or become a source of infection for others. ERS in category 4 should 
be assessed by a veterinarian and humane euthanasia may be indicated. Some cases may 
be able to continue to thrive but may be or become a source of infection for others. Thus, the 
four severity categories (1= mild, 2= mild-moderate, 3= moderate, 4= severe) system 
developed here can be used both in hands-on and hands-off assessments of leprous ERS to 
guide management decisions. Clearly, assigning an ERS to a certain category based on a 
hands-on assessment, calculation of body scores and translation into a category will be less 
prone to miscategorisations than hands-off assessments and assessments of images that 
only show part of an ERS body. 
3.4.2. Molecular diagnostics in live ERS 
This study has shown that is possible to obtain sufficiently large tissue samples for molecular 
diagnostics from live ERS without compromising animal welfare. 
Tissue sampling in live ERS 
The successful isolation and detection of M. leprae DNA from 2mm tissue samples from the 
pinna implies, that the empirically chosen sampling site and type were suitable for molecular 
leprosy diagnostics in ERS. Molecular diagnostics are successfully used in tissue samples 
from other host species, such as humans or NBA (Martinez et al., 2014; Sharma et al., 
2015). However, it had not been explored previously how small a sample may be. In humans 
skin biopsies are mostly taken from individuals displaying clinical symptoms of leprosy, and 
biopsy sites are chosen from active lesions whenever possible. Biopsies are collected in a 
size that also allows for histological assessment (Martinez et al., 2014). Ear tissue samples 
taken from NBA are described as “ear fragments” or “ear notches” but no exact size is 
reported (Loughry et al., 2009; Pedrini et al., 2010). In this study it was shown that a 2mm 
tissue fragment from the ear of an ERS provides sufficient material for leprosy diagnostics, at 
least in this species.  
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Other sample types that have been explored in humans and NBA to avoid invasive tissue 
sampling for molecular diagnostics include blood, urine, nasal swabs, hair bulbs, and slit skin 
smears. They were however found to be less effective and/or harder to interpret that skin 
biopsy samples (Martinez et al., 2014; Sousa Lima et al., 2019). In ERS such samples would 
incur additional problems due to the small size of the species, which restricts the blood 
volume that can be collected at one time to a millilitre. Swabs would require to be specially 
adapted to fit into the nares of an ERS without risking injury while still gaining sufficient 
sampling material for analysis. Slit skin smears would leave a wound that even when closed 
with tissue glue or stitches, could mean an ERS is not immediately fit for release following 
the sampling. Thus, the chosen sampling location and method appear to be a good option 
for molecular diagnostics in live ERS. Whether other sampling locations would hold the 
potential for increased diagnostic sensitivity is explored in more detail using carcass tissues 
in chapter 4 (p. 109).  
Assessing the impact of punch sampling on ERS 
A diagnostic method should never impair an animal’s wellbeing more than absolutely 
necessary or reduce its ability to survive. Ripping of punch sites was a complication that was 
observed several times in this study. It was difficult to prevent even with careful placement of 
the punches. However, not all punch sites ripped, and some were intact up to 18 months 
after sampling. The severity of tissue loss seen where punch sites ripped was similar to that 
observed as a result of non-iatrogenic injuries the ERS experienced. Taking punch samples 
did not appear to increase the risk of developing leprosy lesions.  
Taking tissue punch samples provided information on the presence of M. leprae DNA in 
clinically healthy ERS that could not be gathered in any other way. The impact of even 
ripped punch sites on the animal appears to be small and within the range of adversaries a 
member of this species may experience naturally. Sampling did not relate to an increased 
risk of developing leprosy lesions for the ERS. The value of the information gathered 
compared to the impact it is having on the ERS justifies the continued use of this method 
until better methods are developed. Additionally, sampling under general anaesthesia, 
eliminates acute pain perception during the sampling. From similar injuries that humans 
regularly inflict on themselves (piercings) it appears to be quite generally accepted that they 
do not cause any continued pain unless they become inflamed or infected, something that 
was not observed in ERS in this study.  
Ability to confirm leprosy cases using punch biopsies  
A limitation in the method discussed above is that it is not possible to determine if a negative 
PCR result indicates the true absence of bacteria or whether a bacterial load below the not 
currently defined threshold for detection could still be present. Observations in other host 
species show that some individuals are completely resistant to an infection with M. leprae 
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(Bennett, Parker and Robson, 2008; Balamayooran et al., 2015). It is therefore possible that 
at least some of the PCR negative ERS identified in this study are truly free of leprosy bacilli. 
Assessing the correlation between molecular and clinical leprosy diagnosis in ERS offered 
additional information on the matter. For human leprosy patients PCR sensitivity varies 
depending on where a patient is on the leprosy spectrum (Scollard et al., 2006; Reibel, 
Cambau and Aubry, 2015). The reported sensitivity for the detection of PB cases varies 
between 30 and 83% (Reibel, Cambau and Aubry, 2015). Sensitivity for PCR in MB cases in 
other hosts, is usually given somewhere between 87% to 100% (Reibel, Cambau and Aubry, 
2015; Fontes et al., 2018).  
All ERS with clinical leprosy lesions described prior to this study have had MB LL or BL 
(Meredith et al., 2014; Simpson et al., 2015; Avanzi et al., 2016) and have tested positive for 
leprosy bacilli DNA. One would expect these cases to be easily diagnosed via PCR since the 
tissue sample was taken from the lesion itself. However, in this study samples were not 
taken from leprosy lesions in order to monitor the natural progression of the lesions. It was 
furthermore assumed that due to the previously described bilateral nature of leprosy lesions 
in ERS bacteria would still be present in both ears even if only one ear showed signs of a 
clinical lesion. As a result, samples were taken from the unaffected ear in ERS presenting 
with unilateral lesions. Of the six clinical cases of leprosy included in this part of the study, 
only two were positive for M. leprae DNA by PCR. M. leprae DNA was not detected in the 
remaining cases suggesting that the assumption based on bilateral observations may not be 
justified or that the bacterial load was too low to detect. 
One could argue that the four ERS from which no M. leprae DNA was isolated may not be 
true leprosy cases but have visually similar lesions of a different origin. However, in three of 
the four ERS, leprosy specific αPGL-I ratios above the cut off for positivity were detected. All 
these ERS came from BI. It is thus likely that they are indeed true leprosy cases and that the 
positioning of the punch sampling site was responsible for the absence of M. leprae DNA.  
The fourth ERS did not have any detectable αPGL-I. This ERS did not present with any 
lesions on the ears, only a single lesion on the right hock, resulting in a full body score of 4 
(severity category 1). As αPGL-I levels are correlated with disease severity, they may be 
below the cut-off for positivity in such a mild case, and thus not allow for the same 
reassurance that is available for the other ERS. Whether this ERS was misdiagnosed 
clinically or the PCR is false negative cannot currently be determined. Resampling of the 
animal at a later point in time could provide clarity.  
The two ERS with clinical lesions that had a positive PCR result both had severity category 4 
lesions, one with a full body score of 27, the other of 30. In these ERS lesions were present 
on both ears and in one on both hocks, in the other on one hock and on the scrotum. It is 
thus easily conceived that these two ERS may have had higher bacterial loads, i.e. a small 
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tissue sample was more likely to contain bacteria than in the others. The PCR method used 
in this study is purely qualitative, not quantitative. It does thus not allow any judgement on 
the limit of detection for M. leprae DNA in ERS. In humans real-time quantitative PCR 
techniques are thought to offer increased detection rates, sensitivity and specificity in leprosy 
diagnostics compared to conventional PCR methods (Martinez et al., 2014). Such methods 
could be explored for ERS as well to determine a minimum level of detection specific to this 
species. However, if bacilli are not evenly distributed in all tissues or within a tissue, false 
negative results are still possible even with the most sensitive diagnostic method. This 
subject is addressed in chapter 4 (p. 109).  
It is likely that sampling the skin lesion itself would improve the level of detection. However, 
with a punch biopsy of the type used in this study this is not readily possible. Future studies 
could explore if sufficient material for molecular diagnostics could be collected from a fine 
needle aspirate from the lesion. It has been described in humans that fine needle aspirates 
are suitable for histological confirmation of the presence of AFB (Baddam et al., 2018). It 
appears therefore realistic, that samples collected with this method would contain enough 
bacteria to allow a detection of their DNA via PCR. A fine needle aspirate would cause less 
trauma to the sensitive skin over the lesion, and the needle could be inserted from the 
relatively healthy skin at the outer border of the lesion and pointed towards the lesion centre.  
Similar insecurities remain in other hosts where molecular methods may return false 
negative results based on sampling location, and false negative results can never be 
excluded with absolute certainty (Martinez et al., 2014). It is has therefore been 
recommended that molecular methods in humans should always be combined with clinical 
assessment and serological tools to assess whether a true infection is present (Sousa Lima 
et al., 2019) and in NBA serological methods are thought to be the most sensitive tool to 
detect leprosy cases, before both clinical and molecular methods (Truman, 2005; Sharma et 
al., 2015).  
Despite its shortcomings, PCR from ear punch tissue samples allowed the identification of 
ERS in which leprosy bacilli are present before they show signs of clinical disease in this 
study. It is thus a valuable tool in ERS leprosy diagnostics. It is not currently known whether 
non-clinical ERS in which M. leprae DNA can be detected play a role in sustaining leprosy 
within the squirrel population, and it is unfortunately beyond the scope of this study to 
address this point. Another important aspect is, whether all ERS in which M. leprae DNA is 
present will develop clinical leprosy later in life. This is explored in chapter 5 (p. 141).  
95 
 
3.4.3. Serological testing of ERS 
αPGL-I 
Serum samples 
ERS do mount a humoral immune reaction to an infection with leprosy bacilli (Avanzi et al., 
2016). This study showed that the point of care αPGL-I UCP LFA is suited to measure this 
reaction and that the reaction is correlated to the presence of clinical signs of leprosy. 
Therefore, an ERS with both a positive αPGL-I results and clinical signs is very likely to be a 
leprosy case. αPGL-I is, however, not regularly elevated before the onset of clinical disease 
in this species, unlike in NBA, where serological methods are the most sensitive screening 
tool (Truman et al., 1986; Truman, 2005; Balamayooran et al., 2015).  
αPGL-I can only offer information on the host humoral immune reaction to the presence of 
leprosy bacilli (van Hooij et al., 2018). An earlier, cellular immune response to the presence 
of leprosy bacilli could be present, but would not be identified (Nath, Saini and Valluri, 2015; 
A. van Hooij et al., 2016). In humans, monocyte produced IP-10 improves the ability to 
discern contacts from TT/BT cases (Geluk et al., 2012), and acute phase protein, such as 
liver produced C-reactive protein (CRP), is elevated early in LL/BL (van Hooij et al., 2018), 
thus allowing for an earlier detection of these cases. However, these markers did not 
correlate with the presence of leprosy bacilli DNA or clinical signs of leprosy in ERS, based 
on an unpublished trial carried out in collaboration with the leprosy serology experts in 
Leiden. Differences may exist in the cellular immune response of both species, or in the 
structure of the proteins involved, resulting in the test antibodies used on the human strips 
not binding to ERS proteins. Therefore, serological markers that could be used to identify 
leprosy infection before the onset of clinical symptoms in ERS would need to be investigated 
in a species-specific approach.  
Being able to confirm a clinical leprosy diagnosis using the αPGL-I UCP LFA is still highly 
valuable on its own, particularly when considering that molecular methods were not reliable 
for confirming clinical disease under the conditions of this study. Being able to readily 
distinguish live leprous ERS from those with similar looking skin lesions caused by other 
conditions is highly relevant. It may result in further diagnostics identifying conditions that are 
actually treatable on a short timescale. It could also guide decisions and management of 
ERS that have been taken into human care, for example where they were found injured or 
trapped after lesions causing welfare concerns were observed.  
ERS with clinical leprosy should not be released into the wild, when this would pose the risk 
of introducing leprosy bacilli into a population to which the disease or the particular strain of 
the bacteria is not endemic. They need to be excluded from translocation projects 
(Woodford, 2000). Release of animals affected by a chronic disease is always controversial, 
and often discouraged, especially when further public health implications exist. Rehabilitation 
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and release efforts in badgers are an example (Mullineaux, 2018). Having a point of care tool 
like the αPGL-I to confirm an infection is thus very important.   
The correlation of clinical lesion severity and αPGL-I titre observed in ERS is a phenomenon 
also described in other hosts. The αPGL-I assay alone is much less sensitive in PB human 
cases (30-60% αPGL-I positive) than in MB cases (80-100% αPGL-I positive) (Lastória and 
de Abreu, 2014b). Thus, the αPGL-I UCP LFA has an increased potential for false negative 
results in mild cases that users need to be aware of. The current dataset does not allow to 
determine the exact time point from the onset of clinical disease at which αPGL-I levels can 
be expected to be above the threshold for positivity. While re-tests at a later point in time 
may provide clarity, they will not always be possible. If the clinical signs are very typical for 
early leprosy, it is better to be cautious and still treat such ERS as potential leprosy cases.   
Unfortunately, no ERS infected with M. lepromatosis were available for inclusion in this 
study, and it was not possible to assess the ability of the αPGL-I UCP LFA to confirm an 
infection with this pathogen in ERS.  
Blood drop and prick trial 
The strong correlation of αPGL-I UCP LFA results from blood drop and serum imply that the 
two sample types can be used as equals in ERS.  
This is a significant advantage for animal welfare, as it is not necessary to collect a whole 
blood sample, something that usually requires general anaesthesia in wild ERS. The small 
sample size is also of advantage where ERS that have suffered previous blood loss are 
concerned, as the blood volume needed is much smaller.   
However, collecting a blood drop sample by pricking an ERS with a small needle, to reduce 
invasiveness and allow sampling of a conscious animal in a handling cone, proved difficult. 
Prick needles developed for use on human fingers were too small in diameter and were 
difficult to handle in ERS. The needle easily pierced right through a squirrel ear and correct 
positioning on the tail was not straightforward. It was found that in an anaesthetised squirrel 
a regular injection needle was safer to use as the handler could be permanently aware of 
where the needle tip was and guide the depth of the prick. Sufficient immobility to use such a 
needle would be difficult to guarantee in a conscious ERS.  
The front footpad did not bleed at all following pricking and would put the handler at risk of 
being bitten by a conscious animal. On the ear hair residuals interfered with blood drop 
formation and due to the thinness of the ear there was a high risk of pricking through the ear 
and into the handler’s hand. The hind footpad again never produced a large enough blood 
drop for sampling. The tail needed to be prepared extensively to be able to collect a blood 
drop here in at least a few ERS. The steps necessary are unlikely to be practical in a 
conscious ERS where sudden, uncontrolled movement of the tail could occur and the risk of 
degloving injuries exists when fixation of the tail is attempted. 
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Different ideas should be explored for the collection of usable blood drops in ERS. For 
example, Nobuto blood filter strips could be trialled, as these are successfully used in NBA 
(Loughry et al., 2009). However, it would be necessary to assess if blood collected in this 
manner could be used for the αPGL-I UCP LFA.  
Body cavity fluid 
If the UCP-LFA had performed equally well in body cavity fluid as in live squirrel samples, it 
could have been used in passive surveillance efforts relying on opportunistic carcass 
samples. The latter is often the case where wildlife species are concerned. The use of body 
cavity fluids for leprosy diagnostics is not reported in the other host species.  
Unfortunately, test sensitivity was reduced in this sample type and detected αPGL-I ratios 
lower in body cavity fluid compared to the other two sample types. Either only a small 
fraction of the αPGL-I diffuses out of the blood vessels post mortem and can be detected in 
body cavity fluid or αPGL-I breaks down quickly after the death of the animal, a process that 
cannot fully be halted by freezing the carcass. As animal welfare is no longer a concern post 
mortem and tissue samples can readily be collected at this point, molecular methods appear 
more reliable for diagnosing leprosy in ERS post mortem than measuring αPGL-I in body 
cavity fluids.  
3.4.4. Diagnosing leprosy in live ERS 
All methods explored here are highly valuable for ERS leprosy diagnostics. However, no 
single diagnostic method can identify all live ERS in which leprosy bacilli are present. The 
same is true for the other host species. In humans, the diagnosis is still primarily clinical, 
backed up by laboratory tests (Lastória and de Abreu, 2014a), while in NBA, where clinical 
signs of disease in wild specimen are rare, serological methods are preferred, often 
combined with molecular methods (Loughry et al., 2009; Sharma et al., 2015). In ERS it may 
make sense to use all three methods in some animals, but in others using two out of the 
three may be sufficient. This needs to be considered, particularly in the context of 
conservation efforts where funding is usually limited. The order in which tests should be run 
or whether they can be omitted may vary depending on why the leprosy status of a squirrel is 
being assessed. The main reasons for using leprosy diagnostics in an ERS are a) the 
observation of suspicious clinical lesions and b) surveillance or pre-translocation screening 
efforts. A thorough clinical assessment should form the basis of any leprosy assessment. 
Below effective test combinations are proposed in a diagnostic decision tree (Figure 37).  
Aside from choosing the best test combination, defining a terminology that is logical and thus 
accessible to all those who would want to diagnose leprosy in ERS needs to be established 
to allow for consistent result reporting.  
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For the purpose of this thesis, the following definitions and diagnostic decision tree were 
proposed. They should also be valid to apply beyond this piece of work until further 
diagnostic methods and more information becomes available:  
• Leprosy case : An ERS with clinical signs of leprosy as defined in 3.4.1. (p. 89) or 
lesions that match the lesions descriptions provided by other authors (Simpson et 
al., 2015) with a leprosy specific αPGL-I titre above the cut-off for positivity, and/or 
where M. leprae or M. lepromatosis DNA is isolated. For future use, this isolation 
should be attempted from a sample of the lesion itself. Where this is not possible, 
false negative PCR results can occur.  
• Subclinical leprosy case : An ERS without clinical signs of leprosy, in which M. 
leprae or M. lepromatosis DNA is isolated from a tissue sample, and an immune 
response to the pathogen can be detected. While they may exist, current methods 
are unlikely to be able to identify them. 
• Colonised squirrel : An ERS without clinical signs of leprosy, in which M. leprae or 
M. lepromatosis DNA is isolated from a tissue sample, but no immune reaction of the 
host to the pathogen can be detected. Once appropriate markers to detect a specific 
cellular response to leprosy bacilli in ERS are identified, some animals that are 
currently placed here may be reclassified as subclinical cases.  
• Leprosy contact : Any ERS from a population in which leprosy is endemic, even 
when no clinical sign of disease or bacterial DNA can be detected. If a αPGL-I titre 
above the cut-off for positivity occurs in such an animal, it is still classified as 
contact. 
• Leprosy unlikely, further tests necessary : ERS with clinical signs similar to 
leprosy lesions, but a αPGL-I titre below the cut-off for positivity or serology is 
unavailable and in which no leprosy bacilli DNA is detected or PCR is not attempted. 
Further differential tests be performed or leprosy specific diagnostic tests repeated 
at a later point in time. Where the suspicion that this is a leprosy case based on the 
clinical assessment is very strong, these animals can also be called leprosy 
suspicious, further tests necessary.  
• Leprosy unlikely : ERS without clinical signs of disease in which no leprosy bacilli 
DNA is detected and that originate from a population to which leprosy is not 
endemic. 
The combination of diagnostic tests that should be used to reach each diagnosis are 
depicted in grey in the decision tree in Figure 37. The box of the αPGL-I serology when no 
skin changes are seen in the clinical assessment is white, as in this case the test is unlikely 




FIGURE 37:  DIAGNOSTIC DECISION TREE TO ASSESS THE LEPROSY STATU S OF ERS 
A focus of future research should be to develop diagnostic methods able to differentiate 
subclinical leprosy cases and colonised squirrels. Ideally, in developing diagnostic methods 
further they should be less invasive and adaptable for conscious ERS in a handling cone. 
This could allow for wider active surveillance, as sampling could then be more readily 
integrated in ongoing conservation projects. 
Additional diagnostic options - future research  
Fine needle aspirates (Baddam et al., 2018) were already discussed on page 92 et seq.. 
They could be an option to collect material directly from a leprosy lesion without risking a 
large, potentially poorly healing injury that could result from a biopsy in the lesioned tissue. 
However, they provide a very small sample which may not always contain enough bacteria 
for PCR detection. Acid-fast staining of air-dried fine needle aspirates could also be 
attempted. Another way to add histological methods to live ERS diagnostics would be slit 
skin smears from lesions, where the potential problems of the slit injury can be successfully 
mitigated. However, they are only reliable when performed and interpreted by experienced 
personnel (Scollard et al., 2006). Still they could have a role where clinicians do not have 
access to serological or molecular diagnostics, but want to know quickly whether a 
suspicious skin lesion in an ERS contains AFB. This could guide whether treatment of an 
ERS presenting with lesions should be attempted.  
Additionally, it could be assessed whether the blood volumes collectable from ERS are 
suitable for molecular diagnostics. In humans, detection of M. leprae DNA is possible from 3 
to 5ml blood samples in 70% of PB cases, 95.25% of MB patients, and in some (6.25%) 
household contacts. If smaller volumes were sufficient for a detection, it should be compared 
how test sensitivity in this sample type compares to the detection in tissue punch samples. If 
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sensitivity is similar or even improved, a single sample type could be used for PCR (cellular 
portion) and serological (serum) diagnostics, thus reducing the impact of sampling on the 
ERS.  
It has also been shown that an infection with leprosy leads to differential expression of 
miRNAs in the lesion tissue and in blood samples of human patients (Singh, Singh and 
Chauhan, 2013; Salgado, Pinto, et al., 2018). miRNAs are small (18-22 nucleotides) non-
coding RNA molecules with the capacity of translational downregulation of messenger 
RNAs. Thus they have a role in regulating cell and tissue homeostasis and in the molecular 
pathogenesis of disease, probably by regulating the host immune response (Soares et al., 
2017). The expression of a large number of miRNAs has been shown in skin sections when 
household contacts were compared to leprosy patients, and within the leprosy spectrum and 
the reactional stages (Singh, Singh and Chauhan, 2013). In blood, differential expression of 
miRNAs has also been shown, but varied from the patterns observed in tissue sections of 
lesioned skin (Salgado, Pinto, et al., 2018). miRNAs could serve as biomarkers of infection, 
to aid understanding of leprosy pathogenesis and as therapeutic targets once their role is 
fully understood. Consistent patterns of expression in leprous ERS would need to be 
identified and individual miRNAs validated for this purpose (Soares et al., 2017). No 
research has been done in ERS in this area, but may be interesting in the search for 
additional diagnostic markers with the potential to identify early colonisation/infection, 
assuming that pathogen invasion alters host-cell homeostasis. Collecting samples with intact 
miRNAs will require sampling of live squirrels, but acquiring a sufficiently large tissue section 
from leprosy lesions may cause animal welfare concerns. Furthermore, the sample sizes 
would necessarily be low due to the mainly sporadic occurrence of clinical cases, thus the 
statistical power to identify significant differences in miRNA expression in this species may 
be limited. Samples from opportunistically collected carcasses may be of limited use for 
miRNA assessment. Individual miRNAs have variable degradation times which may lie 
anywhere between four hours and five days, sometimes longer (Gantier et al., 2011; Marzi et 
al., 2016). Therefore, while relatively fresh carcasses with a known time of death that could 
be factored into the analysis could be useful. Carcasses found in the wild where the time of 
death is unknown may not present with the same miRNA composition they had while the 
animal was alive. Collecting blood samples from ERS may be a more viable strategy, 
however, here the low volume (only up to 1ml at any one time) of the samples may again 
limit the amount of analysis that can be done. Waiting until miRNA biomarkers for leprosy 
are firmly established in humans and then using a targeted approach to assess the presence 
of similar expression patterns in ERS may be a more viable strategy than attempting to 




The clinical diagnosis of leprosy was successfully adapted to the presentations seen in live 
ERS, and a scoring and categorisation system for lesions proposed that allows disease 
progression in ERS to be followed over time and to infer how lesions influence ERS welfare. 
Molecular and serological tests were successfully adapted and validated for use in live ERS. 
It needs to be kept in mind that no true gold standard for the diagnosis of leprosy exists 
today across the host spectrum. Combining the diagnostic methods introduced in this 
chapter does allow the identification of cases with an improved level of confidence. However, 
the number of colonised ERS in a population may be underestimated and subclinically 
infected ERS may not be identified as such. The methods introduced here can be used in 
research, clinical and pre-relocation screenings alike, but are currently not commercially 
available. As refined and improved methods are developed in the future, they can be 
integrated into the diagnostic decision tree in accordance with their individual properties and 
















Chapter 4: Clinical and histopathological characterisation 
of leprosy in ERS  
4.1. Introduction 
Following the definition of leprosy lesions in ERS for diagnostic and classification purposes 
in chapter 3 (p. 89) the clinical presentation of leprosy in ERS can now be explored further.  
Data presented in chapter 3 showed that the clinical presentation of leprosy can be more 
varied than the previously published literature had suggested (p. 70). Nevertheless, it was 
possible to propose a clear and simple definition (p. 89). This raised the question whether 
leprosy lesions in ERS are pathognomonic, i.e. characteristic enough so that the diagnosis 
can be made immediately where they are observed. While it is difficult to test this first 
hypothesis directly, given the fact that the full spectrum of leprosy lesions in ERS may not 
yet be known, it can be challenged indirectly, for example by assessing how often a clinical 
diagnosis made can be backed up with laboratory results and by comparing clinical signs 
observed in different leprous ERS.  
A disease is not always just characterised by the specific clinical signs it induces in the host, 
but sometimes also by less specific, secondary changes, such as loss of body condition and 
weight or general ill health. In some chronic diseases such unspecific changes may precede 
typical clinical signs, one example being diabetes (Baumert et al., 2014). In humans, such 
secondary changes do usually occur only after the onset of leprosy specific clinical signs, if 
at all (Lane et al., 2006). It is not known whether leprosy in ERS is linked to any unspecific 
changes or if such could even be indicators of an early leprosy infection. Health parameters 
assessed in this study, such as BCS, weight or GHS can be used to explore this topic and to 
test the second hypothesis of this chapter, that leprosy has an impact on health indicators in 
individual ERS. 
In humans and NBA’s both sexes appear to be similarly at risk of an infection with leprosy 
bacilli and of developing leprosy, but some studies have found a higher proportion of males 
(human) or females (NBA) being infected (Morgan and Loughry, 2009; Gaschignard et al., 
2016). The dataset collected in this study offers the opportunity to test a third hypothesis: 
Leprosy is as frequently observed in male as in female ERS.  
While unsuitable as a routine diagnostic tool for live ERS, histopathology has been pivotal in 
the initial identification of leprosy in ERS (Meredith et al., 2014), and can provide some 
information not obtainable by other means. Most importantly this includes information on the 
inflammatory reaction the host shows in response to leprosy bacilli, allowing characterisation 
of leprosy lesions within the histological Ridley-Jopling spectrum (Ridley and Jopling, 1966). 
Currently, the spectrum of inflammatory reactions to leprosy infection in ERS is narrower 
than in other host species (see p. 10 and p. 17) and limited to BL and LL leprosy. In a 
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recently described condition this may not be a matter of true absence of other variations, but 
such variations may simply not have been observed yet. Therefore, histological assessment 
of lesions in ERS leprosy case carcasses was completed to assess whether new 
presentations could be observed. Thus, the fourth aim of this chapter is to assess whether 
the full spectrum of leprosy lesions described in other hosts is present in ERS as well. 
Having several leprous ERS carcasses available does also allow to assess whether it is 
acceptable to rely on molecular over histological methods in live ERS, by comparing the 
presence of AFB and M. leprae DNA in different tissues. By addressing the fifth hypothesis 
of this chapter (molecular and histological methods are both suited to identify leprosy in 
ERS) it can be determined whether relying on molecular over histological methods in ERS 
diagnostics is sensible, or might result in cases being overlooked. 
Leprosy can cause localised or systemic disease in humans and armadillos. For ERS it has 
been shown previously that leprosy bacilli DNA can occasionally be isolated from different 
skin areas, spleen, lung and liver tissue using molecular and histological methods (Avanzi et 
al., 2016). In chapter 3 the ear was empirically chosen as tissue sampling site for molecular 
leprosy diagnostics (p. 72). While some colonised ERS were identified, it is impossible to say 
if any, or how many, were missed, or if another tissue would have offered different results or 
identified even more colonised ERS. By assessing the presence of AFB across a range of 
ERS carcass tissues and isolating M. leprae DNA from the same tissues the sixth hypothesis 
of this chapter that leprosy bacilli are present in a range of tissues in ERS is addressed. High 
bacterial loads are likely to make it easier to identify an infection with leprosy bacilli than low 
bacterial loads, a point proven by the continued difficulties in human medicine to identify PB 
leprosy cases before severe clinical signs are present (Lane et al., 2006). The bacterial 
index, which can be determined in acid-fast stained tissue sections, was therefore used as 
additional parameter to determine the tissue best suited for leprosy diagnostics in ERS.  
Addressing these six aims/hypotheses of this chapter will broaden the information base 
available on clinical and histological characteristics of ERS leprosy, identify if there are 
additional parameters that could aid leprosy diagnostics or allow to predict which ERS are 
more likely to be infected, and allow to further refine sampling for leprosy diagnostics in 
carcasses and live ERS.   
4.2. Methods 
4.2.1. Clinical presentation of leprosy in ERS 
Information included in this chapter covers data from live ERS assessments and full post 
mortem examinations. For ERS seen live, a general health assessment was completed for 
each animal every time it was seen, as described in chapter 2 (p.43), and the 
presence/absence of leprosy lesions and their severity were noted in accordance with the 
scoring and categorisation system described in chapter 3 (p. 82). Blood samples were 
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collected from the femoral vein during each assessment and the αPGL-I UCP LFA 
performed to assess the presence of anti-leprosy bacilli antibodies described in chapter 3 (p. 
75). Where ear tissue punches were collected, they were screened for M. leprae and M. 
lepromatosis DNA as described in chapter 3 (p. 72).  
Opportunistically collected carcasses from BI and AR and additional carcasses that had 
been submitted to the UoE Red Squirrel Surveillance scheme were assessed and samples 
collected following the protocol introduced in chapter 2 (p. 46). Disposable scalpels and 
tweezers were used for all sampling and changed after every organ. Individual clean single 
use plastic petri dishes were used to separate organs and cut sections as necessary. 
Where ante- and post-mortem information was available for an animal, the data was collated 
to provide the most comprehensive information (usually isolation of M. leprae DNA from 
tissue samples collected post mortem) and the animal was sorted into the session in which it 
was seen alive. Session numbers were kept in line with the other chapters of this thesis (1= 
autumn 2016 to 5 = autumn 2018) with an added session to describe animals seen only post 
mortem (6 = carcasses collected at different points in time). ERS with clinical lesions or a 
positive PCR for leprosy bacilli DNA were included, aiming to cover all ERS affected by 
leprosy, clinical leprosy cases as well as colonised squirrels (For definitions see chapter 3, p. 
97 and Figure 37). Contact ERS without clinical signs of leprosy and from which no leprosy 
bacilli DNA had been isolated were used as “healthy” controls for the purpose of 
comparisons. The proportion of “healthy” ERS from the two populations included in 
comparisons was kept similar to the proportion of affected ERS from both populations. ERS 
of unknown PCR status without clinical signs of disease were excluded in this chapter. 
As clinical disease and general state of the live animals changed over time, returning 
animals were included several times. Therefore, not all data in this set is independent. The 
purpose of this research effort was to describe the spectrum of leprosy lesions in ERS in as 
much detail as possible. Where the same individual ERS was seen several times, its 
condition and leprosy signs changed, and were thus relevant to be included again, artificially 
being treated as independent descriptions of leprosy lesions, to increase the available 
dataset. Chapter 5 will address these dependent samples as such.  
Analysis 
Data collected was summarised and analysed using R as specified under the individual 
subheadings below.  
Leprosy lesions are pathognomonic. They are very similar between individuals. 
Firstly, it was assessed in how many instances a clinical leprosy diagnosis could be backed 
up with a laboratory confirmation. Field and post mortem data were included. Secondly, 
samples from two carcasses (R3-17, R38-18) submitted to the UoE Red Squirrel 
Surveillance scheme under the suspicion that they might be infected with leprosy bacilli were 
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examined following the protocols of this study. Thirdly, the similarity of leprosy lesions seen 
in ERS throughout the study was assessed. To achieve this, the lesion scores and 
categories assigned to the different ERS were summarised, along with the location of the 
body in which lesions were observed. Images from the observed animals were grouped by 
category to illustrate the similarities and variations between lesions. Again, both live ERS 
and post mortem data of affected ERS were included. 
Leprosy has an impact on ERS beyond the immediate clinical signs  
The null hypothesis that BCS, weight and general health are similar in clinically diseased, 
colonised and contact ERS that are apparently unaffected by leprosy was tested using a 
Kruskal-Wallis test. Where significant differences between the three groups existed, an 
additional pairwise Wilcoxon rank sum test was run to determine between which groups the 
differences were statistically significant (p< 0.05). The data collected for comparison is 
ranked (BCS, GHS) or not normally distributed (weight). Only live assessed ERS were 
considered, as in ERS only assessed post mortem the presence of additional conditions 
impacting BCS, weight and GHS was highly likely.    
Only ERS affected by leprosy (clinical case or colonised) were then considered to assess the 
effect of leprosy severity on BCS, weight and GHS. A Spearman’s rank correlation was used 
to assess whether changes in BCS, weight or general health were correlated to the leprosy 
severity category. The different clinical categories of 1-4 and an additional category 0 for 
colonised ERS were used to represent severity.  
Influence of ERS sex on proportion colonised by/infected with leprosy bacilli 
The null hypotheses that the proportion of males and females colonised by leprosy bacilli or 
showing clinical signs of leprosy does not differ was tested using a chi-square test. Live and 
post mortem data was included in this analysis.  
A Wilcoxon rank sum test was used to assess whether sex had an influence on disease 
severity represented by leprosy category (ranked data).  
4.2.2. Histopathological and molecular assessment of leprosy affected ERS 
Twelve carcasses were selected for detailed assessment following a pre-screening of ear 
tissue for M. leprae/M. lepromatosis DNA to identify animals in which leprosy bacilli were 
present. Ten animals with a positive PCR for M. leprae were selected and two negative 
controls. One of these subsequently was shown to carry M. leprae DNA, so that in total 11 
PCR positive ERS, seven of which also showed clinical leprosy lesions, and one negative 
control were assessed in detail. No M. lepromatosis positive carcasses became available 
during the time of this study.  
From each of the 12 carcasses the following tissues/organs were collected: ear, eye, nose, 
muzzle, mandibular lymph nodes, lung, front footpad, liver, spleen, intestines, kidney, hock 
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skin, hind footpad, mammary gland (females) and testicles (males). Details for the included 
ERS can be found in appendix III (p. 226). The ERS included in this part of the study were 
BIC001_16, BIC002_16, BIC003_16, BIC006_16, BIC007_16, BIC009_16, BIC010_16, 
BIC014_17, BIC016_17, BIC018_18, ARC016_18, and, as negative control, ARC017_18.  
Sample collection started with skin samples, followed by the eyes and nose. Then the ventral 
neck skin was incised to collect the submandibular tissue, which included lymph nodes as 
well as saliva glands, connective tissue and fat. Only histologically confirmed lymph node 
tissue was later included in the analysis. The skin incision was then elongated along the 
ventral midline. In males, testicles were collected while dissecting off the skin. After 
assessing subcutaneous fat cover and the integrity of the abdominal muscles, the abdominal 
cavity was opened, beginning the incision at the sternum to the pelvis and cutting along the 
caudal rim of the ribcage to expose all abdominal organs. The spleen was removed first, 
followed by the gastrointestinal tract, liver, kidneys and adrenal glands. The diaphragm was 
then cut on the ventral edge, and the rib cage opened on the left. The muscles of the neck 
and lower jaw were cut, so that tongue, trachea, lungs and heart could be removed and 
separated. Testicles and mammary tissue were only assessed histopathologically and not 
via PCR. The muzzle was originally collected in two parts (“muzzle” and “scent glands corner 
of the mouth”), but as results did not vary between the two segments they were combined for 
analytical purposes. Not all organs were still present in all squirrels, depending on the state 
of decay and whether the animals had been predated. For paired organs the left one was 
fixed in 10% formalin for a minimum of 48 hours before trimming and the right in 70% 
ethanol. For unpaired organs representative sections were collected and stored as before 
(Figure 38, p. 107). 
Histopathology 
For histopathological assessment the fixed tissue and organ sections were trimmed and 
submitted for blocking and staining to the histology laboratory at Easter Bush Pathology, The 
(Royal) Dick School of Veterinary Studies, UoE. Up to four organs per animal were grouped 
for one block/slide, always following the same pattern (Table 16).  
TABLE 16:  TISSUES BLOCKED PER SLIDE  
Slide 1  Slide 2 Slide 3 Slide 4 





Hind footpad Lung Intestines Spleen 





FIGURE 38:  SQUIRREL SITUS , TISSUE/ORGAN SAMPLES COLLECTED FOR DETAILED 
MOLECULAR (RED, RIGHT BODY SIDE) AND HISTOPATHOLOGICAL (BLUE , LEFT BODY SIDE ) 
ASSESSMENT ARE HIGHLIGHTED . 
From each block two stained slides were requested, one stained in Ziehl-Neelsen (ZN) one 
in Haematoxylin & Eosin (HE). ZN staining has been used in all previous assessments for 
leprosy bacilli using ERS tissues (Meredith et al., 2014; Simpson et al., 2015; Avanzi et al., 
2016) with consistently good success. The laboratory used had previous positive experience 
in applying ZN staining to ERS tissues for leprosy diagnostics.  
Slides were assessed using an Olympus BX41 light microscope at 20x and 40x 
magnification mounted with an Olympus DP72 camera, using Olympus cell imaging software 
for Life Science Microscopy. Each section was visually examined in full, moving through the 
section in tight zigzags. Presence/absence of AFB was documented, along with their 
number, given as bacterial index in accordance with the Ridley-Jopling classification (Ridley 
and Jopling, 1966, also see p. 10) and location in ZN stained sections. In H&E stained 
sections the presence/absence of an inflammatory reaction was noted. Where present, the 
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type of inflammation, and cell types involved were noted and, where appropriate, a category 
within the Ridley-Jopling classification (TT, BT, BB, BL, LL or InL) assigned. Observations 
made were discussed with an experienced veterinary pathologist prior to further analysis. 
For each section information on the presence/absence of macroscopic lesions was also 
available.  
During the histological assessment of the ZN and H&E stained tissue sections notes were 
kept on location and state of bacteria, the tissue itself and on cell types forming the 
inflammatory lesions seen. These notes are summarised in appendix IV (p. 235).  
Molecular diagnostics 
From all available organs of the 12 focus carcasses a two to three mm cube of tissue 
(approx. 15mg) was cut in a sterile petri dish with a single use scalpel and the ethanol 
allowed to evaporate while the rest of the sample was returned into 70% ethanol for 
continued storage. The tissue cube was cut into 5-6 smaller pieces and DNA extraction 
carried out following the same protocol detailed in chapter 3 (p. 73 et seqq.). The only 
adjustment made was the use of 80µl AE buffer in the final elution step.  
PCR amplification and amplicon visualisation were carried out following the protocols 
detailed in chapter 3 (p. 73 et seqq.). For the two animals from AR, and for one from BI two 
amplifications were run for each organ, using both LPM 244 and RLEP 7 and 8, to ensure 
that a co-infection with M. lepromatosis was not overlooked. As M. lepromatosis has never 
been isolated on BI and all results for the pilot animal were negative, the other samples 
originating from BI were only tested for the presence of M. leprae DNA.  
Analysis 
The whole histological spectrum of leprosy lesions is present in ERS 
The Ridley-Jopling categories established by classifying the inflammatory reactions in 
leprosy lesions in H&E stained sections in conjunction with the BIn determined from the ZN 
stained section of the same lesion were used to assess whether the whole spectrum of 
leprosy lesions is present in ERS.   
There is no difference in the ability to identify ERS leprosy cases using molecular and 
histopathological methods 
To compare the performance of the histological and molecular methods, PCR results and 
detection of AFB were compared for tissues for which both were available.  
A 2x3 contingency table was created to see how many tissues tested positive with one of the 
two or both tests. A Fisher’s exact test was used to assess the null hypothesis that the 
probability of a positive result is the same regardless of the diagnostic method being applied.   
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There is no difference in the ability to identify ERS leprosy cases using a range of 
different tissues  
It was summarised in how many of the eleven assessed ERS each organ was positive in the 
histological and molecular assessment, testis and mamma only included for histological 
assessment. Not all organs were available from all ERS. Thus, the proportion of each 
available organ positive for leprosy in molecular and histological diagnostics is presented as 
well. As “other leprosy lesions” were only present in three animals, and located in different 
areas of the body, they were not included in this analysis 
To assess the difference in the ability to identify leprosy bacilli in the specific tissues using 
molecular and histopathological methods 10 tissues available from all ERS were used to 
create a 2x3 contingency table for each organ. Based on the positive results for both tests, 
the proportion of animals was calculated that would have been identified as a leprosy case 
had only one specific organ been used.  
The BIn documented was used to determine which tissue/organ was most likely to harbour 
large numbers of bacteria, i.e. had a high BIn in most assessed carcasses. Additionally, it 
was assessed whether the distribution of leprosy bacilli through the ERS body was 
influenced by disease severity. To achieve this, the ERS were split into two groups, severely 
affected ERS (category 4; n= 6) and colonised or mildly affected ERS (category 0 and 1; n= 
5). Due to the small sample size and variation within the sample, analysis of these results 
was purely descriptive. 
4.3. Results 
All ERS identified as affected by leprosy in this part of the study were affected by M. leprae.  
4.3.1. Clinical characterisation of leprosy in ERS 
A total of 55 assessments of ERS affected by leprosy were available. Twelve were only 
assessed post mortem (nBI= 10, nAR= 2). Only one carcass was a juvenile, all other 
assessments were made in adult ERS. Forty-three assessments were completed in live ERS 
(nBI= 41, nAR= 2), ear tissue punches for PCR were collected during 22 of them. For four 
ERS additional information was added following post mortem assessment (nBI= 3, nAR= 1).  
Leprosy lesions are pathognomonic. They are very similar between individuals.  
Clinical skin lesions meeting the definition for leprosy lesions (p. 89) were seen in 34 
assessments (30 live, four carcasses). PCR results were available for 15 of these animals 
and in nine (four carcasses, five live) the presence of M. leprae DNA was confirmed, while 
no bacterial DNA could be isolated from four (all live). Three of these, however, had a 
positive αPGL-I serology result to confirm them as leprosy cases.  
αPGL-I serology results were available for 30 (live) out of the 34 assessments with clinical 
lesions. Three of these were negative, two in animals with very small and early lesions in just 
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one body area, and one with very early lesions in four body areas, and thus a higher score 
and category. Seropositivity is linked to lesion intensity and a re-test at a later point in time 
may have a positive result. Unfortunately, a PCR result was only available for one of these 
three animals. It was negative as well, placing this animal as leprosy unlikely if the decision 
tree (p. 99) is strictly followed.  
Still, currently out of 34 clinically suspected leprosy cases only three (8.8%) could not 
immediately be confirmed using molecular or serological methods, with no PCR information 
available for two of them. In 91.2% the clinical diagnosis was confirmed, even with 
incomplete PCR data.  
An additional consistent observation made in post mortem examinations and in one animal 
that had to be euthanised due to severe welfare concerns in autumn 2017, was that the cut 
surface of a fresh leprosy lesion is usually slightly yellow, bulks outward over the cut surface, 
and retains the firm rubbery texture (Figure 39).  
 
FIGURE 39:  LEPROSY LESION ON SQUIRREL PINNA REMOVED IMMEDIATELY  AFTER HUMANE 
EUTHANASIA . THE TEXTURE OF THE LESION IS FIRM-RUBBERY AND THE CUT SURFACE OF THE 
LESION IS BULGING AND SLIGHTLY YELLOW  
M. leprae DNA was isolated from all 21 animals without clinical lesions included here (8 
carcasses, 13 live). All of the 13 squirrels seen live from which serum was available had a 
negative αPGL-I result, and were thus classed as colonised. None of these animals showed 
any skin changes in the clinical examination.  
In neither of the two ERS submitted to the UoE Red Squirrel Surveillance scheme (R3-17, 
R38-18) under the suspicion of being leprosy cases were leprosy bacilli DNA or AFB 
detected. R3-17 presented with multiple bulbous skin lesions predominantly around eyes 
and a diffuse swelling with some hair loss of the chin/throat area. Smaller lesions, again with 
incomplete hair loss were observed on ears and right forearm. The surface of the lesions 
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was dull, and the skin came off in some areas when touched (Figure 40). When cut, the 
lesions were not bulking over the cut surface and were shiny, wet but not runny, and off 
white to pale yellow (Figure 41). In the histopathological assessment, this squirrel was 
diagnosed as a case of atypical histiocytosis (Figure 42). 
 
FIGURE 40:  CLINICAL LESIONS SEEN IN R3-17. INCOMPLETE HAIR LOSS TO SWELLINGS ON 
EYELIDS, CAUDAL RIM OF THE EAR AND DIFFUSE SWELLING WITH TH INNING OF THE COAT ON 
CHIN AND THROAT  
 
FIGURE 41:  CUT SURFACE OF THE CHIN LESION OF R3-17  
 
FIGURE 42:  ZN (LEFT) AND HE (RIGHT) HISTOLOGICAL IMAGE OF THE CHIN LESION OF R3-17 
SHOWING ABSENCE OF AFB  AND PRESENCE OF ATYPICAL ROUND CELLS AND 




R38-18 had presented with an areas of hair loss and moderate skin thickening over the 
dorsal aspect of the nose and nostrils. No abnormal changes were observed on the skin of 
ears and hocks. No other lesions were seen on the animal, but it failed to thrive even under 
human care and was eventually euthanised. No obvious singular cause for its ill health could 
be identified (Figure 43). No leprosy bacilli DNA could be isolated from ear or nose lesion of 
this ERS. The animal was a very young adult male. As the size of the lesion was fairly large, 
this would be unexpected in a leprosy case of this age, where the disease is usually still non-
clinical.  
 
FIGURE 43:  NOSE LESION OBSERVED IN R38_18 ANTE MORTEM .  
 
To assess lesion similarity between leprosy cases the lesion scores assigned to all animals 
during clinical assessment (total n= 55) were used. ERS without lesions (n= 21) were 
assigned a score of 0. The minimum score where lesions were present was two, i.e. when a 
lesion is present it will at the very least be assigned one point for size and one for its 
character (p. 82 et seqq.). Scores for observed lesions (n= 34, all BI) were scattered 
between two and 51, with very few animals with lesions being assigned the exact same 
score. The most frequent score of 4 was assigned four times, a score of 2 was assigned 
thrice. Six score values were assigned twice and the remaining 15 values were only 
assigned to one animal each (Figure 44). This shows that clinical sign intensity and thus 




FIGURE 44:  NUMBER OF TIMES (Y-AXIS) EACH NUMERICAL , ADDITIVE LESION SCORE (X-AXIS) 
WAS ASSIGNED TO AN ERS AT THE TIME OF ASSESSMENT . A SCORE OF 0 WAS ASSIGNED 
WHEN NO LESIONS WERE PRESENT. THE OTHER SCORES WERE CALCULATED AS DETAILED IN 
CHAPTER 3  
Where clinical lesions were seen they were mainly classed as either mild (category 1, 
32.4%) or severe (category 4, 47%). Mild to moderate (category 2, 14.7%) or moderate 
(category 3, 5.9%) lesions were observed much less frequently (Figure 45).  
 
FIGURE 45:  CATEGORIES ASSIGNED TO LEPROSY AFFECTED ERS. LESION CATEGORY 1= 
MILD, CATEGORY 2= MILD-MODERATE , 3= MODERATE , 4= SEVERE;  CATEGORY 0 INCLUDES 
THE COLONISED ANIMALS WITHOUT CLINICAL SIGNS . EACH DOT REPRESENTS ONE ANIMAL  
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There was variability as to where lesions first appeared, the number of body areas affected, 
and whether lesions were bilateral, or unilateral, even within the same severity category. 
While fundamental characteristics like shiny appearance, hair loss and firm rubbery 
consistence were present in all cases, there were marked differences in the appearance of 
lesions seen in individual squirrels (Figure 46, Figure 47, Figure 48, and Figure 49).  
 
FIGURE 46:  EXAMPLES ILLUSTRATING THE DIVERSE FORMS MILD LESIONS  (CHAPTER 3, P. 82 
ET SEQQ.) CAN TAKE  
 
FIGURE 47:  EXAMPLES ILLUSTRATING THE DIVERSE FORMS MILD -MODERATE LESIONS 




FIGURE 48:  EXAMPLE ILLUSTRATING A MODERATE LESION (CHAPTER 3, P. 82 ET SEQQ.) 
 
FIGURE 49:  EXAMPLES ILLUSTRATING THE DIVERSITY OF SEVERE LESION S (CHAPTER 3, P. 82 
ET SEQQ.) 
Lesions were most often observed on the ears (94.1%). Only in two ERS with clinical leprosy 
lesions were no lesions noted on the ears. Eighteen ERS had lesions on both ears, eight just 
on the left and six just on the right ear. The hocks were the second most common location 
for leprosy lesions (22 out of 34 ERS, 64.7%), with 17 ERS having lesions on both hocks, 
four only on the left, and one only on the right. Both ERS that did not have lesions on the 
ears did have hock lesions. Less common locations for leprosy lesions were the nose and 
eyelid (two out of 34 ERS each, 5.9%). A swelling of a front footpad that was thought to be a 
leprosy lesion based on its texture was only seen in a single carcass. M. leprae DNA was 
detected in this footpad (BIC007_16, 2.9%; Figure 50). In three out of 17 male ERS with 
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leprosy lesions, scrotal lesions were observed (17.6%), making this the third most likely 
location for leprosy lesion in this sex.  
 
FIGURE 50:  SWELLING OF THE FRONT FOOTPAD IN BIC007_16   
 
Leprosy has an impact on ERS beyond the immediate clinical signs  
Forty-three assessments of ERS affected by leprosy, 30 clinically diseased ERS (all BI) and 
13 colonised ERS (nBI= 41, nAR= 2), as well as, 44 assessments of live ERS unaffected by 
leprosy (nBI= 42, nAR= 2) were included to compare the effects of leprosy on the three chosen 
condition indicators. Only two ERS were selected for inclusion in the unaffected by leprosy 
group from AR, as squirrels in this population tend to have a higher weight than ERS on BI. 
Therefore, having a higher proportion of ERS from AR in the unaffected group than in the 
affected group could result in an apparent effect on the chosen parameters that are not truly 
linked to leprosy but to inherent traits of the population the ERS came from. Keeping the 
proportion of ERS from both populations similar for both groups should avoid this problem.  
Most ERS were in normal (58.6%) or thin (40.2%) body condition. Only one ERS showing 
clinical signs of leprosy was emaciated (1.2%). Out of the thirty ERS clinically affected by 
leprosy 19 (63.3%) were in normal body condition, ten (33.3%) were thin, and one, as 
mentioned, emaciated. Nine (69.2%) of colonised ERS were in normal body condition, and 
four (30.8%) were thin. Twenty-three ERS unaffected by leprosy (52.3%) were in normal 
body condition and 47.7% (n= 21) were thin. It is possible to observe differences in body 
condition between contact, colonised and clinically diseased ERS as they are present in the 
sample set if the null hypothesis of no difference between the three groups were true (p= 




FIGURE 51:  BCS  OF ERS (CLINICAL CASES = ORANGE , COLONISED= BLUE , CONTACT= 
GREEN) AT THE TIME OF ASSESSMENT . BCS  1= EMACIATED , BCS  2= THIN, BCS  3= NORMAL . 
ERS unaffected by leprosy had a mean body weight of 306.6g (SD= 19.0g, Min= 265g, 
Max= 370g). ERS affected by leprosy were on average heavier. Colonised ERS had a mean 
body weight of 319.2g (SD= 42.4g, Min= 270g, Max= 390g), and ERS with clinical leprosy 
lesions had a mean body weight of 327.2g (SD= 25.0g, Mon= 280g, max= 390g).  
The differences in the average body weight between contact, colonised and clinically 
diseased ERS are unlikely to occur by chance alone. The average weight increases from 
contact over colonised to case ERS (Kruskal-Wallis test, p= 0.002887, Figure 52). While the 
difference observed between contact and colonised ERS (Wilcoxon rank sum test, p= 
0.6124) and colonised and case ERS (p= 0.4793) were not statistically significant, the 




FIGURE 52:  RANGE OF BODY WEIGHTS OBSERVED IN ERS AFFECTED BY LEPROSY (CASE= 
BLUE , COLONISED= ORANGE) AND UNAFFECTED BY LEPROSY (CONTACT= GREEN).  
Most ERS were in good health (GHS category 1) at the time of assessment (nTotal= 64 
(73.6%); ncontact= 35 (79.5%); ncolonised= 7 (53.8%); ncase= 22 (73.3%)). Some had minor or old 
injuries (GHS category 2) while still generally being in good health (nTotal= 18 (20.7%%); 
ncontact= 9 (20.5%%); ncolonised= 5 (38.5%); ncase= 4 (13.3%)).  
One (7.7%) colonised ERS was chronically unwell but able to cope (GHS category 5). One 
(3.3%) ERS showing clinical signs of leprosy was sorted into GHS categories 3, 4, 5, and 6 
each (3= acutely unwell, improvement likely, 4= acutely unwell, improvement unlikely, 6= 
chronically unwell, unable to cope).  
Looking at the general health status of contact, colonised and clinically diseased animals, 
the null hypothesis that there is no difference between the groups cannot be rejected 





FIGURE 53:  GHS OF CLINICAL CASE (ORANGE), COLONISED (BLUE ) AND CONTACT (GREEN) 
ERS. GHS 1= IN GOOD HEALTH ;  GHS 2= IN GOOD HEALTH WITH MINOR OR OLD /HEALED 
INJURY;  GHS 3= ACUTELY UNWELL WITH GOOD PROGNOSIS ;  GHS 4= ACUTELY UNWELL , 
UNLIKELY TO IMPROVE ;  GHS 5= CHRONICALLY UNWELL , COPING;  GHS 6= CHRONICALLY 
UNWELL , NOT COPING  
In the next analysis only ERS affected by leprosy (case and colonised ERS) were 
considered. When the observed body condition is split by severity category, four out of 13 
colonised ERS (30.8%) were thin, and the remaining 69.2% in normal body condition. ERS 
with mild leprosy lesions (n= 10) were also thin (20%) or in normal body condition (80%). All 
ERS with mild to moderate leprosy lesions (n= 5) were in normal body condition. ERS with 
moderate leprosy lesions (n= 2) were in normal body condition (50%) or thin (50%). There 
appears to be a mild tendency of severely affected ERS (n= 13) to be in a lower body 
condition. One was emaciated (7.7%), seven thin (53.8%), and five in normal body condition 
(38.5%). However, the null hypothesis that there is no correlation between body condition 
and leprosy severity categories cannot be rejected (Spearman’s rank correlation, p=0.091, 




FIGURE 54:  NUMBER OF ANIMALS WITH A CERTAIN BCS  (Y-AXIS) IN EACH LEPROSY SEVERITY 
CATEGORY (X-AXIS:  0= COLONISED, NO CLINICAL LESION , 1= MILD, 2= MILD TO MODERATE , 
3= MODERATE , 4= SEVERE) 
Colonised ERS had an average weight of 319.2g (SD= 42.4g, Min= 270g, Max= 390g). ERS 
with mild leprosy lesions had an average weight of 313.9g (SD= 23.8g, Min= 280g, Max= 
350g). ERS with mild-moderate lesions were on average slightly heavier with 327.0g (SD= 
30.1g, Min= 300g, Max= 375g). Only two ERS were seen with moderate lesions. Both 
weighed 330g. ERS with severe lesion were again slightly heavier with 336.2g (SD= 23.6g, 
Min= 300g, 390g). Despite this tendency towards the higher weight in ERS more severely 
affected by leprosy, the differences are not statistically significantly correlated with the 
severity of observed leprosy lesions (Spearman’s rank correlation, p=0.069, rho= 0.28) 




FIGURE 55:  MEDIAN WEIGHT OF ERS ASSIGNED TO THE DIFFERENT SEVERITY CATEGORIES OF 
LEPROSY (0= COLONISED, 1=MILD LESION , 2= MILD-MODERATE LESION , 3= MODERATE 
LESION, 4= SEVERE LESION) 
Colonised ERS (n= 13) were either in good health (53.8%), in good health with minor or old 
injuries (38.5%) or chronically unwell but able to cope (7.7%), as mentioned above. All ERS 
with mild, mild-moderate and moderate leprosy lesions were in good health or in good health 
with minor or old injuries (mild lesions: 80% GHS cat.1, 20% GHS cat. 2; mild-moderate 
lesions: 80% GHS cat. 1, 20% GHS cat. 2; moderate lesions: 50% GHS cat. 1, 50% GHS 
cat. 2). Nine (69.2%) ERS with severe leprosy lesions were still otherwise in good health. 
One (7.7%) ERS with severe leprosy lesions was classed in GHS categories 3, 4, 5, and 6 
each.  
The severity of leprosy lesions is still not statistically significantly correlated to the GHS 
category that the ERS was assigned to (Spearman’s rank correlation, p= 0.8241, rho=           




FIGURE 56:  ERS ASSIGNED TO EACH GHS CATEGORY (Y-AXIS:  GHS 1= IN GOOD HEALTH ;  
GHS 2= IN GOOD HEALTH WITH MINOR OR OLD /HEALED INJURY ;  GHS 3= ACUTELY UNWELL 
WITH GOOD PROGNOSIS;  GHS 4= ACUTELY UNWELL , UNLIKELY TO IMPROVE ;  GHS 5= 
CHRONICALLY UNWELL , COPING;  GHS 6= CHRONICALLY UNWELL , NOT COPING) IN RELATION 
TO THE SEVERITY OF THEIR  LEPROSY LESIONS (X-AXIS :  0= COLONISED, NO CLINICAL LESION , 
1= MILD, 2= MILD TO MODERATE , 3= MODERATE , 4= SEVERE) 
Influence of ERS sex on proportion colonised by/infected with leprosy bacilli 
Out of the 55 ERS affected by leprosy assessed live or post mortem, 12 male ERS were 
colonised by leprosy bacilli and 17 were observed with leprosy lesions. Nine female ERS 
were colonised by leprosy bacilli and 17 clinically diseased (Figure 57).  
This distribution is likely (chi-square test, p= 0.8122) when the null hypothesis of no 
difference in the occurrence of clinical lesions between the two sexes is true. When further 
dividing the dataset based on severity category in the two sexes the picture does not to 
change (Wilcoxon rank sum test, p= 0.71, Figure 58). Based on this dataset leprosy appears 
to affect both sexes evenly and the chances of an ERS being found in a certain severity 






FIGURE 57:  ERS COLONISED (N) BY M. LEPRAE OR SHOWING CLINICAL SIGNS OF LEPROSY 
(Y) BY SEX (BLUE = FEMALE , RED=MALE ).  
 





4.3.2. Histopathological and molecular assessment of leprosy affected ERS 
Samples were available from 11 ERS carcasses affected by leprosy. All animals were adults, 
four were male (three with abdominal, one with scrotal testes) and seven female (three 
inactive, two in oestrus, one pregnant and one lactating). Seven showed clinical signs of 
leprosy (two male, five female). Most (n=6) had severe lesions, their additive point scores 
ranging from 15 to 51. In one ERS mild lesions with a point score of 4 were recorded. All 
these animals, as well as three animals colonised by M. leprae came from BI. Another ERS 
colonised by M. leprae came from the AR population. The number of each organ available 
for histological and molecular assessment along with the number of animals in which 
macroscopic lesions were seen in these particular organs is summarised in Table 17.  
TABLE 17:  NUMBER OF SPECIMEN AVAILABLE FOR EACH ORGAN TYPE FOR  
HISTOPATHOLOGICAL AND MOLECULAR ANALYSIS ;  NUMBER OF ERS IN WHICH THESE 
SPECIMEN SHOWED MACROSCOPIC LESIONS INDICATING LEPR OSY 
Sample type 
No. available for 
histology 





Ear 11 11 6 
Eye 10 9 0 
Nose 11 11 3 
Muzzle 11 11 0 
Mandibular lymph 
node 
6 9 2 (enlarged) 
Lung 10 10 0 
Front footpad 11 11 0 
Liver 11 11 0 
Spleen 11 11 0 
Intestines 11 11 0 
Kidney 11 11 0 
Hock skin 11 11 7 
Hind footpad 11 11 0 
Mammary gland 7 0 0 
Testicle 4 0 0 
Note that macroscopic lesions were only observed in a limited number of skin tissues and, in 
form of swelling, in the mandibular lymph nodes but not in internal organs. Other leprosy 
lesions (a small intranasal mass, a scrotal lesion and a lesion on the scalp) were available 
from three animals. Again, two of these were located in the skin. From all three M. leprae 
DNA was isolated. Only the scalp and scrotal lesions were assessed histologically as not 
enough of the intranasal mass was left. In the section of the scalp lesion assessed no AFB 
or signs of inflammation were present, while the scrotal lesion was classed as LL with a BIn 
of 5.  
The whole histological spectrum of leprosy lesions is present in ERS 
It was possible to classify lesions in four of the 15 tissues collected per ERS, namely ear, 
hock skin, nose, and one scrotal lesion, using the Ridley-Jopling system. Other tissues like 
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footpads or muzzle to which the system would in theory be applicable to did not show 
lesions.  
An inflammatory reaction was observed in all 11 ear sections, nine hock sections, six nose 
sections and the scrotal lesion. One ear section could not be classified due to advanced 
autolysis. In one hock skin section the inflammation seen was classed as non-lepromatous 
and in another one no final decision could be made whether the inflammation seen was non-
lepromatous or a very early stage of a lesion (Figure 59).  
 
FIGURE 59:  MINIMAL PERINEURAL INFLAMMATORY INFILTRATE OBSERVED IN A SECTION OF 
THE HOCK SKIN OF ARC016_17.  THIS COULD POTENTIALLY DEVELOP INTO A LEPROSY 
LESION (BIN IN ZN STAIN = 0) 
The Ridley-Jopling categories assigned in the remaining samples are detailed in Table 18. 
Figure 60 through to Figure 63 show examples of lesions representative of the different 
categories.  
TABLE 18:  RIDLEY-JOPLING CATEGORISATION OF LESIONS SEEN IN THIS SET O F ERS 
SAMPLES :  NUMBER OF ERS PLACED IN EACH CATEGORY AND BIN’S ASSIGNED (NO. OF ERS 
A PARTICULAR BIN WAS ASSIGNED TO ;  FOR BIN CATEGORY DEFINITIONS SEE P. 10 ET SEQ.) 
Tissue 
Frequency with which lesions of each category (InL, BB, BL, LL) were 
observed and bacterial indices (BIn) seen 










1 0 (n=1) 2 
4 (n=1) 
6 (n=1) 















FIGURE 60:  EXAMPLE OF THE INFLAMMATORY REACTION SEEN IN THE EAR  LESION OF 
BIC006_16,  CLASSED AS INL  (BIN IN ZN STAIN = 1). 
 
FIGURE 61:  EXAMPLE OF THE INFLAMMATORY REACTION SEEN IN THE HOC K LESION OF 
BIC001_16,  CLASSED AS BB  (BIN IN ZN STAIN = 4) 
 
FIGURE 62:  EXAMPLE OF INFLAMMATORY INFILTRATE OBSERVED IN NASAL  SKIN OF 




FIGURE 63:  EXAMPLE OF INFLAMMATORY INFILTRATE OBSERVED IN THE E AR OF BIC003_16  
AND CLASSED AS LL  (BIN IN ZN STAIN = 6) 
In one of the LL lesions seen in hock skin, characteristics were observed that may indicate 
an ENL or a secondary infection (Figure 64). There were acute inflammation and necrosis 
reaching the epidermis and lymphocytes and epithelioid cells observed in the deep dermis.  
 
FIGURE 64:  RANGE OF INFLAMMATORY INFILTRATES OBSERVED IN THE HO CK OF BIC007_16.  
LEFT:  LYMPHOCYTES AND EPITHELIOID CELLS IN THE DEEP DERM IS;  RIGHT:  ACUTE 
INFLAMMATION AND NECROSIS REACHING THE EPIDERMIS  
No presentations consistent with a borderline tuberculoid or tuberculoid form of leprosy were 
present in any of the samples. Even with expert advice the classification of the lesions was 
not always straightforward.  
There is no difference in the ability to identify ERS leprosy cases using molecular and 
histopathological methods 
Only tissues that were assessed with both molecular and histological methods were included 
in this comparison, i.e. 10 for all eleven carcasses (ear, eye, hock skin, nose, muzzle, front 
footpad, hind footpad, lung, intestines, spleen, liver, and kidney; n= 110), and one for 10 
carcasses (lung). Thus, a total of 120 tissue samples from ERS affected by leprosy were 
used to assess whether molecular and histopathological methods would return positive 
results equally. Eyes and mandibular lymph nodes were excluded as the numbers available 
for histological and molecular assessment differed. Mamma and testis were excluded as 
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they were only assessed histologically and here found to be negative in all instances as well 
as being collected sex specifically. 
Molecular methods were able to confirm the presence of leprosy bacilli in more tissues than 
histological methods. Not all tissues tested positive with either method, despite all carcasses 
being affected by leprosy. No M. leprae DNA or AFB were detected in 49.2% (nNeither= 59) of 
the tissue samples examined. Out of the 61 tissue samples in which one or the other was 
detected 49.2% were identified with both methods, 47.5% only by PCR and 3.3% only using 
histological methods (Table 19).  
The null hypothesis that whichever test is used does not affect the outcome, i.e. whether a 
tissue is identified as containing leprosy bacilli, needs to be rejected (Fisher’s exact test, p= 
0.0000000000152). Molecular methods are able to identify the presence of leprosy more 
often than histological methods. One squirrel (ARC016_18) would have been completely 
missed as being affected by leprosy with histological methods alone.  
TABLE 19:  NUMBER OF TISSUES FROM LEPROUS SQUIRRELS THAT TESTED  POSITIVE FOR M. 
LEPRAE DNA,  THE PRESENCE OF AFB  OR BOTH. 
 Test with positive result 
M. leprae DNA 
and/ or AFB 
detected 
PCR Both AFB Neither 
29 30 2 59 
 
There is no difference in the ability to identify ERS leprosy cases using a range of 
different tissues  
Up to 13 different tissues/organs per carcass were assessed using molecular methods and 
up to 14 were assessed macroscopically and histologically. Macroscopic lesions were only 
present in a small number of tissues per carcass, or not at all. In no animal were all 
assessed tissues positive. In ERS with severe lesions more than half of the assessed tissues 
contained M. leprae DNA and more than 14% of the tissues contained AFB. In ERS without 
or with only mild clinical lesions M. leprae DNA and AFB could be isolated from a much 
smaller proportion of organs and AFB were present in less than a sixth of the assessed 
tissues (Table 20).  
Pathognomonic macroscopic skin lesions were seen on hocks (7 out of 11 carcasses 
(63.6%)), ears (6 out of 11 carcasses (54.5%)), and noses (3 out of 11 carcasses (27.3%)). 
Another form of macroscopic lesion that was deemed as potentially due to a leprosy infection 
was a swelling of the mandibular lymph nodes (2 out of 9 carcasses (22.2%)). No 
macroscopic changes that would have been assigned to leprosy were seen in any of the 
other tissues. In all macroscopically identified leprosy lesions AFB and M. leprae DNA were 
present. However, far more tissues contained leprosy bacilli than one would have expected 
based on the macroscopic lesions. Thus, while macroscopic lesions can be helpful in 
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choosing a sampling site for leprosy diagnostics, detecting the presence of leprosy bacilli is 
possible without them. 
TABLE 20:  SUMMARY OF TISSUES AVAILABLE FOR MACROSCOPIC , MOLECULAR AND 
HISTOLOGICAL ASSESSMENT FROM THE 11 CARCASSES INCLUDED IN THIS ANALYSIS , ALONG 
WITH THEIR LEPROSY SEVERITY CATEGORY , AND THE PROPORTION OF POSITIVE SAMPLES IN 































BIC001_16 14 4  
(28.6) 




BIC002_16 14 4  
(28.6) 




BIC003_16 14 2  
(14.3) 




BIC007_16 13 2  
(15.4) 




BIC014_17 14 3  
(21.4) 




BIC016_17 14 2  
(14.3) 




BIC010_16 13 1  
(7.7) 




BIC006_16 13 0  
(0) 
0 12 1  
(8.3) 
13 1  
(7.7) 
BIC009_16 14 0  
(0) 
0 13 1  
(7.7) 
14 1  
(7.1) 
BIC018_18 11 0  
(0) 




ARC016_18 13 0  
(0) 
0 13 1  
(7.7) 
13 0  
(0) 
Looking in more detail into the tissues from which M. leprae DNA was isolated, ears and 
spleen are those from which it was most frequently possible to isolate bacterial DNA, 
followed by the liver and hock skin (Figure 65, p. 130). In the other organs bacterial DNA 
was detected less frequently and mostly in severely affected squirrels.  
In the histological assessment the ear was the tissue in which AFB were most frequently 
seen again, followed by the spleen, nose, hock, mandibular lymph nodes and the liver 
(Figure 66, p. 130). Generally, the paler colours implied that it was less frequently possible to 





FIGURE 65:  M. LEPRAE DNA  ISOLATION FROM LEPROSY AFFECTED ERS CARCASSES :  
COLOUR RANGE REPRESENTS THE NUMBER (LEFT, BLUE STARS MARKING TISSUES NOT 
AVAILABLE FOR ALL CARCASSES ) OR PROPORTION (RIGHT, RELATIVE TO THE ACTUAL 
NUMBER OF SAMPLES AVAILABLE PER TISSUE ) OF CARCASSES IN WHICH ISOLATION WAS 
ACHIEVED FROM A PARTICULAR TISSUE  
 
FIGURE 66:  AFB  IN ERS CARCASS TISSUES :  COLOUR RANGE REPRESENTING THE NUMBER 
(LEFT, RED STARS MARKING TISSUES NOT AVAILABLE FOR ALL CA RCASSES) OR PROPORTION 
(RIGHT, RELATIVE TO THE ACTUAL NUMBER OF SAMPLES AVAILABLE  PER TISSUE) OF ERS 




Often the presence of leprosy bacilli in a particular tissue could be detected with both 
molecular and histological methods. In three instances in three separate tissues histological 
methods were able to identify the presence of leprosy bacilli in a tissue that would have been 
missed using molecular methods, while molecular methods detected their presence in 35 
tissues where no AFB were seen. Only combining both methods in the ear allowed the 
identification of all 11 squirrels as affected by leprosy. Using any other tissue, some affected 
ERS would have been missed. In front and hind footpads, muzzle, eye, and intestines only 
M. leprae DNA was identified but in no instance AFBs. Kidneys are not a suitable tissue to 
use in leprosy diagnostics in ERS, as they did not contain bacteria in any of the carcasses 
assessed (Table 21).  
TABLE 21:  PROPORTION OF ERS THAT WOULD HAVE BEEN IDENTIFIED AS AFFECTED BY 






Test with which the presence of M. leprae was 
detected 
PCR Both AFB Neither 
Ear 100 % 2 8 1 0 
Spleen 81.1 % 3 6 0 2 
Liver 63.6 % 4 3 0 4 
Hock skin 63.6 % 0 7 0 4 
Mandibular 
lymph node* 
60 % 2 3 1 4 
Nose 54.5 % 0 6 0 5 
Front 
footpad 
54.5 % 6 0 0 5 
Hind footpad 45.5 % 5 0 0 6 
Muzzle 45.5 % 5 0 0 6 
Eye* 40 % 4 0 0 6 
Intestines 27.3 % 3 0 0 8 
Lung* 20 % 1 0 1 8 
Kidney 0 % 0 0 0 11 
Mamma# 0 % NA NA 0 7 
Testicle# 0 % NA NA 0 4 
*Tissues were not available for all carcasses and/or not for both tests  
#Tissues were only available depending on squirrel sex and only assessed histologically 
In ERS carcasses severely affected by leprosy, M. leprae DNA was present across a range 
of 12 tissues, and AFB were detected in seven different tissues. The bacteria were therefore 
widely distributed through the ERS’s body. Even in non-clinically/mildly affected squirrels 
bacterial DNA could be detected in the skin (ear, hock) internal organs (spleen, liver) and in 
the eye. Histological detection of AFB in this group was difficult and only possible in ear 
(BIn= 1, 1, and 6, respectively), and in one instance each in the spleen (BIn= 1) and hock 
(BIn= 6).  
A high BIn makes it likely that the bacteria were actively reproducing in a tissue, while a low 
BIn could also occur in tissues that do not offer the bacteria optimal conditions for growth. 
The highest BIn’s were observed in skin tissue, the ear clearly being the one tissue with the 
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highest bacterial loads followed by the hock and nose. Bacterial loads in the lymph nodes 
were more variable and may not only be influenced by bacterial growth in the lymphatic 
tissue but also by bacteria from the head area being filtered and retained there. AFB were 
less frequently detected in internal organs than in skin tissues and the BIn was lower (Table 
22, Figure 67).  
TABLE 22:  BIN NOTED FOR TISSUES OF CARCASSES SEVERELY AFFECTED BY LEPROSY IN 
WHICH AFB  WERE DETECTED 
Tissue BIn’s observed in the tissue across the carcasses 
Ear (n= 6) 6 6 6 6 6 5 
Hock skin (n= 5) 6 6 5 4 4 - 
Nose (n= 6) 6 5 4 4 4 4 
Mandibular lymph node 
(n= 4) 
6 5 4 1 - - 
Spleen (n= 5) 4 2 1 1 1 - 
Liver (n= 3) 4 1 1 - - - 
Lung (n= 1) 1 - - - - - 
 
FIGURE 67:  NUMBER OF TIMES IN WHICH A BIN COULD BE DETERMINED IN A TISSUE (LEFT) 
AND MEDIAN BIN OBSERVED IN THESE TISSUES (RIGHT). 
4.4. Discussion 
Data presented in chapter 3 implied that leprosy signs in ERS are more variable than 
previously reported looking only at carcasses (Meredith et al., 2014; Avanzi et al., 2016). The 
data introduced in this chapter supports this notion, both with respect to clinical signs of 
leprosy, which are found to vary between individuals while sharing some common 
characteristics and with respect to histological presentations where InL and BB lesions were 
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described for the first time. The data also showed a minor impact of leprosy on individual 
ERS health (assessed using three health indicators) and that ERS sex does not influence 
disease presentation. The remaining aims of this chapter were also successfully achieved by 
demonstrating that molecular methods are more likely to detect the presence of leprosy 
bacilli DNA in an ERS than histological methods are to detect AFB and establishing that the 
ear is the optimal sampling location for ERS leprosy diagnostics. These results are 
discussed in detail below.  
4.4.1. Clinical presentation of leprosy in ERS 
In terms of new information on the clinical presentation of leprosy in ERS, only one juvenile 
ERS colonised by M. leprae could be included in this study. The clinical signs discussed 
here are thus reflecting leprosy in adult ERS.  
The proportion of ERS seen with clinical signs of disease in this study is also worth 
considering. While 55 ERS were identified as affected by leprosy, only 34 had clinical signs 
of the disease. Thus, just 38.2% of ERS affected by leprosy bacilli did not (yet) show clinical 
signs of disease. While clinical disease thus appears to be more frequently observable in 
ERS than in for example NBA (Truman, 2005; Morgan and Loughry, 2009), this observation 
made in the context of this particular study should not let one jump to generalised 
conclusions. All clinically diseased ERS came from the BI population, none from the AR 
population, even though colonisation with M. leprae was detected here. Clinical cases 
previously identified in surveillance efforts in Scotland were rare (Meredith et al., 2014). In 
other host species only a small proportion of individuals is thought to be likely to develop 
clinical leprosy following natural infection (5-10% in humans (Scollard, Truman and 
Ebenezer, 2015), 5% in NBA (Truman et al., 1986)). It is therefore conceivable that the 
situation in the wider British ERS population is actually similar to that in other hosts, with few 
individuals developing clinical disease. This reinforces the notion that it is important to 
reliably identify ERS colonised and sub-clinically infected by leprosy bacilli, if the true 
epidemiological situation in this host species is to be evaluated. This is addressed further in 
chapter 6 (p. 169 et seqq.). It also highlights the need for targeted future studies to be 
conducted in other ERS populations to assess the average risk for a British ERS infected 
with leprosy bacilli to develop clinical signs of disease.  
Leprosy lesions are pathognomonic. They are very similar between individuals.  
ERS clinically identified as leprosy suspects were confirmed to be infected with M. leprae in 
almost all instances (91.2%) in this study. It cannot be said whether this proportion would 
have been higher, if PCR data had been available for all ERS. The sensitivity of the αPGL-I 
UCP LFA is 88%, so a false negative serology in these two instances is possible. In the one 
ERS (BI100_18) clinically identified as leprosy suspect in which both PCR and serology were 
negative, the lesion was very small (lesion score 4, lesion category 1) and the tissue sample 
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for PCR collected from the unaffected ear. Thus, false negative laboratory results are 
possible, and retesting at a later point in time or PCR analysis of lesion tissue might have 
confirmed this ERS as leprosy case as well. Overall, the definition used for clinical lesions (p. 
89) in this study thus appears to be a good guide for the identification of leprosy cases by an 
experienced assessor.  
The two surveillance cases (R3-17, R38-18) that were not leprosy cases, despite initial 
clinical suspicion, did show distinct differences in their clinical presentation. While the ear 
was beginning to thicken and showed incomplete hair loss in R3-17, the lesions on chin and 
eyelids were larger and more advanced than the ear lesions. In the leprosy cases seen in 
this study the ear and hocks were the primary location of leprosy lesions, other body areas 
only becoming affected in advanced stages of the disease. All lesions on R3-17 presented 
with some fur cover, making them quite distinct from leprosy lesions of the same size 
described so far. The cut surface of the lesions in R3-17 was pale and not bulging and thus 
different from what has been observed in leprosy lesions. Such lesions could however easily 
be mistaken for leprosy lesions by an examiner with limited experience or during a superficial 
assessment by an assessor with ERS leprosy experience.  
For R38-18 the hair loss and thickening of the skin was limited to the nose, the ears and 
hocks were unaffected and the ERS was still very young. These differences in lesion pattern 
should be considered before the suspicion of leprosy is proposed. The low number of ERS 
identified as leprosy suspects in the squirrel surveillance scheme during the two years of this 
study may again indicate how rare clinical leprosy is in the wider Scottish ERS population. It 
could also indicate that the currently published descriptions allow those familiar with them to 
identify most non-leprous ERS as such.  
Looking at the description of other ERS skin diseases in the literature malignant melanomas 
are very rarely described and in the case report again had a different distribution pattern 
from leprosy lesions, occurring first on the eyelids (Fukui et al., 2002). In all other skin 
infections a more scaly, exudative or purulent presentation than what is typical for leprosy 
can be expected (McInnes et al., 2009; Simpson et al., 2013; Wibbelt et al., 2017). 
Therefore, it appears appropriate to say that ERS leprosy lesions are pathognomonic. This 
could however change, as more skin conditions keep being described for ERS. In humans, 
where the body of dermatological conditions described is far more extensive, even every 
form of leprosy has its own range of differential diagnosis (Moschella and Garcia-Albea, 
2016).  
Observations in autumn 2016 (chapter 3, p. 80) had suggested that leprosy lesions form on 
ears and hock first. Data presented in this chapter supports this initial observation, and adds 
the scrotum in male ERS to the list of likely locations for early leprosy lesions. Unlike in 
humans, no leprosy lesions have been observed on the torso of ERS.  
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Clinical presentations of leprosy in ERS, while similar in location and texture of the lesions, 
are variable when it comes to the size of lesions, their shape, particularly in advanced cases, 
and the presence and absence of ulcerations. ERS leprosy lesions seen in this study were 
mostly categorised as mild or severe and only seven were placed in categories 2 and 3 
(20.6%). Longitudinal datasets, such as presented in chapter 5, could address whether 
categories 2 and 3 represent transient stages of the infection and could be summarised into 
one category to simplify the system established in this study going forward.   
In humans and NBA individual variability of clinical lesions is high, allowing for five main 
forms of clinical presentation to be defined. However, the lesions seen here and currently 
described for ERS vary on a narrower spectrum. Single nodular lesions, as they appear in 
ERS leprosy cases are described for LL in NBA as well (Frota et al., 2012; Sharma et al., 
2013). Multiple, but not single, nodules with a shiny surface are described in human BL 
leprosy. However, in this species hair loss in this form is usually incomplete (Bhat and 
Prakash, 2012). Based on the descriptions provided by Simpson et al. (2015) the ERS 
leprosy lesions observed on the Isle of Wight are similar to some InL in humans (Bhat and 
Prakash, 2012). Still, while there are similarities in the clinical presentation of leprosy in the 
three most intensely researched hosts, differences do exist, and it should be avoided to try 
and categorise pathognomonic clinical presentations of leprosy in ERS using the system 
developed for humans. Where they are similar, similarities can be pointed out, but at this 
early stage in ERS leprosy research it should be considered that host-pathogen interaction 
determining the clinical presentation resulting from an infection with leprosy bacilli may differ 
between the species.  
Leprosy has an impact on ERS beyond the immediate clinical signs 
Being colonised or clinically infected with M. leprae does not have a statistically significant 
effect on BCS or GHS in ERS. Severe lesions may however have a negative impact that 
while not statistically significant, may be biologically relevant for the individual.  
ERS showing clinical signs of leprosy were found to be significantly heavier than colonised 
or unaffected ERS. Within the group of clinically diseased ERS weight showed a slight 
tendency to increase with lesion severity category, though this correlation was not 
statistically significant. A similar pattern has been described in NBA (Truman et al., 1991). As 
in NBA the higher weight could imply that these ERS are older than the ERS in the other 
groups, though weight gain in adulthood has not been studied specifically in ERS. As it is 
notoriously difficult to age ERS once they are adult (Bosch and Lurz, 2012), further research 
based on this observation could offer relevant information not just for ERS leprosy research 
but for ERS research in an ecological context, where for example the average age of 
members of the population could be of interest.  
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Influence of ERS sex on leprosy  
In humans, leprosy is not a sex specific disease, while in NBAs one study suggested that 
females may be more frequently affected, while others did not find an effect of sex on 
leprosy susceptibility in this species (Scollard et al., 2006; Morgan and Loughry, 2009). In 
ERS sex and leprosy susceptibility do not appear to be linked based on the sample set 
available in this study. Lesion severity does also not appear to be linked to ERS sex. 
However, in humans, certain events that only occur in females, such as pregnancy and the 
associated hormonal changes, have been reported to be risk factors in LL patients for 
developing ENL (White and Franco-Paredes, 2015). It could therefore be of interest to 
particularly monitor female ERS with clinical signs of leprosy using a hands-off approach like 
monitoring a maternal drey with camera traps during the breeding period to assess whether 
pregnancy has an effect on their disease intensity or is linked to complications.  
A limitation of this study is, that no ERS infected with M. lepromatosis were available for 
assessment. Skin lesions caused by M. leprae and M. lepromatosis previously have been 
described to be similar (Avanzi et al., 2016). However, on the Isle of Wight, crusty lesions 
have been described in ERS infected with M. lepromatosis, which have not been described 
elsewhere (Simpson et al., 2015). Thus, while some of the information collected in this 
chapter on leprosy presentation in ERS infected with M. leprae may well be transferrable, it 
remains possible, that an infection with M. lepromatosis can cause additional presentations 
that the current work did not cover.  
In summary, the data presented in this chapter has fulfilled the aim of providing new 
information of the characteristics of clinical leprosy in ERS. It has underlined that leprosy 
lesions in ERS appear to be pathognomonic, and flagged up, that while they do look similar 
to lesions described in other host species, they are distinct in some respects, and appear 
slightly less variable. They should at this early stage of ERS leprosy research be assessed 
with an open mind. It should be avoided to try to fit them into categories defined for other 
hosts. Leprosy has little impact on the general health of affected individuals and does not 
appear to be a sex-specific disease in ERS. It may be a disease of older ERS.   
4.4.2. Histopathological and molecular assessment of leprosy affected ERS 
While not all histological presentations of leprosy described in other hosts were seen in this 
study, i.e. the fourth hypothesis of this chapter was not confirmed, some new histological 
presentations of ERS leprosy lesions were observed. They are discussed below, particularly 
considering why it would be relevant to further try and determine the full extent of histological 
leprosy presentations in ERS. In respect to the fifth hypothesis, it was possible to establish in 
this study that molecular methods are more often able to identify leprosy cases than 
histological methods. The study also showed that specific tissues, particularly the ear and 
spleen, can increase the chances of identifying ERS colonised by or infected with leprosy 
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bacilli. In severe clinical leprosy cases bacteria are present in a wider range of tissues than 
in mild cases or colonised ERS. Thus, the sixth hypothesis of this chapter had to be rejected.  
The whole histological spectrum of leprosy lesions is present in ERS 
It was possible to describe inflammatory reactions showing the characteristics of two 
additional histological categories of leprosy in ERS in this study (InL and BB) in addition to 
the ones previously published (LL, BL and BT) (Avanzi et al., 2016). All lesions seen in this 
study were InL, BB, BL or LL, thus further strengthening the impression that lesions on the 
lepromatous end of the spectrum are much more likely to be detected in ERS than 
tuberculoid lesions, with TT lesions remaining undescribed. However, to establish whether 
the inflammatory reactions seen in ERS resemble those in the other host species or are 
indeed fully comparable, a specialised leprosy histopathologist should compare sections 
from across the host spectrum directly with each other. It was very difficult to class ERS 
slides based on published descriptions of the other two hosts. It is possible that ERS 
inflammatory reactions do not perfectly fit the Ridley-Jopling categorisation system. To learn 
more about the CD4+/CD8+ ratio in ERS leprosy lesions immunohistochemical staining 
should be employed, as this would offer additional information as to where on the Ridley-
Jopling scale lesions of this species fit in.  
The prominent nerve invasions with large numbers of AFB described for other hosts (Han et 
al., 2008) has not been observed in ERS yet, while some nerve involvement, particularly in 
the form of lymphocyte cuffs or individual AFB in nerves have been seen. Within clinically 
visible granulomas in ERS normal structures like nerve bundles or larger vessels were no 
longer identifiable. Granulomas in ERS appeared to often form initially close to the cartilage 
and then expanded through the dermis until they reached the epidermis and, in some 
instances, ulcerated. This pattern is very different from what is described for BL-LL lesions in 
humans and actually in some respects similar to what is described for TT lesions in humans 
(Ridley and Jopling, 1966; Massone, Belachew and Schettini, 2015). However, other 
characteristics, like globi formation and large numbers of foamy macrophages have placed 
ERS leprosy lesions at the lepromatous end of the histological spectrum. The Ridley-Jopling 
classification system was originally introduced for research purposes to reflect to which 
extent a patient is resistant to/able to produce an adequate immune response to an infection 
with leprosy bacilli (Ridley and Jopling, 1966). With this original goal in mind, it currently 
appears worthwhile to detail cell types and involvement of different structures when 
describing the histology of ERS leprosy lesions instead of placing lesions into a Ridley 
Jopling category. The latter could miss important, unique characteristics in the immune 
response ERS show to an infection with leprosy bacilli. 
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There is no difference in the ability to identify ERS leprosy cases using molecular and 
histopathological methods 
Molecular methods in this study used a cubical tissue section, while the histopathological 
sections are ultrathin, but can in the case of an ERS, span a complete organ. In both 
methods, leprosy bacilli could be missed, if they are very localised. Still, molecular methods 
were more sensitive in detecting bacterial presence in this study.  
In humans Fite-Faro (FF) is the accepted standard stain for AFB detection in leprosy patients 
and described as more sensitive than Ziehl-Neelson (ZN) staining in humans and NBA 
(Walsh, Meyers and Binford, 1986; Scollard, Truman and Ebenezer, 2015). It is thought to 
be the more reliable stain as M. leprae is sensitive to an additional alcohol decolorizing step 
occurring in ZN staining compared to FF and may thus show less well (Rendini and Levis, 
2017). In ERS diagnostic success using ZN staining has been good, and the laboratory used 
in this study had experience in this staining method. Future research could assess whether a 
modification of the staining process would offer advantages in ERS too, or if there is no 
significant difference between the two staining techniques in this species. If FF were to 
perform significantly better than ZN this could close, or at least narrow, the gap between 
molecular and histological methods. 
Both methods can complement each other, depending on the situations in which a leprosy 
diagnosis is needed. Molecular methods are fast and can be automated for high throughput. 
They are thus highly suitable for pre-translocation disease screening and surveillance. 
Producing and analysing histological slides of the same number of ERS can take much 
longer, depending on investigator speed and experience. However, for a low number of 
samples bacteriological staining can be performed within hours to assess whether a tissue 
contains AFB. Thus, if the aim is to quickly establish whether a single ERS is a MB leprosy 
case, using histological methods could be an advantage. However, acid-fast stains are not 
species specific and would only be diagnostic for leprosy if AFB are seen within a nerve 
(Massone, Belachew and Schettini, 2015), while the PCR is highly specific. The PCR 
protocol used in this study is producing a qualitative, not a quantitative result. Therefore, if it 
is of interest how many leprosy bacilli are present in a tissue, it needs to be backed up with 
histological methods that allow a BIn to be established. Alternatively, and likely to be more 
accurate, a quantitative real time PCR for the detection of M. leprae DNA, as already 
recommended for use in humans (Braet et al., 2018),  could be applied to ERS. Only 
histological methods currently allow a characterisation of the cells involved in the formation 
of a leprosy lesion and thus offer information on the host reaction to the pathogen.  
Neither method, as used in this study, readily allows to determine the viability of leprosy 
bacilli identified. This is a gap that will be difficult to address, based on the nature of most 
ERS samples available for full post mortem assessment, which often present in advanced 
stages of decay. However, reverse transcriptase PCR to detect M. leprae RNA could show 
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the presence of viable M. leprae (Turankar et al., 2016), if the technique was adapted for the 
use in ERS samples. Another option to explore in future research efforts to determine the 
viability of M. leprae detected in ERS tissues could be the adaption of bacteriophage-based 
methods combined with PCR, which are currently established for Mycobacterium avium 
subsp. paratuberculosis and for Mycobacterium bovis (Swift, Convery and Rees, 2016). This 
method may not be adaptable due to the specific characteristics of M. leprae, but if it was 
successfully adapted, it could allow for a highly informative diagnosis within 48 hours (Swift, 
Convery and Rees, 2016). 
There is no difference in the ability to identify ERS leprosy cases using a range of 
different tissues  
Leprosy bacilli were detected in a range of tissues. This implies that while macroscopic 
leprosy lesions in squirrels are mostly restricted to the skin, the distribution of the bacteria is 
not limited to the periphery, even in non-clinical and mild cases. This was unexpected, given 
the relatively high core body temperature of ERS (38-40°C) (Bosch and Lurz, 2012). 
However, no AFB were detected in ERS testes and kidneys, the latter also being PCR 
negative, organs that have been described as containing AFB in humans with LL leprosy 
(Soares et al., 2017). It could be possible that these organs would become infected, if the 
disease had had more time to progress, as for NBA involvement of all organs is described as 
well, but only after extended periods of time (Truman, 2005). No study comparable to the 
one presented here to establish the optimal tissue for leprosy diagnosis has been published 
for NBA or humans.  
Of the skin tissues assessed in this study, footpads, both front and back, contained M. leprae 
DNA in only about half of the cases and in no case were AFB or inflammation seen 
histologically. The whole chest/front leg area appears to be largely unaffected by leprosy in 
ERS. On the hind legs it is important to notice that the hock rather than the foot is the initial 
location for leprosy lesions, even though lesions can extend towards the foot in advanced 
stages.   
Interestingly, AFB were only observed in the nose in severe leprosy cases and not in mild 
ones or in colonised ERS. The transmission of leprosy is still not fully understood, however 
nasal discharge, which can contain large numbers of bacteria in humans, is thought to play a 
role (Bratschi et al., 2015). In ERS bacteria only appear to be present here late in the 
disease history, and profuse discharge from the nose is unusual in ERS. Thus, other 
mechanisms may be more relevant for disease transmission in this species. 
Lower bacterial loads in internal organs (Figure 67, p. 132) could imply that bacteria are not 
as readily multiplying in these warmer body areas as they are in the ear (median BIn 6) or 




Clinical lesions caused by M. leprae in ERS appear to be pathognomonic, as they all share 
some uniting characteristics that are not found in other skin conditions currently described in 
ERS. Leprosy, at least in cases that are less than severe, does not seem to have a negative 
impact on general ERS health. It may be a disease of older ERS. Leprosy in ERS presents 
in some features similar to leprosy in other host species, but neither clinically nor 
histologically does it perfectly match the criteria for the individual categories established for 
humans. At this early stage of ERS leprosy research it is thus useful to invest time in more 
detailed and species-specific documentation systems to explore the full spectrum of lesions 
present in this host. Direct comparisons of samples from the different host species by 
specialists should be made to determine to what extent categories established in humans 
are really applicable to this new host. Exploring the similarities and differences further will be 
of interest to determine whether lessons from human medicine can be used to understand 
host-pathogen interactions in ERS or if they need to be considered with a pinch of salt. 
Molecular methods were able to detect M. leprae in more individuals and tissue types than 
histological methods. The ear is the best location for diagnostic leprosy sampling in ERS. 
Not only is it the one location in which bacteria are found in most affected ERS, it is also a 















Chapter 5: Disease progression of leprosy in ERS  
5.1. Introduction 
As pointed out in previous chapters leprosy was initially described in ERS carcasses. This 
did not allow any inference on incubation period or disease progression in this species 
(Meredith et al., 2014; Simpson et al., 2015; Avanzi et al., 2016; Butler et al., 2017). ERS are 
too dissimilar in their life history and biology from other host species such as humans and 
NBA to assume outright that information available about leprosy development and 
progression in these species can be transferred to ERS.    
Rapid development of leprosy lesions (2 months) in humans is an exception. On average 
two to four years pass between likely time of infection and the development of clinical 
disease. Sometimes it takes decades (Lastória and de Abreu, 2014b). The intensification of 
symptoms is also slow, implied by the fact that even after medical attention is sought, a 
correct diagnosis is sometimes not made for years (Li et al., 2016). In wild NBA clinical 
leprosy is rare and is usually observed in NBA older than two years, which led to an estimate 
for the incubation period in this species of 12-24 months (Walsh, Meyers and Binford, 1986; 
Oli et al., 2017). Even under laboratory conditions and high infection pressure the 
development of initial clinical signs takes three months or up to a year (Sharma et al., 2018). 
In the two most studied hosts, leprosy clearly presents as a very slowly progressing disease.  
While Avanzi et al. (2016) described the presence of leprosy bacilli DNA in young ERS, they 
only observed clinical signs of disease in adults, i.e. ERS that were likely to be older than 9 
months. The aim of this part of the study was to determine whether the development and 
progression of clinical leprosy lesions could be observed in ERS within a two-year 
timeframe. The detailed clinical assessments of leprosy and health status made at each field 
assessment and results of molecular and serological tests were utilised to investigate lesion 
progression in individual ERS and provide a first, cautionary estimate of the incubation 
period in this species.  
5.2. Methods 
ERS assessments, sampling and sample analysis were carried out as described in chapters 
2 and 3. All ERS trapped and released in the six-monthly sampling sessions on BI and AR 
were microchipped. Scanning for the presence of a microchip was always performed at the 
end of the data collection to avoid unconscious bias in the assessment of returning animals.  
Information on the presence/absence of leprosy lesions, the lesion category, lesion score, 
results of serological tests, where applicable PCR, and the resulting diagnosis reached 
(Figure 37, p. 99), were considered in conjunction with age, sex, breeding condition, BCS, 
weight and GHS of each ERS.  
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In this chapter results are presented as a timeline, starting from an animal’s initial 
assessment (time point 0) in six months steps, up to 24 months. Thus, animals that were 
seen for example in session 3 for the first time could not possibly provide a full dataset, but 
maximally provide data for 0, six and 12 months. The reader can determine in which session 
an ERS was assessed first from the animal ID, as summarised in Table 23.  
TABLE 23:  SAMPLING SESSIONS AND THE RANGE OF SHORT ANIMAL ID’S ASSIGNED, IF AN 
ERS WAS FIRST SEEN IN EACH  
 Animal ID’s for which initial assessment occurred 
Session BI AR 
1 BI 1 to BI 26 NA 
2 BI 27 to BI 52 AR 1 to AR 17 
3 BI 53 to BI 72 AR 18 to AR 23 
4 BI 73 to BI 97 AR 24 to AR 37 
5 BI 98 to BI 126 AR 38 to AR 62 
 
To understand the timescales on which leprosy acts in ERS it is important to have an idea of 
how old a squirrel is at the time of assessment. During the assessment squirrels were 
assigned to an age group (juvenile, subadult, adult) as described in Table 6 (p. 44). For the 
purpose of this chapter adult squirrels were generally assumed to be one year old the first 
time they were captured, to avoid overestimating their age, despite it being possible that 
some ERS were older than that at first assessment. It will be flagged up when discussing 
individual ERS, if there are factors implying that the squirrel may have been older than that 
at first assessment. It is important to note that following a squirrel for two years after it has 
reached adulthood may already cover 50% to its total expected lifespan in the wild (3-5 
years), and at least 20% of its total possible lifespan (10 years). ERS seen before and 
following the development of clinical signs of leprosy, were used to estimate the time window 
within which the incubation period for leprosy in ERS might fall.   
5.3. Results 
5.3.1. Leprosy status of ERS seen more than once 
Brownsea 
On BI 31 ERS were assessed more than once over the two-year study period. All animals 
were already adults at the time of initial assessment. Fifteen were male and 16 female. Two 
ERS were seen in every assessment session, thus a total of five times. Another two ERS 




FIGURE 68:  NUMBER OF TIMES AND TIME POINTS AT WHICH THE 31 ERS ASSESSED IN MORE 
THAN ONCE ON BI  WERE SEEN. 
In nine ERS clinical lesions indicating leprosy were observed at least once. In six ERS it was 
possible to follow the development of their lesions over time, four of them already showing 
clinical signs at the initial assessment and two developing them within six months from the 
initial assessment. In the other three the lesions were only present the last time they were 
seen (12 and twice 24 months after initial assessment, respectively), thus mainly providing 
information towards how long an ERS may remain free of clinical signs in this population 




FIGURE 69:  PRESENCE (RED) AND ABSENCE (BLACK ) OF LEPROSY LESIONS ACROSS THE 
ASSESSMENTS IN RETURNING ERS 
Serum samples were collected and analysed using the αPGL-I UCP-LFA described in 
chapter 3 (p. 75) for all assessments. Results were noted as positive (serum PGL-I ratio 
equal or greater than 0.1) or negative (serum PGL-I ratio less than 0.1). For some ERS 
results correlated well with the presence of clinical lesions, in others they did not (Figure 70). 




FIGURE 70:  POSITIVE (LIGHT BLUE ) AND NEGATIVE (BLACK ) ALPHA -PGL-I  SEROLOGY 
RESULTS ACROSS THE ASSESSMENTS IN RETURNING ERS 
Tissue samples were not collected at all assessments, as previously explained in chapter 3 
(p. 72 et seqq.). PCR results were thus unfortunately only available for some assessments in 
the ERS included in this chapter. 
No PCR information was available for five ERS included here. For 14 ERS one PCR result 
was available and for the remaining 12 ERS two results were available. In eight the result 




FIGURE 71:  M. LEPRAE DNA  WAS ISOLATED FROM 10 ERS (ORANGE), ONLY IN ONE ERS 
TWICE. BLACK DOTS = NO DETECTION OF M. LEPRAE DNA IN THE PCR, WHITE DOTS = NO 
TISSUE SAMPLING  
Based on the three diagnostic tests (clinical assessment, serology, PCR), eight animals were 
diagnosed as leprosy cases, at least in their final assessment. Not all of them were identified 
as colonised before, and not all ERS diagnosed as colonised in the initial assessment 
developed clinical leprosy within the study period. Most ERS were only classed as contacts, 
though in some instances no PCR result was available as discussed above and thus not all 
tests for full diagnosis performed (Figure 72). It is therefore possible, that the proportion of 




FIGURE 72:  LEPROSY DIAGNOSIS IN REPEATEDLY ASSESSED BI  ERS. RED= LEPROSY CASE , 
ORANGE= COLONISED, DARK BLUE = CONTACT, LIGHT BLUE = CONTACT, BUT NO PCR RESULT 
AVAILABLE AT THIS TIME POINT , BLACK = SUSPICIOUS, ADDITIONAL TESTS NEEDED TO FULLY 
CLARIFY STATUS . 
All ERS assessed repeatedly were and remained in good health, though minor or healed 
injuries were observed in some, as is to be expected in free ranging wild animals. Only one 
ERS was classed as acutely unwell, with improvement being likely (Figure 73). In this male a 




FIGURE 73:  GHS IN REPEATEDLY ASSESSED ERS. GREEN = IN GOOD HEALTH ;  YELLOW :  IN 
GOOD HEALTH , BUT MINOR OR HEALED INJURY PRESENT ;  BLACK = ACUTELY UNWELL , 
IMPROVEMENT LIKELY  
Reproductive status, body condition and weight will be discussed with respect to the 
individual animals. These parameters are likely to be influenced by the season in which an 
ERS was sampled, and underlying individual variation. However, all ERS were in thin or 
good condition across all assessments included here. It is worth remembering that good 
internal fat cover was seen post mortem in ERS classed as thin and that this BCS category 
is therefore no immediate cause for concern, if no other factors imply poor condition in an 
ERS.  
Arran 
On AR, nine ERS were trapped and assessed in more than one session. Eight ERS were 
seen twice (three male, five female), one female was seen three times. All animals were 
already adult at the time of their first assessment. Four ERS were seen for the second time 
six months after the initial assessment, three were seen again after 12 months, one after 18 
months. The animal re-assessed twice was seen 12 and 18 months following the initial 
assessment.  
No leprosy lesions or seropositivity were seen in any of the animals. M. leprae DNA was only 
isolated from a single animal, and only at the second time this animal was assessed. Thus, 
while this animal was diagnosed as being colonised by M. leprae, all the others were 
deemed to only potentially have had contact with leprosy bacilli at some point without 
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becoming colonised or infected. Leprosy is endemic to the AR squirrel population albeit rare 
and apparently without causing clinical disease (see chapter 6, p. 175).  
With only a single change of leprosy status and no further follow up after the change 
occurred, the AR population did unfortunately not contribute any data to the progression of 
leprosy over the two-year study period.  
5.3.2. Effects of leprosy on individual ERS 
Leprosy cases 
Eight out of the 31 ERS were identified as leprosy cases. Five of them were male, three 
female. In another female (BI 55) leprosy was strongly suspected, but the clinical diagnosis 
could not be confirmed. This individual is still included in the initial overview of cases and 
presented in detail under the subheading unconfirmed case (p. 155). To provide an overview 
of disease progression, leprosy lesion category changes over time in these nine ERS were 
summarised. Figure 74 shows that development of lesions in ERS apparently healthy at 
initial assessment can occur within six months (BI 7, BI 11), or can take 12 months or longer 
(BI 20, BI 6, BI 55). Lesion severity did always increase with time. While animals were seen 
with mild lesions at two consecutive assessments, animals with mild to moderate lesions did 
usually progress to severe lesions within the next six months. Six squirrels were classed as 
severely affected but still fit for release. Three squirrels with severe lesions were seen six 
months after initially being classed as severely affected, and still deemed well enough for 
release.  
 
FIGURE 74:  CHANGES IN LESION CATEGORY OF LEPROSY CASES , AND THE SUSPECT CASE 
BI55,  SINCE THE INITIAL ASSESSMENT . DOTS REPRESENT THE LESION CATEGORY ASSIGNED 




It clearly is possible to observe changes in the leprosy status of squirrels within a two-year 
time period. The progression of leprosy appeared to have certain patterns, for example that 
lesions only increased and became more severe with time, but there was individual variation 
in how quickly clinical disease developed and advanced over time. 
Leprosy cases and suspect cases were seen in different reproductive states over time. The 
presence of clinical signs of leprosy did not prevent reproductive activity nor was it 
associated with continued weight loss or an irreversible reduction of BCS over time. Eight of 
the nine ERS in this group had a higher weight in their last assessment, i.e. when they were 
older, than in the initial assessment. It may be relevant to consider that ERS may fill their 
stomachs with up to 50g of food (post mortem observation made during this study). Thus, 
consuming large amounts of bait may have a huge impact on the weight an ERS presents 
with in a single assessment. Additional variation occurred over time and seasons, being 
particularly marked in reproductively active females. The data also underlined that BCS and 
weight are independent variables in ERS, just as in other species (Sakaguchi, 2009). While 
an individual ERS’s BCS varied over time, no general trend to lose body condition over time 
appeared to be present in these animals with clinical signs of leprosy (Table 24, p. 151).  
The lesion score, αPGL-I, and PCR results for each case ERS are graphically illustrated in 
Figure 75 (p. 152). Where an ERS was seen in consecutive assessment sessions, its lesion 
score and αPGL-I values are connected by a line. When an ERS missed an assessment 
time point, a gap is left. Turquoise dots imply at which times tissue sampling and PCR 














TABLE 24:  REPRODUCTIVE STATUS , BCS  AND WEIGHT OF LEPROSY CASES AND SUSPECT 
CASES OVER TIME 
ERS  
Time point 0 6 months 12 months 18 months 24 months       
Parameter 












BCS Normal Normal Thin Normal 
Weight 300g 310g 325g 315g 












BCS Normal Normal Thin Normal 
Weight 300g 290g 300g 300g 























Not seen Not seen Not seen 
BCS Thin Normal 
Weight 345g 390g 










Not seen BCS Normal Normal Thin 
Weight 320g 335g 350g 
BI 16, adult, female 
Reproductive 
status 
Inactive Lactating Inactive 
Not seen Not seen 
BCS Normal Thin Thin 
Weight 305g 360g 330g 
BI 17, adult, female 
Reproductive 
status 
Inactive Lactating Inactive 
Not seen Not seen 
BCS Normal Thin Normal 
Weight 350g 345g 375g 







Not seen Not seen 
Scrotal 
testes 
BCS Normal Normal Normal 
Weight 310g 310g 340g 
BI 55, adult, female 
Reproductive 
status 
Inactive Inactive Inactive 
Study ended 
BCS Normal Normal Normal 





FIGURE 75:  LEPROSY LESION SCORE (PURPLE) AND SERUM ALPHA PGL-I  RATIO (ORANGE) 
FOR THE LEPROSY CASE ERS SEEN OVER TIME. TURQUOISE DOTS INDICATE TIME POINTS AT 
WHICH TISSUE SAMPLES WERE COLLECTED AND WHETHER THE Y WERE POSITIVE OR NEGATIVE 
FOR THE PRESENCE OF M. LEPRAE DNA. 
In BI 3 a mild leprosy lesion on the right ear (cat mild, score 3) was already present in the 
initial assessment. However, at this time αPGL-I was still below the threshold for positivity. 
While the lesion had only mildly progressed six months later (cat mild, score 4), αPGL-I was 
now above the threshold for positivity. When next seen (18 months post initial assessment) 
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lesions had intensified, (cat severe, score 29), now affecting both ears and hocks, with an 
ulceration of the lesion on the left ear. The ulceration had healed in the final assessment (cat 
severe, score 27), though lesions had increased in size and additional small lesion had 
formed on the left eyelid. A small abrasion was present, again on the left ear. Its appearance 
was not quite the same as usually seen in ulcerating lesions and was thus deemed to be 
traumatic. Therefore, the animal scored overall slightly lower in the final assessment than 
before, while its αPGL-I ratio was constantly increasing with time. In the final session a tissue 
sample was collected and the presence of M. leprae DNA confirmed.  
In BI 6 no leprosy lesions were present in the first three assessments. However, throughout 
this time the αPGL-I was slightly above the threshold for positivity (0.16, 0.21, 0.19). When 
the animal was last seen, 24 months after the initial assessment, it had developed mild-
moderate leprosy lesions on both ears and the scrotum (score 12), the αPGL-I ratio was 
slightly higher than before (0.26). Tissue samples were collected twice from this animal, 
before it developed clinical lesions and when lesions were present. However, no M. leprae 
DNA was isolated at either time point. Tissue samples were not collected from the lesion, as 
the punch used was not suitable for sampling bulbous lesions, but from a nearby ear section 
of normal thickness.  
At the initial assessment of BI 7 no leprosy lesions were present and the αPGL-I ratio was 
below the threshold for positivity. Six month later a mild lesion (score 2) had appeared on the 
left ear and the αPGL-I ratio was clearly above the threshold for positivity (0.48). Twelve 
months after the initial assessment lesions were still mild and present on the left ear and left 
hock (score 6) and the αPGL-I ratio had increased (0.77). Eighteen months after the initial 
assessment lesions had intensified to mild-moderate (score 12) and were obvious on the left 
ear and hock, and another lesion was thought to be in the process of forming on the right 
ear. The αPGL-I ratio was lower than before, though still above the threshold for positivity 
(0.44). After 24 months lesions had become severe, as a small ulceration was present on the 
lesion of the left ear (score 18) and lesions were now obvious on both hocks. However, the 
right ear still did not show a fully developed lesion and the change on this ear was not 
classified as a clear leprosy lesion this time. The αPGL-I ratio had increased again (0.76). It 
was not possible to isolate M. leprae DNA from a tissue sample collected at this time. 
However, sampling was again restricted to an area adjacent to the lesion due to the punch 
used.  
In BI 9 leprosy lesions present were severe at both assessments (score 17 and 20, 
respectively) and the αPGL-I ratio was above the threshold for positivity (0.23 and 0.53, 
respectively). In the first assessment a dry ulcer was present on the left ear, and lesions 
visible on both ears and hocks. The situation was very similar six months later, the initial 
ulceration had healed but a new ulcer was present in a different area of the lesion, and the 
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size of some of the lesions had slightly increased. Additionally, a lesion was now present on 
the right ear as well.  
No leprosy lesions were observed when B11 was first seen and its αPGL-I ratio was just 
below the threshold for positivity (0.9). Six months later mild to moderate lesions were 
present, with a typical lesion on the left ear and slight swelling of muzzle and nose. At this 
point the αPGL-I ratio was clearly above the threshold for positivity (0.39). Eighteen months 
after the initial assessment the lesions were severe and present on both ears and hocks. At 
this time a scrotal abscess was observed and the ERS classed as acutely unwell, however, 
with a good prognosis, particularly after the abscess had been cleaned during the 
assessment. It cannot be excluded, that a lesion had been present in the area of the scrotum 
in which the abscess presented. Interestingly, the αPGL-I ratio was barely above the 
threshold for positivity at this point in time (0.13).  
At the time of initial assessment, the leprosy lesions seen in BI 16 were mild to moderate 
(score 8) only affecting both ears. The αPGL-I ratio was high compared to other animals 
(1.03). Six months later, lesions had become severe (score 29) with dry ulcerations on both 
ears and additional lesions on both hocks. The αPGL-I ratio had dropped (0.43) but 
remained above the threshold for positivity. At this time the animal would have been 
considered for euthanasia, as we did not yet know that ulcerations could heal. The fact that it 
had dependent young/was lactating and not returning to them may cause them to starve was 
the reason it was released. Another six months later it was confirmed that this decision had 
been correct and it was evident that ulcerations could heal. While the lesions on both hocks 
and the ears had slightly increased in size, ulcerations were no longer present (score 31). 
The αPGL-I ratio had risen again (1.59).  
In the initial assessment of BI 17 a mild lesion (score 2) was present on its right ear. Initially, 
the αPGL-I ratio was barely above the threshold for positivity (0.11). Six months later the 
lesion score had increased to 4 as the lesion had increased in size, and the αPGL-I ratio was 
increased to 0.26. When seen 12 months after the initial assessment the lesion had further 
increased in size and an additional small lesion had formed on the left eyelid (mild to 
moderate lesions, score 7), and the αPGL-I ratio was again slightly higher than before (0.28).  
BI 20 appeared to be in good health throughout all assessments, though in the last a toe that 
might have been previously broken was noted on the left hindfoot. No tissue was collected in 
the initial assessment, but six month later a sample was taken. At this time BI 20 was 
already colonised by M. leprae, but no clinical signs of disease were present and the αPGL-I 
ratio was well below the threshold for positivity (0.06 and 0.07, respectively). Eighteen 
months later leprosy lesions were present on both ears, the left hock and the scrotum 
(severe, score 30). On the right ear and scrotum dried ulcers were present on the lesions. 
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The αPGL-I ratio was above the threshold for positivity (0.23), and M. leprae DNA could 
again be isolated from a tissue sample collected from the non-swollen area of one ear. 
Unconfirmed case 
During the initial assessment of BI 55 no leprosy lesions were noted and the αPGL-I ratio 
was 0. However, M. leprae DNA was isolated from a tissue sample collected and the animal 
diagnosed as colonised by M. leprae. Six months later the clinical and serological situation 
was unchanged, but no tissue sample was collected. The αPGL-I ratio remained at 0, and 
from a new tissue sample collected 12 months after initial assessment from the opposite ear 
no M. leprae DNA was isolated (Figure 76). At this time a mild single clinical lesion (score 5) 
was seen on the right hock (Figure 77).  
 
FIGURE 76:  LEPROSY LESION SCORE (PURPLE) AND SERUM ALPHA PGL-I  RATIO (ORANGE) 
FOR BI  55 OVER TIME. TURQUOISE DOTS INDICATE TIME POINTS AT WHICH TISSUE SAMPLES 
WERE COLLECTED AND WHETHER THEY WERE POSITIVE OR NE GATIVE FOR THE PRESENCE OF 
M. LEPRAE DNA.   
 
FIGURE 77:  LESION OBSERVED ON THE RIGHT HOCK OF BI  55. CONSISTENCY, HAIR LOSS , 
AND BULBOUS NATURE ARE IN LINE WITH THE PRESENTATIO N TYPICAL FOR A LEPROSY 
LESION.  
As the lesion was typical and the squirrel resided in an area in which clinical leprosy cases 
were regularly occurring, it was still suspected that this was a leprosy case, however, without 
the laboratory confirmation it could only be called suspicious. Re-testing/additional 
assessment at a later point in time, had it been possible, would have been likely helpful in 
clarifying whether this was a case of leprosy or not.  
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In summary, the following important observations were made in the leprosy cases and 
suspect cases:  
 Lesion progression is highly individual. It can be slow (BI 7, BI 9, BI 17), but in some 
instances more rapid intensification of lesions occurs (BI 3, BI 16) 
 Ulcerations on leprosy lesions can heal without treatment (BI3, BI 9, BI16) 
 M. leprae DNA can be detected up to 12 or even 24 months before clinical signs of 
leprosy are documented (BI 20, BI 55)  
 It is possible, that M. leprae DNA is detectable before the onset of clinical signs, but 
is not detectable when clinical signs are present (BI 7, BI 6, BI 55) 
 The αPGL-I ratio increases as clinical signs of leprosy intensify in most ERS 
however, values may fluctuate throughout the progression of the disease (BI 7, BI 
11, BI 16) 
 In some ERS the αPGL-I ratio may be above the threshold of positivity before clinical 
signs of disease are obvious. However, the ratio increases further when lesions 
develop (BI 6) 
Colonised ERS 
Seven squirrels were classified as colonised by M. leprae in at least one of their 
assessments, based on the isolation of M. leprae from an ear tissue sample. Four were 
male, three female. Leprosy colonised ERS were also seen in different reproductive states 
over time. The colonisation with leprosy bacilli was not associated with continued weight loss 
or an irreversible reduction of BCS over time. Six of the seven ERS in this group had a 
higher weight in their last assessment, than in the initial assessment. Again, the highest 
variations in body weight were seen in reproductively active females. No general tendency to 
lose body condition over time appears to be present in colonised ERS (Table 25, p. 157).  
The same graphic format as in leprosy cases was chosen to display lesion score (always 0), 
αPGL-I, and PCR results in colonised ERS, to allow for a more intuitive comparison of the 
two groups. Again, lesion score and αPGL-I values are connected by a line, when an ERS 
was seen in consecutive assessment sessions, and a gap was left when a session was 
missed. Turquoise dots imply at which times tissue sampling and PCR assessment took 







TABLE 25:  REPRODUCTIVE STATUS , BCS  AND WEIGHT OF ERS COLONISED BY M. LEPRAE 
ERS  
Time point 0 6 months 12 months 18 months 24 months 
Parameter 









Not seen Not seen BCS Normal Normal Normal 
Weight 325g 340g 335g 
BI 12, adult, female 
Reproductive 
status 
Lactating Pregnant Lactating Inactive Inactive 
BCS Normal Normal Thin Normal Normal 
Weight 355g 325g 345g 365g 325g 
BI 24, adult, female 
Reproductive 
status 
Inactive Lactating Inactive 
Not seen Not seen 
BCS Normal Normal Normal 
Weight 320g 390g 360g 







Not seen Not seen 
Study 
ended BCS Normal Thin 
Weight 270g 295g 
BI 37, adult, female 
Reproductive 
status 
Inactive Pregnant Inactive 
Not seen 
Study 
ended BCS Normal Thin Thin 
Weight 300g 385g 335g 





Not seen Not seen 
Scrotal 
testes Study 
ended BCS Normal Thin 
Weight 270g 290g 










BCS Thin Thin Thin 




FIGURE 78:  LEPROSY LESION SCORE (PURPLE) AND SERUM PGL-I  RATIO (ORANGE) FOR THE 
LEPROSY COLONISED ERS SEEN OVER TIME. TURQUOISE DOTS INDICATE TIME POINTS AT 
WHICH TISSUE SAMPLES WERE COLLECTED AND WHETHER THE Y WERE POSITIVE OR NEGATIVE 
FOR THE PRESENCE OF M. LEPRAE DNA.  IN BI  42 LESION SCORE AND ALPHA -PGL-I  RATIO 
WERE 0 AT BOTH ASSESSMENTS AND THE PCR NEGATIVE AT 18 MONTHS. 
In BI 5’s initial assessment a small bulbous lesion under the chin was noted and initially 
suspected to be an unusual leprosy lesion. However, the αPGL-I ratio at this time was zero. 
The lesion had disappeared six months later, the αPGL-I ratio was still close to 0 (0.03). As a 
disappearance of leprosy lesions is not yet described for ERS and this lesion was unusual to 
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begin with, it was assumed that it had been caused by something other than leprosy bacilli. 
In the third assessment after 12 months no clinical lesions were present and the αPGL-I ratio 
was 0. However, at this time a tissue sample was collected and M. leprae DNA isolated. 
Unfortunately, the ERS did not return again in the later sessions of this study.  
At the first two assessments of BI 12, the αPGL-I ratio was slightly above the threshold for 
positivity (0.15; 0.12), in the later assessments it was below. No clinical lesions indicating 
leprosy were seen in this squirrel during the two years of the study. Half-way through M. 
leprae DNA was isolated from a tissue sample, however, not from a second sample taken at 
the end of the study.  
At no point were skin lesions noted in BI 24. The serum αPGL-I ratio remained close to 0 and 
below the threshold for positivity. The animal was identified as being colonised by M. leprae 
six months after the initial assessment, but did not develop lesions within the next six 
months. Unfortunately, it did not return in the fourth and fifth sampling session. It remains 
thus unknown if it developed lesions at a later time. 
From a tissue sample collected during the initial assessment of BI 35 M. leprae DNA was 
isolated, and the squirrel classed as colonised. At both sampling times the αPGL-I ratio was 
0 and no clinical lesions indicating leprosy were present. This was a second example of an 
ERS colonised by M. leprae and remaining healthy for at least six months afterwards.  
At no time did BI 37 show any clinical signs of leprosy. However, following the initial 
assessment M. leprae DNA was isolated from a collected tissue sample, implying that it was 
at this time colonised by the bacteria. At the initial and six months assessment the αPGL-I 
ratio was below the threshold for positivity, but above this threshold 12 months after the 
initial assessment (0.15). Unfortunately, no tissue was collected at this time and the squirrel 
could not be assessed again to see if it would develop lesions. It is however interesting to 
note, that the colonisation with M. leprae in this animal did not result in clinical disease over 
twelve months. 
In neither assessment of BI 42 were any skin lesions indicating leprosy observed. The 
αPGL-I ratio in its serum was 0 both times. However, in the first assessment, M. leprae DNA 
was isolated from the collected tissue sample.  
BI 60 is similar to BI 42, though for this animal three assessments are available covering 12 
months. No lesions indicating leprosy were seen at any time and the αPGL-I ratio was 
consistently 0. However, from a tissue sample collected during the first assessment M. 
leprae DNA was isolated. In the third assessment another tissue sample was taken, from 





In summary, the following observations were made in M. leprae colonised ERS: 
 Colonised ERS may stay free from clinical signs of leprosy for six to 18 months after 
being identified as colonised (BI 12, BI 24, BI 35, BI 37, BI 42, BI 60) 
 Colonised ERS may test negative in a later PCR assessment (BI 12, BI 42, BI 60) 
 Colonised ERS may occasionally have αPGL-I ratios above the threshold for 
positivity (BI 12, BI 37)  
 Colonised ERS with αPGL-I ratios transiently above the threshold for positivity may 
still not develop clinical leprosy within a year (BI 12) 
 The αPGL-I ratio is very helpful in clarifying whether an unusual skin lesion is likely 
to actually be caused by leprosy bacilli (BI 5) 
Leprosy contacts 
Fifteen squirrels were seen more than once (12 twice, three thrice), without showing any 
clinical signs of leprosy and the αPGL-I ratio consistently being 0 or below the threshold for 
positivity. For 14 of these animals’ tissue samples were collected at least once, for six even 
twice. From none of these tissue samples could M. leprae DNA be isolated. In 11 animals 
the two assessments were only 6 months apart, but for two each the assessments covered 
12 months and 18 months.  
Six of these squirrels were male, nine female. All of them were in good health and in normal 
or thin body condition. As they were trapped in the same area of BI as the diseased and 
colonised squirrels, it is likely that all of these ERS may have at some point in their life had 
contact to leprosy bacilli and/or infected ERS. It cannot be excluded that they were colonised 
or infected with very low bacterial loads at this point, but based on the currently available 
methods these ERS were defined as leprosy contacts, and in those instances where both 
PCR and serological results were available, it could be cautiously said that they appeared 
unlikely to be affected by leprosy.  
5.4. Discussion 
The development and progression of clinical leprosy lesions was successfully documented in 
one (BI) of two ERS populations within a two-year timeframe. In nine (29%) out of 31 ERS 
assessed several times, disease development and/or progression was observed. Data 
covering the full two-year time frame was only available for four of them, showing that even 
in shorter timeframes changes can be observed.  
Lesion progression could be followed in six ERS for six to 24 months (mean 14 months, SD= 
5.7) in this study. All of these ERS were deemed to be fit for release and likely to continue to 
survive and thrive each time they were seen. Disease progression in other hosts is slow, 
illustrated by the fact that several years may pass following the onset of clinical disease in 
humans before clinical signs are obvious enough to make the clinical diagnosis (Li et al., 
2016; Ferreira et al., 2018) and by an average survival time of more than 2.5 years following 
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experimental infection in NBA (Storrs et al., 1974). Based on the wide variety of clinical 
leprosy presentations and progression documented in other host species (Truman, 2005; 
Lastória and de Abreu, 2014b; Smith et al., 2015), it was assumed that there would be 
individual variation in the progression of leprosy in ERS as well. This assumption is 
supported by the data presented here. It is interesting to observe that while three ERS were 
classed as mild twice at six months intervals, and as many classed twice as severe, a mild-
moderate state was not noted more than once in any ERS included in this dataset and only 
seen in four ERS at all. No ERS with moderate lesions was seen within this longitudinal 
dataset. This could imply that lesion development starts quite slowly, the ERS remaining 
mildly affected for six month or longer, then transitions through mild-moderate and moderate 
stages slightly faster. After lesions become severe ERS seem able to thrive over another 
extended period of time. True regression of lesions was not observed in any of the ERS in 
this study. An apparent regression may occur when ulcerations heal. This implies that the 
total body score established in chapter 3 is not yet perfectly able to document the 
progression of lesions, as the sudden score increase that was integrated for ulcerations due 
to their potential welfare implications, may be too high. Together, this could reflect a need to 
further improve the leprosy lesion categorisation system, for example by adjusting the score 
assigned for ulcerated lesions, joining the mild-moderate and moderate categories as one 
transitional stage and adding another category above severe lesions. This should describe a 
state in which obvious additional health impairments with a negative welfare impact, such as 
severe secondary conditions and emaciation are present. However, such an adaption would 
ideally be based on additional data from more ERS to ensure that alterations are going to 
lead to a true improvement. Altogether, it is difficult to infer on disease progression in ERS in 
general from just nine ERS, but it appears that leprosy in ERS is a slow acting, chronic 
disease, progressing on the scale of months and years comparable to what is described in 
other hosts.  
Interestingly, severe ulcerations were seen on ear lesions of lactating females, with a smaller 
ulceration being observed during pregnancy. Changes in immune status of females during 
pregnancy and lactation have been associated with changes of leprosy status in humans 
(Lockwood and Sinha, 1999; Singh and Perfect, 2007). While ulcerations are not exclusive to 
female squirrels and not always associated with lactation, postpartum immune reconstitution 
could be a risk factor for their development. Other risk factors could include acute infections 
with other pathogens or stressful events like prolonged competition with other ERS for 
scarce resources, for example food or mating partners. Targeted research and long-term 
monitoring of individuals would be necessary to further assess these risk factors. In humans 
ulcers are mainly described as secondary complications on the extremities following 
neurological damage and loss of sensitivity, that may continue to occur even after the 
original leprosy infection is successfully treated (Kunst, 2000; Barreto and Salgado, 2010). 
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Ulcerations to the extremities are also described for TT human patients where RR occur 
(Soares et al., 2017). Furthermore ulcerations are described to occur on the extremities of 
NBA and extremities and face (not explicitly ears) of primates (Kirchheimer, 1975; Gormus et 
al., 1988; Sharma et al., 2013). This implies that differences in the pathogenesis of 
ulcerations may occur between the host species and these could be addressed in future 
studies focussing on comparing the host-pathogen interactions in the different species.  
Looking at changes in αPGL-I ratios, which are linked to the ERS’s immune response to M. 
leprae infection, three ERS (BI3, BI9, BI17) showed the pattern expected following the 
results presented in chapter 3 (p. 88). Their αPGL-I ratios crossed the threshold for positivity 
when clinical signs of leprosy developed and the ratio then consistently increased as clinical 
signs intensified.  
In BI6 αPGL-I ratios above the cut off for positivity were seen up to 18 months before clinical 
lesions developed, and they only slightly increased once clinical signs became apparent. No 
M. leprae DNA could be isolated from tissue samples from this ERS either before or after it 
developed clinical signs of disease. This could be an individual reactionary pattern to the 
pathogen presence which resulted in an early humoral immune response and outside the 
main lesion consistently low bacterial loads in this individual. Future studies should assess 
whether such patterns occur in more ERS and whether there are any particular individual 
factors linked to it. The data collected in this study does not allow to speculate further.  
An interesting pattern was seen in αPGL-I ratios of three other ERS (BI7, BI11, BI16), that 
could also explain an observation made in BI20. In these three ERS αPGL-I ratios initially 
behaved as expected and crossed the threshold for positivity when clinical signs of leprosy 
were first observed and then increased as the lesions slowly intensified. Then, however, as 
lesions progressed αPGL-I ratios dropped, staying above the threshold for positivity though, 
to six month later being higher than before the drop. In the case of BI 7 the drop coincided 
with the development of lesions in a new body area, while it occurred at the same time as an 
additional infection/acute abscess was seen in BI11. In BI16 the drop occurred during 
lactation and while the leprosy lesions were ulcerated. In BI20 detected αPGL-I ratios were 
unexpectedly low for the severe, ulcerated lesions observed in the third assessment. This 
could be explained with a generally weak humoral response in this ERS or with a similar 
temporary decrease in anti-leprosy antibody levels when secondary processes were present. 
In human leprosy patients αPGL-I levels are reported to persist, unless the bacteria are 
eliminated (Lastória and de Abreu, 2014b), however, it is not specified whether this excludes 
fluctuations as long as levels stay above the threshold for positivity as was the case in these 
ERS. The innate immune response initially determines the progression of leprosy in other 
hosts (Pinheiro et al., 2018) and potentially influences the following humoral immune 
response (Fonseca et al., 2017). The humoral immune response can be generally be 
regulated via many pathways (Taher et al., 2017), and no ERS specific data on its regulation 
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is currently published. However, there is no indication yet that this is fundamentally different 
in this species compared to the other hosts. Understanding what causes the αPGL-I ratio 
fluctuations in ERS could help to identify factors determining the outcome of clinical leprosy 
in this species. They could also be indicators for other immunomodulatory processes that 
could have a greater impact on ERS welfare than leprosy itself, for example secondary 
infections. If this were the case, observing fluctuations could spark further testing on samples 
from this ERS to assess if other pathogens are present that may be of relevance to the 
population as a whole.  
BI55, the unconfirmed case, makes the argument for repeated testing if leprosy is suspected 
based on clinical assessment but low or absent αPGL-I are found and PCR results are 
negative. The clinical lesions were still very mild when linked to a negative αPGL-I result and 
it has been shown that the humoral response can lag behind the development of clinical 
lesions (chapter 3). Even more interesting is the observation that the ERS was PCR positive 
for M. leprae DNA before it developed clinical signs of disease but PCR negative when an 
early lesion was present. It has been seen in other ERS with early leprosy lesions that the 
PCR is negative when the tissue sample is collected outside the actual lesion (chapter 4) 
and it is known for humans that PCR results are by far the most reliable when biopsies are 
collected from an active lesion (Fontes et al., 2018). Future research could address whether 
there is a particular process underlying the phenomenon where leprosy bacilli are sometimes 
readily detected in ear tissue before clinical signs develop, but appear limited to the lesions 
at least at the early stages of clinical disease. Some histological observations of very few 
bacteria in the tissue right next to a lesion illustrate this phenomenon (Figure 79). 
Comparative PCR from lesion and adjacent tissue in carcasses displaying early stages of 





FIGURE 79:  AFB  IN LEFT HALF OF IMAGE ARE LOCATED WITHIN A CLINICA LLY OBSERVABLE 
LEPROSY LESION , WHILE THEY BECOME VERY SCARCE AND STAIN ONLY FAINT LY IN THE 
NONINFLAMED ADJACENT TISSUE IN THE TOP RIGHT CORNER  OF THE IMAGE (EAR SECTION 
BI062_17) 
Five colonised ERS had αPGL-I ratios levels below the threshold for positivity at all 
assessment points. For four only one PCR result (positive) was available. One ERS (BI 5) 
could unfortunately not be followed further as it did not return after the session in which the 
tissue sample had been collected. Another two (BI 24, BI 35) did not develop clinical signs of 
leprosy within six months of testing positive for the presence of M. leprae DNA. In two (BI 42, 
BI 60), tissue sampling was repeated after 12 and 18 months respectively, and now no M. 
leprae DNA could be detected. Without following the ERS further it cannot be said whether 
they will or will not develop leprosy, but these two could be an indicator that clearing of 
colonisation/subclinical infection, which has been described for other hosts, is possible in 
ERS as well. Alternatively, it could be speculated that these ERS were just about to develop 
clinical lesions and the bacteria therefore had become localised and where thus not present 
in the tissue sampled, or that a different sampling location would have returned a different 
result, i.e. the negative results being false negatives.  
The other two colonised ERS (BI 12, BI 37) had a αPGL-I ratio slightly above the threshold 
for positivity at one point, but not at the same time point at which they were identified as PCR 
positive but either before or after. BI12 had a slightly elevated αPGL-I ratio when first seen, a 
positive PCR 12 month later, and a negative one another 12 months later, at both times 
having αPGL-I ratios below the threshold for positivity. This could therefore be another 
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example of a cleared colonisation, but it cannot be determined without following the ERS 
further. BI37 did not develop clinical signs of leprosy within 12 months of testing positive for 
M. leprae DNA, but had a αPGL-I ratio very slightly above the threshold for positivity in the 
last assessment. Without following this ERS further, this result cannot appropriately be 
interpreted.   
An onset of clinical signs of leprosy was documented in five ERS in this study, when BI 55 is 
included. In two clinical signs were obvious six months after their initial assessment, in the 
other three signs are likely to have taken more than 6, or in one (BI 6) even more than 12 
months to develop. Additionally, it was possible to show that six ERS colonised with M. 
leprae did not develop clinical signs of leprosy within the next six to 18 months. It cannot be 
said whether these ERS will ever develop clinical signs of leprosy, or if they may even be 
able to eliminate the bacteria, as negative PCR results in a second tissue sample could 
suggest for BI 12, BI 42 and BI 60. The latter is described for the other host species (Sharma 
et al., 2018; van Hooij et al., 2018). Still, assuming that the ERS seen in this study became 
infected as adults, it appears likely, that the incubation period for leprosy in ERS can last 
between just under six months up to 18 months and longer. If the ERS were already infected 
while still juveniles (for example through close contact with a mother with ulcerated lesions) 
the incubation period could be extended by another 9-11 months, i.e. the time it took these 
ERS to reach adulthood. The incubation period in ERS thus appears similar to that reported 
for other host species. Descriptions of early lesions of LL human patients will in most 
instances not capture the very earliest presentations possible, but will document the state in 
which the patient seeks medical attention. It can thus not be said, whether in such cases 
single lesions, as seen here in ERS, do not occur and are specific to this newly discovered 
host, or if that stage is usually just not well documented in people, where LL cases are 
always described to present with multiple lesions (Virmond, Grzybowski and Virmond, 2015; 
Gaschignard et al., 2016).  
For none of the adult ERS seen in this study an exact age or the time at which it became 
infected with leprosy bacilli can be known. It is unlikely to be possible to fully correct for 
these shortcomings in wildlife field studies. However, small, closed populations like BI could 
offer an opportunity to follow ERS from first emergence from the nest and over their full 
lifespan, using marking techniques that allow hands-off monitoring of the individuals. Such 
studies could, in the future, produce data allowing an improved incubation period estimate 
for ERS. However, given the wide range of time reported for the leprosy incubation period in 
other hosts, higher precision may just not be possible in such a variably and slow acting 
disease.  
In none of the ERS did leprosy seem to have a clear negative impact on GHS, BCS, weight 
or reproductive activity. This minimal effect of leprosy infection on an animal host under 
natural conditions has been observed in NBA as well (Truman, 2005; Loughry et al., 2009). 
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Three out of the four females had noticeably produced offspring despite the infection, the 
fourth being slightly lighter and potentially younger than the others. Even severe lesions did 
not appear to hinder successful mating and pregnancy. However, no information is available 
on kit survival, which is often low in this species (Bosch and Lurz, 2012). Whether 
supplementary feeding, which occurs in some areas of BI, mitigated a loss of weight or BCS 
cannot be assessed based on the current dataset, as no information is available on the 
extent to which affected ERS made use of such supplementary food sources.  
There appear to be marked epidemiological differences in leprosy dynamics in the two 
populations, these will be addressed in chapter 6. A factor contributing to the differences in 
progress detection seen in this part of the study is likely to be the proportion of repeatedly 
trapped ERS. It was much lower on AR, where no changes of clinical status were seen, than 
on BI (17.3% vs. 42.5%). It was, however, still possible to document an ERS becoming 
colonised by M. leprae in this population, implying that with an extension of the study, further 
observations might have been made. Another factor could be the climate both populations 
live in. ERS are different from humans and NBA in an important factor that could have an 
impact on how an infection with M. leprae progresses in this species: they have a higher 
core body temperature. The low body temperature of NBA had been identified as a core 
feature making them a suitable host for M. leprae and was used to explain why systemic 
disease occurs in this species (Purtilo et al., 1974; Truman, 2005). It has been suggested 
that colder temperatures in peripheral body areas allow leprosy bacilli to grow in humans 
(Virmond, Grzybowski and Virmond, 2015), however, one of the few studies looking at the 
presence of leprosy bacilli in a variety of human skin areas did not confirm such a pattern 
(Kaur and Kumar, 1978). Peripheral skin temperature in humans is altered by the ambient 
temperature and was shown to vary between 29 and 33°C in healthy, young women 
(Martinez-Nicolas et al., 2015). New methods for the continuous measurement of human 
skin temperatures have been developed in the last decade (Smith et al., 2010; Webb et al., 
2013), but no research applying them in leprosy patients to investigate how temperature 
changes may influence leprosy progression and bacterial growth has been published. Such 
data would be needed to determine, whether differences in ambient temperature, leading to 
changes in skin temperature, could potentially influence leprosy progression in a host. Such 
studies are easier to conduct in the larger host species, in which sensors of the currently 
available size can be used. If ERS sized sensors became available, comparing ear 
temperatures in ERS from BI and AR throughout the year could allow to determine whether a 
significant difference exists that could explain why more individuals in the population living in 
a slightly warmer climate, developed clinical disease.   
If this study was to be repeated, one major alteration that should be made is including a 
tissue sample at the initial assessment in all ERS, to be aware whether ERS are already 
colonised with leprosy bacilli at this point. However, to be able to repeatedly test ERS 
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without clinical signs for the presence of leprosy bacilli, ear tissue samples may not be 
suitable, as they can only be taken a limited number of times. One way around this could be 
to use repeated blood samples to isolate M. leprae DNA, although it would be necessary to 
first assess whether leprosy bacilli DNA can be isolated from 1ml ERS blood samples, as is 
the case in 3-5ml samples from humans (Wen et al., 2013). Other alterations could aim to 
increase re-trapping success or to collect data on disease progression without having to 
handle the ERS. Marked ERS could be followed over time using camera traps combined with 
microchip readers installed in the area covered by the camera. Re-trapping success could be 
increased by saving time using trapping protocols with a shorter handling of each ERS (i.e. 
exclusively clinical assessment of already confirmed leprosy cases in handling cones without 
anaesthesia) and trapping sessions that are continued until no new previously marked ERS 
are trapped. Similar protocols are, for example, established for squirrel population monitoring 
studies (Barkalow, Hamilton and Soots, 1970; Hansen, Nixon and Havera, 1986; Di Pierro et 
al., 2010).   
To overcome the limitations of studying leprosy progression through live sampling, it could 
also be combined with disease progression modelling. Valuable lessons for model 
development could be learned from progression models developed for other progressive 
diseases that can start with mild symptoms, delayed diagnosis, and where disease 
progression can be highly variable between individuals, for example Alzheimer’s (Cook and 
Bies, 2016). Such models can incorporate both biomarkers (i.e. serological or molecular test 
results) as well as clinical outcomes summarised in categories (Cook and Bies, 2016). 
Models exist that can handle variable patient histories and missing entries and are still able 
to make projections for disease progression beyond the point of initial data collection. 
Unfortunately, such models require large dataset (several thousand patients) to be trained 
and evaluated properly (Zhu and Sabuncu, 2018). So, while they would be a very valuable 
addition in the long run, in the short term not enough information is available to adapt them 
well for use in squirrel leprosy research. If more longitudinal data can be collected, it might 
be useful to discuss the dataset to be collected with modellers to see if alterations in the 
information collection protocol could lead to a quicker development of such tools, that may 
be useful for managers to assess for how much longer a diseased ERS is likely to survive. If 
survival is likely to be very limited anyway, humane removal of the individual from the 
population could be a sensible option and may reduce the number of leprosy bacilli that are 
being excreted into the environment. In cases where long term survival of a clinically 
diseased ERS in a small population of high genetic value is likely, the additional generations 
produced by leaving the ERS in the population outweigh any theoretical reduction in 
bacterial load or transmission risk in the population. These considerations only stand so long 




While the onset and progression of clinical leprosy can be observed in ERS within a two-year 
timeframe, an extended incubation period of several months or years along with mostly slow 
progression of clinical disease appears to be present in this host, just like in NBA or humans. 
Progression is variable between individuals and may be influenced by additional risk factors 
that alter the host immune response, such as pregnancy, lactation or secondary infections. 
ERS can thrive from several months up to years after becoming colonised with leprosy bacilli 
without developing clinical signs of disease. It could be possible for some ERS to clear a 
colonisation with M. leprae, however, due to the limitations of current PCR assays, very low 
bacterial loads may just not have been detected in later assessments. This study has offered 
valuable initial insights into the progression of leprosy. Longer-term studies including larger 
numbers of ERS, using additional tools to investigate the ERS immune reaction and to more 
sensitively detect M. leprae DNA, potentially also employing modelling methods to make the 
most of the available data, could still uncover much additional information about host-

















Chapter 6: Squirrel leprosy epidemiology  
6.1. Introduction 
Next to clinical signs and pathology, the epidemiological characteristics of a disease are an 
integral part of its basic description. To complete the basic description of leprosy in ERS 
begun in the earlier segments of this study addressing clinical and pathological aspects of 
leprosy in live ERS, this segment will now focus on disease frequency and distribution.  
Only in the British Isles have ERS been identified as infected with leprosy bacilli (Avanzi et 
al., 2016). Based on opportunistic samples leprosy prevalence (colonisation and clinical 
infection) in submitted carcasses varied in different locations from very low (~1% on the Isle 
of Wight, ~5% in Ireland), over moderate (~13% in Scotland) to very high (~100% on BI) 
(Avanzi et al., 2016; Butler et al., 2017).  
Data from the two focus populations (AR, BI) of this study was used to establish the 
apparent prevalence and morbidity, and to calculate a cautious estimate for the incidence of 
leprosy in live ERS. It was assessed whether the leprosy prevalence and morbidity are 
similar in the two populations. 
The effect the presence of leprosy bacilli is having on the two populations was assessed by 
comparing health indicators between them. The aim of these efforts was to assess whether 
the presence of leprosy colonisation and infection in a population has a negative effect on 
ERS population health. 
Not all ERS populations occurring throughout the British Isles have been assessed for the 
presence of leprosy bacilli, including the intensely managed population around Anglesey, 
Wales. Thus, samples from this population were assessed for the presence of leprosy bacilli. 
Additionally, some samples from BI and all samples from AR were screened for both leprosy 
bacilli and not just the one that was expected to be present on each island. In this manner 
the hypothesis that both leprosy bacilli are present in ERS in different locations throughout 
the British Isles was challenged.  
Testing of GS has been very limited (n= 4 (Avanzi et al., 2016)). Thus, further active 
surveillance was necessary to clarify whether leprosy does affect GS in the British Isles as 
well as ERS. GS are the only other squirrel species established in the wild in the British 
Isles. They were introduced on multiple occasions in the late 19th and early 20th century 
(Schuchert et al., 2014). They are now widespread and have almost completely replaced 
ERS in England, Wales, and central Scotland. Controlling GS is a vital part of ERS 
conservation in the UK (Mackinlay and Patterson, 2011; The Scottish Squirrel Group, 2015). 
GS are native to the eastern USA, where human leprosy cases do occasionally occur today. 
Historically, leprosy spread to the southern United States between the 16th and 18th century. 
First human case reports in Louisiana date back to 1758 and 1866 (International Leprosy 
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Association, 2019). It has been addressed as an emerging public health problem on a larger 
scale since 1894 (Health Resources and Services Administration, 2019). While human 
leprosy cases might thus have occurred occasionally in the southern parts of the natural 
range of GS around the time they were translocated to Europe (Shuttleworth, Lurz and 
Gurnell, 2016), prolonged coexistence of GS with large numbers of human leprosy patients 
in their natural range appears unlikely. In the British Isles human case numbers had already 
declined before GS arrived, but it is possible that leprosy bacilli were present in ERS 
populations now replaced by GS. No clinical signs of leprosy have been described in GS to 
date. It has not been assessed whether they are infected with leprosy bacilli in their native 
range.  
Outside the British Isles ERS are widespread throughout their range, but at this point leprosy 
has not been investigated in ERS or any other wild squirrel population anywhere else. To 
begin to assess whether leprosy is truly limited to ERS in the British Isles, samples were 
acquired from two other countries within the species range, Germany and Italy. In Germany 
ERS are the only endemic tree squirrel species (Shar et al., 2016; Wibbelt et al., 2017). 
Other squirrel species are kept as pets though, including Southeast Asian tree squirrels 
(Callosciurus spp.). Aside from ERS the Calabrian black squirrel (Sciurus meridionalis) is a 
tree squirrel species endemic to Italy (Wauters et al., 2017). Italy also has introduced wild 
populations of GS, Pallas’s squirrels (Callosciurus erythraeus, PS) and Finlayson’s squirrels 
(Callosciurus finlaysoni, FS). Both GS and Callosciurus spp. were introduced into Italy in the 
1980’s (Bertolino et al., 2004; Martinoli et al., 2010). PS are Asian tree squirrels currently 
listed as least concern by the IUCN. It’s native range stretches from north eastern India to 
Myanmar, Thailand, Laos, Vietnam and south eastern China (Lurz et al., 2013). FS are 
native to Indochina (Bertolino et al., 2004). Human leprosy is still endemic to South-East 
Asia, with 153,487 new cases registered in 2017 alone (WHO, 2018a). For both species’ 
exposure to human leprosy patients in their native range is thus, at least in theory, possible. 
However, no cases of leprosy have been reported in either species to date and introductions 
into Italy were limited to a few individuals which then reproduced very successfully locally 
(Bertolino and Lurz, 2013). 
Samples of ERS (Germany, Italy), GS (Scotland, Wales, England, Italy), and PS (Italy, 
Germany) were screened for the presence of leprosy bacilli DNA and AFB to challenge the 
hypothesis that leprosy is exclusive to British ERS. While the first half of this segment of the 
study is largely reusing data presented in the previous chapters, the second half will present 




6.2.1. Leprosy in BI and AR ERS 
Prevalence of leprosy in two British ERS populations 
The diagnostic decision tree introduced in chapter 3 (p. 99) was used to determine the 
leprosy status of all ERS seen in this study on BI and AR, including both live assessed ERS 
and carcasses. Carcasses were included, but always treated separately from live ERS data. 
Including own carcass data allows a direct comparison with previously published carcass 
information. It also allows to compare disease occurrence in live ERS and carcasses 
collected in the same location and timeframe instead of only being able to compare live ERS 
data to carcass data in the published literature. ERS showing clinical signs of disease (i.e. 
cases or suspicious) were considered to be leprosy morbidity events.  
For each population and session, the apparent point prevalence of clinical leprosy and non-
clinical colonisation was calculated by dividing the number of ERS diagnosed as leprosy 
cases or colonised by the total number of ERS assessed in that sampling session, 
respectively. The average estimated point prevalence for live animals across all cohorts was 
also calculated.  
Additionally, an apparent two-year prevalence estimate including each live ERS only once, 
was calculated for each population. For this, ERS that were diagnosed as leprosy cases or 
as colonised at any point within these two years were treated as cases/colonised, i.e. the 
maximal leprosy status a squirrel reached within the two years was used for the two-year 
prevalence estimate. Thus, if an ERS was first colonised but then developed clinical disease 
it was included as clinical case. Where ERS were identified as colonised in one session, but 
a later PCR had a negative result, they were still included as colonised, due to the limitations 
of the diagnostic tests (see chapter 3). Not all diagnostic information was available for all 
ERS, i.e. some tissue samples were missing. Thus, particularly the prevalence of 
colonisation with leprosy bacilli may be underestimated based on the current dataset.  
Simple exact binominal confidence intervals for each apparent prevalence were calculated 
using Minitab ® 17 statistical software. 
The hypothesis that there is no difference in the proportion of ERS affected by (summarising 
case, suspicious and colonised ERS) or diagnosed with a specific leprosy status in the two 
island populations was tested using a Fisher’s Exact test and Wilcoxon rank sum test in R, 
respectively.  
Incidence rate of clinical leprosy in ERS 
The sample set collected in this study is not ideally suited to calculate disease incidence. For 
some squirrels only a single time point is available, i.e. no information whether this animal 
developed disease is available at all. While no ERS on AR developed clinical disease within 
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the study period, and incidence can thus not be calculated for this population, the 31 ERS 
returning multiple times on BI that were introduced in chapter 5 can be used for a first, 
cautious incidence estimate. To be able to attempt an incidence estimate, the assumption 
was made that all animals were 12 months old at the time of the first assessment. This is an 
artificial value and while it is likely that few animals were younger, several may have been 
older.  
If these returning animals are treated as closed cohort, representing about 15% of the total 
estimated squirrel population on BI, it is possible to do a basic calculation of the incidence 
rate that while offering a first estimate, may be proven wrong once more data becomes 
available. 
The incidence rate was calculated as:  
Number of disease onsets 
Sum of squirrel-time at risk 
 
The squirrel time at risk was calculated by adding up the time for each animal of 12 months 
of life before the first assessment and then adding the time  
a) until it was seen with lesions, in animals that did eventually develop lesions, though it is 
likely that lesions first occurred earlier. It was chosen to do this, as the other assumption of 
age at first assessment is likely to be too conservative.  
b) that had passed between initial assessment and the last assessment available for an 
animal, in those animals that did not develop leprosy lesions within the study period.  
Squirrels already diseased at the initial assessment did not contribute animal time at risk. 
Calculation was done twice using this squirrel time at risk, once treating BI 55, the leprosy 
suspect case that could not be confirmed with additional tests, as ERS that did develop 
clinical leprosy, and once treating this animal as not being a clinical case of leprosy. This did 
only influence the number of disease onsets but not the sum-of squirrel-time at risk, as the 
lesion in BI 55 was only observed in its final assessment.  
ERS population health in the presence of M. leprae 
Data collected on four health indicators, namely BCS, reproductive activity, GHS, and 
ectoparasites observed, were compared between the two populations (BI and AR). As 
annual and seasonal factors can influence these indicators, they were compared separately 
by sampling session. The influence geographic factors may have had will be addressed 
when discussing the results of these comparisons. No comparison was possible for autumn 
2016, as only animals on BI were sampled at this time. The results for each factor in this 
session are still included in the graphs to illustrate how they compare to the later sessions.  
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A Wilcoxon rank sum test was used to test the hypothesis that there was no difference in 
BCS of ERS seen on the two different islands. To compare reproductive activity the breeding 
condition information collected during the health assessments was simplified. Male squirrels 
were categorised as not currently reproductively active if their testes were abdominal or 
scrotal without pigmentation, and as reproductively active when scrotal pigment and testes 
were observed. Females were categorised as currently inactive where inactivity had been 
noted during the health assessment and as currently reproductively active if they were in 
oestrus, pregnant or lactating. The fact that our trapping efforts tried to avoid times of 
reproductive activity does introduce an intense bias to the sample set, and it is highly likely 
that the apparent reproductive activity we report here is much lower than the true 
reproductive activity seen in these populations. As this bias was the same for both islands, it 
was still decided to compare this factor between the populations. It can however, not be 
compared to data collected from other populations at other times of the year.   
For sampling sessions in which reproductively active and inactive animals were seen on both 
islands a Fisher’s exact test was used to test the hypothesis that the proportion of 
reproductively active and inactive ERS is the same in both populations.  
It was previously explained how a general health score was assigned to each squirrel during 
the health assessments or post mortem examination (p. 45). Healthy animals were either 
scored as in good health (1) or in good health with minor or old/healed injury (2). Acutely 
diseased animals were separated in those with a good prognosis (3) and those unlikely to 
improve (4). Chronically diseased animals were separated by whether they were able to 
cope with their condition (5) or not (6). A Wilcoxon rank sum test was used to test the 
hypothesis that there was no difference in general health of ERS seen on the two different 
islands.  
The ranked ectoparasite intensity (0= no parasites observed; 1= less than 5 ectoparasites 
observed, 2= less than 10 ectoparasites observed, 3= more than 10 ectoparasites observed; 
see p. 43 and following) was compared between the populations to test the null hypothesis 
that there is no difference in intensity of infestation of ERS from the two island populations. 
Hypothesis testing was carried out using Wilcoxon rank sum test.  
The presence of different external parasites was noted in ranks (none, ticks only, fleas only, 
ticks and fleas, ticks and harvest mites) and a Wilcoxon rank sum test used to test the 
hypothesis that there is no difference in the ectoparasites or ectoparasite combinations 
occurring on both islands.   
6.2.2. Leprosy in other squirrel populations 
Presence of leprosy bacilli in ERS from Wales 
Pinnae of 61 ERS, collected for surveillance purposes from ERS found dead between 2015 
and 2017, with one sample dating back to 1983, from Anglesey, Wales, were provided by a 
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collaborator from Bangor University. The samples were analysed for M. leprae and M. 
lepromatosis DNA using the protocol previously described (p. 72 and p. 108). 
Presence of leprosy bacilli in GS in the United Kingdom 
Adult GS had been humanely killed in pest control efforts by qualified individuals and were 
made available through the Scottish Wildlife Trust and Pryor & Rickett Silviculture and a 
collaborator at Bangor University. In assessed areas ranges of GS and ERS border on each 
other or overlap.  
Where sufficiently intact, ears, hind and front feet had been removed by collaborators in the 
field and were immediately send to UoE. Some carcasses were submitted whole and ears 
removed during post mortem examination at UoE. Samples were separated into two groups 
per animal, one then immersed in formalin, the other in ethanol. Fixation time before further 
processing varied, but was longer than 48 h in every instance.  
Samples for histological screening were processed at the UoE (RDSVS), while samples for 
molecular screening were transported to the Moredun Research Institute.  
Tissues from 53 GS were trimmed for histological assessment. From ears a 2-3 mm wide 
longitudinal section presenting the full length of the ear was prepared. The section cut from 
feet was 2-3mm wide, longitudinal, using the most accessible oval plantar pad and allowing 
the section to reach into the soft skin of the sole where possible. In hind feet the hind plantar 
pad was also included where feasible (Figure 80).  
 
FIGURE 80:  SECTIONS OF FOOTPADS WERE ALWAYS PREPARED USING THE FOURTH TOE AND 
EAR SECTIONS ALWAYS CUT FROM THE CAUDAL PART OF THE  EAR  
Tissues from the same animal were dehydrated and embedded in the same paraffin block. 
Two sections per block were stained by the staff of the Easter Bush Pathology histology 
laboratory at RDSVS, one with ZN stain to verify the presence or absence of AFB, the other 
with H&E to assess the presence and nature of inflammatory reactions. The later were only 
to be examined when AFB were found. Slides were analysed using an Olympus BX41 light 
microscope mounted with an Olympus DP72 camera, using Olympus cell imaging software 
for Life Science Microscopy. The tissue was screened at x20 magnification, moving very 
slowly but continuously through the whole tissue. If suspicious structures were observed, 
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magnification was increased to x40 to be able to confirm or reject that a structure could be 
an AFB. 
Tissues from the same GS described above and pinnae from the additional 24 GS were 
screened for the presence of M. leprae DNA following the same extraction and amplification 
protocol detailed in chapter 3 (p. 70).  
Presence of leprosy bacilli in squirrels from Germany and Italy 
Samples from Germany and Italy were kindly provided by collaborators at the Friedrich 
Loeffler Institute (Germany), Wildtierhilfe Odenwald (Germany), and the University of Milan 
(Italy). All samples had been collected opportunistically and banked for research purposes.  
Samples were available from 65 ERS, 41 PS, and three GS. All samples available from Italy 
were fixed in 70% ethanol, while from Germany separate samples from most individuals 
were available and split into two groups as for GS and fixed in 70% ethanol and formalin, 
respectively (Table 26).  
TABLE 26:  TISSUES AVAILABLE OF ITALIAN AND GERMAN SQUIRRELS  
Tissues fixed in formalin were used for histological screening, while those fixed in ethanol 
were used for molecular analysis. Both histological screening for AFB and PCR screening for 
M. leprae and M. lepromatosis DNA was done following the same protocols as described for 
UK red squirrels in chapter 3 (p. 72). Only a limited clinical assessment of the fixed tissues 
for gross lesions was feasible. Additional gross pathological information was provided by the 
collaborators sending the samples.  
6.3. Results  
6.3.1. Leprosy in BI and AR ERS 
Prevalence of leprosy in two British ERS populations 
Based on the clinical, serological and molecular information (see appendix V for more detail, 
p. 236) available for each ERS seen in this study, a diagnosis following the decision tree 
established in chapter 3 (p. 99) was made. Results are summarised per cohort in Table 27.  
Type of tissue Italy (ethanol) Germany (formalin) Germany (ethanol) 
ERS 
Pinna 43 22 22 
Hind footpad NA 22 15 
Nose NA 7   NA 
PS  
Pinna 39 NA 2 
GS 
Pinna 3 NA NA 
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all tests done) 
BI 
Autumn 2016 6 1 NA 0 19 
Spring 2017 8 1 6 8 3 
Autumn 2017 4 0 4 6 6 
Spring 2018 4 0 1 8 12 
Autumn 2018 5 1 0 23 0 
Carcasses 7 0 6 5 0 
AR 
Spring 2017 0 0 0 17 0 
Autumn 2017 0 0 0 6 0 
Spring 2018 0 0 0 14 0 
Autumn 2018 0 0 2 23 0 
Carcasses 0 0 3 26 0 
*This category was added for ERS that appear to be early cases after the clinical 
assessment, but could not currently be backed up with positive results in the other tests. 
Additional test or re-sampling at a later point in time would be necessary to clarify the status 
of these ERS. 
On BI the point prevalence for clinical leprosy (= morbidity) varied between 16% and 31% in 
the live cohorts, with an average prevalence of 21% (SD= 0.06, 95% CI= 0.14, 0.29), while 
the prevalence of colonisation varied between 0% and 23% with an average of 9.4% (SD= 
0.11, 95% CI= -0.04, 0.23). The total affected apparent prevalence varied between 17% and 
54% and was on average 30.8% (SD= 0.16, 95% CI= 0.11, 0.51). In BI carcasses the 
prevalence of both, clinical cases and colonisation, was higher with 39% and 33%, 
respectively. Thus, the total affected apparent prevalence in carcasses was 72% (95% CI= 
0.47, 0.90). 
On AR the prevalence of clinical leprosy was 0% in all live cohorts and in carcasses. 
Apparent colonisation prevalence varied between 0% and 8% in the live cohorts with an 
average of 2% (SD= 0.04, CI= -0.04, 0.08). The colonisation prevalence was again higher in 
AR carcasses than live ERS with 10% (CI= 0.02, 0.27) (Table 28, p. 177). 
Over the course of this two-year study 73 individual live ERS were seen on BI and 52 on AR. 
These were used to estimate the apparent two-year prevalence. For BI it is 22% (95% CI= 
0.13, 0.33) for clinical leprosy cases, 1% (95% CI= 0.0003, 0.074) for suspect cases and 
14% (95% CI= 0.07, 0.24) for colonisation. Thus, slightly more than a third (36%/37%) of the 
ERS assessed in this timeframe are thought to have been affected by leprosy. For 11 out of 
46 clinically negative ERS classed as contacts no PCR data was available. Therefore, up to 
an additional 15% of animals could in theory be colonised.  
The two-year prevalence estimate for colonisation with leprosy bacilli for the ERS assessed 





















































































































































Significantly more ERS are affected by leprosy on BI than on AR, both seen live (p= 
0.0000065) and assessed as carcasses (p= 0.000022, Fisher’s exact test). The difference 
remains significant when the different diagnostic outcomes (case, suspicious, colonised, 
contact) are considered as ranks (Wilcoxon rank sum test, plive= 0.00000499), pcarcass= 
0.0000076). However, when only the results from individual live trapping sessions are 
compared, the difference is not in all instances statistically significant, while it is always 
biologically relevant. In autumn 2017 and 2018 and spring 2018 the null hypothesis that 
there is no difference in leprosy status between ERS from the two islands cannot be rejected 
(pa17=0.079, pa18= 0.1479, ps18= 0.08166). In spring 2017 it can be rejected (ps17= 0.00019). 
When results were considered summarising ERS simply as affected (cases and colonised) 
or unaffected (no clinical signs and no M. leprae DNA isolated) by leprosy, the null 
hypothesis of no difference can still not be rejected for the same sessions (pa17= 0.1317, 
pa18= 0.4305, ps18= 0.1392), despite clear biologically relevant differences, like the absence 
of leprosy affected ERS on AR in autumn 2017 and spring 2018. In autumn 2018 the 
proportion of affected ERS is similar for both islands, but the significant biological difference 
is, that no clinical disease is observed on AR while it is seen on BI. The null hypothesis of no 
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difference can be rejected in spring 2017 (p= 0.00015) when more of the ERS seen on BI 
were affected by leprosy (53.8%) than not (46.2%), while no ERS were affected by leprosy 
on AR.  
Incidence rate of clinical leprosy in ERS 
The sum of squirrel-time at risk was 618 months, or 51.5 years. Assuming BI 55 is not a 
clinical leprosy case the incidence rate is thus 4/51.5= 0.078. If BI 55 is indeed a clinical 
leprosy case, as is deemed likely, despite the negative serology (see chapter 5, p. 160 et 
seqq.), the incidence rate of leprosy in the BI population could be estimated to be 5/51.5 = 
0.097 based on the sample set available here. This would equate to between 78 and 97 new 
cases of clinical leprosy in a population of 1000 squirrels (7.8 – 9.7%) per year or between 
~16 and ~19 new clinical leprosy cases occurring in the ca. 200 individual strong population 
on BI per year.  
ERS population health in the presence of M. leprae 
In total 126 live assessments and 18 carcasses were available for BI and 62 live 
assessments and 29 carcasses for AR. The null hypothesis that there is no difference in 
body condition of ERS from the two island populations could not be rejected for live ERS in 
any of the sessions (spring 2017 (p= 0.55), autumn 2017 (p= 0.07), spring 2018 (p= 0.49), 
autumn 2018 (p= 0.15)). It was however rejected for carcasses (p= 0.008) (Figure 81). The 
bias present when using carcasses for comparative assessments in the two islands were 
already discussed in chapter 2 (p. 58). It was still decided to include the information here, as 
leprosy affected carcasses were present in both populations and it was of interest to see if 
significant differences existed that could not simply be explained by the higher proportion of 




FIGURE 81:  BCS  OF ERS ASSESSED ON BI  AND AR. 
The null hypothesis that there is no difference in the proportion of reproductively active ERS 
in the two populations was tested for three live sampling sessions and for carcasses. As no 
sampling took place on AR in autumn 2016 and no reproductively active ERS were seen in 
autumn 2018 on either island, no hypothesis testing was possible for these sessions. For all 
other sessions the null hypothesis could not be rejected (Spring 2017: p= 1; Autumn 2017: 
p= 1; Spring 2018: p= 0.32; Carcass: p= 0.73). At least during the “off-peak” reproductive 
season, reproductive activity in these two populations does not show statistically significant 




FIGURE 82:  PROPORTION OF ERS CLASSED AS REPRODUCTIVELY ACTIVE IN THE DIFFERENT 
SAMPLING SESSIONS AND POST MORTEM ON BI  AND AR.  NUMBERS IN THE COLUMNS 
REPRESENT THE NUMBER OF ANIMALS IN A CATEGORY . PINK = REPRODUCTIVELY ACTIVE , 
BLUE = INACTIVE , SEXES ARE NOT SEPARATED  
The null hypothesis that there is no difference in general health scores assigned in the 
populations could not be rejected in spring 2017 (p= 0.52), autumn 2017 (p= 0.945), autumn 
2018 (p= 0.32), or carcasses collected from both islands (p= 0.77).  
It was however rejected for spring 2018 (p= 0.012) (Figure 83). Overall, general health 
among the assessed squirrels from both islands was similar and good. Most animals seen 
alive were in good health (score 1 +2), only occasionally were acutely (score 3 +4) and 
chronically unwell (score 5 + 6) ERS seen. In carcasses acute disease unlikely to improve 
(score 4) was seen most often on both islands. In spring 2018 more ERS on AR showed 




FIGURE 83:  GHS (1= IN GOOD HEALTH , 2= IN GOOD HEALTH , MINOR INJURY LIKELY TO HEAL , 
3= ACUTELY UNWELL , IMPROVEMENT LIKELY , 4= ACUTELY UNWELL , IMPROVEMENT UNLIKELY , 
5= CHRONICALLY UNWELL , ABLE TO COPE , 6= CHRONICALLY UNWELL , UNABLE TO COPE ) OF 
ERS ASSESSED ON BI  AND AR  THROUGHOUT THE TRAPPING SESSIONS 
The null hypothesis that there is no difference in the intensity of ectoparasite infestation was 
rejected in autumn 2017 (p= 0.01), and was close to rejection in spring 2018 (p= 0.06). In 
both instances higher parasite intensities were seen more frequently on BI than on AR. In 
spring 2017 (p= 0.11) and autumn 2018 (p= 0.22) the null hypothesis could not be rejected 
(Figure 84).  
Assessment of ectoparasite intensity was not possible from carcasses, as ectoparasites 
usually leave the carcass as it cools down and most carcasses were found at least hours, 




FIGURE 84:  ECTOPARASITE INTENSITY FOR ERS ASSESSED LIVE ON BI  AND AR.  OBSERVED 
PARASITE LOADS ARE SLIGHTLY HIGHER ON BI,  BUT THE DIFFERENCES WERE ONLY 
STATISTICALLY SIGNIFICANT IN AUTUMN 2017 AND SPRING 2018 
In autumn 2017 (p= 0.32) and autumn 2018 (p= 0.91) the null hypothesis that there is no 
difference in the parasites observed on ERS during the assessments could not be rejected, 
despite harvest mites only being observed at this time of the year and only on BI. Most ERS 
seen at this time of the year were infested with ticks, and many additionally with fleas. 
In spring 2017/18 (both p= 0.04) the null hypothesis was rejected. While barely any ticks 
appeared to be active on AR this early in the year, and some ERS here did not appear to 
harbour any ectoparasites at the time of trapping, ERS on BI were already infested with 




FIGURE 85:  NUMBER AND TYPES OF ECTOPARASITES IDENTIFIED IN THE DIFFERENT 
ASSESSMENTS ON BOTH ISLANDS  
Overall, none of the four health indicators suggested consistent major differences in the 
health of ERS from these two island populations which are affected by leprosy differently.  
6.3.2. Leprosy in other squirrel populations 
Presence of leprosy bacilli in ERS from Wales 
No M. lepromatosis DNA was detected in any of the samples. M. leprae DNA was isolated 
from two samples, both collected from female squirrels in 2017. Most of the samples (n= 40) 
were collected in this year. These results were also published, together with results from 
additional screenings carried out by Charlotte Avanzi on samples from the same population, 
in a letter to the Veterinary Record (Schilling, Del-Pozo, et al., 2019).  
Presence of leprosy bacilli in GS in the United Kingdom 
No AFB or M. leprae/M. lepromatosis DNA were present in any of the 77 GS samples tested. 
Samples came from Dumfries & Galloway (n= 43), the Scottish borders (n= 18), Dorchester 
(n= 5), and from Wales (n= 11). In these areas ranges of GS and ERS border on each other 
or overlap. Dorchester is an exception: here ERS are no longer present although BI is close 
by (ca. 9km/5.6 miles from where GS were collected). Public observations of ERS showing 
clinical signs indicative of leprosy have occasionally been reported from Dumfries & 
Galloway/the Scottish borders but not from Wales. 
Presence of leprosy bacilli in squirrels from Germany and Italy 
Gross lesions, AFB and M. leprae/M. lepromatosis DNA were absent from all samples 
screened from Germany and Italy. These results, together with the screening results for UK 
GS and additional information from samples screened by collaborators from Switzerland, 
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France and Mexico, were published in Frontiers of Veterinary Science (Schilling, Avanzi, et 
al., 2019, p. xv).  
6.4. Discussion 
The data collected in the two focus populations of this study allowed for apparent leprosy 
prevalence estimates of both. Both the total prevalence and morbidity varied greatly between 
the populations, supporting the hypothesis that leprosy presence differs between ERS 
populations. While M. leprae DNA was successfully detected in a not previously assessed 
British ERS population, no leprosy bacilli were detected in the GS sampled from Britain or in 
any of the squirrels screened in Germany and Italy. Thus, the hypothesis that leprosy 
exclusively occurs in ERS in the British Isles cannot currently be refuted. All results are 
discussed in more detail below.  
6.4.1. Leprosy in BI and AR ERS 
Prevalence of leprosy in two British ERS populations 
The null hypothesis that leprosy prevalence and morbidity is similar in two different British 
ERS populations was rejected based on the results of this study. While no leprosy related 
morbidity was observed on AR, 1/6 to almost 1/3 of the live ERS seen on BI in the different 
assessment sessions presented with clinical signs of leprosy. An even higher proportion of 
carcasses from this location showed clinical signs of leprosy. However, the differences in 
disease prevalence were not always statistically significant, as in both populations assessed 
here most animals were not directly affected by leprosy bacilli. They may however have had 
contact to leprosy bacilli through the shared environment or direct contact with colonised or 
diseased ERS. Additionally, results are slightly skewed by the fact that tissue samples were 
not taken from all ERS on BI in all sessions and thus the true proportion of affected ERS 
could be underestimated here, while overestimating the number of ERS just constituting 
contact animals.   
While ERS without clinical signs of disease were found to be colonised by M. leprae on both 
islands the proportion of colonised ERS was higher on BI in most assessment sessions, 
despite not all ERS trapped here being tissue sampled. However, in autumn 2018, no 
colonised ERS were detected on BI, while two were identified on AR. The overall proportion 
of ERS affected by leprosy was much lower on AR than on BI. 
Avanzi et al. (2016) had found leprosy bacilli in all BI ERS carcasses available to them 
(collected between 2010 and 2015), with eight out of 25 showing clinical signs of disease 
(32% morbidity, 100% affected). This study found a lower proportion of BI ERS affected, 
both when considering live sampled ERS (36/37% affected, 22/23% morbidity, two-year 
prevalence) and carcasses (72% affected, 39% morbidity). Even if all live ERS for which no 
PCR data was available in the two-year prevalence estimate were colonised, the proportion 
of affected ERS would at maximum be 48%. Given the variability observed in prevalence 
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and morbidity in the different sampling cohorts, it would be of interest to collect data over a 
longer period of time to assess, whether there is a variation in numbers of affected/case ERS 
that correlates with external changes or if differences are mainly due to chance/trapping 
success in the individual sessions. Generally, the data available from BI implies that there is 
a risk of overestimating the prevalence of ERS leprosy when only carcass data is used, 
making it important that live sampling is continued to be used in ERS leprosy epidemiology 
research. 
The two-year prevalence and morbidity on BI were slightly higher than the average 
calculated from the individual cohorts, thus implying that individual affected/diseased ERS 
seen repeatedly over the course of the study might have influenced the averages. Chapter 5 
had shown that leprosy is a chronic disease in ERS that can progress over at least half of an 
animal’s expected lifespan. This may mean that tools used in chronic disease epidemiology 
may need to be employed to be able to for example study factors that influence leprosy 
development and progression in ERS. One option would be life course approaches that 
would involve studying the long-term effects of biological, behavioural and social  factors 
operating across an individual’s life and across generations on leprosy risk (Ben-Shlomo and 
Kuh, 2002).  
The awareness, that carcass data may overestimate leprosy prevalence in an ERS 
population is important when considering data from low prevalence populations, like AR or 
the Isle of Wight. On AR Avanzi et al. (2016) had found M. lepromatosis DNA in one out of 
10 of carcasses sampled, while this study found a 4% two-year prevalence in live ERS with 
no diseased ERS seen and M. leprae DNA in 10% (3 out of 29) of the carcasses screened. 
Thus, while the leprosy bacillus identified differed, the proportion of colonised carcasses was 
similar in this study to Avanzi et al. (2016). In three of the four live cohorts no leprosy bacilli 
DNA was detected at all. As on BI, live ERS data suggested a much lower prevalence than 
carcass data.  
Low prevalence may result in non-detection events if ERS from a population are only 
sampled at one point in time or only low numbers of ERS can be assessed. On the Isle of 
Wight M. lepromatosis DNA was isolated from 1.1% (1 out of 92) of carcasses screened 
(Butler et al., 2017), indicating that the infection may be sustained in a population at even 
lower rates than in the populations included in this study. This should be kept in mind when 
sampling sizes for prospective screening efforts are calculated. Combined with the facts that 
samples available from wild animals are always limited and diagnostic tests for ERS leprosy 
still imperfect, this makes it unlikely that true absence of leprosy from ERS populations can 
be determined, something that is for example possible for SQPV (Romeo et al., 2019). 
Unfortunately, not enough M. leprae DNA was available from the AR ERS to sequence the 
strain. It can thus not be known whether it is the same strain as found on BI or not. Little is 
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known regarding virulence of different strains/branches of M. leprae. A recent study showed 
that M. leprae strain 4P (which does not naturally occur in NBA) has a growth advantage 
over strain 3I (which is found in NBA in the wild) following experimental infection of NBA with 
one or both strains (Sharma et al., 2018). This could imply that some divergence in virulence 
may exists between different, modern M. leprae strains, or that natural adaptation to a host 
results in lower virulence. However, it is currently thought to be unlikely that ancient and 
modern strains of the same lineage vary significantly in virulence based on their close 
genetic relatedness, since there does not appear to be a loss of any known virulence genes 
(Schuenemann et al., 2013, 2018). Thus, differences in pathogen virulence on both islands 
would only be a potential explanation for the observed differences, if two separate M. leprae 
strains were present in the two populations, something that cannot be determined based on 
the current data. M. lepromatosis was not detected on AR in the current study. Based on 
information available from humans, clinical signs following an infection with M. lepromatosis 
can be more severe (i.e. DLL with necrotizing vasculitis) than those observed in a patient 
infected with M. leprae (Han et al., 2014; Velarde-Félix, Alvarado-Villa and Vera-Cabrera, 
2016; Ahuja et al., 2018). However, infections with M. lepromatosis still appear rarer than 
infections with M. leprae, a good decade after its discovery (Ahuja et al., 2018). Previous 
studies found that M. leprae and M. lepromatosis cause highly similar clinical signs in ERS 
(Avanzi et al., 2016), and the fact that no further cases were identified on AR could indicate 
that it’s virulence is at least not higher than that of M. leprae in ERS.  
It is known that many differences exist between the two ERS populations, including their 
genetic composition and origins (Ballingall et al., 2016; Hardouin et al., 2019) as well as 
population densities and habitat characteristics (see chapter 2, p. 35 et seqq.). These 
differences could contribute to the differences in disease prevalence observed between the 
two islands. Studying genetically determined susceptibility of ERS populations to leprosy 
along with the interaction patterns of individuals within the population and with their 
environment could provide valuable insights into the determining factors of prevalence 
variation and should be addressed by future research.   
The uniqueness of the current dataset and the absence of a diagnostic gold standard only 
allowed for an apparent prevalence estimate. Now that some initial data is available, future 
studies could be designed to use maximum likelihood modelling (Hui and Walter, 1980; 
Lewis and Torgerson, 2012) or Bayesian Estimation approaches (Joseph, Gyrokos and 
Coupal, 1995), to allow true prevalence estimates.  
Incidence rate of clinical leprosy on BI 
The proportion of diseased ERS on BI varied from session to session despite the chronic 
character of the disease and the good re-trapping success. While some diseased ERS were 
seen multiple times, disease onsets could be observed as well, implying that clinical leprosy 
on BI is not limited to a few ERS that are then observed again and again, but actively being 
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transmitted and causing new cases in the population. More long-term studies of the 
population would be necessary to establish whether the incidence rate estimate calculated 
here is truly realistic and to assess whether disease incidence is consistent over time or 
variable based on external influences. As mentioned above, epidemiological studies using 
life course approaches might be more suitable to study leprosy incidence in ERS than short-
term surveillance and monitoring efforts due to the chronic nature of the disease.  
ERS population health in the presence of leprosy 
Live ERS on both islands were mostly in normal body condition or thin, which, as explained 
previously, does not necessarily mean malnourished, as substantial internal fat stores may 
be present. Thus, the presence of clinical leprosy and the higher rate of colonisation by 
leprosy bacilli on BI does not appear to put the ERS at a disadvantage where foraging and 
maintaining body condition is concerned. Based on the data presented in this study it 
appears unlikely that leprosy has a major negative impact on the nutritional status of an ERS 
population. Differences in BCS seen in carcasses can be explained with the high proportion 
of road kill animals included on AR (see chapter 2, p. 66). 
There also appears to be no impact of a higher proportion of ERS in a population being 
affected by leprosy on reproductive success. However, this factor should further be 
investigated by following the populations over time and determining factors like successfully 
raised offspring per season as well.  
There was no statistically significant difference in the GHS observed in ERS in both 
populations in all but one session. In this one session (spring 2018) AR ERS were in “poorer” 
health than the ERS on BI. However, the statistical difference observed here may not be 
biologically relevant. While the majority of ERS on both islands seen in spring 2018 were in 
good health, some of those on AR had old injuries (BI: 24 ERS GHS 1; AR: Nine ERS GHS 
1, three ERS GHS 2). On each island one animal was seen with an acute injury that was 
likely to heal. On AR one chronically diseased animal able to cope was also seen. Therefore, 
the already smaller sample on AR was split across more scores than the ERS seen on BI, 
which influenced the statistical significance of differences. 
In one out of four sessions statistically significantly higher ectoparasite intensities were 
observed on BI than on AR. However, this was the session in autumn 2017 during which 
only six ERS were trapped on AR and two of three trapping days were very rainy, when only 
a limited number of traps were opened to allow for more frequent checks and avoid 
unnecessary exposure of trapped ERS to the elements. Adverse weather conditions can 
have an impact on the ectoparasite burdens observed and the discrepancy in number of 
ERS trapped could have amplified this effect. It is thus unlikely to be related to the 
presence/absence of leprosy in the sampled ERS. Spring 2018 was unusually cold on both 
islands, still some ERS on AR had high parasite burdens, others very low. On BI most ERS 
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had relatively low burdens. Therefore, the statistically significant difference observed 
between the two populations at this time is again unlikely to be linked to the presence of 
leprosy bacilli in a population, as in the population with the higher parasite burdens no ERS 
affected by leprosy were observed. 
Based on the differences in climate on the two islands (see chapter 2, p. 35 et seqq.) it could 
have been expected that particularly tick activity and presence on ERS would be higher on 
BI than on AR, as average temperatures during our sampling times were well above the 
threshold for activity for ticks on BI but not on AR. As for fleas, in a habitat more densely 
populated by ERS, drey sharing may occur more frequently and less dreys may be unused, 
thereby giving fleas, easier and more frequent access to a host. Thus, flea burdens could 
also be expected to be higher on BI than on AR, regardless of the presence of any infectious 
disease.  
The statistically significant differences in parasite composition observed on the ERS in the 
spring sessions on both islands are likely due to the still much lower temperatures on AR, 
which would naturally reduce tick activity at this time of the year (Cardon et al., 2011; Maaz 
et al., 2018).  
Thus, while the health indicators used here did flag up some differences between the two 
populations, these were unlikely to be linked to the differences in leprosy prevalence within 
the ERS populations and more likely due to differences between the two habitats, and most 
importantly the local climate.  
The fact that the BI population, which is more intensely affected by leprosy, does not appear 
to be at a health disadvantage compared to the AR population allows to expand the 
hypothesis made for individual ERS - that the immediate impact leprosy is having is minor. 
Furthermore, it could now be stated that leprosy does not drive ERS population health 
regardless of the frequency with which it occurs in the population. This does correlate with 
observations in other species. In NBA a generally low impact of leprosy on wild populations 
is reported, regardless of the prevalence of disease (Truman, 2005; Morgan and Loughry, 
2009), while hyperendemic areas of human leprosy continue to exist and do not result in 
mortality rates high enough to cause declines of local human populations. On the contrary, 
throughout the history of the disease, affected humans have - by force or voluntarily - formed 
colonies and lived for extended periods of time in these enclaves, sometimes having families 
here (White and Franco-Paredes, 2015). If the social stigma, which is only relevant to 
humans, is briefly ignored, negative consequences following an infection with leprosy bacilli 
only exist for some individuals, but in no host species for populations. Obvious disability has 
not been observed in ERS, as it is likely that impaired individuals would be readily predated, 
and loss of sensitivity was not assessed. What has occasionally been observed was 
pulmonary (BI 026_16) or systemic disease (BI062_17) or a large cheek abscess 
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(BIC002_16) in ERS also affected by leprosy. Based on these few cases it cannot be 
concluded though, whether leprosy was an important confounding factor in the onset of 
these conditions or an accidental finding. The latter could be suspected given the good 
health seen in the majority of affected ERS in this study.  
Health indicator data collection was not the main focus for the design of the study and 
planning more targeted assessments in the future could be worthwhile. Particularly, these 
could compare the reproductive success in terms of young survival and comparing 
ectoparasite burdens when environmental conditions are similar for both islands, instead of 
comparing at the same time of the year. An additional factor that future studies might include 
is screening for the presence of other pathogens within the populations. This could address 
whether leprosy could be an indicator for weaker immunity in a population, either due to 
genetic make-up or over-ageing. It could also allow to assess whether being infected with 
leprosy increases the risk for an ERS to develop other diseases or not.  
6.4.2. Leprosy in other squirrel populations 
Presence of leprosy bacilli in ERS from Wales 
After BI and AR Wales is now the third location in which M. leprae DNA has been isolated 
from ERS tissue samples. This illustrates that M. leprae is present in ERS more widely than 
previously reported (Avanzi et al., 2016). The Welsh ERS population has undergone severe 
declines and genetic bottlenecks in the past, but is now actively managed towards greater 
diversity and external factors like habitat quality and GS are managed to favour ERS (Ogden 
et al., 2005). This has included the successful introduction of captive bred and wild-caught 
ERS  (Ogden et al., 2005; Shuttleworth, Kenward and Jackson, 2008). It cannot be said at 
this point whether leprosy bacilli were introduced and transmitted as part of these re-
introductions. Clinical leprosy has not been observed in any resident or introduced ERS in 
Wales, and based on the data from this study, bacterial levels in colonised ERS seem low. 
As discussed for the AR population, it cannot currently be explained how only non-clinical 
infection at low prevalence is being sustained in an ERS population. 
Unfortunately, as for the ERS from AR, not enough M. leprae DNA could be extracted to 
sequence the Welsh strain. It is thus unknown whether the same strain is present as on BI, 
or if ERS here are affected by other strains that could indicate a different origin. Further 
efforts made in collaboration with Charlotte Avanzi, after data collection for this study was 
complete, to identify additional colonised ERS in the Welsh population were unsuccessful. 
Thus, this matter continues to be unresolved. As the Anglesey population is being closely 
monitored, the opportunity of continued screening for clinical signs of disease exists and it 
could be considered to test a proportion of all ERS carcasses available annually for the 
presence of leprosy bacilli to gather more information on prevalence and epidemiology over 
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time. However, such a measure is probably not necessary from an ERS conservation point 
of view.  
Presence of leprosy bacilli in GS in the United Kingdom 
From the information provided by Avanzi et al. (2016) for clinically healthy ERS in the British 
Isles, a case rate of 210 per 1000 was used to calculate the sample size needed to detect at 
least one case of leprosy with 95% confidence using Winpepi DESCRIBE. Based on this 
assumption a sample size of just 19 individuals should have been enough to pick up at least 
one GS colonised with leprosy bacilli. This number was exceeded within this study and most 
of our samples came from areas where there was at least some overlap with ERS identified 
as colonised or infected with leprosy bacilli. Thus, at least some GS included in this study 
are likely to have been exposed to leprosy bacilli within the shared environment. However, 
the data collected in this study showed that the initial assumption was too optimistic and that 
if the prevalence of leprosy in GS is much lower, the number of samples screened in this 
study may not have been large enough to identify a case. For example, if 100 colonised GS 
were present in every 1000, it would have already been necessary to screen 42 to find a 
case. This would still have been within the sample size of this study. However, if just 10 in 
1000 were colonised, the necessary sample size to detect a case would increase to 446. 
Furthermore, there is always the risk of false negative results where bacterial loads are low. 
The possibility that some GS in the UK might still carry leprosy bacilli can therefore not be 
excluded.  
GS introduced to Europe may not have had contact to leprosy bacilli in their native range, as 
in most of it no human or NBA leprosy cases were documented prior to the introduction of 
GS to Europe. In many instances it is a disadvantage to be naïve to a pathogen, as this is 
often linked to higher disease susceptibility. However, it is also possible that a new host is 
not competent to transmit a newly encountered pathogen (Daszak, Cunningham and Hyatt, 
2000; Han, Kramer and Drake, 2016). Leprosy is not a highly infectious disease and leprosy 
bacilli are highly genetically conserved and due to their reduced genome, obligate 
intracellular pathogens. They need to not only successfully evade the host immune system 
for a successful colonisation or infection, but also find suitable conditions for reproduction in 
the host (Rojas-Espinosa and Lovik, 2001; Fulton et al., 2016). This could make it more 
difficult for the pathogen to adapt to a new host species, reducing the risk of a spontaneous 
spill-over to a new host. Interestingly, past M. leprae spill-overs into a new host species 
seem to have occurred without obvious adaptive changes to the bacterial genome (Benjak et 
al., 2018). Ideally future research will first clarify which genetic traits make some ERS 
susceptible to leprosy. It could then be assessed whether GS share these traits and are 
likely to be susceptible to leprosy. Apart from that only large-scale screening of hundreds of 
GS samples could provide further insights into the matter, but current methods would never 
be able to conclusively demonstrate the absence infection.   
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Presence of leprosy bacilli in squirrels from Germany and Italy 
There are no obvious reasons why ERS in continental Europe would not have had contact to 
leprosy bacilli from a human source in the past. There is also the chance for more recent 
contacts in countries such as Italy where autochthonous transmission in humans still 
appears to occur (Maritati and Contini, 2016; Cusini et al., 2017) or through imported leprosy 
cases across their range, even though these usually receive appropriate treatment quickly.  
However, our sample size was relatively small, and particularly in Germany several juvenile 
ERS were included, a group that potentially is less likely to carry detectable levels of leprosy 
bacilli. Sample numbers from Italy for ERS and PS were above the minimum sample size if 
more than 21 in 1000 animals were affected. However, as with GS, lower prevalence is 
possible and, in this case, sample sizes would not have been sufficient to detect a single 
case. The large-scale screening efforts including hundreds of individuals necessary to detect 
cases if the prevalence is lower, may not appear justified for a disease that currently does 
not appear to pose a human or animal health threat on the European continent.  
Conclusion 
Data collected in the BI and AR populations showed that leprosy prevalence can vary greatly 
between ERS populations, even when sampling efforts and methods are comparable. 
Incidence could only be calculated on BI, as no morbidity events were observed on AR. 
Leprosy does not appear to negatively impact population health, neither in a low prevalence 
(AR) nor in a high prevalence population (BI), where clinical leprosy cases are regularly 
observed.  
Detecting M. leprae in Wales established another location within the British Isles in which 
ERS are colonised or infected with leprosy bacilli. GS, on the other hand were not shown to 
carry leprosy bacilli, even in areas where they may at least occasionally share the 
environment with leprous ERS. If leprosy occurs in ERS or other squirrels in Germany and 
Italy, prevalence is likely to be low, based on the fact that this study did not identify any 
cases or colonised animals. Further studies should clarify what makes British ERS 
susceptible to leprosy. If susceptibility is determined by a limited set of clearly defined 
genetic mutations (currently no specific candidate identified, as TLR-1 results not in line with 
findings in other host species (Avanzi et al., 2016)), it may be more practical to assess 
whether these traits are present in other ERS populations and squirrel species rather than to 







Chapter 7: Leprosy in its endangered wildlife host 
7.1. Introduction 
An ancient disease like leprosy can still challenge us to rethink what we believed was known 
about it. The recent discovery of a new pathogen species, M. lepromatosis, as a causative 
agent (Han et al., 2008) and that of a completely new host species for both genetically highly 
conserved leprosy bacilli (Avanzi et al., 2016) are two examples. However, in comparison to 
other mycobacterial diseases, including ones that receive much more research attention, like 
tuberculosis, and still pose many unanswered questions, it should perhaps not be surprising 
(Mukundan et al., 2015).  
In this study of leprosy, caused by M. leprae in two otherwise apparently healthy British ERS 
populations, methods to diagnose leprosy were adapted for use in live ERS and new insights 
were provided into the clinical and histological presentation as well as the clinical 
progression of leprosy. The study established that leprosy can be present in ERS 
populations at low prevalence and without causing clinical disease or may affect more than a 
third of the population and cause clinical disease in a high proportion of these affected 
animals. In both scenarios negative impacts on population health appear to be minor and 
negative effects on individual welfare were only observed in few, advanced cases. It was not 
possible to detect leprosy in GS in Britain or in squirrels in Germany or Italy. Given the 
relative ease and regularity with which ERS leprosy cases can be identified within the British 
Isles this implies that differences exist in the epidemiological situation outside the British 
Isles.  
While this study was focussed on ERS, human interests in a potentially zoonotic pathogen 
that was thought to have been eradicated from the United Kingdom decades ago (Fulton et 
al., 2016) cannot be ignored. Many are likely to agree that the main aim of mycobacterial 
disease research and interventions is the improvement of human health. Extensive research 
efforts into bovine and badger tuberculosis, for example, aim to safeguard human health and 
guarantee safe food. They can at the same time drive improvements in animal hygiene and 
welfare, and thus result in advantages for all species involved (OIE, 2019). Furthermore, 
appreciation that studying natural infections in animals can offer insights into drivers of host 
specificity, disease transmission, and  comparative pathogenesis and pathology, and thus 
enhance the understanding of human disease, is increasing (Mukundan et al., 2015). 
Beyond natural systems, animal models of disease are an important tool in disease 
research, and whether a newly discovered host could be used as such a model is a question 
that will inevitably be asked. This concluding discussion will thus not just focus on ERS 
leprosy, but also touch on what information studying leprosy in ERS can offer to human 
leprosy research and how.  
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7.2. Leprosy: a minor threat to ERS – an opportunity for research? 
A case for further improvement of diagnostic methods 
While this study has succeeded in adapting diagnostic methods for effective use in live ERS 
(chapter 3), its findings still support an important statement made by human leprosy 
researchers: “The absence of the diagnosis of leprosy is not the same as the absence of 
leprosy” (Salgado et al., 2016). Even in a (diagnostic) best case in ERS where typical clinical 
leprosy lesions are present (chapters 3 and 4), backing up the diagnosis with laboratory 
methods is not always possible. While molecular methods greatly increase the ability to 
identify ERS colonised by leprosy bacilli, it is currently impossible to establish the true 
diagnostic sensitivity of such methods, as a gold standard for identifying non-clinical cases 
that it could be measured against does not exist. How important these non-clinical cases 
could be in sustaining leprosy within an ERS population is illustrated by the fact that this was 
the only “form” of leprosy observed on AR. While it was currently chosen to call these ERS 
colonised for reasons detailed in chapter 3 (p. 97), some or all of them may actually be sub- 
or pre-clinically infected and could play an active role in disease transmission. Developing 
tools to identify subclinically infected ERS is thus an important step in investigating leprosy 
transmission dynamics in ERS. Early diagnosis of leprosy remains a major challenge in other 
hosts, such as humans as well. Identifying early cellular host reactions to the presence of 
leprosy bacilli is seen as an important step towards achieving this (Geluk, 2018). A 
collaboration between human and animal immunologists could offer valuable insights in the 
endeavour to establish the necessary tools for early diagnosis and fuller epidemiological 
understanding of leprosy. While it would not immediately offer information on whether or 
under which circumstances an ERS will develop clinical disease, it would be a highly 
valuable tool in longitudinal studies investigating this matter. 
The fact that the ear has proven superior to all other assessed tissues in ERS molecular 
leprosy diagnostics (chapter 4, p. 128) could also be of use to efforts in the human sector to 
increase the use of molecular diagnostic methods for early identification of cases (Salipante 
and Hall, 2011; Sousa Lima et al., 2019). Assessing whether a similar prime diagnostic 
tissue exists in other hosts could be used optimise sampling strategies in surveillance 
programs. Currently, slit skin smears from the ear and blood samples of asymptomatic 
household contacts of leprosy patients are already used in human leprosy surveillance 
efforts (Gama et al., 2018). Ensuring that these are truly the best possible samples makes 
sense. In NBA and other wildlife species the impact of molecular surveillance efforts could 
be minimized, if optimal sampling locations were to be established along with the minimum 
tissue volume necessary to enable diagnostics. 
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ERS leprosy surveillance  
Why was, out of the wide range of wildlife species, leprosy discovered in endangered wild 
ERS? The likely answer is: “Because there was an interest by dedicated individuals and an 
opportunity to investigate.” Without their special status within the British Isles, it is unlikely 
that large scale surveillance efforts would have been made. Without dedicated researchers 
and, ideally, well-funded surveillance efforts covering a range of wildlife species, we are 
likely to continue to be unaware of the full range of host species and potential reservoirs, not 
only for leprosy but for many other diseases as well (Guberti, Stancampiano and Ferrari, 
2014). We often simply lack the necessary knowledge about pathogen abundance and 
diversity in natural systems (Smith, Acevedo-Whitehouse and Pedersen, 2009). Initiatives 
like the PREDICT project which enables the global surveillance of pathogens that can spill 
over from animal hosts to people or national surveillance schemes like the APHA Diseases 
of Wildlife Scheme (APHA, 2019; UCDavis, 2019), are important initiatives to address these 
shortcomings, as are local surveillance efforts by wildlife experts and groups. They increase 
the ability to predict and prevent the emergence of infectious diseases. Wider conservation 
efforts, preserving ecosystem services including disease regulation can reduce the risk of 
disease spill overs (Cunningham, Daszak and Wood, 2017).  
The discovery of leprosy in ERS thus underlines the importance of wildlife disease 
surveillance. In countries where autochthonous human leprosy cases with unknown sources 
are occurring, governments could consider to not just support a clinical screening of ERS 
whenever they are handled, but also to integrate molecular leprosy testing into wildlife 
surveillance efforts in general. If an animal host for leprosy does exist in these countries as 
well, this might allow to identify it and enable targeted follow up research as has happened 
here in the UK for ERS. Particularly around active leprosaria, as they exist for example in 
southern Europe (Suarez-Garcia et al., 2017), passive surveillance in wildlife causalities 
might be a valuable first step in clarifying whether an animal host for leprosy bacilli is present 
in these countries, as exposure to human excreted pathogen is most feasible in these areas.  
Leprosy lesion spectrum in ERS  
This study was not able to establish whether the full spectrum of clinical and histological 
lesions described in other hosts are present in ERS as well. For example, TT or PNL (p. 6 
and p. 10) remain undescribed in ERS. From an ERS population health and conservation 
perspective it is unlikely to be highly relevant whether these forms can occur. They are likely 
to be rare and restricted to few individuals, and in other hosts have even less short term 
negative effects than LL (Fischer, 2017), with which ERS can cope for extended periods of 
time, as seen in chapters 5 and 6 of this study. If, out of epidemiological interest, further 
efforts were to be made to identify such cases, this could be achieved by simply firmly 
adding leprosy to the differential diagnosis list for any skin lesion or peripheral neurological 
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impairment observed in ERS and by assessing the presence of leprosy bacilli DNA and/or 
AFB (ZN/FF staining) in all such cases. This could also support continued surveillance 
efforts in the British Isles, if they were to be made. The serological and molecular tests 
introduced in this study are currently not commercially available. ZN stains can however be 
ordered from most laboratories, and could thus provide an initial widely available screening 
tool for the presence of AFB in ERS carcasses, until the other methods also suitable for live 
ERS become widely available. Additionally, ZN staining of fine-needle aspirates from 
suspicious skin lesions could be a method readily accessible to many users (Fontes et al., 
2018), once it has been validated. As mentioned in chapter 4, it would also need to be 
assessed whether FF stains would be more sensitive in ERS than ZN as has been reported 
for other hosts (Scollard, Truman and Ebenezer, 2015). While the histological identification 
of AFB is straightforward and can be achieved after minimal training, full assessment and 
categorisation of the inflammatory reaction caused by the presence of leprosy bacilli is likely 
to remain a task for trained specialists, and mainly be of academic interest in ERS.  
ERS leprosy transmission 
The role colonised or subclinically infected individuals play in the continued transmission of 
leprosy still needs to be established. In humans the total number of asymptomatic patients is 
currently unknown, and their role in leprosy transmission thus very difficult to judge (Smith et 
al., 2015; Neumann et al., 2016). It is however assumed that clinically diseased individuals at 
the lepromatous/MB end of the leprosy spectrum are the main source for new leprosy 
infections excreting the bacteria in aerosolised form with nasal secretions (Lockwood and 
Suneetha, 2005; daSilva et al., 2018). ERS with clinical, MB leprosy were seen on BI in this 
study but not on AR. MB individuals could be a source of infection for susceptible 
conspecifics; however, nasal discharge was not observed in any of the cases and sneezing 
is very rare in ERS. Furthermore, AFB were only detected in the nose of carcasses with 
severe, long standing clinical symptoms (chapter 4, p. 128), thus potentially limiting the time 
for excretion via this route to the late stages of the disease. On AR clinical cases of leprosy 
have not been documented in the ERS population, despite M. leprae and M. lepromatosis 
being present in the population. How then is the infection sustained in this population? Either 
the assumptions made for humans are not transferrable, and non-clinical ERS can transmit 
leprosy bacilli to other ERS, via a route that remains to be determined, or MB, clinically 
diseased ERS are present on AR and actively transmitting despite not having been observed 
in this study. Direct ERS to ERS contacts are mostly limited to drey sharing and interactions 
during mating and maternal care. Social grooming between adults is rare and intraspecies 
fights are generally avoided, as aggressive displays usually are enough to get another ERS 
to retreat (Bosch and Lurz, 2012). Other sources of infection may also exist from which 
members of the ERS population occasionally become infected without themselves 
necessarily contributing much to the further transmission of the disease while they are alive. 
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ERS carcasses could in theory be gnawed on by conspecifics, as particularly pregnant 
females are known to gnaw bones as a source of calcium (Bosch and Lurz, 2012), thus 
exposing other ERS to leprosy bacilli in tissues, even if their numbers remained low. 
However, such events are likely to be rare, in most instances ERS carcasses would be 
consumed by predators or scavengers. Other potential sources of infections are soil and 
standing water sources in the environment the ERS live in, in which leprosy bacilli can 
survive and remain viable for up to 45 days (Lavania et al., 2008; Chinchilla, 2011; Mohanty 
et al., 2016; Turankar et al., 2016). In a pilot study in collaboration with the Geluk group at 
Leiden University Medical Centre screening 10 soil samples from AR and BI each did only 
find M. leprae DNA in one sample from BI and in none of the AR samples (5%) (Tio-Coma et 
al., 2019). Not enough M. leprae DNA was isolated to sequence the strain and confirm that it 
is identical with the one present in ERS. In the same study four out of 25 soil samples (16%) 
collected around the dwellings of human leprosy patients in Bangladesh and three out of 28 
soil samples (10.7%) collected from armadillo burrows in Suriname contained M leprae DNA 
(five species of armadillos are endemic to Suriname, including NBA). Further studies, 
targeting ERS caches and soil under trees with actively used dreys could help clarify 
whether forage, soil and water are realistic sources for leprosy infection in ERS.  
Other potential sources of disease include other unknown vertebrate reservoir hosts sharing 
an environment with ERS, a matter that would need to be addressed by at least screening 
carcasses of other species found in areas to which ERS leprosy is endemic for the presence 
of leprosy bacilli DNA. Free living amoeba, helminths, and insects have also been implied as 
potentially having a role in leprosy transmission and could be relevant for sustaining infection 
in the ERS population as well (Blake et al., 1987; Wheat et al., 2014; Valois, Campos and 
Ignotti, 2015; Franco-Paredes and Rodriguez-Morales, 2016; Neumann et al., 2016). Recent 
proof that M. leprae can be propagated in tick cell lines and that transovarial transmission of 
M. leprae occurs in Ixodes scapularis ticks, make it necessary to investigate the role ticks 
could play as vector in more depth (Ferreira et al., 2018), particularly considering that at 
least during the warmer periods of the year ticks are regularly found on ERS.  
Genetic susceptibility to leprosy in ERS 
Clinically, ERS leprosy lesions can look similar to lesions described in other hosts, however, 
they are not identical in all characteristics, the occurrence of single nodular LL lesions being 
an example. It also needs to be remembered, that all clinical observations made in this study 
came from only one ERS population, the one on BI. They are in line with earlier observations 
made in ERS carcasses in Scotland and thus likely to be representative of at least part of the 
spectrum of lesions leprosy bacilli can cause in this host (Meredith et al., 2014; Avanzi et al., 
2016). However, observations made in this population may not be able to tell the whole 
story. It is possible, that the BI M. leprae strain differs from the strains present on AR or 
Anglesey and that particular characteristics of the M. leprae strain present on BI are 
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contributing to the high proportion of clinical cases. Unfortunately, efforts to sequence M. 
leprae strains isolated from ERS on AR and in Wales failed as not enough DNA could be 
extracted. If the necessary pathogen samples to understand these epidemiological 
differences are not currently available, maybe host samples could offer some clarification. 
Even in the small, inbred BI population leprosy presentations differ between individuals from 
the apparent absence of pathogen to colonisation or clinical cases. Genetically determined 
host specific characteristics could be responsible for the variation within the population and 
for the higher proportion of clinical cases compared to other ERS populations (Simpson et 
al., 2015; Butler et al., 2017; Hardouin et al., 2019). Tissue samples and DNA extracts 
collected throughout this study could be utilised to investigate host genetics. Avanzi et al. 
(2016) had already used a candidate gene approach to assess whether the TLR1 gene, 
associated with leprosy susceptibility in humans and NBA, showed similar polymorphisms in 
ERS. They were not present in the expected sites. However, they did identify some 
mutations in this gene less frequently in leprosy infected than in healthy ERS suggesting that 
certain genetic traits in ERS may control their susceptibility to leprosy (Avanzi et al., 2016). 
Since then the ERS genome has been sequenced, using samples from Britain, as part of the 
Wellcome Sanger Institute 25 Genomes for 25 Years project. This would allow the use of 
samples from BI (cases, colonised and apparently free) to identify mutations associated with 
different leprosy outcomes in ERS in a more open, hypothesis-free, whole genome 
approach, as has been proposed for humans (Cambri and Mira, 2018). Samples from ERS 
from other affected populations across Scotland could then be used to assess whether 
genetic variations identified in the inbred BI population are present in ERS susceptible to 
leprosy elsewhere too. If a clear genetic profile of leprosy susceptible ERS could be 
established, promotion of these traits could be discouraged, and where ERS are selected for 
breeding or translocation programs leprosy resistant ERS could be favoured.  
Coinfections 
An aspect that has not been covered in this study but may alter the impact leprosy is having 
on ERS are coinfections. The impact different co-infections may have in other hosts is not 
very well understood either, but appear mainly linked to alterations in the host immune 
response (Geluk, 2018; Sandre, Poenaru and Boggild, 2018). Currently, no coinfections with 
SQPV or Staphylococcus strains capable of causing exudative dermatitis, adenoviruses, or 
other infectious diseases causing mortality in ERS have been described. In this study they 
were not tested for. It would be important to assess the presence of such additional 
pathogens in ERS with different leprosy status to see if a correlation exists. Were a co-
infection to be identified, that causes particularly high mortality when leprosy bacilli are also 
present, or amplifies the progression of leprosy, special effort would need to be made to 
avoid the introduction of these pathogens into ERS populations in which leprosy is present. 
Whether other conditions that can relate to changes in host immune response such as 
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pregnancy and lactation or starvation during food shortages (Lockwood and Sinha, 1999; 
Nogueira et al., 2015; Osakunor, Sengeh and Mutapi, 2018) have an impact on leprosy 
progression will be difficult to study in ERS under field conditions. Individuals would have to 
be followed very closely and repeatedly trapped, which may create a confounding stressor.  
Conservation implications of ERS leprosy 
Where an interest in identifying ERS leprosy cases exists for the purpose of relocation and 
reintroduction purposes, it is again important to remember that the absence of a leprosy 
diagnosis does not equal the absence of leprosy. There is value in clinically screening ERS 
for leprosy lesions before entering them in translocation programs anywhere throughout their 
range and, in areas where leprosy is known to be endemic (i.e. the British Isles) to also use 
molecular screening to identify colonised ERS. Both may reduce the risk of moving ERS that 
may potentially be transmitting the pathogen. It will however not be possible with current 
methods to ensure that all ERS used in translocation efforts are free of leprosy bacilli. 
However, by at least avoiding translocating already chronically diseased individuals the 
general standards for translocation efforts would be upheld (Woodford, 2000; Mullineaux, 
2018). Where ERS are intended to be released to boost an existing population of unknown 
leprosy status, assessing the status of the existing population as well as that of the animals 
to be released may be useful to at least have some level of clarity on whether leprosy was 
already endemic to the population. If this baseline data is available when at a later point in 
time cases are discovered it may be easier to decide whether a cointroduction of the 
pathogen has occurred. As leprosy appears to be a disease of older ERS (chapter 4, p. 135), 
those with clinical signs of disease are unlikely to be suitable for translocation efforts, not just 
because they are carrying a chronic disease, but also because they may be nearing the end 
of their lifespan. It can however be considered to release such individuals back to exactly 
where they were taken from, if individual welfare is not impaired (mild up to moderate 
lesions, some individuals with severe lesions but good general health and condition). Until 
ERS leprosy transmission is understood, little can be done beyond general good hygiene 
measures, including regular feeder disinfection or removal of feeders in areas where many 
ERS with disease symptoms are seen, to reduce disease burden in areas to which leprosy is 
already endemic. 
Zoonotic implications 
Where ERS are taken into human care, worries by individuals in contact with them, can be 
mitigated by attempting to diagnose leprosy in the ERS, as long as all those involved remain 
aware that no test can guarantee freedom of infection. In any case, good hygiene measures 
throughout any direct handling, and reducing handling to a minimum, something that should 
be standard in animals that will be released back into the wild, should mitigate the risk that 
may exist. The low susceptibility in the human population is likely to further ensure that the 
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risk of transmission even in such settings remains low (HAIRS, 2016). Where leprosy is 
confirmed in an ERS that has had prolonged close contact to a human, medical advice can 
be sought, and antibiotic post-exposure prophylaxis following WHO protocols considered 
(WHO, 2017). Individuals with regular contact to ERS should be aware of early symptoms of 
leprosy, such as anaesthetic hypopigmented skin areas, and the prolonged incubation period 
of the disease. Contact to ERS, and that they can be infected with leprosy bacilli in the 
British Isles, should explicitly be mentioned when the advice of a general practitioner is 
sought. This allows the general practitioner to address this concern with particular care and 
to rule out this possibility swiftly. A pre- and post-exposure vaccine is also under 
development, and may become available in the future (Duthie et al., 2018). It could then 
become a standard vaccination for those in the British Isles working closely with ERS, just as 
rabies prophylaxis is a firm standard for anyone working with potential host species (Public 
Health England, 2018).  
ERS as potential models for leprosy research 
The fact, that at least nuanced differences in the clinical presentation of leprosy between 
ERS and other hosts exist, and that only some ERS are susceptible to the bacilli and even 
fewer will develop clinical disease may already limit the interest of leprosy researchers to use 
this host species as a model for human disease, as may the fact, that the disease, when it 
occurs, progresses slowly (chapter 5). With these characteristics, ERS do not immediately 
offer an advantage over currently established models such as NBA and mice footpads 
(Pena, Sharma and Truman, 2018). Only in the British Isles have ERS currently been found 
to be susceptible to leprosy, and here the species is under special protection (Bosch and 
Lurz, 2012), making it very unlikely that permission would be granted to take individuals into 
captivity for medical research. Additionally, the high sensitivity of ERS to stress and the high 
standards that enclosures need to meet for the species to thrive, make them unsuitable for 
laboratory experiments. While burrow dwelling NBA settle into modified rabbit laboratory 
cages (Pena, Sharma and Truman, 2018), i.e. into a space of roughly 60cm x 45cm x 45cm 
per animal (Orchid Scientific, 2019), tree-dwelling ERS will only thrive in large scale 
enclosures and only reproduce in captivity in optimal conditions (enclosure size ca. 7.5m x 
3.7m x 3.7m for three ERS (Forder, 2006)). Thus, the cost of using captive ERS as leprosy 
models, even if susceptible individuals could be identified in non-protected populations, are 
likely to exceed the costs of existing models by far.  
However, British ERS can play a role in leprosy research without being taken into captivity. 
In human leprosy the discussion has moved from elimination being the target of interventions 
to zero transmission as a new, more realistic target. It is however acknowledged that to 
achieve zero-transmission, transmission first needs to be understood, including all 
contributing factors and involved hosts and vectors (Salgado et al., 2016). Naturally leprosy 
infected ERS could assist in understanding leprosy transmission in a  ‘comparative 
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mycobacteriology’ framework (Mukundan et al., 2015). BI is a particularly valuable 
population in this respect, as the small island ecosystem has fewer variables to consider 
than most other settings in which leprosy naturally occurs, and the small, inbred population 
still includes three groups of ERS, those apparently resistant to leprosy, those colonised and 
those showing clinical signs of disease. ERS contacts on the island could be monitored, for 
example by using proximity collars (Mukundan et al., 2015) and/or microchipping of ERS in 
combination with the provision of microchip reader and motion sensor camera equipped nest 
boxes and feeders. At the same time health status, incidence of leprosy and its progression 
could be monitored in regular (annual) assessments. This would provide valuable  
information to inform disease transmission models roughly comparable to those existing for 
SQPV (Tompkins, White and Boots, 2003; White et al., 2016). Understanding transmission 
dynamics in any host species could provide transferrable information across the host range.  
Integrating ancient ERS samples from museum collections into ERS leprosy research efforts 
could offer new clues for understanding leprosy dynamics through the ages, particularly 
when combined with efforts mentioned above to integrate leprosy into wildlife surveillance 
efforts globally.  
This could become particularly relevant when considering one question: how was it possible 
that leprosy was apparently eliminated from the human population in the British Isles while it 
persisted in ERS? It is possible that non-clinical infections of humans do occur undetected. 
For several mycobacteria complex reservoir systems are suspected and the most important 
source of infection for some of these is still not determined (Haydon et al., 2002; Viana et al., 
2014). The variety of potential sources of infection discussed by leprosy researchers, none 
of which, not even NBA (Schmitt et al., 2010), can consistently be linked to human infection, 
could imply that such a complex reservoir system exists for leprosy. Ideally, future research 
efforts should address whether humans in the British Isles do still carry leprosy bacilli without 
developing clinical disease. Additionally, involving social scientists to compare the 
circumstances in which leprosy can be present in an animal host without human cases 
occurring (British Isles), with those found in areas in which leprosy is hyperendemic, ideally 
covering situations in which infected NBA are present and absent (i.e. Brazil and India) could 
be of interest. It may just underline how socio-economic conditions and hygiene appear to 
play major roles in reducing leprosy transmission (Schmitt et al., 2010; Franco-Paredes and 
Rodriguez-Morales, 2016) – or it may offer new insights that have been overlooked so far, 
when Europe was just deemed to have generally become free of leprosy.  
Concluding remarks 
Leprosy appears to be an endemic disease of ERS in the British Isles. Since its identification 
in 2014 much has been learned, but many open questions still remain. Continued 
investigation of this ancient disease in its newly discovered, endangered wildlife host could 
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offer valuable information, and meet species conservation needs. While leprosy does not 
appear to pose a major conservation threat to ERS, it could hold clues to better understand 
disease resistance in this species. Using ERS populations in natural settings in disease 
research focussing on transmission dynamics could benefit humans, and may be a way to 
further increase the recognition of wildlife and biodiversity conservation as important 
contributors to safeguarding health in a One Health and conservation medicine framework.  
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Appendix I: General health assessment protocol 
 
FIGURE 86:  ORIGINAL HEALTH CHECK PROTOCOL  
 




Appendix II: Post mortem protocol 
 
FIGURE 88:  FRONT PAGE OF THE SQUIRREL POST MORTEM PROTOCOL USED  IN THIS PROJECT 
 





Appendix III: Post mortem findings  
CR= crown-rump length, NAD= No abnormalities detected, NA= Not assessed, no measurements or BCS given when carcass to destroyed to 
determine 
Animal State of carcass General 
information 






Adult, female, late 
lactation, normal 
BCS, 345g, 185 
mm CR, 71 mm 
shin 
Leprosy lesion (score 
39, cat.4), leprosy lesion 
on left hock not quite 
usual appearance, 
some in skin, but also 
swelling of the joint 
capsule 
Mandibular lymph nodes enlarged, lung not fully 
ventilated, right lung very dark, not floating, 
intranasal mass (3mm diameter) in right conchae, 
left adrenal slight mustard colour, maybe enlarged, 
three small white spots, intestines quite red, gas in 
stomach and intestines, some food, uterus well 
retracted despite still lactating, very deep in pelvis, 
left kidney basin maybe slightly widened, liver 
15.1g 
Present 





164 mm CR, 
63.4mm shin 
Leprosy lesion (score 
38, cat.4), Leprosy 
lesions on both ears, the 
nose, both hocks and on 
scrotum and preputium 
Testes actually inguinal, displaced by scrotal and 
preputial mass; buccal abscess left head side 
reaching all the way to the mandibula, skin can be 
pulled off, oral cavity/teeth NAD, mandibular lymph 
node enlarged; lungs and trachea filled with red 
foamy fluid, pericardium filled with red fluid; liver 
very firm, tweezer imprints stay for a long time, 
intestines reddened some sections of small and 
large intestine and rectum leathery with white 
specs on them; white imprint of intestines on 
stomach; white matter in fur next to scrotum, 
swelling of lateral toe right front foot 
Present 




emaciated, 295 g, 
174 mm CR, 66 
mm shin 
Leprosy lesion (score 
23, cat.4); Leprosy 
lesions left ear and right 
hock mild, right ear and 
left hock severe, very 
thick coat and long ear 
tufts for June 
Skull base fractured from airgun shot; stomach 
well filled, intestines only little filling, gastro-
intestinal tract throughout, reddening; liver slightly 
off colour/with a shade of yellow; caudal lungs 
NAD, cranial lungs filled with red liquid; left kidney 




BIC004_16 Frozen not very 
long after death, 









No leprosy lesions Lung filled with red coloured foam and marmorised 
appearance (dark streaks), lung itself pale 
yellowish, floats, small amount of red, clear liquid 
in thorax and pericard; some mediastinal lymph 
nodes of red colour, faecal matter in intestines and 
formed faeces in fur  
Absent 





BCS, 300 g rest-
weight, 180 mm 
CR, 67.9mm shin 
No leprosy lesions Eyes autolytic, maggots under skin, in thorax and 
liver; no right kidney found; stomach and small 
intestine mildly filled with food, caecum, large 
intestine and rectum massively filled with light 
brown crumbly food paste, no obvious obstruction, 
rectal wall reddened 
Present 
BIC006_16 Frozen shortly 
after death 
Adult, female, 
inactive, fat, 430g 
(wet), 175mm CR, 
62.4mm shin 
No leprosy lesions Liver appears rather large (18.8g); lung and 
trachea filled with foamy red liquid; red fluid in 
pericardium and thorax; stomach large, filled 
mainly with fluid; animal has bred before but is 
currently reproductively inactive 
Present 







Leprosy lesion (score 
25, cat.4), cranial rim 
and inside of left ear two 
small lesions, right hook 
looks closed lesion, left 
hook larger, ulcerated 
lesion 
Right front footpad appears swollen; mesenteric 
vessels filled with blood, dark red areas in neck; 
lung pink-red marmorised, floats, but red liquid 
seeping of cut surfaces, liver 10g 
Present 
BIC008_16 Partly eaten by 
bird of prey 
Adult, female, 
inactive, normal 
BCS, 175g (rest 
weight), 66.6mm 
shin 
No leprosy lesions Most of head, upper body, and internal organs 
eaten by bird of prey; only rectum, kidneys, 
bladder and uterus left for assessment, NAD 
Absent 







No leprosy lesions; left 
hind footpad appears 
scaly and there are 
sores between the toes 
Large number of fleas still present on carcass; 
intestines from stomach to rectum appear 
reddened; stomach wall very thick, stomach filled 
with black gravely substance; liver 9.3g; lungs 













Leprosy lesion (score 4, 
cat.1), lesion on right 
hock 
Found with hind legs paralysed; euthanised by 
veterinarian in hospital; lung, hearth and liver 
cannot be assessed due to severe crystallisation 
in these organs following euthanasia; lumbosacral 
region of spine appears overly mobile, but not 
crepitation and no bleeding into surrounding 
muscle; free clear, dark red liquid in thorax and 
abdomen; fluid in bladder mildly reddened 
Present 
BIC011_16 Mummified Adult, 170mm 
CR, 62.8mm shin 
NA NA Absent 
BIC012_17 Mummified Adult, 60.6mm 
shin 
NA NA NA 
BIC013_17 Mummified Adult, 63.5mm 
shin 




Adult, female, in 
oestrus, thin, 
340g, 181mm CR, 
69.6mm shin 
Leprosy lesion (score 
51, cat.4); large 
ulcerated lesions on 
ears and hocks, non-
ulcerated lesion on nose 
Peritoneum and omentum quite red, probably 
freezing artefact; stomach well filled, but intestines 
not; very strong blood supply to uterus; liver 13.3g; 
right caudal lung liver like and only partially 
floating, mild crystal formation in lung following 
euthanasia 
Present 







No leprosy lesions Blood coagula in atria, very thin atrial walls; some 
red liquid around nose; no obvious bruises or 
other signs of blunt trauma expected after a fall; 










Leprosy lesion (score 
15, cat.4), ulcerated 
lesion on left ear, closed 
lesions on both hocks 
Both adrenal glands relatively large (10x4 and 
10x7 mm), left gland pear shaped and pale; 
muscular swelling around right elbow, muscle 
appears pale, joint swelling left carpus and right 
tarsus, capsule thickened, minimal increased 
liquid filling in right tarsus; uterus very intensely 
vascularised; crystal formation following 
euthanasia in liver (16g), heart and lung 
Present 





No leprosy lesions Small amount of red liquid in thorax, caudal lung 






still pink colour; no bruises or broken bones; 
spleen very pale 
BIC018_18 Advanced 









No leprosy lesions Skull and thoracic organs removed post mortem, 
significant manipulation of carcass assumed; right 
caudal body wall ruptured; some intestinal 
invagination; abdominal organs advanced 
autolysis; liver 7.4g. 
Present 









No leprosy lesions, 
small areas of hair loss 
on left muzzle and 
hocks 
Lactated before, currently reproductively inactive; 
some free red liquid in thorax (~3ml) and abdomen 
(2ml); gas build up in stomach and intestines, 
rectum widened; stomach and gut contents very 
dark (almost black) and liquid, some soiling on 
hind legs, probably diarrhoea ante mortem; right 
atrium enlarged, cardiac muscle appears 
contracted in some areas (scars?); some lung 
sections darkened, brown fluid can be pressed of 
cut surface 
Present 







No leprosy lesions Digestive tract empty, only mild gas build up; very 
thin muscle cover, no fat cover internally or 
externally; lungs darkened in several sections; few 
fleas visible 
Absent 









No leprosy lesions More than 15 fleas, some engorged ticks; no 
internal fat cover, oral cavity completely filled with 
freshly hatched maggots, some in nose as well; 
soiling around anus and hind legs, very liquid 
intestinal content, in sections intestines reddened 
and content red liquid, intestinal wall in some 
segments thickened, particularly thick caecum; 
mandibular lymph nodes enlarged; some free red 









No leprosy lesions Multiple fractures including skull and left tibia and 
fibula; body wall of left caudal abdomen ruptured, 
trachea ruptured, lungs collapsed; "fat eyes" 




355g, ca. 180mm 
CR, 67.3mm shin 
stomach and intestines; good fat cover of the body 
and organs 








No leprosy lesions Wound under left elbow: ca. 3mm wound 
penetrating into thorax, lungs collapsed, ~3ml red 
fluid in thorax; mucosa pale, no broken bones, 
intestines barely filled, but stomach well filled with 
nut and blackberry; liver pale, 9.3g 
Absent 
ARC003_17 Frozen after onset 






No leprosy lesions Open fracture right elbow; skull crushed and 
deformed; otherwise NAD 
Absent 
ARC004_17 Frozen after being 
in road for some 
time, run over 
several times, 
roadkill 
Adult, sex and 
BCS NA, 310g, 
71mm shin 
No leprosy lesions Carcass too damaged for full post mortem 
assessment 
Absent 
ARC005_17 Frozen after onset 






No leprosy lesions Multiple fractures to the pelvis; left femur fractured, 
3-5 digit nails and last phalanx scrapped off on 
right hind foot, liver 7.8g, some lung sections very 
dark but still floating, digestive tract quite empty 
Absent 
ARC006_17 Frozen after being 









No leprosy lesions Crushed skull, eyes destroyed; tongue, intestines, 
and left kidney missing; pelvis exposed; liver 11.2g 
Absent 
ARC007_17 Frozen shortly 






No leprosy lesions Crushed skull, brain mass pressed out of skull in 
between skin and cartilage of the left ear; liver 
10.7g NAD; lung may have had some changes 
ante mortem, very difficult to tell from changes 
(darkening, marmorisation) than could have 
occurred post mortem. 
Absent 
ARC008_17 Frozen shortly 






No leprosy lesions Larval and nymph ticks present, but poorly 
engorged; left shin and skull fractured; caudal right 
abdominal wall ruptured, intestines under skin; 
liver 7.8g, ruptured, quite pale; pericardium 




lungs generally in good condition and very pink 
only small sections of caudal lobes darkened 











No leprosy lesions Spine fractured and left abdominal wall ruptured, 
intestines along leg and some outside the body; 
maggots focussed on head/oral cavity; skin and 
superficial muscle layers dried out; large amount 
of dark fluid in thorax; lungs very dark; spleen 
cannot be identified 
Absent 
ARC010_17 Frozen after onset 







No leprosy lesions Pelvis, left femur and skull fractured; heart 
ruptured from impact, large amount of coagulated 
red fluid in thorax; mild changes to the lung, but 
mostly pink, well inflated; trachea ruptured; liver 
6.2g ruptured; stomach and small intestine fairly 
empty, some faecal matter in caecum and large 
intestines 
Absent 
ARC011_17 Frozen shortly 





No leprosy lesions Pelvis, ribcage, skull, right radius and ulna 
fractured; diaphragm ruptured, some intestines in 
thorax, some lung in abdomen; brain destroyed; 
liver 8g, ruptured in several locations; lung and 
trachea ruptured; right eye destroyed, atria 
ruptured, kidneys very dark red (cortex) 
Absent 
ARC012_17 Frozen after onset 





360g, 170mm CR, 
66.9mm shin 
No leprosy lesions NAD Absent 
ARC013_17 Frozen shortly 






No leprosy lesions Skull fractured Absent 
ARC014_17 Frozen shortly 





No leprosy lesions Very young adult, probably from late litter year 
before, winter coat; skull and ribcage fractured; 
right testicle scrotal, left abdominal; intestines 
mostly empty, only small amount of food in 






8.5 g; trachea ruptured large amounts of red fluid 
in thorax, some coagulated 
ARC015_17 Frozen shortly 
after death, roadkill 
Adult, female, 
inactive, thin, 
220g, 162mm CR, 
68.4mm shin 
No leprosy lesions Very young adult; no internal fat cover at all; ticks 
and fleas observed, whole carcass appears 
anaemic; skull fractured, bleeding into skull; very 
pale; empty stomach, large intestine filled, some 
content very yellow; kidney's very beige; liver 5.4g 
pale; lung mostly pink, small section in cranial 
lobes darkened 
Absent 
ARC016_17 Frozen shortly 





No leprosy lesions Skull and ribcage fractured; trachea and aorta 
ripped; heart dislocated into abdominal cavity; little 







430g, 180mm CR, 
70.4mm shin 
No leprosy lesions Despite spine and hip bones being easily 
palpable, the animal had very good intestinal and 
sternal fat stores; pregnant (right horn), 4 foetus 
SSL 2cm, silvery firm elastic tumour to the right of 
the vulva caudal of last mammary 
complex(1.1x0.8x0.5 cm); stomach very full with 
peanut mush, dilated, small amount of food in 
small intestine, large intestine mostly empty, 
caecum dilated, content brown liquid, GIT 
generally quite red in colour, lymph nodes in 
mesenterium clearly visible; liver 14.8g, caudate 
lobe appears large, some discoloration around gall 
bladder; kidneys appear dark in colour, well 
covered in fat; lungs very dark and firm, dark 
sections do not float, right heart dilated, wall thin, 








340g, 171mm CR, 
71.4mm shin 
No leprosy lesions Observed in garden on squirrel feeder with first 
one, then both front feet missing. Trapped and 
taken to Hessilhead wildlife rescue, euthanised as 
not deemed fit to survive in the wild. Lung and 
heart cannot be assessed (crystallisation); both 
stumps dry and clean looking, skin healing slightly 




of through carpal joint, cut surface on bone very 
clean, left paw taken off slightly above carpus 
through radius and ulna, cutting side shows signs 
of calcification; stomach very full (50g) with nut 
material, small intestine fairly empty, caecum and 
large intestine average filling; liver 8g NAD; some 
abdominal fat, generally good condition for end of 
winter despite the disability 
ARC019_18 Frozen shortly 






No leprosy lesions Skull fractured, healed tail fracture; digestive tract 
pale, well filled, chewed up nuts in stomach, 
caecum very well filled with fluid of colour and 
consistency of dark, thick pea soup, other gut 
sections mildly filled; tongue tip (1cm) ripped off 
rest of tongue; liver pale, 10.3g; small amount of 
clear reddish liquid in thorax; white foam in 
trachea; some lung sections pink, some very dark 
red, red fluid can be pressed from dark section, 
dark sections still floating; right atrium appears 
enlarged, but normal wall thickness, intra-atrial 
wall may have had an opening prior to dissection, 
good internal fat cover 
Absent 
ARC020_18 Frozen shortly 
after death, roadkill 
Adult, male, 
scrotal pigment, 
345g, 181mm CR, 
69.4mm shin 
No leprosy lesions Scrotum opened (no blood in area, possibly 
opened by scavenger); opening in left body wall, 
intestines protruding from openings; pelvic 
fracture; digestive tract well filled, not all parts can 
still be identified; spleen missing; liver destroyed, 
partly missing; base of skull fractured; heart 
destroyed, only part lung remains, nice and pink 
Absent 
ARC021_18 Frozen sometime 
after death, 
maggots on 






No leprosy lesions Ruptured trachea filled with dark red foam; 
endoparasites in rectum; right thorax 2 broken ribs 
and spine broken between 2nd and 3rd thoracic 







No leprosy lesions Liver appears enlarged, 19g; some red 
peritracheal fluid, might be due to cutting into 




380g, 179mm CR, 
67mm shin 
sac; left atrium slightly larger than right; lung very 
dark in colour only about 15% of tissue of normal 







335g, 175mm CR, 
72.2mm shin 
No leprosy lesions Some gas and fluid among normal gastrointestinal 
contents; liver 12g; ca. 1/3 of lung darkened, 1/6 
very dark not floating, rest of lung pink-grey and 
puffy; right heart wall extremely thin, enlarged   
Absent 
ARC024_18 Frozen sometime 
after death, skin 





No leprosy lesions, skin 
abrasion on left elbow, 
Fractured pelvis, most ribs broken; body wall 
ruptured; intestines prolapsed through rectum; 
stomach and liver ruptured; liver partly in thorax; 
heart not clearly identifiable; trachea ruptured 
Absent 
ARC025_18 Frozen shortly 
after death, roadkill 
Adult, male, 
scrotal pigment, 
320g, 177mm CR, 
69.4mm shin 
No leprosy lesions Skull, right femur, pelvis and right ribcage 
fractured; testicles in body cavity; diaphragm 
ruptured; tongue bitten off; subcutaneous bleeding 
right thorax; free red fluid in thorax and body 
cavity; lung and heart NAD 
Absent 
ARC026_18 Frozen shortly 
after death, some 





No leprosy lesions Multiple fractures; diaphragm ruptured; right heart 
appears slightly dilated; lung very dark red in 
some areas; free red fluid in body cavities 
Absent 
ARC027_18 Frozen shortly 






No leprosy lesions Liver 6 g; very straight fracture on skull base; 
otherwise NAD 
Absent 
ARC028_18 Frozen shortly 







No leprosy lesions; soft 
elastic swelling (5x5mm) 
in left hind footpad, skin 
intact 
Skull and left wrist shatter fractures; abdominal 
wall ruptured; liver ruptured; diaphragm ruptured  
Absent 
ARC029_18 Frozen shortly 
after death, likely 
run over more than 







No leprosy lesions Tibia and fibula of left hind leg and skull fractured; 






Appendix IV: Histological findings 
In 11 ear sections some inflammation was observed, in eight it was characterised as chronic-
granulomatous, in two just as chronic. In one section autolysis was too severe to 
characterise the inflammation, in another milder signs of autolysis were present. One was 
impaired by freezing artefacts (vacuoles).  Signs of ulceration were detected in two ear 
sections. Increased numbers of lymphocytes were seen in all 11 ear sections, macrophage 
numbers were also increased in all, in eight these were foamy. Epithelioid cells were only 
seen in one section, as were histiocytes. Where AFB were seen in the ear section, they were 
mainly intact, only in one fragmentation was noted. Two lesions were limited to an area close 
to the ear cartilage, five expanded through the dermis, two reached from the cartilage to 
almost the epidermis and one from the dermis to the epidermis. A clear Unna-band was 
seen in four sections. In nine sections perineural and perivascular inflammatory infiltrate was 
observed. In one all normal structure had been destroyed and been replaced by the infiltrate. 
Periadnexal infiltration was present in three sections in five the adnexe could no longer be 
clearly identified, in two no periadnexal infiltration occurred. In two non-clinical ears the 
inflammatory infiltrate was only located close to the cartilage, in two others it was seen in the 
dermis. In two severe cases is reached from the cartilage to the epidermis, in the other three 
it was located in the dermis, in the last severe case it reached from the dermis to the 
epidermis. It is interesting to see that mild/early lesions appear to be located deeper in the 
tissue.  
In eight hock skin sections inflammation was seen, in four instances chronic granulomatous, 
in two granulomatous and in two too minimal to give it a label. In one section some autolysis 
was observed. Interestingly the cells within the leprosy lesion appeared less affected than 
the healthy tissue. One hock skin section showed signs of ulceration. All had increased 
numbers of lymphocytes, three featured foamy macrophages, four others had increased 
numbers of macrophages and only in one no increase in these cells was seen. Epithelioid 
cells were only seen in one section, as were neutrophils, a multinucleated giant cell, and a 
Langhans cell. Where AFB were seen they were mainly intact, in two sections some AFBs 
showed signs of fragmentation. The inflammation was limited to the deep dermis in two 
sections, reaching from here into the dermis in another. It was located in the dermis in four 
sections and touched the epidermis in one. A clear Unna-band was identified in two sections. 
Perineural infiltration was seen in four sections, in three the inflammatory infiltrate had 
largely replaced normal structures. Perivascular infiltration could still be observed in some 
areas of six sections. Periadnexal infiltration was seen in one section, in three the adnexe 
could no longer be identified, in four no periadnexal infiltration occurred. In the non-clinical 
and mild case in which a histological lesion was seen in the hock it was located in the deep 
dermis or dermis, in the severe cases it was still twice located in the deep dermis, thrice in 
the dermis and only once reaching the epithel.  
In five nose sections chronic-granulomatous inflammation could be identified. In one other it 
is likely to have been present, but severe autolysis hindered clear classification. Lymphocyte 
aggregates and foamy macrophages were present in all five analysable sections. A 
multinucleated giant cell was seen in one section. Intact AFB were present in four nose 
sections, while they were fragmented in two. In two nose sections the main infiltrate was 
limited to the area close to the bone/cartilage, in the other three it expanded from here to the 
olfactory epithel (inner nose). Perineural infiltration was noted in three sections, perivascular 
in four, and periadnexal infiltration was noted once. All cases in which inflammation in the 
nasal tissue was seen were classed as severe. It is interesting to note that the inflammation 
was mainly located in the inner nose, not the outer skin.  
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In one mandibular lymph node section a granulomatous inflammation could be identified. 
Two others were suspicious but severe autolysis hampered the analysis. In the best 
conserved section lymphocytes were aggregated together with macrophages. AFB seen in 
lymph node sections showed at least some fragmentation. 
 
Appendix V: Diagnostic information available for AR and BI ERS 
TABLE 29:  TOTAL DIAGNOSTIC INFORMATION AVAILABLE FOR BOTH ERS POPULATIONS  
Island/Cohort 
Clinical assessment Serology PCR 
Total Pos. Neg. Total Pos. Neg. Total Pos. Neg. 
BI 
Autumn 2016 26 7 19 25 9 16 1 1 NA 
Spring 2017 26 9 17 26 10 16 15 7 8 
Autumn 2017 20 4 16 20 5 15 11 5 6 
Spring 2018 25 4 21 25 5 20 9 1 8 
Autumn 2018 29 6 23 29 5 24 29 2 27 
Carcasses* 18 7 11 NA NA NA 18 13 5 
Total 144 37 107 125 34 91 83 29 54 
AR 
Spring 2017 17 0 17 17 1 16 17 0 17 
Autumn 2017 6 0 6 6 0 6 5 0 5 
Spring 2018 14 0 14 14 0 14 9 0 9 
Autumn 2018 25 0 25 25 0 25 25 2 23 
Carcasses* 29 0 29 NA Na NA 29 3 26 
Total 91 0 91 62 1 61 85 5 80 
*On BI three ERS were seen live and included as carcasses as well (all leprosy cases), on 
AR four (one colonised).  
 
 
 
